data_2mew_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mew _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 16.5 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 76.4 mttt -112.89 143.45 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 HG21 HD11 ' A' ' 7' ' ' ILE . 76.5 mt -117.3 137.51 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -118.19 135.96 53.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' O ' HD22 ' A' ' 53' ' ' LEU . 72.2 mt -120.37 130.32 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.455 ' HG2' HD21 ' A' ' 53' ' ' LEU . 38.7 mttt -99.84 131.6 45.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 3.7 mp -110.75 134.94 52.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -126.81 141.85 51.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 75' ' ' GLY . . . -172.13 147.42 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -67.32 -40.99 86.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -94.4 113.97 25.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 44.4 p-80 -58.97 -37.72 77.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 109.388 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.1 mt-10 -52.98 -54.19 38.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.259 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 9.2 mp -55.97 -49.38 73.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' ' HD2' ' A' ' 52' ' ' ARG . 8.5 tt -61.46 -31.51 71.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 65.1 m-20 -66.78 -38.68 87.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.334 -0.854 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.09 -38.82 75.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.8 t -65.43 -45.35 84.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.898 . . . . 0.0 109.44 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.24 -48.19 74.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.54 -43.98 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' NZ ' ' CG2' ' A' ' 70' ' ' ILE . 26.5 tttm -59.72 -49.7 76.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 22' ' ' SER . 97.5 mt -61.05 -41.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.49 -44.89 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.02 -43.96 97.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.8 -41.65 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.506 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.13 -48.26 74.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.443 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.0 m -56.7 -30.98 64.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -75.4 160.45 30.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.13 -35.38 67.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 52.6 p -62.81 157.22 21.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -111.95 148.24 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.548 ' CG1' ' CG2' ' A' ' 54' ' ' ILE . 24.8 t -122.67 139.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 t -113.51 140.85 47.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -149.37 17.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.8 146.37 84.23 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.782 -1.758 . . . . 0.0 111.674 0.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 mt -97.36 119.81 62.22 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.03 144.85 48.31 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.496 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -123.87 173.56 4.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.444 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.5 Cg_endo -70.01 135.93 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.698 2.265 . . . . 0.0 111.766 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 38.0 m . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 45' ' ' THR . 45.7 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 96.3 m-70 -97.92 145.69 26.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.351 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.4 mtmm -141.83 143.81 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HD2' ' CD2' ' A' ' 19' ' ' LEU . 89.3 mtt-85 -130.88 152.98 49.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.217 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 2.7 tm? -124.45 125.77 44.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.942 . . . . 0.0 109.663 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.548 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 64.8 mt -112.12 120.8 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' OD1' HD13 ' A' ' 53' ' ' LEU . 86.9 m-20 -86.83 144.09 27.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 68.3 mt -120.94 132.01 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.335 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -111.09 138.98 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.24 63.19 10.57 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.1 Cg_endo -70.11 143.32 48.82 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.641 2.227 . . . . 0.0 111.717 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -120.98 168.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 109.503 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.27 -24.46 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.642 2.228 . . . . 0.0 111.836 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.47 -21.91 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.5 m -73.11 -40.93 64.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.67 -41.25 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 0.0 109.373 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 21.4 t70 -60.64 -40.15 90.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 tp -63.27 -38.38 90.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.378 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.455 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 68.1 mtm -69.65 -33.89 73.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 29.8 mtp180 -73.19 -27.36 61.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.423 ' CG2' ' NZ ' ' A' ' 25' ' ' LYS . 71.1 mt -107.24 134.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -108.68 126.56 53.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.93 145.19 54.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 150.82 65.31 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.704 2.269 . . . . 0.0 111.777 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.43 148.33 15.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 93.15 5.19 64.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.89 148.56 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -1.202 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 52.3 t0 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -133.92 145.81 49.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.449 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.2 mt -117.11 144.56 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -117.12 135.56 53.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.511 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.462 ' O ' HD22 ' A' ' 53' ' ' LEU . 71.4 mt -120.77 129.57 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HG2' HD21 ' A' ' 53' ' ' LEU . 56.5 mttm -103.53 132.9 49.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.659 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -108.11 137.62 45.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 27.2 mttt -125.84 137.23 53.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -168.57 140.51 2.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.601 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -55.63 -48.78 74.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB2' HD11 ' A' ' 18' ' ' LEU . 95.5 m-20 -97.63 132.58 43.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.739 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 46.8 p-80 -69.65 -29.17 66.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -57.17 -45.96 83.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.359 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 8.2 mp -68.51 -44.77 73.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.52 HD21 ' CD ' ' A' ' 52' ' ' ARG . 8.2 tt -62.31 -45.83 91.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.444 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -57.37 -43.74 83.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.84 -41.53 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.34 -45.22 92.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.31 93.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.853 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -61.88 -44.3 97.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.77 -41.85 96.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.388 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.465 HG23 HD11 ' A' ' 26' ' ' ILE . 81.8 mt -67.16 -39.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.83 -42.56 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.78 -37.67 88.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 33' ' ' THR . 40.2 t -74.2 -40.35 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.16 76.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -60.36 -37.51 80.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -59.32 -30.92 68.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 29' ' ' VAL . 29.0 p -76.95 162.45 27.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.89 -36.23 67.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.4 p -64.71 158.64 24.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -111.96 146.68 37.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.384 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 38' ' ' SER . 4.4 p -119.08 147.14 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 37' ' ' VAL . 19.2 t -125.18 142.35 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.03 -150.78 18.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 146.67 83.48 Favored 'Cis proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.781 -0.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.473 ' CD1' HD12 ' A' ' 53' ' ' LEU . 7.5 mt -94.64 126.52 47.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' HG23 ' A' ' 41' ' ' ILE . 49.4 Cg_endo -70.3 141.15 42.34 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.611 2.207 . . . . 0.0 111.784 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -126.58 174.24 4.36 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.465 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -69.41 139.81 42.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 23.4 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 45' ' ' THR . 59.6 t . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 96.5 m-70 -104.44 145.08 30.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.9 mtmm -137.62 143.03 41.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.52 ' CD ' HD21 ' A' ' 19' ' ' LEU . 32.4 mtp85 -128.63 153.32 47.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.502 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 3.4 tm? -123.94 128.04 48.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.476 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 69.2 mt -111.28 128.32 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD1' HD13 ' A' ' 53' ' ' LEU . 89.1 m-20 -92.82 142.45 27.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.442 HG23 HD13 ' A' ' 56' ' ' ILE . 66.4 mt -120.22 131.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.44 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.86 138.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' SER . 38.8 t70 48.22 60.78 14.97 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.1 Cg_endo -70.26 143.74 49.32 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.698 2.265 . . . . 0.0 111.754 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -126.03 169.71 11.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.3 Cg_endo -68.11 -25.29 37.71 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.719 2.279 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.96 -22.75 66.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.4 m -71.19 -41.75 69.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.99 -41.65 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.385 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' HA ' ' HE1' ' A' ' 68' ' ' MET . 90.4 m-20 -59.01 -40.08 83.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 0.0 109.395 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.73 91.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 70' ' ' ILE . 5.0 tp -61.04 -40.59 94.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.461 ' HE1' ' HA ' ' A' ' 65' ' ' ASP . 70.3 mtm -67.9 -33.19 74.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 93.2 mtt-85 -73.54 -29.48 62.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -107.77 134.13 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.478 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.13 125.64 54.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 151.12 57.44 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.68 151.43 69.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.786 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.76 150.17 16.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.71 64.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.8 t -126.07 148.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -1.194 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.512 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -121.89 145.75 47.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.515 HD11 ' CB ' ' A' ' 59' ' ' PRO . 84.6 mt -116.04 138.47 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 57.0 mtm180 -119.08 137.82 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 56' ' ' ILE . 79.6 mt -113.85 136.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.479 ' NZ ' ' HD3' ' A' ' 51' ' ' LYS . 44.7 tttt -111.45 124.27 51.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -102.75 126.0 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.377 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 59.0 mttt -116.49 131.06 57.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -166.28 142.6 4.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.511 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -62.31 -38.35 89.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 60.7 t0 -91.55 118.82 30.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 55.0 p-80 -65.01 -31.87 73.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.897 . . . . 0.0 109.446 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.8 mt-10 -61.39 -39.23 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 15' ' ' ASP . 75.4 mt -63.63 -38.99 93.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 61.6 mt -64.95 -37.14 86.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.64 -41.86 95.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 97.1 mt-10 -67.24 -37.79 84.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.486 ' CB ' HD21 ' A' ' 11' ' ' LEU . 22.3 m -62.5 -40.02 95.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.517 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . -68.56 -44.33 74.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -61.3 -46.35 90.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 44.4 mttt -63.8 -46.93 82.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 22' ' ' SER . 81.8 mt -70.0 -40.44 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 23' ' ' ALA . 75.1 t -63.71 -44.74 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -63.31 -42.4 99.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 66' ' ' ALA . 42.0 t -73.28 -42.22 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.448 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.573 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.57 -48.47 72.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.18 -40.39 77.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.51 -29.81 64.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 30' ' ' ALA . 28.5 p -76.6 161.61 28.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -57.0 -30.78 64.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.46 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -66.66 155.01 39.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -108.78 150.15 28.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.573 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 47.5 t -125.45 140.87 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -119.1 140.01 50.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.79 -151.65 19.65 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.97 140.24 63.03 Favored 'Cis proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.701 -1.791 . . . . 0.0 111.683 -0.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.498 HD13 HG21 ' A' ' 41' ' ' ILE . 4.1 mt -90.27 122.88 66.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.423 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.74 129.53 17.79 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.738 2.292 . . . . 0.0 112.018 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 2.9 mp -105.59 171.59 4.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 48.2 Cg_endo -69.54 128.3 16.02 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.669 2.246 . . . . 0.0 111.749 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 35.1 m . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 45' ' ' THR . 59.3 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.254 0.549 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 92.8 m-70 -106.9 146.91 30.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HD3' ' NZ ' ' A' ' 10' ' ' LYS . 47.6 mttm -127.59 150.91 49.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 62.6 mtp85 -133.6 144.81 49.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 tp -121.53 133.24 55.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.434 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 65.9 mt -120.7 120.98 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.69 137.04 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 9' ' ' ILE . 49.4 mt -119.54 127.65 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.99 139.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.05 61.51 13.9 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.515 ' CB ' HD11 ' A' ' 7' ' ' ILE . 50.3 Cg_endo -70.23 144.38 51.33 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.723 2.282 . . . . 0.0 111.823 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.4 m -123.86 165.97 21.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.8 Cg_endo -67.95 -26.11 37.95 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.797 2.331 . . . . 0.0 111.741 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -67.17 -22.44 65.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.22 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.4 m -71.42 -41.7 69.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.45 -42.28 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.271 -0.893 . . . . 0.0 109.323 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.519 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 91.1 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.342 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -63.07 -40.92 99.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' ILE . 32.1 tp -61.92 -39.59 92.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.44 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.519 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 72.6 mtm -67.02 -31.93 72.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 77.8 mtp180 -70.46 -30.38 67.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.6 mt -110.14 136.04 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -101.32 129.79 47.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 148.61 37.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.12 149.07 64.1 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.65 2.233 . . . . 0.0 111.783 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 148.43 27.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.9 3.43 65.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.3 t -126.31 148.33 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.5 t0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -111.9 149.5 31.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 59' ' ' PRO . 73.0 mt -110.71 142.35 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.4 mtm180 -118.58 136.76 53.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.17 132.86 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -108.58 132.09 54.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.54 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . 3.4 mp -117.69 129.51 55.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.516 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 83.0 mttt -116.25 137.29 52.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -160.26 145.69 15.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.77 -39.09 90.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.501 ' CB ' HD12 ' A' ' 18' ' ' LEU . 92.3 m-20 -97.33 125.09 41.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.589 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.568 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 19.5 p80 -71.17 -30.06 65.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.09 -39.2 89.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.501 HD12 ' CB ' ' A' ' 15' ' ' ASP . 9.4 mp -72.92 -44.01 61.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.496 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.54 ' CD1' ' CB ' ' A' ' 11' ' ' LEU . 40.8 tp -58.75 -42.81 89.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.2 -46.33 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -40.3 85.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 m -60.64 -44.29 96.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.19 99.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -59.99 -47.14 87.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -56.32 -47.86 77.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 26' ' ' ILE . 75.2 mt -65.64 -41.66 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.862 . . . . 0.0 109.36 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG1' ' CE ' ' A' ' 31' ' ' LYS . 69.1 t -62.67 -46.17 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -59.28 -40.91 87.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.68 -42.2 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.54 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -66.18 -46.59 76.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' CE ' ' CG1' ' A' ' 27' ' ' VAL . 23.2 mttm -57.43 -37.11 72.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 m -57.41 -34.28 68.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.9 m -74.26 154.71 38.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.43 -29.23 9.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -65.28 158.78 25.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -113.71 152.56 30.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.54 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 39.4 t -123.42 140.97 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -115.29 149.13 38.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.64 -147.32 18.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.6 148.45 88.64 Favored 'Cis proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.731 -1.779 . . . . 0.0 111.813 -0.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -98.41 123.21 51.21 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.43 140.53 36.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.699 2.266 . . . . 0.0 111.842 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.539 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -120.29 176.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.1 Cg_endo -69.8 141.85 46.19 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.536 2.157 . . . . 0.0 111.696 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 50' ' ' HIS . 18.3 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.602 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 45' ' ' THR . 46.4 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.568 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 61.8 m80 -105.88 149.79 26.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.18 141.06 45.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.492 ' HG3' ' CD2' ' A' ' 19' ' ' LEU . 35.8 mtt-85 -122.87 150.52 42.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 8' ' ' ARG . 27.3 tp -121.99 126.91 49.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.532 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.13 128.92 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 85.5 m-20 -97.85 146.45 25.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 7' ' ' ILE . 66.4 mt -120.29 133.94 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.44 136.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 47.1 59.53 16.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CB ' HD11 ' A' ' 7' ' ' ILE . 50.4 Cg_endo -70.11 144.24 51.58 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.78 2.32 . . . . 0.0 111.825 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 167.96 12.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.426 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.42 -26.12 41.22 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.722 2.281 . . . . 0.0 111.631 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.78 -25.29 66.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.173 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -70.23 -39.16 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.5 -42.78 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.445 ' HA ' ' HE1' ' A' ' 68' ' ' MET . 89.0 m-20 -56.78 -44.11 81.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.324 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.55 86.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -65.1 -40.36 94.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.445 ' HE1' ' HA ' ' A' ' 65' ' ' ASP . 65.1 mtm -68.38 -29.74 68.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 41.8 mtp85 -75.43 -29.44 59.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 67' ' ' LEU . 74.5 mt -111.26 136.03 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -106.54 155.95 19.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.395 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 1.2 pp -70.35 140.18 87.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.12 154.45 66.32 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.724 2.283 . . . . 0.0 111.74 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 150.63 11.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 88.13 7.28 73.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 ' O ' HD11 ' A' ' 72' ' ' LEU . 48.7 t -131.26 147.9 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -1.154 . . . . 0.0 109.478 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 56.0 t0 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -124.97 146.14 49.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.7 mt -113.48 141.72 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 86.5 mtm-85 -121.57 136.7 54.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.593 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.72 140.05 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 16.2 tttp -108.15 125.11 51.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 47.4 mt -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.374 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' CE ' ' HD3' ' A' ' 10' ' ' LYS . 93.5 mttt -130.63 132.9 45.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.567 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -171.01 151.3 3.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.401 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.5 -32.33 64.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 92.6 m-20 -90.8 108.21 19.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.875 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 46.3 t-80 -58.75 -46.93 86.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.927 . . . . 0.0 109.466 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -59.28 -45.39 91.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 24.6 tp -62.61 -38.46 90.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 15.6 tp -57.73 -38.32 75.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.485 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . 45.6 t0 -65.08 -40.2 94.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.74 -41.17 85.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.4 p -67.78 -34.05 76.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . . . -71.28 -41.85 69.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -60.45 -43.53 96.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 29' ' ' VAL . 64.8 tttt -59.15 -49.17 78.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 109.498 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 22' ' ' SER . 28.2 mm -66.5 -39.51 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 HG12 ' A' ' 37' ' ' VAL . 82.7 t -60.62 -42.2 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 25' ' ' LYS . 22.0 t -72.25 -40.71 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.53 -45.87 81.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -61.21 -38.09 85.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 29' ' ' VAL . 85.8 p -57.34 -28.69 63.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -82.0 161.18 23.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.64 -35.78 66.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.429 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' ' OG ' ' A' ' 60' ' ' SER . 19.6 m -64.53 149.5 48.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.25 150.52 25.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' ' 38' ' ' SER . 7.5 p -118.83 147.09 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.511 ' N ' HG21 ' A' ' 37' ' ' VAL . 39.1 m -119.27 145.06 46.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.1 -155.75 16.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.61 141.27 67.57 Favored 'Cis proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.672 -1.803 . . . . 0.0 111.72 0.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.5 mt -94.36 120.79 64.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.361 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.6 128.16 14.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.728 2.285 . . . . 0.0 111.827 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mp -108.29 171.32 4.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.444 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.51 137.0 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.777 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.557 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.574 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 75.4 m80 -94.9 148.22 22.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.8 mtmt -138.6 146.63 42.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.555 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 87.6 mtt-85 -128.58 154.29 46.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.898 . . . . 0.0 109.371 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -123.78 129.01 50.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.629 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.476 HG22 HD12 ' A' ' 54' ' ' ILE . 64.2 mt -114.38 122.65 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 86.7 m-20 -93.11 141.53 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ILE . 69.2 mt -118.95 129.37 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.349 -0.844 . . . . 0.0 109.252 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 HG22 ' A' ' 57' ' ' ILE . 69.4 mt -110.13 142.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 35' ' ' SER . 12.2 t0 50.26 60.84 14.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.33 140.12 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.666 2.244 . . . . 0.0 111.923 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.469 ' OG ' ' OG ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -127.09 167.81 16.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.18 -26.17 36.49 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.697 2.265 . . . . 0.0 111.64 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -64.55 -21.98 66.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.8 m -73.32 -40.55 64.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.18 -39.69 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 91.2 m-20 -61.99 -42.09 98.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.334 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.7 81.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 67' ' ' LEU . 3.4 tm? -62.72 -40.19 96.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.453 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 64.6 mtm -69.23 -29.48 67.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.387 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 50.3 mtt180 -75.96 -29.67 58.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 59.9 mt -113.72 133.21 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -101.93 142.39 33.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 109.475 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.05 155.0 4.74 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HG3' ' HA ' ' A' ' 22' ' ' SER . 50.6 Cg_endo -69.95 144.37 52.82 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.759 2.306 . . . . 0.0 111.792 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.02 147.0 48.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.08 62.32 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 77' ' ' ASP . 49.7 t -129.69 147.87 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.51 ' N ' HG13 ' A' ' 76' ' ' VAL . 86.2 m-20 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.513 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 23.8 pttm -130.77 151.2 51.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.428 HG13 ' HG3' ' A' ' 59' ' ' PRO . 85.3 mt -118.76 139.76 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.513 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 82.4 mtt180 -118.94 135.09 54.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.04 136.02 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.419 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.457 ' HE2' HD13 ' A' ' 53' ' ' LEU . 77.5 mttt -111.74 130.74 55.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 13.8 mt -112.72 137.02 51.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.632 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -122.26 142.86 50.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -170.64 148.05 2.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.691 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -57.3 -48.39 79.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.615 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -89.52 127.9 35.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.599 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.4 p-80 -75.08 -34.61 61.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.31 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -57.92 -41.42 82.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.865 . . . . 0.0 109.393 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.73 -43.55 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 50.4 mt -54.33 -40.7 68.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -64.23 -36.44 84.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -70.36 -38.91 74.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 26' ' ' ILE . 25.6 t -69.86 -42.07 74.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 40' ' ' PRO . . . -68.26 -38.26 81.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 21.3 tttt -61.29 -47.14 87.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.33 -43.64 98.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 22' ' ' SER . 79.7 mt -67.49 -39.81 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.444 ' CG1' ' HE3' ' A' ' 31' ' ' LYS . 72.7 t -63.08 -43.08 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.7 mt-10 -62.61 -39.27 93.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.92 -37.7 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . . . -68.88 -48.38 63.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 78.6 mttt -58.74 -40.3 83.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -50.27 -28.6 8.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -78.34 165.7 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -57.72 -32.66 67.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 56.5 p -64.93 157.71 27.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -107.03 152.35 24.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 44.6 t -124.94 143.66 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.421 ' N ' HG12 ' A' ' 37' ' ' VAL . 5.8 t -123.94 137.84 54.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.541 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.26 -151.2 16.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.37 56.65 Favored 'Cis proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.677 -1.801 . . . . 0.0 111.794 -0.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.414 HG23 ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -90.98 124.5 61.73 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD2' HG23 ' A' ' 41' ' ' ILE . 50.4 Cg_endo -71.1 140.73 38.3 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.654 2.236 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -116.68 174.77 2.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.416 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.53 135.39 28.5 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.661 2.241 . . . . 0.0 111.81 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.49 ' OG1' ' ND1' ' A' ' 50' ' ' HIS . 31.9 m . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.389 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.565 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.4 m-70 -102.23 153.97 19.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 mtmt -136.3 141.76 43.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.508 ' CD ' ' HB3' ' A' ' 19' ' ' LEU . 61.0 mtp85 -121.7 149.41 43.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.212 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD13 ' HE2' ' A' ' 10' ' ' LYS . 32.6 tp -124.57 128.84 49.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.53 121.26 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.335 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 84.6 m-20 -90.9 146.38 23.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.564 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.92 130.73 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.337 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.47 140.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 30.5 t0 47.84 61.69 13.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.428 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.3 Cg_endo -70.9 141.63 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 111.715 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.16 167.88 14.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.14 -22.2 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.725 2.283 . . . . 0.0 111.573 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -67.46 -25.56 65.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m -70.92 -41.37 71.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.183 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.9 -42.05 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.5 t0 -57.31 -45.94 83.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.246 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.24 76.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.4 tp -66.72 -39.09 87.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 63.8 mtm -70.13 -26.2 63.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.383 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -79.99 -27.85 39.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -112.47 137.12 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.1 139.0 41.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -59.35 144.22 84.16 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.95 151.33 62.21 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.667 2.245 . . . . 0.0 111.818 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.55 26.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.11 5.41 65.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -129.45 147.06 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -1.182 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.7 t0 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -132.75 148.8 52.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.2 mt -114.59 138.99 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 88.6 mtt180 -121.26 136.5 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.893 . . . . 0.0 109.549 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -116.02 135.63 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.385 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' CG ' ' CD1' ' A' ' 53' ' ' LEU . 80.0 mttt -108.64 131.37 54.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -110.47 138.87 46.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 61.2 mttp -122.57 134.2 54.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.501 ' HB1' ' CG ' ' A' ' 19' ' ' LEU . . . -168.73 146.62 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.493 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.37 -37.11 86.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -96.64 123.19 40.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.566 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.8 p-80 -72.78 -30.01 63.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 16' ' ' HIS . 75.3 mm-40 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.28 -37.19 84.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CG ' ' HB1' ' A' ' 13' ' ' ALA . 59.5 mt -70.44 -37.42 74.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -62.18 -42.32 99.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.02 -45.72 73.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.2 t -63.86 -40.46 96.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . . . -65.7 -41.92 91.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.482 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -57.42 -46.06 83.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.461 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -58.46 -44.42 89.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 22' ' ' SER . 24.6 mm -65.68 -43.13 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.55 -46.23 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -62.83 -44.71 95.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.589 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 32' ' ' SER . 40.7 t -66.77 -45.29 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.558 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.33 -43.64 90.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.602 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -56.02 -39.22 71.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 29' ' ' VAL . 86.5 p -60.12 -24.98 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 30' ' ' ALA . 24.3 p -80.42 163.14 24.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.477 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -56.74 -30.18 63.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.8 p -72.37 155.35 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -112.11 145.11 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.558 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 43.9 t -124.42 141.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -117.6 138.64 51.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.71 -158.41 23.77 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.35 56.53 Favored 'Cis proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.685 -1.798 . . . . 0.0 111.781 -0.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.98 131.48 37.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.44 141.19 41.86 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.603 2.202 . . . . 0.0 111.82 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.513 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -125.37 174.76 3.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 109.482 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 51.6 Cg_endo -70.51 146.66 56.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.747 2.298 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.564 HG22 ' CD2' ' A' ' 50' ' ' HIS . 25.3 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 45' ' ' THR . 50.4 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.245 0.545 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 71.1 m80 -101.02 151.1 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 46.9 mtmt -137.76 141.5 40.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -125.9 146.67 49.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.285 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 29.0 tp -122.54 133.66 54.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.686 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 68.7 mt -115.26 126.7 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.314 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -91.22 142.14 28.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ILE . 59.6 mt -123.04 130.47 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.969 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 57' ' ' ILE . 67.7 mt -112.55 141.58 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.709 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 35' ' ' SER . 65.5 t0 45.9 62.3 11.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.601 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.26 141.63 43.69 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.735 2.29 . . . . 0.0 111.663 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -129.4 170.67 10.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.9 Cg_endo -67.44 -28.67 38.66 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.705 2.27 . . . . 0.0 111.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.54 -24.9 68.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.28 -0.887 . . . . 0.0 109.133 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -71.57 -40.77 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.25 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 88.5 m-20 -58.89 -44.12 91.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.17 99.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.4 tp -60.96 -39.5 89.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.407 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.518 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.29 -31.47 72.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.459 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 19.2 mtp180 -71.06 -30.06 66.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 67' ' ' LEU . 70.3 mt -112.58 133.82 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.26 141.32 38.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.44 148.59 79.96 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.3 149.44 63.48 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.742 2.294 . . . . 0.0 111.788 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.21 147.88 28.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.35 70.13 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 19' ' ' LEU . 47.0 t -126.75 148.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.147 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 23.0 t70 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 37.1 mtmt -126.84 147.34 50.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.438 HG13 ' HG3' ' A' ' 59' ' ' PRO . 82.2 mt -113.65 137.34 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -123.11 136.47 54.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.444 ' O ' HD23 ' A' ' 53' ' ' LEU . 69.4 mt -114.58 134.3 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.457 ' HG2' HD22 ' A' ' 53' ' ' LEU . 40.4 mttt -105.35 128.73 53.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.1 mp -112.67 133.8 54.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 88.3 mttt -128.4 138.4 52.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 19' ' ' LEU . . . -169.57 147.61 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.49 -38.13 86.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -97.24 125.09 41.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.7 p-80 -71.13 -28.6 64.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -65.75 -39.7 91.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' A' ' 13' ' ' ALA . 68.2 mt -67.41 -36.62 81.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.59 -43.61 98.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.34 -40.3 85.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.7 t -65.14 -41.54 94.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' HD12 ' A' ' 54' ' ' ILE . . . -68.54 -40.84 80.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -58.99 -48.15 82.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 22' ' ' SER . 84.0 mt -62.67 -46.45 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.89 -48.35 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.66 -48.08 83.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.47 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 27.6 t -69.0 -42.53 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.571 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -64.46 -47.6 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -54.16 -40.76 67.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -58.39 -33.69 69.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.447 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -72.84 153.85 40.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -50.67 -29.51 11.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 p -69.76 157.72 36.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -117.47 138.87 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 44.0 t -117.64 142.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 t -114.86 142.48 46.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.99 -153.15 19.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 49.9 Cg_endo -70.4 140.97 65.7 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.815 -0.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.18 128.06 48.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.414 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.72 138.18 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.74 2.293 . . . . 0.0 111.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -118.3 176.2 1.76 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.317 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.9 Cg_endo -70.21 142.95 47.25 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.562 2.175 . . . . 0.0 111.778 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 12.3 t . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.6 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' OG1' ' A' ' 45' ' ' THR . 61.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 90.7 m-70 -108.85 152.44 24.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.412 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 53.4 mtmt -134.18 145.78 49.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.615 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -131.19 146.66 52.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 109.229 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.3 tm? -121.81 132.33 54.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.533 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.4 mt -117.77 122.2 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.249 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.453 ' OD1' HD12 ' A' ' 53' ' ' LEU . 82.4 m-20 -90.11 145.64 24.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.609 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.408 HG12 HG11 ' A' ' 37' ' ' VAL . 65.5 mt -127.58 128.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.29 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 58' ' ' ASP . 72.2 mt -109.95 142.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER 48.83 62.26 12.51 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.61 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.9 Cg_endo -69.95 146.07 57.93 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.691 2.261 . . . . 0.0 111.775 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.466 ' OG ' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -129.76 165.75 30.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' OG ' ' A' ' 60' ' ' SER . 45.3 Cg_endo -67.49 -24.82 41.99 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.611 2.207 . . . . 0.0 111.649 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -64.66 -26.35 68.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.055 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.1 m -70.01 -38.71 76.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.242 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.29 -43.65 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.454 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 21.4 t70 -57.73 -41.87 82.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.349 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -65.58 -39.41 91.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 16.2 tp -63.7 -42.32 98.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.454 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 69.0 mtm -64.69 -31.83 73.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 31.4 mtp180 -71.07 -29.79 65.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.7 mt -109.48 136.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -107.76 135.18 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.405 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 72' ' ' LEU . 8.1 mp -62.33 145.91 93.61 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.507 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.29 147.04 58.58 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.676 2.251 . . . . 0.0 111.742 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 152.88 39.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.64 3.61 55.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.79 146.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.8 m-20 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.526 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 4.2 pttm -126.06 158.19 36.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.95 141.22 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.526 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 62.1 mtt85 -118.41 135.4 54.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 9' ' ' ILE . 67.9 mt -119.49 134.24 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -107.16 132.64 52.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -111.02 139.65 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -126.78 129.54 48.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.536 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -163.61 151.69 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -71.82 -30.75 65.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.53 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -97.12 115.24 27.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.627 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 45.2 t-80 -61.07 -46.49 90.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -56.38 -41.97 77.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.473 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 1.5 tm? -57.36 -39.61 76.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.292 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.536 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 66.7 mt -61.86 -39.13 90.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.79 -39.42 84.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.02 -38.3 90.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 26' ' ' ILE . 87.0 p -65.55 -33.04 74.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.16 -34.34 63.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -63.8 -43.95 94.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.54 -46.11 84.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 22' ' ' SER . 26.1 mm -69.68 -44.07 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.21 -44.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.48 -45.31 93.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.5 t -71.71 -41.33 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.579 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.96 -46.31 78.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -59.2 -39.14 81.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.7 m -59.23 -31.11 68.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -75.37 163.34 27.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -56.03 -33.48 64.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 61.0 p -67.62 161.05 26.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.912 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -122.91 138.0 54.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.579 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 44.8 t -112.75 140.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.2 m -114.33 146.39 40.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.35 -149.72 16.97 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.98 148.05 86.39 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.767 -1.764 . . . . 0.0 111.8 -0.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 53' ' ' LEU . 4.3 mp -90.07 128.61 49.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.543 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.02 123.92 10.11 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.686 2.258 . . . . 0.0 111.595 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.1 mp -106.8 173.25 3.24 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.4 Cg_endo -69.01 151.14 73.36 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.798 2.332 . . . . 0.0 111.909 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 14.8 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' A' ' 45' ' ' THR . 48.3 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 92.3 m-70 -105.29 150.62 25.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 22.7 mtmm -133.41 146.73 51.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 86.6 mtt-85 -130.62 149.49 52.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 41' ' ' ILE . 27.8 tp -122.38 128.36 50.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.412 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.5 mt -110.23 127.56 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -96.59 138.34 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.446 HG12 HG12 ' A' ' 37' ' ' VAL . 62.2 mt -118.16 131.23 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -111.98 138.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 49.22 57.86 18.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.591 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.6 Cg_endo -70.27 138.3 35.88 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.626 2.218 . . . . 0.0 111.826 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.22 168.1 10.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.3 -21.66 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.707 2.272 . . . . 0.0 111.675 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -68.07 -23.99 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.237 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -70.28 -40.99 73.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.42 -39.54 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.474 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 88.4 m-20 -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.89 84.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' ILE . 26.7 tp -62.92 -37.53 87.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.474 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 73.9 mtm -69.7 -34.55 74.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.358 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.59 -28.1 61.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -107.07 138.74 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.07 138.96 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 147.52 78.15 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.311 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.64 142.58 48.87 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.678 2.252 . . . . 0.0 111.781 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.96 51.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.68 5.19 60.18 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 77' ' ' ASP . 59.6 t -132.16 148.55 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -1.186 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' N ' HG13 ' A' ' 76' ' ' VAL . 89.5 m-20 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 109.478 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 3.6 pttm -136.82 143.0 42.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG13 ' HG3' ' A' ' 59' ' ' PRO . 69.0 mt -115.37 138.35 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 55' ' ' ASP . 93.4 mtt-85 -118.48 132.81 56.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.443 HD13 HD11 ' A' ' 56' ' ' ILE . 72.3 mt -125.1 132.04 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -105.66 136.78 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 3.1 mp -109.5 138.63 45.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 24.1 mttt -127.33 137.6 52.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -165.15 145.77 7.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -57.44 -51.87 67.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.55 127.66 36.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.708 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.559 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 45.8 t-80 -66.49 -37.44 85.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.74 -44.06 81.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.11 -37.79 88.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.515 ' CD2' ' HD3' ' A' ' 52' ' ' ARG . 7.2 tt -65.43 -39.47 92.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -59.99 -42.72 94.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.13 -41.05 91.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.344 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 26' ' ' ILE . 20.3 m -64.57 -44.0 92.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.68 78.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 109.401 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -64.25 -42.59 96.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 tttt -58.1 -49.85 75.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 22' ' ' SER . 26.9 mm -64.83 -40.94 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.506 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 ' CG1' ' HE2' ' A' ' 31' ' ' LYS . 74.7 t -58.43 -45.9 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -61.06 -43.34 99.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 25' ' ' LYS . 21.7 t -71.99 -40.9 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.08 -47.1 84.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HE2' ' CG1' ' A' ' 27' ' ' VAL . 28.9 mttm -59.82 -39.63 85.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -53.99 -31.52 51.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 p -76.38 163.0 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.58 -32.5 67.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.3 p -61.73 159.53 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -113.78 145.06 41.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.518 HG21 ' CB ' ' A' ' 30' ' ' ALA . 31.5 t -123.75 141.59 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 13.2 t -117.83 140.21 50.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.85 -148.42 17.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 144.21 78.04 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.793 -1.753 . . . . 0.0 111.724 0.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.75 119.78 65.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.77 137.15 31.92 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.584 2.189 . . . . 0.0 111.85 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -118.54 174.77 2.46 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.03 133.33 24.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.692 2.262 . . . . 0.0 111.776 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.534 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.559 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 90.8 m-70 -97.94 153.16 18.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 48.9 mtmt -141.33 141.63 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.515 ' HD3' ' CD2' ' A' ' 19' ' ' LEU . 21.6 mtp180 -125.94 158.89 34.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.295 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' A' ' 43' ' ' LEU . 31.1 tp -124.04 127.99 48.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.529 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.435 HD13 HD11 ' A' ' 11' ' ' LEU . 63.7 mt -116.23 120.69 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' CG ' ' NH1' ' A' ' 8' ' ' ARG . 86.5 m-20 -89.2 145.31 25.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 65.8 mt -125.68 126.72 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.0 mt -108.33 141.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 53.12 61.26 11.39 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.54 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.4 Cg_endo -69.95 145.66 56.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.702 2.268 . . . . 0.0 111.737 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.13 166.91 25.71 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.98 -24.03 39.86 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.771 2.314 . . . . 0.0 111.619 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -65.61 -24.6 67.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.217 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.7 m -72.57 -40.75 66.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.312 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.12 -40.84 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.459 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.9 m-20 -62.2 -42.27 99.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.41 89.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.925 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.6 tp -64.44 -39.23 93.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.459 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 58.5 mtm -68.66 -29.94 68.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 61.6 mtt-85 -74.78 -28.76 60.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.589 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -111.32 135.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.75 130.91 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.481 HD21 ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -55.99 152.06 22.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.405 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.34 151.15 71.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.647 2.231 . . . . 0.0 111.795 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.89 149.3 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.44 1.87 66.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG1' HD21 ' A' ' 72' ' ' LEU . 39.5 t -127.29 147.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 45.2 t0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 12.8 pttm -125.72 161.53 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' ILE . 71.4 mt -122.11 137.51 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.603 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HB3' HD21 ' A' ' 53' ' ' LEU . 96.2 mtt180 -113.76 137.2 51.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mm -118.78 125.1 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.644 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 11' ' ' LEU . 24.4 mttt -106.05 132.28 52.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.253 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -117.92 138.87 51.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 84.9 mttt -128.78 132.58 47.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -157.39 141.37 16.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD1' HG21 ' A' ' 49' ' ' VAL . 98.5 m-85 -65.39 -35.51 81.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.41 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.427 ' HB2' HD13 ' A' ' 18' ' ' LEU . 91.7 m-20 -93.7 116.5 29.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.875 . . . . 0.0 109.531 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.574 ' NE2' ' CZ ' ' A' ' 52' ' ' ARG . 46.8 t-80 -62.95 -35.36 79.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.15 -42.81 91.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 15' ' ' ASP . 73.7 mt -67.24 -37.11 83.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 52' ' ' ARG . 12.8 tp -70.79 -37.26 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -62.74 -39.96 95.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.2 mm-40 -69.91 -44.27 70.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 26' ' ' ILE . 97.6 p -60.97 -36.51 79.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . -73.77 -51.06 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 17.1 mttm -65.22 -46.16 81.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 28.8 mtmt -59.85 -47.49 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.663 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 22' ' ' SER . 96.9 mt -68.15 -39.67 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' HE3' ' A' ' 31' ' ' LYS . 66.5 t -62.01 -43.01 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 97.2 mt-10 -64.78 -38.19 90.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -75.17 -38.84 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.634 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.8 -49.25 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.575 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 80.8 mttt -60.14 -37.56 80.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.553 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 m -56.63 -30.19 63.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.1 p -75.66 164.2 26.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -56.66 -35.95 68.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -60.06 159.17 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -109.45 143.03 39.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.517 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 40.7 t -126.38 141.59 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 39.0 m -116.21 149.1 39.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.12 -150.49 18.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 147.92 87.79 Favored 'Cis proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.746 -1.772 . . . . 0.0 111.759 -0.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -101.44 119.97 56.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.94 141.22 39.92 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 111.821 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -118.6 176.17 1.79 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.288 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.6 Cg_endo -69.49 135.55 31.38 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.608 2.206 . . . . 0.0 111.728 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 26.0 m . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 14' ' ' TYR . 45.1 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.282 0.563 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 70.3 m80 -100.75 148.09 25.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 41.6 mtmt -134.88 141.55 46.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' CZ ' ' NE2' ' A' ' 16' ' ' HIS . 86.8 mtt-85 -124.45 151.38 44.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -121.79 125.55 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' N ' ' CD2' ' A' ' 53' ' ' LEU . 64.3 mt -115.39 122.28 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 52.4 t0 -91.2 140.34 29.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' ILE . 63.7 mt -117.59 128.06 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 0.0 109.398 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.91 137.83 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 51.29 63.71 9.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.81 143.09 49.47 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.771 2.314 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -131.07 168.17 18.45 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 44.9 Cg_endo -67.21 -24.42 44.17 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.644 2.23 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -65.83 -27.06 67.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 109.175 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 m -68.94 -41.52 77.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.81 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 109.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 85.6 m-20 -59.16 -42.41 90.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.403 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.33 -38.21 89.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.516 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -63.88 -43.24 96.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 64.6 mtm -65.82 -29.35 69.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.93 . . . . 0.0 109.507 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 12.8 mtt-85 -73.47 -29.77 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' LEU . 71.2 mt -110.85 136.06 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.44 127.9 53.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' A' ' 76' ' ' VAL . 3.3 pp -58.79 143.68 82.29 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.466 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HG2' HG22 ' A' ' 76' ' ' VAL . 49.6 Cg_endo -70.01 150.31 66.49 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.799 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 151.42 18.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 94.75 5.98 60.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 72' ' ' LEU . 46.2 t -121.32 147.75 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.175 . . . . 0.0 109.439 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 56.6 t0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HE3' ' CZ ' ' A' ' 8' ' ' ARG . 58.7 pttt -137.26 142.95 41.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' A' ' 59' ' ' PRO . 83.9 mt -118.79 143.88 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' CZ ' ' HE3' ' A' ' 6' ' ' LYS . 67.8 mtt85 -116.17 136.44 53.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 73.1 mt -121.53 131.17 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 91.0 mttt -97.34 139.04 33.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 16.4 mt -115.01 130.77 57.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.355 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 87.3 mttt -120.53 137.16 54.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -167.94 146.32 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -68.22 -39.45 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -101.75 118.19 36.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 20.6 p80 -55.99 -43.87 78.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 81.2 tt0 -51.46 -53.57 35.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.16 -40.5 70.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.226 -0.921 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.456 HD13 ' HB2' ' A' ' 13' ' ' ALA . 13.4 tp -68.25 -32.61 72.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 86.8 m-20 -63.76 -38.64 91.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.17 -41.59 81.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.8 t -61.68 -38.91 89.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.01 74.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.11 -44.23 97.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 95.2 mttt -63.43 -41.11 98.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.349 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 78.2 mt -68.67 -42.2 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' HA ' HG13 ' A' ' 37' ' ' VAL . 72.0 t -64.73 -48.86 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.75 -43.83 98.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 25' ' ' LYS . 31.8 t -70.55 -41.9 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' ILE . . . -65.07 -47.62 76.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -59.99 -37.29 79.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.32 -30.64 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 p -76.5 160.58 29.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -55.12 -35.17 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.8 p -66.08 157.74 30.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -113.26 139.38 48.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 38' ' ' SER . 7.7 p -113.03 147.33 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 37' ' ' VAL . 8.9 t -120.81 142.09 49.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.03 -149.72 17.33 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.41 144.47 78.13 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 -1.799 . . . . 0.0 111.814 -0.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 53' ' ' LEU . 4.1 mp -89.7 114.18 59.64 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.7 139.26 27.71 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.665 2.244 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -120.82 176.01 2.08 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.64 132.74 24.16 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.572 2.181 . . . . 0.0 111.753 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.576 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.1 m-70 -91.51 153.37 19.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -130.43 132.35 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.446 ' CG ' ' NH1' ' A' ' 52' ' ' ARG . 30.6 mtt-85 -130.03 140.84 50.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.221 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 53' ' ' LEU . 4.3 mp -122.43 138.04 54.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.734 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 71.8 mt -117.74 128.46 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.865 . . . . 0.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 91.5 m-20 -91.37 144.55 25.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.0 mt -120.36 137.11 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.23 136.89 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 45.19 62.17 10.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.448 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.3 Cg_endo -70.01 141.16 43.5 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.77 2.313 . . . . 0.0 111.735 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -127.88 173.0 5.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.33 -27.1 40.87 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.724 2.283 . . . . 0.0 111.804 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -64.79 -24.31 67.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.9 m -71.82 -42.39 67.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.247 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.93 -44.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.14 -48.09 76.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.0 71.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.1 tp -62.44 -34.57 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.64 -30.51 69.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 38.5 mtm105 -74.12 -30.4 62.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 66.9 mt -114.07 131.41 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -106.61 141.65 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.497 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.81 141.25 80.48 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.54 149.94 62.67 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.692 2.261 . . . . 0.0 111.724 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.95 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.39 -3.18 71.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 40.6 t -120.4 148.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -1.216 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 53.9 t0 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.391 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 25.7 pttm -126.55 158.98 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -115.63 137.06 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.443 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -119.66 137.29 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.67 135.6 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 13.7 tttp -107.34 121.01 43.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 37.6 mt -101.65 126.86 48.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 96.4 mttt -121.32 137.37 54.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.521 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -167.26 143.69 4.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.516 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.01 -41.34 99.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.76 114.47 26.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.633 ' CE1' ' CG ' ' A' ' 17' ' ' GLU . 21.1 p80 -61.21 -35.44 77.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.422 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CG ' ' CE1' ' A' ' 16' ' ' HIS . 86.8 mt-10 -65.14 -39.87 93.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.04 -39.48 83.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.521 HD13 ' CB ' ' A' ' 13' ' ' ALA . 14.0 tp -59.69 -38.22 80.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -65.57 -35.28 80.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.93 -39.54 94.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' HG13 ' A' ' 26' ' ' ILE . 17.6 m -68.82 -37.5 79.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -72.71 -37.08 67.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 24.0 tttt -61.34 -45.21 95.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' O ' HG21 ' A' ' 29' ' ' VAL . 80.2 mttt -63.79 -41.34 97.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 22' ' ' SER . 79.5 mt -70.52 -43.29 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.01 -45.36 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.9 mt-10 -61.5 -43.25 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 25' ' ' LYS . 32.2 t -72.94 -37.19 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.535 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -67.18 -49.5 64.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -58.42 -37.23 74.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 m -57.12 -34.67 68.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.8 m -73.37 154.47 40.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -50.99 -35.17 32.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.0 p -60.76 157.24 15.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -112.73 145.42 40.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.535 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 49.9 t -122.42 142.21 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 t -113.91 135.64 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.71 -155.59 21.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.38 138.11 48.94 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.77 0.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.28 115.42 63.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.01 139.41 32.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.619 2.213 . . . . 0.0 111.754 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.527 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mp -118.48 175.53 2.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.3 133.23 24.1 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.642 2.228 . . . . 0.0 111.76 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.511 ' OG1' ' ND1' ' A' ' 50' ' ' HIS . 21.6 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.249 0.547 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 82.6 m-70 -101.27 150.76 22.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -133.44 140.75 47.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.688 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -124.74 149.62 47.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.221 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -122.51 131.68 53.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.745 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.449 HD13 HD11 ' A' ' 11' ' ' LEU . 66.9 mt -119.17 124.39 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.197 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -99.95 140.52 34.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.717 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 66.9 mt -120.89 130.48 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.231 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -111.55 140.2 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t0 51.4 59.91 14.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.59 140.66 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 111.712 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.73 165.1 17.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.31 -19.98 49.34 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.631 2.221 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -71.07 -28.03 64.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -72.08 -39.23 69.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.244 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.11 -41.58 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.309 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 87.3 m-20 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.878 . . . . 0.0 109.346 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.79 75.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.355 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 67' ' ' LEU . 3.5 tm? -66.04 -41.87 90.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.427 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 67.6 mtm -65.53 -28.76 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -77.43 -28.41 52.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.1 mt -110.94 134.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -106.95 131.38 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.9 144.54 3.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.9 148.49 64.31 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.698 2.265 . . . . 0.0 111.827 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.06 152.0 41.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.46 -3.89 56.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 19' ' ' LEU . 48.4 t -124.76 148.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -1.181 . . . . 0.0 109.454 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 26.3 pttm -132.79 161.84 33.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 56' ' ' ILE . 10.5 mm -118.75 141.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 77.1 mtm180 -125.71 127.08 45.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 68.5 mt -114.96 135.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HG2' HD12 ' A' ' 53' ' ' LEU . 54.0 mttm -104.87 127.46 52.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -101.24 134.64 43.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.406 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 67.8 mttm -121.48 135.42 55.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 19' ' ' LEU . . . -169.33 149.3 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.38 -39.96 67.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.34 119.38 32.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.572 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.8 p-80 -64.93 -38.21 90.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.7 mt-10 -59.83 -38.16 81.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.446 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.529 HD22 ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -75.08 -36.62 61.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.36 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 14.4 tp -67.22 -35.86 80.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -62.9 -42.4 99.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.36 -40.96 98.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 m -63.26 -37.82 88.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.31 -44.62 62.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -59.62 -43.72 93.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.89 -45.93 92.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 22' ' ' SER . 89.6 mt -64.55 -40.13 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.47 -44.82 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.503 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.1 -41.12 97.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.81 -43.36 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.462 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.544 ' CB ' ' CG1' ' A' ' 37' ' ' VAL . . . -65.83 -48.7 70.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -57.64 -37.89 74.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.86 -29.2 64.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 p -73.28 163.84 27.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.5 -33.25 67.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 60.7 p -69.37 158.82 34.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -108.29 151.09 26.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' CG1' ' CB ' ' A' ' 30' ' ' ALA . 26.6 m -127.98 145.45 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -118.38 147.86 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.32 -156.29 18.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.36 142.68 72.42 Favored 'Cis proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.781 -0.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.528 HG21 HD11 ' A' ' 41' ' ' ILE . 4.4 mt -95.48 121.56 61.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 133.35 24.93 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.714 2.276 . . . . 0.0 111.899 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.9 mp -110.09 172.64 3.44 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -68.92 141.03 47.49 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.701 2.267 . . . . 0.0 111.713 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 11.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.917 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 45' ' ' THR . 46.6 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.572 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 72.3 m80 -106.92 145.65 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 16.7 mttt -133.23 145.21 50.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 11' ' ' LEU . 89.0 mtt-85 -129.22 145.71 51.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.174 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 26.5 tp -121.62 130.98 53.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.2 mt -116.42 118.21 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 81.5 m-20 -89.47 148.77 23.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.747 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.515 ' CD1' ' HB ' ' A' ' 7' ' ' ILE . 32.5 mt -124.51 130.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.354 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.87 136.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t0 48.51 60.86 14.93 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.349 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 49.4 Cg_endo -69.72 142.2 47.47 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.773 2.316 . . . . 0.0 111.846 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -125.27 173.97 4.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.6 Cg_endo -67.88 -22.96 41.75 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.693 2.262 . . . . 0.0 111.663 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.44 -24.73 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.265 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -73.24 -40.2 64.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.24 -40.25 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.863 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.468 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 87.3 m-20 -63.79 -39.54 94.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.32 88.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 70' ' ' ILE . 20.2 tp -63.78 -38.45 91.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.468 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 60.4 mtm -69.26 -30.41 68.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 52.2 mtt180 -75.77 -29.06 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.518 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.1 mt -111.4 135.91 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.434 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -112.86 134.68 54.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.96 146.76 13.95 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.77 152.37 69.26 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.639 2.226 . . . . 0.0 111.806 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.44 149.12 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.14 -6.03 63.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 ' CG2' HD22 ' A' ' 18' ' ' LEU . 67.1 t -125.61 148.53 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -1.192 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.7 m-20 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 22.3 pttm -130.5 153.56 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.432 HD11 ' CB ' ' A' ' 59' ' ' PRO . 72.6 mt -117.83 142.33 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.362 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.517 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 68.3 mtt180 -121.84 134.96 54.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 81.0 mt -117.06 135.7 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.434 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 28.3 tttp -105.75 130.51 53.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 49.8 mt -107.87 127.94 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.571 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HD3' ' A' ' 10' ' ' LYS . 70.6 mttt -122.39 136.5 54.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -167.08 141.02 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -54.39 -50.78 66.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-20 -83.79 131.78 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.745 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 79.3 t60 -71.08 -35.57 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.339 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.19 -35.49 69.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.424 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 22' ' ' SER . 82.7 mt -64.31 -35.08 79.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CD1' ' CB ' ' A' ' 13' ' ' ALA . 6.6 mp -73.56 -39.28 64.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -64.54 -45.33 87.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.15 -41.64 73.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.0 m -65.09 -39.79 93.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.52 87.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.09 -39.68 94.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 29' ' ' VAL . 49.7 mttt -65.04 -43.02 93.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.918 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 22' ' ' SER . 30.2 mm -65.53 -45.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.89 -45.34 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.86 -48.81 77.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 25' ' ' LYS . 64.6 t -69.26 -47.05 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.483 ' HB1' ' CG1' ' A' ' 37' ' ' VAL . . . -61.84 -49.32 76.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -58.32 -37.87 75.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 t -57.75 -30.36 65.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 30' ' ' ALA . 29.4 p -75.09 163.3 27.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -56.51 -34.19 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.8 p -64.99 156.84 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -107.9 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.483 ' CG1' ' HB1' ' A' ' 30' ' ' ALA . 12.6 m -132.42 145.15 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.873 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 9.0 m -122.65 152.74 40.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.81 -143.84 17.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' HB3' HG12 ' A' ' 54' ' ' ILE . 50.6 Cg_endo -70.98 146.7 85.46 Favored 'Cis proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.759 -1.767 . . . . 0.0 111.746 -0.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.32 114.47 60.49 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.266 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' HD22 ' A' ' 43' ' ' LEU . 52.8 Cg_endo -72.58 140.0 32.11 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.723 2.282 . . . . 0.0 111.948 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' ' HD2' ' A' ' 44' ' ' PRO . 3.9 mm? -118.43 166.87 12.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' ' CD1' ' A' ' 43' ' ' LEU . 49.1 Cg_endo -69.68 128.2 15.75 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.634 2.222 . . . . 0.0 111.756 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' ND1' ' A' ' 50' ' ' HIS . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 45' ' ' THR . 59.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.576 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 70.8 m-70 -97.55 157.9 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 38.6 mtmt -142.07 137.36 30.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.67 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -131.99 150.3 52.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD11 ' HG ' ' A' ' 43' ' ' LEU . 7.7 mp -127.15 145.69 50.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.167 -0.958 . . . . 0.0 109.741 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 40' ' ' PRO . 70.2 mt -123.81 117.94 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 38.7 t0 -78.56 140.67 38.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.14 124.84 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.354 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -107.81 139.48 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.544 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.76 63.62 9.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.432 ' CB ' HD11 ' A' ' 7' ' ' ILE . 50.5 Cg_endo -70.54 144.78 50.87 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.63 2.22 . . . . 0.0 111.675 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -131.4 172.05 8.03 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.597 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.24 -26.55 35.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 111.829 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -62.63 -20.99 65.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.7 m -74.32 -39.17 63.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.88 -40.17 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 88.8 m-20 -62.68 -41.3 99.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.11 95.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.33 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.0 tp -64.0 -36.69 84.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.327 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.444 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 64.4 mtm -70.65 -27.06 63.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -78.67 -28.03 45.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.4 mt -112.93 135.32 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.82 133.73 51.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 145.7 98.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.58 150.64 63.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.685 2.256 . . . . 0.0 111.823 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.65 150.77 35.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.73 3.41 64.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 13' ' ' ALA . 48.5 t -130.66 147.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.174 . . . . 0.0 109.449 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HE3' ' NH1' ' A' ' 8' ' ' ARG . 52.0 pttt -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' ILE . 77.0 mt -119.0 140.18 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.485 ' NH1' ' HE3' ' A' ' 6' ' ' LYS . 62.6 mtt180 -116.92 137.35 52.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG12 HD11 ' A' ' 56' ' ' ILE . 24.1 mm -112.46 133.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.458 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 78.4 mttt -109.22 133.89 52.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD11 ' HB1' ' A' ' 23' ' ' ALA . 16.0 mt -112.83 133.23 54.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 77.6 mttt -122.73 131.45 53.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.86 144.97 12.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 109.429 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.3 -36.39 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.08 116.74 32.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 15.4 p80 -60.3 -46.22 90.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 86.9 tt0 -53.91 -46.55 71.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.219 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.515 HD11 ' CG2' ' A' ' 76' ' ' VAL . 3.4 tm? -61.96 -40.59 96.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.225 -0.922 . . . . 0.0 108.804 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 6.5 tt -67.51 -32.8 73.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD1' ' NH1' ' A' ' 52' ' ' ARG . 91.3 m-20 -63.64 -39.54 94.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.438 -0.789 . . . . 0.0 109.325 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.3 mm-40 -64.58 -49.5 70.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.44 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' HG13 ' A' ' 26' ' ' ILE . 37.2 m -58.89 -45.71 89.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -62.62 -51.42 67.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -57.78 -45.51 85.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 49.5 mttm -59.76 -46.24 89.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 22' ' ' SER . 97.2 mt -64.2 -41.14 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.489 ' CG1' ' HE3' ' A' ' 31' ' ' LYS . 77.7 t -61.13 -46.31 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 -41.26 96.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG22 ' CD1' ' A' ' 70' ' ' ILE . 38.6 t -72.59 -39.97 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.544 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.64 -46.56 78.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 50.0 mttt -59.56 -37.3 78.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -57.42 -30.79 65.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.2 p -76.35 163.82 26.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.52 -34.16 70.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.6 p -62.85 157.66 20.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -111.84 146.57 37.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 42.7 t -123.66 141.02 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 21.3 t -116.79 138.81 51.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.08 -150.06 17.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.31 143.95 76.4 Favored 'Cis proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.844 -0.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 41' ' ' ILE . 21.4 mt -95.7 126.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.84 136.78 33.64 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.634 2.223 . . . . 0.0 111.827 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -120.81 175.62 2.27 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 50.6 Cg_endo -70.84 138.57 34.68 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.695 2.264 . . . . 0.0 111.707 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.476 HG23 ' ND1' ' A' ' 50' ' ' HIS . 21.7 p . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 45' ' ' THR . 55.3 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 62.2 m-70 -102.91 148.97 24.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -135.54 141.3 45.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.519 ' NH1' ' OD1' ' A' ' 20' ' ' ASP . 19.8 mtp180 -123.92 152.05 42.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 27.1 tp -121.64 130.7 53.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.0 mt -118.49 125.82 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.381 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 86.9 m-20 -89.79 142.46 27.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.515 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ILE . 61.8 mt -119.5 131.06 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.439 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -109.7 139.39 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.23 63.92 9.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.1 Cg_endo -69.5 144.67 56.2 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.763 2.309 . . . . 0.0 111.748 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.6 m -132.69 166.5 28.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.47 -25.66 41.3 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.7 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -63.57 -25.65 68.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.4 m -67.36 -43.72 80.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.183 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.53 -43.32 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.515 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 57.1 t0 -54.13 -43.28 70.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.313 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.13 96.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 70' ' ' ILE . 28.5 tp -59.16 -41.07 87.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.515 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 75.3 mtm -64.58 -35.18 80.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -70.57 -27.27 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 67' ' ' LEU . 71.2 mt -107.32 132.92 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -108.17 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.71 141.3 97.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 151.38 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.669 2.246 . . . . 0.0 111.862 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.71 31.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.37 58.45 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.515 ' CG2' HD11 ' A' ' 18' ' ' LEU . 88.4 t -125.62 148.15 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -1.201 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -128.0 145.5 50.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.0 mt -111.97 137.5 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.378 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 57.7 mtm180 -122.96 135.5 54.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.8 mt -116.01 137.74 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -110.25 128.83 55.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -112.6 120.65 42.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.254 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' A' ' 51' ' ' LYS . 28.5 mtpt -116.6 138.75 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -170.41 152.66 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.51 -36.01 73.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' OD2' ' HG ' ' A' ' 18' ' ' LEU . 50.6 t0 -93.13 114.3 26.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 6.5 p80 -67.14 -28.37 68.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.445 ' OE2' ' CE1' ' A' ' 16' ' ' HIS . 66.3 mm-40 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 57.9 mt -64.1 -38.26 90.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' CD2' ' HB2' ' A' ' 13' ' ' ALA . 60.1 mt -70.46 -34.52 72.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.514 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -63.92 -42.88 97.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -42.8 73.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.4 m -64.85 -38.62 91.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.417 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.33 78.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -60.4 -46.85 88.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 17.7 mtmm -60.9 -45.55 94.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 22' ' ' SER . 84.8 mt -65.03 -44.98 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.59 -48.19 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.17 -44.24 97.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 25' ' ' LYS . 18.5 t -68.11 -40.49 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -63.59 -47.43 81.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -56.36 -38.16 71.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -57.91 -32.34 67.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -74.31 152.25 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -50.32 -31.13 13.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 p -68.98 156.64 38.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -107.41 148.03 29.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 38' ' ' SER . 6.0 p -121.49 147.78 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 37' ' ' VAL . 66.8 m -124.08 144.74 49.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.537 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.05 -155.09 16.34 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.41 140.61 63.58 Favored 'Cis proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.702 -1.791 . . . . 0.0 111.792 -0.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 mt -91.03 131.01 38.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.94 118.81 5.89 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.664 2.243 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -94.55 166.66 14.8 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.371 -0.831 . . . . 0.0 109.529 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.3 Cg_endo -67.66 143.66 62.99 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 111.604 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 49' ' ' VAL . 36.6 m . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.958 . . . . 0.0 109.512 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 45' ' ' THR . 50.0 t . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.57 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 97.6 m-70 -98.76 145.23 27.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.0 mtmm -135.98 151.09 49.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -127.41 147.94 50.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -122.02 131.16 53.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.472 ' N ' HD21 ' A' ' 53' ' ' LEU . 66.8 mt -120.53 117.39 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -89.05 145.36 25.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 7' ' ' ILE . 68.7 mt -124.22 122.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.34 144.16 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.6 t0 47.69 62.66 11.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.474 ' CB ' HD11 ' A' ' 7' ' ' ILE . 49.7 Cg_endo -70.41 148.88 61.81 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.73 2.287 . . . . 0.0 111.716 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -137.18 167.86 19.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.39 -25.86 41.64 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 122.685 2.256 . . . . 0.0 111.673 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.23 -26.11 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.131 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 -42.42 77.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.26 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.56 -44.39 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 58.5 t0 -55.91 -41.82 75.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.61 84.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' ILE . 21.2 tp -61.38 -40.21 93.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 71.6 mtm -67.7 -34.48 76.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -71.23 -29.49 65.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 67' ' ' LEU . 69.3 mt -108.94 133.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.442 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -116.54 123.45 47.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.82 150.62 26.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.08 148.65 63.43 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.628 2.219 . . . . 0.0 111.742 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.31 153.09 31.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.954 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.11 8.57 55.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 77' ' ' ASP . 48.1 t -128.62 147.85 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -1.19 . . . . 0.0 109.472 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.506 ' N ' HG13 ' A' ' 76' ' ' VAL . 89.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 64.7 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.292 0.568 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -132.49 143.22 49.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 59' ' ' PRO . 79.9 mt -116.96 138.89 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 91.9 mtm-85 -119.71 136.74 54.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.583 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.11 131.97 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.405 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.508 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 68.3 tttt -97.6 125.5 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.6 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 44.3 mt -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -131.04 134.15 46.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -163.62 144.46 8.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' OD2' HD11 ' A' ' 18' ' ' LEU . 54.1 t0 -95.45 119.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 56.1 p-80 -61.6 -40.27 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 95.0 mt-10 -51.42 -52.26 47.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 8.3 mp -59.24 -43.94 92.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.495 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 12.7 tp -65.58 -29.98 70.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.323 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 90.4 m-20 -67.3 -41.24 85.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 98.8 mt-10 -69.91 -35.45 74.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.447 ' O ' HG12 ' A' ' 26' ' ' ILE . 18.2 m -63.31 -40.22 96.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -70.2 -36.58 74.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 15.6 tttp -66.71 -39.74 88.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 67.1 mttm -65.2 -44.04 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 22' ' ' SER . 26.4 mm -69.49 -39.55 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.2 -43.52 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 98.1 mt-10 -64.75 -38.42 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 66' ' ' ALA . 41.2 t -71.58 -40.82 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.477 ' CB ' ' HB ' ' A' ' 37' ' ' VAL . . . -65.78 -46.81 77.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.53 -38.95 82.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.8 m -59.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -77.93 163.65 25.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.91 -36.07 67.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 55.7 p -66.47 157.95 30.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -111.91 147.76 35.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -116.72 147.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -124.37 144.24 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.15 -154.15 16.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.15 143.18 73.83 Favored 'Cis proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.733 -1.778 . . . . 0.0 111.738 -0.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 42' ' ' PRO . 2.7 mp -93.7 127.2 46.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.42 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 41' ' ' ILE . 50.6 Cg_endo -70.82 137.31 32.1 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.685 2.257 . . . . 0.0 111.849 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -127.57 175.83 3.1 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.0 Cg_endo -68.94 141.18 47.86 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.615 2.21 . . . . 0.0 111.751 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 16.0 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' HB ' ' A' ' 45' ' ' THR . 44.4 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 99.5 m-70 -88.99 148.79 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.408 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 51.6 mtpt -126.02 128.61 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.494 ' NE ' ' OD1' ' A' ' 20' ' ' ASP . 36.4 mtt-85 -126.46 144.31 50.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 53' ' ' LEU . 4.0 mm? -121.16 139.95 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.5 mt -122.44 122.28 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 85.0 m-20 -93.0 144.9 24.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.846 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.0 mt -123.75 129.72 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.237 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.4 mt -107.66 141.97 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.895 . . . . 0.0 109.689 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . 1.0 OUTLIER 46.84 61.43 13.44 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.0 Cg_endo -70.01 142.79 47.73 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.665 2.243 . . . . 0.0 111.699 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -126.76 168.05 15.67 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.558 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.23 -27.67 40.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.686 2.258 . . . . 0.0 111.619 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -62.62 -25.99 68.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.1 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 m -68.19 -43.51 77.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.241 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.42 -41.76 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.335 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 89.8 m-20 -56.53 -44.1 80.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.119 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -66.07 -35.57 80.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.293 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.75 -27.38 69.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.296 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.451 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 75.7 mtm -82.1 -29.06 31.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.187 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -76.9 -22.83 52.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.5 mt -119.19 132.34 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -107.19 138.29 43.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.522 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 148.32 61.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HG2' HG23 ' A' ' 76' ' ' VAL . 48.8 Cg_endo -69.76 145.88 58.53 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.212 . . . . 0.0 111.817 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.45 150.01 32.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.0 58.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 73' ' ' PRO . 47.4 t -124.18 148.77 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -134.5 151.39 51.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 7' ' ' ILE . 72.6 mt -117.21 138.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.452 ' HB3' HD11 ' A' ' 53' ' ' LEU . 69.9 mtm180 -121.54 135.66 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.8 mt -118.03 135.89 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.187 -0.946 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 84.0 mttt -104.36 137.12 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 14.1 mt -106.07 136.26 46.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.376 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.8 mttp -117.68 129.35 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -167.11 143.22 4.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -62.62 -39.46 93.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 18' ' ' LEU . 50.2 t0 -95.07 120.42 35.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.499 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 47.1 t-80 -65.6 -35.43 80.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -56.37 -39.91 73.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.2 mp -63.36 -40.63 97.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.421 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.564 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 50.3 mt -62.6 -39.8 94.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -61.41 -46.19 91.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.83 -50.74 69.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.7 p -57.51 -43.95 84.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 -50.11 72.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -56.67 -40.49 75.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -61.19 -49.34 77.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -67.6 -39.84 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -57.2 -46.69 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.536 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.77 -41.0 94.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 70' ' ' ILE . 35.1 t -72.08 -39.76 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.86 73.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.73 -40.09 86.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -60.56 -26.97 67.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.7 p -81.99 162.58 22.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.463 ' OG ' ' OG ' ' A' ' 60' ' ' SER . 41.9 m -66.87 147.01 53.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.627 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -102.64 147.03 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.32 150.71 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 2.9 t -129.32 142.17 50.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -150.84 17.06 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.21 141.07 68.26 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.675 -1.802 . . . . 0.0 111.727 -0.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.5 131.12 35.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.62 120.31 7.14 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.709 2.273 . . . . 0.0 111.923 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 14.6 mt -93.36 166.99 14.94 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 44.0 Cg_endo -66.76 132.11 27.68 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.749 2.3 . . . . 0.0 111.595 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 49' ' ' VAL . 40.0 m . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 45' ' ' THR . 49.9 t . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 68.7 m80 -105.73 147.02 29.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.6 mtmt -134.97 155.83 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -130.04 151.68 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 36.8 tp -124.33 131.55 53.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 67.7 mt -117.12 123.84 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 37.7 t0 -89.95 137.38 32.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.27 130.39 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.1 mt -111.85 138.4 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.684 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.41 61.32 12.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.41 137.37 33.41 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.649 2.232 . . . . 0.0 111.792 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -129.15 172.73 6.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 44.8 Cg_endo -67.61 -25.28 40.79 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.68 2.253 . . . . 0.0 111.542 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.11 -26.13 67.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -72.34 -39.19 68.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.329 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.61 -42.63 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.5 m-20 -61.43 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.353 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.61 -37.44 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.4 tp -63.47 -39.71 95.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 59.2 mtm -68.31 -32.13 72.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -73.76 -29.07 62.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.506 ' CD1' HG23 ' A' ' 29' ' ' VAL . 73.2 mt -109.39 135.53 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.58 150.94 79.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.89 147.57 62.31 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.662 2.241 . . . . 0.0 111.799 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.35 146.93 32.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.93 69.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 47.1 t -127.82 148.58 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.478 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -109.33 144.43 37.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.502 HD11 ' CB ' ' A' ' 59' ' ' PRO . 69.1 mt -114.7 136.7 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 45.0 mtm180 -122.85 136.8 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.437 ' O ' HD12 ' A' ' 53' ' ' LEU . 83.0 mt -113.26 133.28 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 18.2 tttt -103.13 121.46 42.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 50.3 mt -104.05 126.37 51.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HE2' ' HE2' ' A' ' 10' ' ' LYS . 36.4 mttt -121.72 137.63 54.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 109.415 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.504 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . . . -168.72 146.05 3.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.57 -52.17 49.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.14 130.26 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.569 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.5 p-80 -74.9 -28.88 60.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.878 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.78 -37.89 86.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.36 -36.1 83.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' A' ' 76' ' ' VAL . 70.9 mt -69.94 -36.42 75.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.41 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.67 -41.39 88.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.45 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.03 -43.17 83.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 26' ' ' ILE . 84.2 p -66.26 -35.81 81.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.354 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 27' ' ' VAL . . . -68.61 -38.76 80.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -61.13 -44.54 97.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -61.22 -45.72 93.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 22' ' ' SER . 29.2 mm -65.73 -41.58 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 23' ' ' ALA . 79.2 t -61.8 -44.42 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.97 -47.26 78.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 66' ' ' ALA . 34.1 t -67.44 -43.38 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.555 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -63.23 -47.06 84.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.444 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -55.74 -39.52 71.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.6 m -56.05 -31.66 63.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 p -78.04 162.21 26.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.49 -29.03 63.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.382 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 26.3 t -69.85 148.3 49.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -107.57 150.29 27.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 41.7 t -122.08 140.93 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -117.86 141.75 48.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.84 -149.36 16.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.24 145.85 81.6 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.75 -1.771 . . . . 0.0 111.878 0.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.26 125.17 53.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.85 118.15 5.54 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.077 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 12.5 mt -97.89 168.25 10.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.897 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.5 Cg_endo -68.33 147.99 73.0 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.721 2.281 . . . . 0.0 111.67 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 50' ' ' HIS . 18.8 p . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.537 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 45' ' ' THR . 48.6 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.569 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 69.8 m80 -103.39 149.2 25.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 14.5 mtmt -137.02 144.41 43.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.599 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -124.71 152.08 44.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.4 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -125.97 135.0 51.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 67.1 mt -121.07 124.58 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 87.1 m-20 -90.3 145.15 25.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -126.82 125.55 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 57' ' ' ILE . 65.6 mt -106.97 139.71 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.654 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' SER . 3.6 t70 53.19 62.23 10.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.636 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.502 ' CB ' HD11 ' A' ' 7' ' ' ILE . 49.8 Cg_endo -70.21 141.33 43.14 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.753 2.302 . . . . 0.0 111.67 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.49 166.59 22.14 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.08 -21.74 42.32 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.663 2.242 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -67.67 -25.49 65.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.113 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 m -70.59 -42.46 70.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.82 -42.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 86.2 m-20 -57.59 -45.56 85.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB2' HG12 ' A' ' 29' ' ' VAL . . . -61.33 -37.75 84.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' ILE . 3.8 tp -63.7 -40.45 96.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.98 -29.95 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -74.59 -29.26 61.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.1 mt -110.11 136.62 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.21 134.9 42.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 149.32 85.35 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.77 141.04 44.12 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.685 2.257 . . . . 0.0 111.758 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.86 149.77 49.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.7 9.15 56.68 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.519 HG12 ' CD2' ' A' ' 19' ' ' LEU . 58.0 t -133.79 142.05 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -1.113 . . . . 0.0 109.427 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.442 ' N ' HG13 ' A' ' 76' ' ' VAL . 86.6 m-20 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.5 mtm -59.94 -35.27 74.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.461 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.61 -127.97 34.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.35 9.93 61.27 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 16.5 mt-30 -108.16 148.7 29.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -1.148 . . . . 0.0 109.474 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 76.4 mttt -112.89 143.45 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 HG21 HD11 ' A' ' 7' ' ' ILE . 76.5 mt -117.3 137.51 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -118.19 135.96 53.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' O ' HD22 ' A' ' 53' ' ' LEU . 72.2 mt -120.37 130.32 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.455 ' HD2' ' OE1' ' A' ' 79' ' ' GLU . 38.7 mttt -99.84 131.6 45.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 3.7 mp -110.75 134.94 52.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -126.81 141.85 51.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 75' ' ' GLY . . . -172.13 147.42 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -67.32 -40.99 86.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -94.4 113.97 25.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 44.4 p-80 -58.97 -37.72 77.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 109.388 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.563 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.1 mt-10 -52.98 -54.19 38.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.259 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 9.2 mp -55.97 -49.38 73.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' ' HD2' ' A' ' 52' ' ' ARG . 8.5 tt -61.46 -31.51 71.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 65.1 m-20 -66.78 -38.68 87.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.334 -0.854 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.09 -38.82 75.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.8 t -65.43 -45.35 84.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.898 . . . . 0.0 109.44 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.24 -48.19 74.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.54 -43.98 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' NZ ' ' CG2' ' A' ' 70' ' ' ILE . 26.5 tttm -59.72 -49.7 76.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 22' ' ' SER . 97.5 mt -61.05 -41.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -57.49 -44.89 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.02 -43.96 97.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.8 -41.65 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.506 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.13 -48.26 74.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.443 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.0 m -56.7 -30.98 64.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -75.4 160.45 30.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.13 -35.38 67.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 52.6 p -62.81 157.22 21.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -111.95 148.24 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.548 ' CG1' ' CG2' ' A' ' 54' ' ' ILE . 24.8 t -122.67 139.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 t -113.51 140.85 47.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -149.37 17.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.8 146.37 84.23 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.782 -1.758 . . . . 0.0 111.674 0.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 mt -97.36 119.81 62.22 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.03 144.85 48.31 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.496 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -123.87 173.56 4.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.444 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.5 Cg_endo -70.01 135.93 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.698 2.265 . . . . 0.0 111.766 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 38.0 m -78.85 138.77 38.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.88 144.35 51.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 31.5 t 47.59 39.55 10.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 47' ' ' SER . 68.6 mtt85 62.2 34.84 15.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 45' ' ' THR . 45.7 t -125.85 133.22 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 96.3 m-70 -97.92 145.69 26.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.351 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.4 mtmm -141.83 143.81 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HD2' ' CD2' ' A' ' 19' ' ' LEU . 89.3 mtt-85 -130.88 152.98 49.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.217 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 2.7 tm? -124.45 125.77 44.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.942 . . . . 0.0 109.663 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.548 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 64.8 mt -112.12 120.8 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' OD1' HD13 ' A' ' 53' ' ' LEU . 86.9 m-20 -86.83 144.09 27.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 68.3 mt -120.94 132.01 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.335 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -111.09 138.98 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.24 63.19 10.57 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.1 Cg_endo -70.11 143.32 48.82 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.641 2.227 . . . . 0.0 111.717 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -120.98 168.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 109.503 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.27 -24.46 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.642 2.228 . . . . 0.0 111.836 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.47 -21.91 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.5 m -73.11 -40.93 64.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.67 -41.25 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 0.0 109.373 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 21.4 t70 -60.64 -40.15 90.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 tp -63.27 -38.38 90.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.378 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.455 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 68.1 mtm -69.65 -33.89 73.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 29.8 mtp180 -73.19 -27.36 61.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.423 ' CG2' ' NZ ' ' A' ' 25' ' ' LYS . 71.1 mt -107.24 134.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -108.68 126.56 53.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.93 145.19 54.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 150.82 65.31 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.704 2.269 . . . . 0.0 111.777 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.43 148.33 15.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 93.15 5.19 64.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.89 148.56 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -1.202 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 52.3 t0 -136.59 156.77 48.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 27.3 m -134.97 148.47 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.441 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' OE1' ' HD2' ' A' ' 10' ' ' LYS . 85.0 tt0 -112.25 131.69 55.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.449 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 9.4 tp -128.7 136.74 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 37.0 tttt 67.22 44.05 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 49.2 mt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.5 mtp -58.32 -34.35 70.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.893 . . . . 0.0 109.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.9 -170.26 45.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 -0.19 55.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -109.28 150.64 27.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.199 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -133.92 145.81 49.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.449 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.2 mt -117.11 144.56 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -117.12 135.56 53.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.511 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.462 ' O ' HD22 ' A' ' 53' ' ' LEU . 71.4 mt -120.77 129.57 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HG2' HD21 ' A' ' 53' ' ' LEU . 56.5 mttm -103.53 132.9 49.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.659 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -108.11 137.62 45.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 27.2 mttt -125.84 137.23 53.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -168.57 140.51 2.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.601 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -55.63 -48.78 74.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB2' HD11 ' A' ' 18' ' ' LEU . 95.5 m-20 -97.63 132.58 43.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.739 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 46.8 p-80 -69.65 -29.17 66.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -57.17 -45.96 83.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.359 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 8.2 mp -68.51 -44.77 73.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.52 HD21 ' CD ' ' A' ' 52' ' ' ARG . 8.2 tt -62.31 -45.83 91.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.444 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -57.37 -43.74 83.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.84 -41.53 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.34 -45.22 92.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.31 93.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.853 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -61.88 -44.3 97.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -60.77 -41.85 96.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.388 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.465 HG23 HD11 ' A' ' 26' ' ' ILE . 81.8 mt -67.16 -39.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.83 -42.56 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.78 -37.67 88.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 33' ' ' THR . 40.2 t -74.2 -40.35 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.16 76.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -60.36 -37.51 80.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -59.32 -30.92 68.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 29' ' ' VAL . 29.0 p -76.95 162.45 27.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.89 -36.23 67.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.4 p -64.71 158.64 24.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -111.96 146.68 37.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.384 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 38' ' ' SER . 4.4 p -119.08 147.14 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.484 ' N ' HG23 ' A' ' 37' ' ' VAL . 19.2 t -125.18 142.35 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.03 -150.78 18.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 146.67 83.48 Favored 'Cis proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.781 -0.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.473 ' CD1' HD12 ' A' ' 53' ' ' LEU . 7.5 mt -94.64 126.52 47.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' HG23 ' A' ' 41' ' ' ILE . 49.4 Cg_endo -70.3 141.15 42.34 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.611 2.207 . . . . 0.0 111.784 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -126.58 174.24 4.36 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.465 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -69.41 139.81 42.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 23.4 p -86.87 158.38 19.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 46.5 tp10 -142.28 133.52 26.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 8.9 p 47.41 49.62 15.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 47' ' ' SER . 73.4 mtm180 61.8 28.9 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.459 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 59.6 t -116.01 136.23 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.944 . . . . 0.0 109.429 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 96.5 m-70 -104.44 145.08 30.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.9 mtmm -137.62 143.03 41.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.52 ' CD ' HD21 ' A' ' 19' ' ' LEU . 32.4 mtp85 -128.63 153.32 47.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.502 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 3.4 tm? -123.94 128.04 48.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.476 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 69.2 mt -111.28 128.32 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' OD1' HD13 ' A' ' 53' ' ' LEU . 89.1 m-20 -92.82 142.45 27.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.442 HG23 HD13 ' A' ' 56' ' ' ILE . 66.4 mt -120.22 131.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.44 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.86 138.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' SER . 38.8 t70 48.22 60.78 14.97 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.449 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.1 Cg_endo -70.26 143.74 49.32 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.698 2.265 . . . . 0.0 111.754 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -126.03 169.71 11.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.3 Cg_endo -68.11 -25.29 37.71 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.719 2.279 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.96 -22.75 66.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.4 m -71.19 -41.75 69.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.99 -41.65 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.385 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' HA ' ' HE1' ' A' ' 68' ' ' MET . 90.4 m-20 -59.01 -40.08 83.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 0.0 109.395 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.73 91.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 70' ' ' ILE . 5.0 tp -61.04 -40.59 94.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.461 ' HE1' ' HA ' ' A' ' 65' ' ' ASP . 70.3 mtm -67.9 -33.19 74.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 93.2 mtt-85 -73.54 -29.48 62.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -107.77 134.13 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.478 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.13 125.64 54.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 151.12 57.44 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.68 151.43 69.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.786 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.76 150.17 16.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.71 64.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.8 t -126.07 148.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -1.194 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 50.4 t0 -132.92 153.89 50.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.512 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 27.8 m -135.3 147.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' OE2' ' HG ' ' A' ' 82' ' ' LEU . 86.2 tt0 -101.67 143.7 31.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.486 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.449 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 18.2 tt -121.44 147.51 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 43.2 tttm 66.85 47.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' CD1' ' C ' ' A' ' 82' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.38 136.6 37.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.49 10.66 79.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.93 -32.08 74.13 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -105.85 124.82 50.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 109.471 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -121.89 145.75 47.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.515 HD11 ' CB ' ' A' ' 59' ' ' PRO . 84.6 mt -116.04 138.47 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 57.0 mtm180 -119.08 137.82 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 56' ' ' ILE . 79.6 mt -113.85 136.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.479 ' NZ ' ' HD3' ' A' ' 51' ' ' LYS . 44.7 tttt -111.45 124.27 51.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -102.75 126.0 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.377 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 59.0 mttt -116.49 131.06 57.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -166.28 142.6 4.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.511 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -62.31 -38.35 89.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 60.7 t0 -91.55 118.82 30.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.564 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 55.0 p-80 -65.01 -31.87 73.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.897 . . . . 0.0 109.446 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.8 mt-10 -61.39 -39.23 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 15' ' ' ASP . 75.4 mt -63.63 -38.99 93.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 61.6 mt -64.95 -37.14 86.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.64 -41.86 95.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 97.1 mt-10 -67.24 -37.79 84.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.486 ' CB ' HD21 ' A' ' 11' ' ' LEU . 22.3 m -62.5 -40.02 95.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . -68.56 -44.33 74.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -61.3 -46.35 90.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 44.4 mttt -63.8 -46.93 82.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 22' ' ' SER . 81.8 mt -70.0 -40.44 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 23' ' ' ALA . 75.1 t -63.71 -44.74 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -63.31 -42.4 99.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 66' ' ' ALA . 42.0 t -73.28 -42.22 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.448 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.57 -48.47 72.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.18 -40.39 77.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.51 -29.81 64.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 30' ' ' ALA . 28.5 p -76.6 161.61 28.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -57.0 -30.78 64.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.46 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -66.66 155.01 39.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -108.78 150.15 28.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.573 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 47.5 t -125.45 140.87 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -119.1 140.01 50.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.79 -151.65 19.65 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.97 140.24 63.03 Favored 'Cis proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.701 -1.791 . . . . 0.0 111.683 -0.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.498 HD13 HG21 ' A' ' 41' ' ' ILE . 4.1 mt -90.27 122.88 66.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.423 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.74 129.53 17.79 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.738 2.292 . . . . 0.0 112.018 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 2.9 mp -105.59 171.59 4.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 48.2 Cg_endo -69.54 128.3 16.02 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.669 2.246 . . . . 0.0 111.749 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 46' ' ' GLU . 35.1 m -82.91 153.63 24.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' N ' HG22 ' A' ' 45' ' ' THR . 80.8 tt0 -126.34 122.48 35.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 t 52.4 -89.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' GLU . 75.4 mtm180 -134.78 22.72 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 45' ' ' THR . 59.3 t -115.33 128.24 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 92.8 m-70 -106.9 146.91 30.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HD3' ' NZ ' ' A' ' 10' ' ' LYS . 47.6 mttm -127.59 150.91 49.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 62.6 mtp85 -133.6 144.81 49.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 tp -121.53 133.24 55.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.434 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 65.9 mt -120.7 120.98 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.69 137.04 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.441 HD11 HD13 ' A' ' 9' ' ' ILE . 49.4 mt -119.54 127.65 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.99 139.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.05 61.51 13.9 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.515 ' CB ' HD11 ' A' ' 7' ' ' ILE . 50.3 Cg_endo -70.23 144.38 51.33 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.723 2.282 . . . . 0.0 111.823 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.4 m -123.86 165.97 21.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.8 Cg_endo -67.95 -26.11 37.95 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.797 2.331 . . . . 0.0 111.741 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -67.17 -22.44 65.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.22 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.4 m -71.42 -41.7 69.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.45 -42.28 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.271 -0.893 . . . . 0.0 109.323 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.519 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 91.1 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.342 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -63.07 -40.92 99.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' ILE . 32.1 tp -61.92 -39.59 92.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.44 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.519 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 72.6 mtm -67.02 -31.93 72.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 77.8 mtp180 -70.46 -30.38 67.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.6 mt -110.14 136.04 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -101.32 129.79 47.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 148.61 37.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.12 149.07 64.1 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.65 2.233 . . . . 0.0 111.783 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 148.43 27.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.9 3.43 65.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.3 t -126.31 148.33 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 51.5 t0 -136.14 155.51 50.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.458 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.3 p -139.67 127.23 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -113.33 135.31 53.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.7 mm -66.98 -31.73 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 0.0 109.527 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.456 ' O ' HD23 ' A' ' 82' ' ' LEU . 36.5 mttt -59.28 -34.37 72.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 81' ' ' LYS . 51.3 mt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.501 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.0 ttm -58.28 -32.94 68.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -53.2 -34.0 46.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.94 -120.82 23.7 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -104.16 157.68 16.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -1.119 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -111.9 149.5 31.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 59' ' ' PRO . 73.0 mt -110.71 142.35 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.4 mtm180 -118.58 136.76 53.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.435 HG12 ' OXT' ' A' ' 82' ' ' LEU . 70.6 mt -120.17 132.86 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -108.58 132.09 54.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.54 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . 3.4 mp -117.69 129.51 55.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.516 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 83.0 mttt -116.25 137.29 52.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -160.26 145.69 15.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.77 -39.09 90.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' CB ' HD12 ' A' ' 18' ' ' LEU . 92.3 m-20 -97.33 125.09 41.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.589 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.568 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 19.5 p80 -71.17 -30.06 65.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.09 -39.2 89.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.501 HD12 ' CB ' ' A' ' 15' ' ' ASP . 9.4 mp -72.92 -44.01 61.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.496 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' CD1' ' CB ' ' A' ' 11' ' ' LEU . 40.8 tp -58.75 -42.81 89.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.2 -46.33 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -40.3 85.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 m -60.64 -44.29 96.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.19 99.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -59.99 -47.14 87.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -56.32 -47.86 77.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 26' ' ' ILE . 75.2 mt -65.64 -41.66 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.862 . . . . 0.0 109.36 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG1' ' CE ' ' A' ' 31' ' ' LYS . 69.1 t -62.67 -46.17 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -59.28 -40.91 87.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.68 -42.2 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.54 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -66.18 -46.59 76.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' CE ' ' CG1' ' A' ' 27' ' ' VAL . 23.2 mttm -57.43 -37.11 72.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 m -57.41 -34.28 68.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.9 m -74.26 154.71 38.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.43 -29.23 9.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -65.28 158.78 25.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -113.71 152.56 30.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.54 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 39.4 t -123.42 140.97 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -115.29 149.13 38.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.64 -147.32 18.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.6 148.45 88.64 Favored 'Cis proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.731 -1.779 . . . . 0.0 111.813 -0.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -98.41 123.21 51.21 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.43 140.53 36.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.699 2.266 . . . . 0.0 111.842 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.539 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -120.29 176.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.1 Cg_endo -69.8 141.85 46.19 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.536 2.157 . . . . 0.0 111.696 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 50' ' ' HIS . 18.3 p -103.81 163.12 12.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.602 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 48' ' ' ARG . 71.5 tt0 -129.27 126.67 39.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.31 -0.869 . . . . 0.0 109.407 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.6 t 56.87 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 46' ' ' GLU . 56.8 mtt180 -143.4 27.71 1.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 45' ' ' THR . 46.4 t -115.41 127.22 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.568 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 61.8 m80 -105.88 149.79 26.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -135.18 141.06 45.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.492 ' HG3' ' CD2' ' A' ' 19' ' ' LEU . 35.8 mtt-85 -122.87 150.52 42.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 8' ' ' ARG . 27.3 tp -121.99 126.91 49.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.532 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.13 128.92 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 85.5 m-20 -97.85 146.45 25.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 7' ' ' ILE . 66.4 mt -120.29 133.94 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.44 136.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 47.1 59.53 16.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.512 ' CB ' HD11 ' A' ' 7' ' ' ILE . 50.4 Cg_endo -70.11 144.24 51.58 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.78 2.32 . . . . 0.0 111.825 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.89 167.96 12.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.426 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.42 -26.12 41.22 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.722 2.281 . . . . 0.0 111.631 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.78 -25.29 66.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.173 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -70.23 -39.16 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.5 -42.78 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' HA ' ' HE1' ' A' ' 68' ' ' MET . 89.0 m-20 -56.78 -44.11 81.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.324 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.55 86.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -65.1 -40.36 94.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.445 ' HE1' ' HA ' ' A' ' 65' ' ' ASP . 65.1 mtm -68.38 -29.74 68.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 41.8 mtp85 -75.43 -29.44 59.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 67' ' ' LEU . 74.5 mt -111.26 136.03 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -106.54 155.95 19.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.395 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 1.2 pp -70.35 140.18 87.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.12 154.45 66.32 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.724 2.283 . . . . 0.0 111.74 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 150.63 11.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 88.13 7.28 73.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' O ' HD11 ' A' ' 72' ' ' LEU . 48.7 t -131.26 147.9 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -1.154 . . . . 0.0 109.478 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 56.0 t0 -130.09 158.3 40.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.385 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 57.0 t -133.86 148.58 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 71.5 mm-40 -93.62 153.85 18.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -61.39 -23.25 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.441 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 82' ' ' LEU . 78.9 mttt -54.43 -35.0 62.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.514 ' OXT' ' CD2' ' A' ' 82' ' ' LEU . 6.4 tt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.6 mtt -59.06 -35.6 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.503 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 82.0 20.24 63.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.9 57.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -73.17 146.46 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -1.135 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -124.97 146.14 49.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.7 mt -113.48 141.72 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 86.5 mtm-85 -121.57 136.7 54.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.593 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 68.9 mt -114.72 140.05 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 16.2 tttp -108.15 125.11 51.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 47.4 mt -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.374 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' CE ' ' HD3' ' A' ' 10' ' ' LYS . 93.5 mttt -130.63 132.9 45.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.567 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -171.01 151.3 3.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.401 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.5 -32.33 64.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 92.6 m-20 -90.8 108.21 19.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.875 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 46.3 t-80 -58.75 -46.93 86.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.927 . . . . 0.0 109.466 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -59.28 -45.39 91.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 24.6 tp -62.61 -38.46 90.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 15.6 tp -57.73 -38.32 75.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.485 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . 45.6 t0 -65.08 -40.2 94.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.74 -41.17 85.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.4 p -67.78 -34.05 76.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . . . -71.28 -41.85 69.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -60.45 -43.53 96.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 29' ' ' VAL . 64.8 tttt -59.15 -49.17 78.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 109.498 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 22' ' ' SER . 28.2 mm -66.5 -39.51 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 HG11 HG12 ' A' ' 37' ' ' VAL . 82.7 t -60.62 -42.2 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 25' ' ' LYS . 22.0 t -72.25 -40.71 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.53 -45.87 81.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -61.21 -38.09 85.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 29' ' ' VAL . 85.8 p -57.34 -28.69 63.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -82.0 161.18 23.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.64 -35.78 66.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.429 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.469 ' OG ' ' OG ' ' A' ' 60' ' ' SER . 19.6 m -64.53 149.5 48.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.25 150.52 25.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' ' 38' ' ' SER . 7.5 p -118.83 147.09 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.511 ' N ' HG21 ' A' ' 37' ' ' VAL . 39.1 m -119.27 145.06 46.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.1 -155.75 16.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.61 141.27 67.57 Favored 'Cis proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.672 -1.803 . . . . 0.0 111.72 0.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.5 mt -94.36 120.79 64.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.361 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.6 128.16 14.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.728 2.285 . . . . 0.0 111.827 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mp -108.29 171.32 4.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.444 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.51 137.0 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.777 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 32.6 m -75.03 143.45 43.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -140.1 144.55 36.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.9 m 49.15 41.28 19.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 59.13 30.24 19.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.4 t -127.14 135.11 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.574 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 75.4 m80 -94.9 148.22 22.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.8 mtmt -138.6 146.63 42.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.555 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 87.6 mtt-85 -128.58 154.29 46.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.898 . . . . 0.0 109.371 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -123.78 129.01 50.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.629 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.476 HG22 HD12 ' A' ' 54' ' ' ILE . 64.2 mt -114.38 122.65 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 86.7 m-20 -93.11 141.53 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ILE . 69.2 mt -118.95 129.37 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.349 -0.844 . . . . 0.0 109.252 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 HG22 ' A' ' 57' ' ' ILE . 69.4 mt -110.13 142.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 35' ' ' SER . 12.2 t0 50.26 60.84 14.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.33 140.12 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.666 2.244 . . . . 0.0 111.923 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.469 ' OG ' ' OG ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -127.09 167.81 16.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.18 -26.17 36.49 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.697 2.265 . . . . 0.0 111.64 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -64.55 -21.98 66.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.8 m -73.32 -40.55 64.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.18 -39.69 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 91.2 m-20 -61.99 -42.09 98.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.334 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.7 81.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 67' ' ' LEU . 3.4 tm? -62.72 -40.19 96.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.453 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 64.6 mtm -69.23 -29.48 67.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.387 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 50.3 mtt180 -75.96 -29.67 58.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 59.9 mt -113.72 133.21 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -101.93 142.39 33.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 109.475 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.05 155.0 4.74 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HG3' ' HA ' ' A' ' 22' ' ' SER . 50.6 Cg_endo -69.95 144.37 52.82 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.759 2.306 . . . . 0.0 111.792 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.02 147.0 48.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.08 62.32 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 77' ' ' ASP . 49.7 t -129.69 147.87 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.51 ' N ' HG13 ' A' ' 76' ' ' VAL . 86.2 m-20 -116.97 149.76 39.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.41 134.21 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -104.76 136.79 43.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.3 mt -118.56 131.58 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.454 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 19.2 tptp -57.97 -37.42 74.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 109.414 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 81' ' ' LYS . 23.8 tp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.464 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.36 -35.1 71.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.466 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.99 -110.54 2.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.98 11.9 58.32 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -111.96 143.86 42.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 23.8 pttm -130.77 151.2 51.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.428 HG13 ' HG3' ' A' ' 59' ' ' PRO . 85.3 mt -118.76 139.76 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.513 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 82.4 mtt180 -118.94 135.09 54.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.04 136.02 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.419 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.457 ' HE2' HD13 ' A' ' 53' ' ' LEU . 77.5 mttt -111.74 130.74 55.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 13.8 mt -112.72 137.02 51.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.632 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -122.26 142.86 50.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -170.64 148.05 2.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.691 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -57.3 -48.39 79.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.615 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -89.52 127.9 35.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.599 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.4 p-80 -75.08 -34.61 61.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.31 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -57.92 -41.42 82.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.865 . . . . 0.0 109.393 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.73 -43.55 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 50.4 mt -54.33 -40.7 68.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -64.23 -36.44 84.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -70.36 -38.91 74.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 26' ' ' ILE . 25.6 t -69.86 -42.07 74.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 40' ' ' PRO . . . -68.26 -38.26 81.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 21.3 tttt -61.29 -47.14 87.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.33 -43.64 98.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 22' ' ' SER . 79.7 mt -67.49 -39.81 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.444 ' CG1' ' HE3' ' A' ' 31' ' ' LYS . 72.7 t -63.08 -43.08 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.7 mt-10 -62.61 -39.27 93.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.92 -37.7 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . . . -68.88 -48.38 63.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 78.6 mttt -58.74 -40.3 83.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -50.27 -28.6 8.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.1 p -78.34 165.7 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -57.72 -32.66 67.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 56.5 p -64.93 157.71 27.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -107.03 152.35 24.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 30' ' ' ALA . 44.6 t -124.94 143.66 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.421 ' N ' HG12 ' A' ' 37' ' ' VAL . 5.8 t -123.94 137.84 54.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.541 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.26 -151.2 16.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HB3' ' HB3' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.37 56.65 Favored 'Cis proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.677 -1.801 . . . . 0.0 111.794 -0.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG23 ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -90.98 124.5 61.73 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD2' HG23 ' A' ' 41' ' ' ILE . 50.4 Cg_endo -71.1 140.73 38.3 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.654 2.236 . . . . 0.0 111.664 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -116.68 174.77 2.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.416 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.53 135.39 28.5 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.661 2.241 . . . . 0.0 111.81 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.49 ' OG1' ' ND1' ' A' ' 50' ' ' HIS . 31.9 m -83.22 145.76 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 48' ' ' ARG . 80.7 tt0 -116.83 119.94 36.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.4 m 56.19 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLU . 95.6 mtt-85 -139.1 18.27 2.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.96 128.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.565 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.4 m-70 -102.23 153.97 19.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 mtmt -136.3 141.76 43.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' CD ' ' HB3' ' A' ' 19' ' ' LEU . 61.0 mtp85 -121.7 149.41 43.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.212 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD13 ' HE2' ' A' ' 10' ' ' LYS . 32.6 tp -124.57 128.84 49.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -116.53 121.26 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.335 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 84.6 m-20 -90.9 146.38 23.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.564 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.92 130.73 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.337 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.47 140.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 30.5 t0 47.84 61.69 13.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.428 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.3 Cg_endo -70.9 141.63 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 111.715 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.16 167.88 14.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.14 -22.2 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.725 2.283 . . . . 0.0 111.573 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -67.46 -25.56 65.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m -70.92 -41.37 71.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.183 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.9 -42.05 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.5 t0 -57.31 -45.94 83.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.246 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.24 76.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.4 tp -66.72 -39.09 87.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 63.8 mtm -70.13 -26.2 63.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.383 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -79.99 -27.85 39.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -112.47 137.12 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.1 139.0 41.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 pp -59.35 144.22 84.16 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.95 151.33 62.21 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.667 2.245 . . . . 0.0 111.818 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.55 26.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.11 5.41 65.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -129.45 147.06 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -1.182 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 54.7 t0 -130.37 158.08 40.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.6 p -124.62 133.93 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -98.23 139.89 33.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.411 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.1 mt -116.05 135.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.509 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -54.51 -38.13 66.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.5 tp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.497 179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.8 mtp -58.91 -35.52 73.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.63 -178.32 49.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.29 -9.66 63.12 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -116.8 154.72 30.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.214 -1.168 . . . . 0.0 109.483 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -132.75 148.8 52.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.2 mt -114.59 138.99 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 88.6 mtt180 -121.26 136.5 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.893 . . . . 0.0 109.549 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' CG2' HG11 ' A' ' 78' ' ' VAL . 67.3 mt -116.02 135.63 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' CG ' ' CD1' ' A' ' 53' ' ' LEU . 80.0 mttt -108.64 131.37 54.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -110.47 138.87 46.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 61.2 mttp -122.57 134.2 54.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.501 ' HB1' ' CG ' ' A' ' 19' ' ' LEU . . . -168.73 146.62 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.493 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.37 -37.11 86.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -96.64 123.19 40.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.566 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.8 p-80 -72.78 -30.01 63.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 16' ' ' HIS . 75.3 mm-40 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.28 -37.19 84.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.501 ' CG ' ' HB1' ' A' ' 13' ' ' ALA . 59.5 mt -70.44 -37.42 74.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -62.18 -42.32 99.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.02 -45.72 73.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.2 t -63.86 -40.46 96.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . . . -65.7 -41.92 91.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.482 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -57.42 -46.06 83.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.461 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -58.46 -44.42 89.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 22' ' ' SER . 24.6 mm -65.68 -43.13 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.55 -46.23 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -62.83 -44.71 95.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.589 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 32' ' ' SER . 40.7 t -66.77 -45.29 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.558 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.33 -43.64 90.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.602 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -56.02 -39.22 71.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 29' ' ' VAL . 86.5 p -60.12 -24.98 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 30' ' ' ALA . 24.3 p -80.42 163.14 24.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.477 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -56.74 -30.18 63.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.8 p -72.37 155.35 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -112.11 145.11 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.558 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 43.9 t -124.42 141.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -117.6 138.64 51.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.71 -158.41 23.77 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.35 56.53 Favored 'Cis proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.685 -1.798 . . . . 0.0 111.781 -0.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.98 131.48 37.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.44 141.19 41.86 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.603 2.202 . . . . 0.0 111.82 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.513 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -125.37 174.76 3.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 109.482 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 51.6 Cg_endo -70.51 146.66 56.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.747 2.298 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.564 HG22 ' CD2' ' A' ' 50' ' ' HIS . 25.3 p -103.28 158.09 16.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.484 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' SER . 72.6 mm-40 -151.67 149.77 29.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER 43.68 43.2 4.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' SER . 2.7 mtp85 61.53 39.81 14.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 45' ' ' THR . 50.4 t -128.66 132.22 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 71.1 m80 -101.02 151.1 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 46.9 mtmt -137.76 141.5 40.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -125.9 146.67 49.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.285 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 29.0 tp -122.54 133.66 54.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.686 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 68.7 mt -115.26 126.7 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.314 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -91.22 142.14 28.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ILE . 59.6 mt -123.04 130.47 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.969 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 57' ' ' ILE . 67.7 mt -112.55 141.58 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.709 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 35' ' ' SER . 65.5 t0 45.9 62.3 11.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.601 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.26 141.63 43.69 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.735 2.29 . . . . 0.0 111.663 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -129.4 170.67 10.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.9 Cg_endo -67.44 -28.67 38.66 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.705 2.27 . . . . 0.0 111.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.54 -24.9 68.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.28 -0.887 . . . . 0.0 109.133 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -71.57 -40.77 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.25 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 88.5 m-20 -58.89 -44.12 91.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.17 99.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.377 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.4 tp -60.96 -39.5 89.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.407 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.518 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.29 -31.47 72.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.459 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 19.2 mtp180 -71.06 -30.06 66.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 67' ' ' LEU . 70.3 mt -112.58 133.82 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.26 141.32 38.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.44 148.59 79.96 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.3 149.44 63.48 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.742 2.294 . . . . 0.0 111.788 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.21 147.88 28.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.35 70.13 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 19' ' ' LEU . 47.0 t -126.75 148.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.147 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 23.0 t70 -128.69 153.59 47.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 HG11 ' CG2' ' A' ' 9' ' ' ILE . 47.0 t -126.0 134.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' OE1' ' HD2' ' A' ' 10' ' ' LYS . 85.4 tt0 -101.86 139.76 37.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.9 mt -118.55 133.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 109.618 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 82' ' ' LEU . 15.9 tttt -53.79 -40.11 66.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' OXT' ' O ' ' A' ' 81' ' ' LYS . 17.1 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.5 mtt -126.29 163.61 22.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.1 58.68 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.53 -29.22 63.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.43 143.95 42.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 37.1 mtmt -126.84 147.34 50.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.438 HG13 ' HG3' ' A' ' 59' ' ' PRO . 82.2 mt -113.65 137.34 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -123.11 136.47 54.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.444 ' O ' HD23 ' A' ' 53' ' ' LEU . 69.4 mt -114.58 134.3 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.457 ' HG2' HD22 ' A' ' 53' ' ' LEU . 40.4 mttt -105.35 128.73 53.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.1 mp -112.67 133.8 54.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 88.3 mttt -128.4 138.4 52.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 19' ' ' LEU . . . -169.57 147.61 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.49 -38.13 86.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -97.24 125.09 41.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.7 p-80 -71.13 -28.6 64.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -65.75 -39.7 91.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' A' ' 13' ' ' ALA . 68.2 mt -67.41 -36.62 81.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.59 -43.61 98.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.34 -40.3 85.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.7 t -65.14 -41.54 94.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' HD12 ' A' ' 54' ' ' ILE . . . -68.54 -40.84 80.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -58.99 -48.15 82.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 22' ' ' SER . 84.0 mt -62.67 -46.45 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.89 -48.35 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.66 -48.08 83.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.47 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 66' ' ' ALA . 27.6 t -69.0 -42.53 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.571 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -64.46 -47.6 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -54.16 -40.76 67.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -58.39 -33.69 69.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.447 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -72.84 153.85 40.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -50.67 -29.51 11.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 p -69.76 157.72 36.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -117.47 138.87 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 44.0 t -117.64 142.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 t -114.86 142.48 46.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.99 -153.15 19.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 49.9 Cg_endo -70.4 140.97 65.7 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.815 -0.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.18 128.06 48.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.414 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.72 138.18 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.74 2.293 . . . . 0.0 111.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -118.3 176.2 1.76 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.317 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.9 Cg_endo -70.21 142.95 47.25 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.562 2.175 . . . . 0.0 111.778 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 12.3 t -110.71 166.85 10.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.6 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 48' ' ' ARG . 79.6 tt0 -143.15 127.73 18.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.338 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 t 53.75 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' GLU . 86.9 mtm-85 -138.45 23.8 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' ' OG1' ' A' ' 45' ' ' THR . 61.5 t -112.36 121.12 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 90.7 m-70 -108.85 152.44 24.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.412 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 53.4 mtmt -134.18 145.78 49.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.615 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -131.19 146.66 52.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 109.229 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.3 tm? -121.81 132.33 54.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.533 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.4 mt -117.77 122.2 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.249 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.453 ' OD1' HD12 ' A' ' 53' ' ' LEU . 82.4 m-20 -90.11 145.64 24.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.609 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.408 HG12 HG11 ' A' ' 37' ' ' VAL . 65.5 mt -127.58 128.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.29 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 58' ' ' ASP . 72.2 mt -109.95 142.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER 48.83 62.26 12.51 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.61 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.438 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.9 Cg_endo -69.95 146.07 57.93 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.691 2.261 . . . . 0.0 111.775 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.466 ' OG ' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -129.76 165.75 30.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' OG ' ' A' ' 60' ' ' SER . 45.3 Cg_endo -67.49 -24.82 41.99 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.611 2.207 . . . . 0.0 111.649 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -64.66 -26.35 68.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.055 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.1 m -70.01 -38.71 76.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.242 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.29 -43.65 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.454 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 21.4 t70 -57.73 -41.87 82.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.349 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -65.58 -39.41 91.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 16.2 tp -63.7 -42.32 98.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.454 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 69.0 mtm -64.69 -31.83 73.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 31.4 mtp180 -71.07 -29.79 65.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.7 mt -109.48 136.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -107.76 135.18 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.405 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 72' ' ' LEU . 8.1 mp -62.33 145.91 93.61 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.507 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.29 147.04 58.58 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.676 2.251 . . . . 0.0 111.742 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 152.88 39.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.64 3.61 55.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.79 146.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.8 m-20 -113.73 147.37 38.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.527 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.08 133.25 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -114.63 143.99 44.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.9 mt -118.67 133.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -57.36 -34.39 68.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.887 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.7 mt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.492 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.4 mtt -121.65 151.28 40.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 87.14 14.28 64.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.47 -22.78 66.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -117.04 146.06 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.526 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 4.2 pttm -126.06 158.19 36.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.4 mt -116.95 141.22 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 62.1 mtt85 -118.41 135.4 54.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 9' ' ' ILE . 67.9 mt -119.49 134.24 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -107.16 132.64 52.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.449 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -111.02 139.65 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -126.78 129.54 48.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.536 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -163.61 151.69 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -71.82 -30.75 65.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.53 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -97.12 115.24 27.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.627 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 45.2 t-80 -61.07 -46.49 90.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -56.38 -41.97 77.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.473 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 1.5 tm? -57.36 -39.61 76.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.292 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.536 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 66.7 mt -61.86 -39.13 90.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.79 -39.42 84.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.02 -38.3 90.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 26' ' ' ILE . 87.0 p -65.55 -33.04 74.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.16 -34.34 63.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -63.8 -43.95 94.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.54 -46.11 84.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 22' ' ' SER . 26.1 mm -69.68 -44.07 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.21 -44.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.48 -45.31 93.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.5 t -71.71 -41.33 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.579 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.96 -46.31 78.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -59.2 -39.14 81.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.7 m -59.23 -31.11 68.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -75.37 163.34 27.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -56.03 -33.48 64.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 61.0 p -67.62 161.05 26.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.912 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -122.91 138.0 54.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.579 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 44.8 t -112.75 140.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.2 m -114.33 146.39 40.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.35 -149.72 16.97 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.98 148.05 86.39 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.767 -1.764 . . . . 0.0 111.8 -0.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 53' ' ' LEU . 4.3 mp -90.07 128.61 49.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.543 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.02 123.92 10.11 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.686 2.258 . . . . 0.0 111.595 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.1 mp -106.8 173.25 3.24 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.4 Cg_endo -69.01 151.14 73.36 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.798 2.332 . . . . 0.0 111.909 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 14.8 t -120.06 163.62 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ARG . 95.1 mt-10 -141.39 139.77 33.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m 48.2 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' GLU . 90.1 mtt180 -138.22 26.17 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' A' ' 45' ' ' THR . 48.3 t -115.05 121.31 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 92.3 m-70 -105.29 150.62 25.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 22.7 mtmm -133.41 146.73 51.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 86.6 mtt-85 -130.62 149.49 52.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 41' ' ' ILE . 27.8 tp -122.38 128.36 50.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.412 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.5 mt -110.23 127.56 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -96.59 138.34 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.446 HG12 HG12 ' A' ' 37' ' ' VAL . 62.2 mt -118.16 131.23 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -111.98 138.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 4.9 t70 49.22 57.86 18.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.6 Cg_endo -70.27 138.3 35.88 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.626 2.218 . . . . 0.0 111.826 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.22 168.1 10.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.45 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.3 -21.66 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.707 2.272 . . . . 0.0 111.675 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -68.07 -23.99 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.237 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -70.28 -40.99 73.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.42 -39.54 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.474 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 88.4 m-20 -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.89 84.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' ILE . 26.7 tp -62.92 -37.53 87.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.474 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 73.9 mtm -69.7 -34.55 74.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.358 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.59 -28.1 61.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -107.07 138.74 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.07 138.96 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 147.52 78.15 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.311 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.64 142.58 48.87 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.678 2.252 . . . . 0.0 111.781 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.96 51.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.68 5.19 60.18 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 77' ' ' ASP . 59.6 t -132.16 148.55 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -1.186 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' N ' HG13 ' A' ' 76' ' ' VAL . 89.5 m-20 -133.8 147.48 51.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 109.478 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.31 142.25 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -115.4 137.31 52.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.05 -36.83 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' LEU . 26.2 mttt -93.55 147.84 22.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' LYS . 49.9 mt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.405 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.8 mtp -57.4 -34.85 69.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.99 -175.17 50.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.87 6.35 62.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -103.6 150.59 23.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -1.206 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 3.6 pttm -136.82 143.0 42.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG13 ' HG3' ' A' ' 59' ' ' PRO . 69.0 mt -115.37 138.35 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 55' ' ' ASP . 93.4 mtt-85 -118.48 132.81 56.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.443 HD13 HD11 ' A' ' 56' ' ' ILE . 72.3 mt -125.1 132.04 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -105.66 136.78 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 3.1 mp -109.5 138.63 45.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HE3' ' OE2' ' A' ' 79' ' ' GLU . 24.1 mttt -127.33 137.6 52.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -165.15 145.77 7.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -57.44 -51.87 67.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.55 127.66 36.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.708 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.559 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 45.8 t-80 -66.49 -37.44 85.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.74 -44.06 81.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.11 -37.79 88.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.515 ' CD2' ' HD3' ' A' ' 52' ' ' ARG . 7.2 tt -65.43 -39.47 92.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -59.99 -42.72 94.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.13 -41.05 91.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.344 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 26' ' ' ILE . 20.3 m -64.57 -44.0 92.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.68 78.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 109.401 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -64.25 -42.59 96.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 tttt -58.1 -49.85 75.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 22' ' ' SER . 26.9 mm -64.83 -40.94 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.506 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 ' CG1' ' HE2' ' A' ' 31' ' ' LYS . 74.7 t -58.43 -45.9 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -61.06 -43.34 99.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 25' ' ' LYS . 21.7 t -71.99 -40.9 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.08 -47.1 84.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HE2' ' CG1' ' A' ' 27' ' ' VAL . 28.9 mttm -59.82 -39.63 85.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -53.99 -31.52 51.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 p -76.38 163.0 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.58 -32.5 67.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.3 p -61.73 159.53 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -113.78 145.06 41.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.518 HG21 ' CB ' ' A' ' 30' ' ' ALA . 31.5 t -123.75 141.59 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 13.2 t -117.83 140.21 50.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.85 -148.42 17.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 144.21 78.04 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.793 -1.753 . . . . 0.0 111.724 0.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.75 119.78 65.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.77 137.15 31.92 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.584 2.189 . . . . 0.0 111.85 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -118.54 174.77 2.46 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.03 133.33 24.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.692 2.262 . . . . 0.0 111.776 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.5 t -77.77 152.37 33.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ARG . 81.1 tt0 -117.44 125.15 50.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.5 m 54.06 -88.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.518 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' GLU . 56.8 mtt180 -140.55 22.2 2.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.03 131.57 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.559 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 90.8 m-70 -97.94 153.16 18.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 48.9 mtmt -141.33 141.63 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.515 ' HD3' ' CD2' ' A' ' 19' ' ' LEU . 21.6 mtp180 -125.94 158.89 34.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.295 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' A' ' 43' ' ' LEU . 31.1 tp -124.04 127.99 48.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.529 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.435 HD13 HD11 ' A' ' 11' ' ' LEU . 63.7 mt -116.23 120.69 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' CG ' ' NH1' ' A' ' 8' ' ' ARG . 86.5 m-20 -89.2 145.31 25.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 65.8 mt -125.68 126.72 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.0 mt -108.33 141.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 53.12 61.26 11.39 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.54 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.4 Cg_endo -69.95 145.66 56.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.702 2.268 . . . . 0.0 111.737 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.13 166.91 25.71 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.98 -24.03 39.86 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.771 2.314 . . . . 0.0 111.619 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -65.61 -24.6 67.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.217 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.7 m -72.57 -40.75 66.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.312 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.12 -40.84 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.9 m-20 -62.2 -42.27 99.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.41 89.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.925 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.6 tp -64.44 -39.23 93.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.459 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 58.5 mtm -68.66 -29.94 68.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 61.6 mtt-85 -74.78 -28.76 60.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.589 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -111.32 135.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.75 130.91 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -55.99 152.06 22.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.405 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.34 151.15 71.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.647 2.231 . . . . 0.0 111.795 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.89 149.3 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.44 1.87 66.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG1' HD21 ' A' ' 72' ' ' LEU . 39.5 t -127.29 147.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' C ' HG22 ' A' ' 78' ' ' VAL . 45.2 t0 -124.56 155.1 39.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' CG2' HD22 ' A' ' 72' ' ' LEU . 48.4 t -135.41 148.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' OE2' ' HE3' ' A' ' 12' ' ' LYS . 94.1 mt-10 -112.78 156.74 22.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 80' ' ' ILE . 75.6 mt -111.0 140.87 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.45 -37.51 65.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.51 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' MET . 21.7 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' SER . 87.0 mtp 46.15 92.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . -59.53 124.26 35.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.82 -35.97 77.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -118.9 157.65 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -1.162 . . . . 0.0 109.428 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 12.8 pttm -125.72 161.53 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 56' ' ' ILE . 71.4 mt -122.11 137.51 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.603 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.423 ' HB2' ' CD1' ' A' ' 82' ' ' LEU . 96.2 mtt180 -113.76 137.2 51.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.6 mm -118.78 125.1 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.644 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 11' ' ' LEU . 24.4 mttt -106.05 132.28 52.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.253 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -117.92 138.87 51.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 84.9 mttt -128.78 132.58 47.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -157.39 141.37 16.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.566 ' CD1' HG21 ' A' ' 49' ' ' VAL . 98.5 m-85 -65.39 -35.51 81.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.41 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.427 ' HB2' HD13 ' A' ' 18' ' ' LEU . 91.7 m-20 -93.7 116.5 29.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.875 . . . . 0.0 109.531 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.574 ' NE2' ' CZ ' ' A' ' 52' ' ' ARG . 46.8 t-80 -62.95 -35.36 79.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.15 -42.81 91.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' A' ' 15' ' ' ASP . 73.7 mt -67.24 -37.11 83.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 HD21 ' N ' ' A' ' 52' ' ' ARG . 12.8 tp -70.79 -37.26 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -62.74 -39.96 95.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.2 mm-40 -69.91 -44.27 70.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 26' ' ' ILE . 97.6 p -60.97 -36.51 79.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' O ' ' CG2' ' A' ' 27' ' ' VAL . . . -73.77 -51.06 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 17.1 mttm -65.22 -46.16 81.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 28.8 mtmt -59.85 -47.49 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.663 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 22' ' ' SER . 96.9 mt -68.15 -39.67 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' HE3' ' A' ' 31' ' ' LYS . 66.5 t -62.01 -43.01 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 97.2 mt-10 -64.78 -38.19 90.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -75.17 -38.84 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.634 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.8 -49.25 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.575 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 80.8 mttt -60.14 -37.56 80.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.553 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 m -56.63 -30.19 63.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.1 p -75.66 164.2 26.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -56.66 -35.95 68.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -60.06 159.17 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -109.45 143.03 39.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.517 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 40.7 t -126.38 141.59 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 39.0 m -116.21 149.1 39.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.12 -150.49 18.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 147.92 87.79 Favored 'Cis proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.746 -1.772 . . . . 0.0 111.759 -0.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -101.44 119.97 56.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.94 141.22 39.92 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 111.821 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -118.6 176.17 1.79 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.288 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.6 Cg_endo -69.49 135.55 31.38 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.608 2.206 . . . . 0.0 111.728 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 49' ' ' VAL . 26.0 m -83.43 143.65 30.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ARG . 82.3 tt0 -112.97 128.45 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 m 52.81 -89.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.545 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' GLU . 55.2 ttp85 -141.88 26.35 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 14' ' ' TYR . 45.1 t -119.38 131.26 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.513 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 70.3 m80 -100.75 148.09 25.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 41.6 mtmt -134.88 141.55 46.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' CZ ' ' NE2' ' A' ' 16' ' ' HIS . 86.8 mtt-85 -124.45 151.38 44.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CD2' ' C ' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -121.79 125.55 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' N ' ' CD2' ' A' ' 53' ' ' LEU . 64.3 mt -115.39 122.28 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 52.4 t0 -91.2 140.34 29.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 7' ' ' ILE . 63.7 mt -117.59 128.06 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 0.0 109.398 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.91 137.83 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.0 t70 51.29 63.71 9.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.81 143.09 49.47 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.771 2.314 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -131.07 168.17 18.45 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 44.9 Cg_endo -67.21 -24.42 44.17 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.644 2.23 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -65.83 -27.06 67.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 109.175 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 m -68.94 -41.52 77.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.81 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 109.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 85.6 m-20 -59.16 -42.41 90.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.403 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.33 -38.21 89.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.516 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -63.88 -43.24 96.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 64.6 mtm -65.82 -29.35 69.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.93 . . . . 0.0 109.507 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 12.8 mtt-85 -73.47 -29.77 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' LEU . 71.2 mt -110.85 136.06 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.44 127.9 53.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' A' ' 76' ' ' VAL . 3.3 pp -58.79 143.68 82.29 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.466 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HG2' HG22 ' A' ' 76' ' ' VAL . 49.6 Cg_endo -70.01 150.31 66.49 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.799 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 151.42 18.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 94.75 5.98 60.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 72' ' ' LEU . 46.2 t -121.32 147.75 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.175 . . . . 0.0 109.439 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 56.6 t0 -134.82 156.0 49.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.4 p -135.73 146.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.908 . . . . 0.0 109.353 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 78' ' ' VAL . 85.2 tt0 -93.67 120.86 34.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.7 mt -68.8 -32.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -86.51 147.7 25.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 8' ' ' ARG . 25.6 tp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.6 mtt -57.63 -35.02 69.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.507 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.59 -167.02 32.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.19 0.62 54.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -105.44 149.06 26.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -1.223 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HE3' ' CZ ' ' A' ' 8' ' ' ARG . 58.7 pttt -137.26 142.95 41.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' A' ' 59' ' ' PRO . 83.9 mt -118.79 143.88 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' CZ ' ' HE3' ' A' ' 6' ' ' LYS . 67.8 mtt85 -116.17 136.44 53.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 73.1 mt -121.53 131.17 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 91.0 mttt -97.34 139.04 33.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 16.4 mt -115.01 130.77 57.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.355 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 79' ' ' GLU . 87.3 mttt -120.53 137.16 54.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -167.94 146.32 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -68.22 -39.45 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -101.75 118.19 36.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 20.6 p80 -55.99 -43.87 78.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 81.2 tt0 -51.46 -53.57 35.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.16 -40.5 70.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.226 -0.921 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.456 HD13 ' HB2' ' A' ' 13' ' ' ALA . 13.4 tp -68.25 -32.61 72.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 86.8 m-20 -63.76 -38.64 91.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.17 -41.59 81.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.8 t -61.68 -38.91 89.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.01 74.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.11 -44.23 97.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 95.2 mttt -63.43 -41.11 98.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.349 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 30' ' ' ALA . 78.2 mt -68.67 -42.2 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' HA ' HG13 ' A' ' 37' ' ' VAL . 72.0 t -64.73 -48.86 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.75 -43.83 98.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 25' ' ' LYS . 31.8 t -70.55 -41.9 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' ILE . . . -65.07 -47.62 76.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -59.99 -37.29 79.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.32 -30.64 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.5 p -76.5 160.58 29.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -55.12 -35.17 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.8 p -66.08 157.74 30.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -113.26 139.38 48.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 38' ' ' SER . 7.7 p -113.03 147.33 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 37' ' ' VAL . 8.9 t -120.81 142.09 49.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.03 -149.72 17.33 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.41 144.47 78.13 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 -1.799 . . . . 0.0 111.814 -0.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 53' ' ' LEU . 4.1 mp -89.7 114.18 59.64 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.7 139.26 27.71 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.665 2.244 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -120.82 176.01 2.08 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.64 132.74 24.16 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.572 2.181 . . . . 0.0 111.753 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -72.99 139.33 46.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 48' ' ' ARG . 83.1 tt0 -108.91 132.86 53.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 2.7 p 48.66 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.9 mtt180 -140.07 27.16 2.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.949 . . . . 0.0 109.404 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.01 130.44 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.576 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.1 m-70 -91.51 153.37 19.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -130.43 132.35 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.446 ' CG ' ' NH1' ' A' ' 52' ' ' ARG . 30.6 mtt-85 -130.03 140.84 50.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.221 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 53' ' ' LEU . 4.3 mp -122.43 138.04 54.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.734 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 71.8 mt -117.74 128.46 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.865 . . . . 0.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 91.5 m-20 -91.37 144.55 25.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.0 mt -120.36 137.11 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.23 136.89 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 45.19 62.17 10.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.448 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.3 Cg_endo -70.01 141.16 43.5 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.77 2.313 . . . . 0.0 111.735 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -127.88 173.0 5.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.33 -27.1 40.87 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.724 2.283 . . . . 0.0 111.804 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -64.79 -24.31 67.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.9 m -71.82 -42.39 67.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.247 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.93 -44.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.14 -48.09 76.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.46 -40.0 71.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.1 tp -62.44 -34.57 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.64 -30.51 69.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.451 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 38.5 mtm105 -74.12 -30.4 62.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 66.9 mt -114.07 131.41 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -106.61 141.65 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.497 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.81 141.25 80.48 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.54 149.94 62.67 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.692 2.261 . . . . 0.0 111.724 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.95 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.39 -3.18 71.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 40.6 t -120.4 148.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -1.216 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 53.9 t0 -130.39 158.25 40.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.391 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 46.1 t -139.09 140.02 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.573 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' A' ' 12' ' ' LYS . 93.9 mt-10 -94.26 132.55 38.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.92 -39.43 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 25.6 mttm -104.23 144.6 31.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 41.9 mt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.501 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.412 ' HB3' ' HE3' ' A' ' 2' ' ' MET . 89.7 mtp -58.78 -35.78 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 86.77 10.58 72.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.24 -25.35 62.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -104.61 149.62 25.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.421 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 25.7 pttm -126.55 158.98 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -115.63 137.06 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.443 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -119.66 137.29 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.67 135.6 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 13.7 tttp -107.34 121.01 43.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 37.6 mt -101.65 126.86 48.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 96.4 mttt -121.32 137.37 54.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.521 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -167.26 143.69 4.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.516 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.01 -41.34 99.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.76 114.47 26.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.633 ' CE1' ' CG ' ' A' ' 17' ' ' GLU . 21.1 p80 -61.21 -35.44 77.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.422 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CG ' ' CE1' ' A' ' 16' ' ' HIS . 86.8 mt-10 -65.14 -39.87 93.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.04 -39.48 83.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.521 HD13 ' CB ' ' A' ' 13' ' ' ALA . 14.0 tp -59.69 -38.22 80.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -65.57 -35.28 80.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.93 -39.54 94.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' HG13 ' A' ' 26' ' ' ILE . 17.6 m -68.82 -37.5 79.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -72.71 -37.08 67.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 24.0 tttt -61.34 -45.21 95.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' O ' HG21 ' A' ' 29' ' ' VAL . 80.2 mttt -63.79 -41.34 97.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 22' ' ' SER . 79.5 mt -70.52 -43.29 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.01 -45.36 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.9 mt-10 -61.5 -43.25 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 25' ' ' LYS . 32.2 t -72.94 -37.19 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.535 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -67.18 -49.5 64.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -58.42 -37.23 74.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 m -57.12 -34.67 68.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.8 m -73.37 154.47 40.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -50.99 -35.17 32.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.0 p -60.76 157.24 15.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -112.73 145.42 40.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.535 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 49.9 t -122.42 142.21 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 t -113.91 135.64 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.71 -155.59 21.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.38 138.11 48.94 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.77 0.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.28 115.42 63.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.01 139.41 32.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.619 2.213 . . . . 0.0 111.754 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.527 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mp -118.48 175.53 2.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.3 133.23 24.1 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.642 2.228 . . . . 0.0 111.76 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.511 ' OG1' ' ND1' ' A' ' 50' ' ' HIS . 21.6 m -78.63 142.62 37.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 48' ' ' ARG . 82.3 tt0 -112.45 126.31 55.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.0 t 53.25 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 46' ' ' GLU . 91.3 mtt180 -140.3 22.5 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t -119.65 131.24 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.591 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 82.6 m-70 -101.27 150.76 22.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -133.44 140.75 47.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.688 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -124.74 149.62 47.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.221 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -122.51 131.68 53.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.745 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.449 HD13 HD11 ' A' ' 11' ' ' LEU . 66.9 mt -119.17 124.39 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.197 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -99.95 140.52 34.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.717 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 66.9 mt -120.89 130.48 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.231 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -111.55 140.2 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 8.2 t0 51.4 59.91 14.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.59 140.66 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 111.712 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.73 165.1 17.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.31 -19.98 49.34 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.631 2.221 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -71.07 -28.03 64.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 m -72.08 -39.23 69.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.244 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.11 -41.58 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.309 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 87.3 m-20 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.878 . . . . 0.0 109.346 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.79 75.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.355 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 67' ' ' LEU . 3.5 tm? -66.04 -41.87 90.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.427 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 67.6 mtm -65.53 -28.76 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -77.43 -28.41 52.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.1 mt -110.94 134.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -106.95 131.38 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.9 144.54 3.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.9 148.49 64.31 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.698 2.265 . . . . 0.0 111.827 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.06 152.0 41.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.46 -3.89 56.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 19' ' ' LEU . 48.4 t -124.76 148.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -1.181 . . . . 0.0 109.454 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.5 m-20 -118.26 157.14 27.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.3 148.99 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -108.86 137.43 46.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.72 158.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.432 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -85.74 134.07 33.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.475 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.479 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.496 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mmm -59.71 -35.56 74.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.84 66.97 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.62 -28.67 52.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -101.39 145.18 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 0.0 109.49 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 26.3 pttm -132.79 161.84 33.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.515 ' HB ' ' CD1' ' A' ' 56' ' ' ILE . 10.5 mm -118.75 141.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 77.1 mtm180 -125.71 127.08 45.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 68.5 mt -114.96 135.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HG2' HD12 ' A' ' 53' ' ' LEU . 54.0 mttm -104.87 127.46 52.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -101.24 134.64 43.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.406 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 67.8 mttm -121.48 135.42 55.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 19' ' ' LEU . . . -169.33 149.3 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.38 -39.96 67.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.34 119.38 32.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.572 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.8 p-80 -64.93 -38.21 90.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.7 mt-10 -59.83 -38.16 81.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.446 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.529 HD22 ' CG2' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -75.08 -36.62 61.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.36 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 14.4 tp -67.22 -35.86 80.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -62.9 -42.4 99.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.36 -40.96 98.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 m -63.26 -37.82 88.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.31 -44.62 62.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -59.62 -43.72 93.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -60.89 -45.93 92.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 22' ' ' SER . 89.6 mt -64.55 -40.13 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.47 -44.82 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.503 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.1 -41.12 97.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.81 -43.36 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.462 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.544 ' CB ' ' CG1' ' A' ' 37' ' ' VAL . . . -65.83 -48.7 70.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -57.64 -37.89 74.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.86 -29.2 64.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.2 p -73.28 163.84 27.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.5 -33.25 67.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 60.7 p -69.37 158.82 34.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -108.29 151.09 26.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' CG1' ' CB ' ' A' ' 30' ' ' ALA . 26.6 m -127.98 145.45 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -118.38 147.86 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.32 -156.29 18.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.36 142.68 72.42 Favored 'Cis proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.781 -0.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.528 HG21 HD11 ' A' ' 41' ' ' ILE . 4.4 mt -95.48 121.56 61.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 133.35 24.93 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.714 2.276 . . . . 0.0 111.899 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.9 mp -110.09 172.64 3.44 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -68.92 141.03 47.49 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.701 2.267 . . . . 0.0 111.713 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 11.7 t -80.09 141.24 35.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.917 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 79.4 tt0 -129.29 129.98 45.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.357 -0.84 . . . . 0.0 109.36 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 50.9 p 47.43 49.79 15.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.38 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 47' ' ' SER . 13.2 mtt-85 61.75 27.17 16.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 45' ' ' THR . 46.6 t -114.51 140.8 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.572 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 72.3 m80 -106.92 145.65 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 16.7 mttt -133.23 145.21 50.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 11' ' ' LEU . 89.0 mtt-85 -129.22 145.71 51.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.174 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 26.5 tp -121.62 130.98 53.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.2 mt -116.42 118.21 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 81.5 m-20 -89.47 148.77 23.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.747 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.515 ' CD1' ' HB ' ' A' ' 7' ' ' ILE . 32.5 mt -124.51 130.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.354 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.87 136.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 1' ' ' SER . 39.0 t0 48.51 60.86 14.93 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.349 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 49.4 Cg_endo -69.72 142.2 47.47 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.773 2.316 . . . . 0.0 111.846 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -125.27 173.97 4.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.6 Cg_endo -67.88 -22.96 41.75 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.693 2.262 . . . . 0.0 111.663 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.44 -24.73 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.265 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -73.24 -40.2 64.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.24 -40.25 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.863 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.468 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 87.3 m-20 -63.79 -39.54 94.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.32 88.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 70' ' ' ILE . 20.2 tp -63.78 -38.45 91.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.468 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 60.4 mtm -69.26 -30.41 68.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 52.2 mtt180 -75.77 -29.06 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.518 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.1 mt -111.4 135.91 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.434 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -112.86 134.68 54.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.96 146.76 13.95 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.77 152.37 69.26 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.639 2.226 . . . . 0.0 111.806 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.44 149.12 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.14 -6.03 63.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 ' CG2' HD22 ' A' ' 18' ' ' LEU . 67.1 t -125.61 148.53 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -1.192 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.7 m-20 -124.05 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.421 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -132.59 135.14 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -94.56 125.07 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.48 -36.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -123.18 148.14 46.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.55 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.473 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.1 mmm -58.29 -33.96 70.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.38 5.93 61.59 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.2 -31.15 65.2 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -71.0 149.61 46.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.406 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 22.3 pttm -130.5 153.56 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.432 HD11 ' CB ' ' A' ' 59' ' ' PRO . 72.6 mt -117.83 142.33 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.362 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.517 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 68.3 mtt180 -121.84 134.96 54.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 HG21 ' CG1' ' A' ' 78' ' ' VAL . 81.0 mt -117.06 135.7 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.434 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 28.3 tttp -105.75 130.51 53.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 49.8 mt -107.87 127.94 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.571 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HD3' ' A' ' 10' ' ' LYS . 70.6 mttt -122.39 136.5 54.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -167.08 141.02 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -54.39 -50.78 66.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-20 -83.79 131.78 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.745 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 79.3 t60 -71.08 -35.57 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.339 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.19 -35.49 69.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.424 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 22' ' ' SER . 82.7 mt -64.31 -35.08 79.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CD1' ' CB ' ' A' ' 13' ' ' ALA . 6.6 mp -73.56 -39.28 64.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -64.54 -45.33 87.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.15 -41.64 73.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.0 m -65.09 -39.79 93.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.52 87.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.09 -39.68 94.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' O ' HG22 ' A' ' 29' ' ' VAL . 49.7 mttt -65.04 -43.02 93.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.918 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 22' ' ' SER . 30.2 mm -65.53 -45.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.89 -45.34 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.86 -48.81 77.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 25' ' ' LYS . 64.6 t -69.26 -47.05 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.483 ' HB1' ' CG1' ' A' ' 37' ' ' VAL . . . -61.84 -49.32 76.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -58.32 -37.87 75.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 t -57.75 -30.36 65.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 30' ' ' ALA . 29.4 p -75.09 163.3 27.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -56.51 -34.19 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.8 p -64.99 156.84 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -107.9 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.483 ' CG1' ' HB1' ' A' ' 30' ' ' ALA . 12.6 m -132.42 145.15 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.873 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 9.0 m -122.65 152.74 40.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.81 -143.84 17.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' HB3' HG12 ' A' ' 54' ' ' ILE . 50.6 Cg_endo -70.98 146.7 85.46 Favored 'Cis proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.759 -1.767 . . . . 0.0 111.746 -0.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.32 114.47 60.49 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.266 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' O ' HD22 ' A' ' 43' ' ' LEU . 52.8 Cg_endo -72.58 140.0 32.11 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.723 2.282 . . . . 0.0 111.948 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' ' HD2' ' A' ' 44' ' ' PRO . 3.9 mm? -118.43 166.87 12.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HD2' ' CD1' ' A' ' 43' ' ' LEU . 49.1 Cg_endo -69.68 128.2 15.75 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.634 2.222 . . . . 0.0 111.756 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.458 ' OG1' ' ND1' ' A' ' 50' ' ' HIS . 19.0 m -68.88 154.37 42.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 48' ' ' ARG . 74.3 tt0 -122.83 119.58 30.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 m 59.9 -85.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' GLU . 92.6 mtt180 -143.85 22.99 1.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.422 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 45' ' ' THR . 59.6 t -122.52 128.55 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.576 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 70.8 m-70 -97.55 157.9 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 38.6 mtmt -142.07 137.36 30.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.67 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -131.99 150.3 52.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD11 ' HG ' ' A' ' 43' ' ' LEU . 7.7 mp -127.15 145.69 50.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.167 -0.958 . . . . 0.0 109.741 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 40' ' ' PRO . 70.2 mt -123.81 117.94 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 38.7 t0 -78.56 140.67 38.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.14 124.84 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.354 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -107.81 139.48 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.544 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.76 63.62 9.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.432 ' CB ' HD11 ' A' ' 7' ' ' ILE . 50.5 Cg_endo -70.54 144.78 50.87 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.63 2.22 . . . . 0.0 111.675 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -131.4 172.05 8.03 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.597 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.24 -26.55 35.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 111.829 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -62.63 -20.99 65.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.7 m -74.32 -39.17 63.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.88 -40.17 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 88.8 m-20 -62.68 -41.3 99.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.5 -40.11 95.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.33 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.0 tp -64.0 -36.69 84.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.327 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.444 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 64.4 mtm -70.65 -27.06 63.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -78.67 -28.03 45.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.4 mt -112.93 135.32 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.82 133.73 51.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 145.7 98.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.58 150.64 63.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.685 2.256 . . . . 0.0 111.823 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.65 150.77 35.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.73 3.41 64.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 13' ' ' ALA . 48.5 t -130.66 147.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.174 . . . . 0.0 109.449 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 36.7 t0 -129.61 158.38 39.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CG1' HG21 ' A' ' 9' ' ' ILE . 41.2 t -127.9 128.35 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -121.1 139.47 53.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.49 131.25 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.82 146.17 26.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.518 ' OG ' ' CG2' ' A' ' 57' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -56.8 -38.03 71.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 109.499 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.28 92.36 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.98 75.53 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -117.13 127.2 53.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.458 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HE3' ' NH1' ' A' ' 8' ' ' ARG . 52.0 pttt -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' ILE . 77.0 mt -119.0 140.18 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.485 ' NH1' ' HE3' ' A' ' 6' ' ' LYS . 62.6 mtt180 -116.92 137.35 52.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG12 HD11 ' A' ' 56' ' ' ILE . 24.1 mm -112.46 133.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.458 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 78.4 mttt -109.22 133.89 52.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD11 ' HB1' ' A' ' 23' ' ' ALA . 16.0 mt -112.83 133.23 54.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 77.6 mttt -122.73 131.45 53.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.86 144.97 12.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 109.429 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.3 -36.39 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.08 116.74 32.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.533 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 15.4 p80 -60.3 -46.22 90.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 86.9 tt0 -53.91 -46.55 71.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.219 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.515 HD11 ' CG2' ' A' ' 76' ' ' VAL . 3.4 tm? -61.96 -40.59 96.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.225 -0.922 . . . . 0.0 108.804 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 6.5 tt -67.51 -32.8 73.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD1' ' NH1' ' A' ' 52' ' ' ARG . 91.3 m-20 -63.64 -39.54 94.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.438 -0.789 . . . . 0.0 109.325 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.3 mm-40 -64.58 -49.5 70.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.44 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' HG13 ' A' ' 26' ' ' ILE . 37.2 m -58.89 -45.71 89.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -62.62 -51.42 67.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -57.78 -45.51 85.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 49.5 mttm -59.76 -46.24 89.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 22' ' ' SER . 97.2 mt -64.2 -41.14 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' CG1' ' HE3' ' A' ' 31' ' ' LYS . 77.7 t -61.13 -46.31 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 -41.26 96.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG22 ' CD1' ' A' ' 70' ' ' ILE . 38.6 t -72.59 -39.97 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.544 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -65.64 -46.56 78.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 50.0 mttt -59.56 -37.3 78.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -57.42 -30.79 65.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.2 p -76.35 163.82 26.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.52 -34.16 70.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.6 p -62.85 157.66 20.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -111.84 146.57 37.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 42.7 t -123.66 141.02 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 21.3 t -116.79 138.81 51.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.08 -150.06 17.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.31 143.95 76.4 Favored 'Cis proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.844 -0.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 41' ' ' ILE . 21.4 mt -95.7 126.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.374 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.84 136.78 33.64 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.634 2.223 . . . . 0.0 111.827 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -120.81 175.62 2.27 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.528 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 50.6 Cg_endo -70.84 138.57 34.68 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.695 2.264 . . . . 0.0 111.707 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.476 HG23 ' ND1' ' A' ' 50' ' ' HIS . 21.7 p -91.14 162.75 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 48' ' ' ARG . 71.9 tt0 -126.66 126.34 43.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.537 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m 54.46 -88.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 46' ' ' GLU . 14.4 mtp180 -140.2 34.94 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 45' ' ' THR . 55.3 t -128.74 134.59 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.88 . . . . 0.0 109.568 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.533 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 62.2 m-70 -102.91 148.97 24.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -135.54 141.3 45.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.519 ' NH1' ' OD1' ' A' ' 20' ' ' ASP . 19.8 mtp180 -123.92 152.05 42.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 27.1 tp -121.64 130.7 53.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.0 mt -118.49 125.82 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.381 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 86.9 m-20 -89.79 142.46 27.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.515 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ILE . 61.8 mt -119.5 131.06 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.439 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' CG2' ' OG ' ' A' ' 1' ' ' SER . 70.4 mt -109.7 139.39 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.23 63.92 9.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.1 Cg_endo -69.5 144.67 56.2 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.763 2.309 . . . . 0.0 111.748 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.6 m -132.69 166.5 28.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.47 -25.66 41.3 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.7 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -63.57 -25.65 68.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.4 m -67.36 -43.72 80.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.183 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.53 -43.32 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.515 ' HA ' ' CE ' ' A' ' 68' ' ' MET . 57.1 t0 -54.13 -43.28 70.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.313 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.13 96.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 70' ' ' ILE . 28.5 tp -59.16 -41.07 87.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.515 ' CE ' ' HA ' ' A' ' 65' ' ' ASP . 75.3 mtm -64.58 -35.18 80.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -70.57 -27.27 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 67' ' ' LEU . 71.2 mt -107.32 132.92 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -108.17 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.71 141.3 97.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 151.38 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.669 2.246 . . . . 0.0 111.862 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.71 31.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.37 58.45 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 ' CG2' HD11 ' A' ' 18' ' ' LEU . 88.4 t -125.62 148.15 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -1.201 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 51.1 t0 -134.58 155.3 50.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 24.0 m -132.68 148.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.95 146.52 29.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 13.4 tt -122.52 133.89 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 61.1 mttm 61.17 44.03 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.9 tp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.472 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.5 mtp -58.53 -35.55 72.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 109.415 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 96.44 -7.17 65.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.7 -30.21 59.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -75.14 141.12 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -128.0 145.5 50.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.0 mt -111.97 137.5 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.378 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 57.7 mtm180 -122.96 135.5 54.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.8 mt -116.01 137.74 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -110.25 128.83 55.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -112.6 120.65 42.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.254 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' A' ' 51' ' ' LYS . 28.5 mtpt -116.6 138.75 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -170.41 152.66 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.51 -36.01 73.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' OD2' ' HG ' ' A' ' 18' ' ' LEU . 50.6 t0 -93.13 114.3 26.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 6.5 p80 -67.14 -28.37 68.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' OE2' ' CE1' ' A' ' 16' ' ' HIS . 66.3 mm-40 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 57.9 mt -64.1 -38.26 90.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' CD2' ' HB2' ' A' ' 13' ' ' ALA . 60.1 mt -70.46 -34.52 72.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.514 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -63.92 -42.88 97.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -42.8 73.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.4 m -64.85 -38.62 91.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.417 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.33 78.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -60.4 -46.85 88.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 17.7 mtmm -60.9 -45.55 94.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 22' ' ' SER . 84.8 mt -65.03 -44.98 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.59 -48.19 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.17 -44.24 97.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 25' ' ' LYS . 18.5 t -68.11 -40.49 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 37' ' ' VAL . . . -63.59 -47.43 81.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -56.36 -38.16 71.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -57.91 -32.34 67.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -74.31 152.25 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -50.32 -31.13 13.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.7 p -68.98 156.64 38.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -107.41 148.03 29.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 38' ' ' SER . 6.0 p -121.49 147.78 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 37' ' ' VAL . 66.8 m -124.08 144.74 49.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.537 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.05 -155.09 16.34 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.41 140.61 63.58 Favored 'Cis proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.702 -1.791 . . . . 0.0 111.792 -0.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 mt -91.03 131.01 38.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.94 118.81 5.89 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.664 2.243 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -94.55 166.66 14.8 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.371 -0.831 . . . . 0.0 109.529 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.3 Cg_endo -67.66 143.66 62.99 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 111.604 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 49' ' ' VAL . 36.6 m -85.76 142.93 28.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.958 . . . . 0.0 109.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' O ' ' OG ' ' A' ' 47' ' ' SER . 94.9 mt-10 -138.99 138.0 36.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.443 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 49' ' ' VAL . 13.5 p 45.87 49.39 11.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.04 36.83 27.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 47' ' ' SER . 50.0 t -123.15 132.35 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 109.521 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.57 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 97.6 m-70 -98.76 145.23 27.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.0 mtmm -135.98 151.09 49.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -127.41 147.94 50.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.472 HD21 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -122.02 131.16 53.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.472 ' N ' HD21 ' A' ' 53' ' ' LEU . 66.8 mt -120.53 117.39 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -89.05 145.36 25.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 7' ' ' ILE . 68.7 mt -124.22 122.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.34 144.16 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 10.6 t0 47.69 62.66 11.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.474 ' CB ' HD11 ' A' ' 7' ' ' ILE . 49.7 Cg_endo -70.41 148.88 61.81 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.73 2.287 . . . . 0.0 111.716 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -137.18 167.86 19.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.39 -25.86 41.64 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 122.685 2.256 . . . . 0.0 111.673 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.23 -26.11 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.131 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 -42.42 77.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.26 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.56 -44.39 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.46 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 58.5 t0 -55.91 -41.82 75.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.61 84.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' ILE . 21.2 tp -61.38 -40.21 93.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 71.6 mtm -67.7 -34.48 76.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -71.23 -29.49 65.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 67' ' ' LEU . 69.3 mt -108.94 133.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.442 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -116.54 123.45 47.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.82 150.62 26.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.08 148.65 63.43 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.628 2.219 . . . . 0.0 111.742 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.31 153.09 31.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.954 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.11 8.57 55.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 77' ' ' ASP . 48.1 t -128.62 147.85 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -1.19 . . . . 0.0 109.472 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.506 ' N ' HG13 ' A' ' 76' ' ' VAL . 89.9 m-20 -112.82 150.59 31.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.97 143.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.441 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -99.08 136.95 38.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.481 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.7 mm -117.23 127.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.502 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -58.55 -37.84 76.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 0.0 109.489 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.509 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.6 mtp -125.55 158.49 34.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.09 -123.42 23.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.09 65.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 64.7 tt0 -100.2 126.58 46.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -1.221 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -132.49 143.22 49.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 59' ' ' PRO . 79.9 mt -116.96 138.89 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 91.9 mtm-85 -119.71 136.74 54.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.583 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.11 131.97 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.405 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.508 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 68.3 tttt -97.6 125.5 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.6 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 44.3 mt -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -131.04 134.15 46.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -163.62 144.46 8.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' OD2' HD11 ' A' ' 18' ' ' LEU . 54.1 t0 -95.45 119.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 56.1 p-80 -61.6 -40.27 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 95.0 mt-10 -51.42 -52.26 47.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 8.3 mp -59.24 -43.94 92.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.495 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 12.7 tp -65.58 -29.98 70.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.323 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 90.4 m-20 -67.3 -41.24 85.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 98.8 mt-10 -69.91 -35.45 74.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.447 ' O ' HG12 ' A' ' 26' ' ' ILE . 18.2 m -63.31 -40.22 96.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -70.2 -36.58 74.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 15.6 tttp -66.71 -39.74 88.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 67.1 mttm -65.2 -44.04 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 22' ' ' SER . 26.4 mm -69.49 -39.55 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.2 -43.52 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 98.1 mt-10 -64.75 -38.42 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 66' ' ' ALA . 41.2 t -71.58 -40.82 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.477 ' CB ' ' HB ' ' A' ' 37' ' ' VAL . . . -65.78 -46.81 77.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.53 -38.95 82.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.8 m -59.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -77.93 163.65 25.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.91 -36.07 67.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 55.7 p -66.47 157.95 30.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -111.91 147.76 35.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.477 ' HB ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -116.72 147.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -124.37 144.24 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.15 -154.15 16.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.15 143.18 73.83 Favored 'Cis proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.733 -1.778 . . . . 0.0 111.738 -0.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 42' ' ' PRO . 2.7 mp -93.7 127.2 46.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.42 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 41' ' ' ILE . 50.6 Cg_endo -70.82 137.31 32.1 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.685 2.257 . . . . 0.0 111.849 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -127.57 175.83 3.1 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.0 Cg_endo -68.94 141.18 47.86 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.615 2.21 . . . . 0.0 111.751 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 16.0 p -95.45 162.22 13.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 48' ' ' ARG . 96.9 mt-10 -123.15 128.94 50.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.396 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.2 t 51.56 -90.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' GLU . 27.2 mmm180 -138.08 32.22 2.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' O ' ' HB ' ' A' ' 45' ' ' THR . 44.4 t -122.7 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 99.5 m-70 -88.99 148.79 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.408 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.508 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 51.6 mtpt -126.02 128.61 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.494 ' NE ' ' OD1' ' A' ' 20' ' ' ASP . 36.4 mtt-85 -126.46 144.31 50.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 53' ' ' LEU . 4.0 mm? -121.16 139.95 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.5 mt -122.44 122.28 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 85.0 m-20 -93.0 144.9 24.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.846 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.0 mt -123.75 129.72 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.237 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.4 mt -107.66 141.97 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.895 . . . . 0.0 109.689 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 35' ' ' SER . 1.0 OUTLIER 46.84 61.43 13.44 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.0 Cg_endo -70.01 142.79 47.73 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.665 2.243 . . . . 0.0 111.699 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -126.76 168.05 15.67 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.558 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.23 -27.67 40.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.686 2.258 . . . . 0.0 111.619 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -62.62 -25.99 68.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.1 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 m -68.19 -43.51 77.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.241 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.42 -41.76 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.335 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 89.8 m-20 -56.53 -44.1 80.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.119 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -66.07 -35.57 80.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.293 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.75 -27.38 69.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.296 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.451 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 75.7 mtm -82.1 -29.06 31.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.187 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -76.9 -22.83 52.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.5 mt -119.19 132.34 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -107.19 138.29 43.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.522 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 148.32 61.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HG2' HG23 ' A' ' 76' ' ' VAL . 48.8 Cg_endo -69.76 145.88 58.53 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.212 . . . . 0.0 111.817 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.45 150.01 32.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.0 58.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 73' ' ' PRO . 47.4 t -124.18 148.77 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -122.22 147.26 46.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.69 130.46 56.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.7 mt -124.77 131.89 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.72 -34.94 70.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.477 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 1' ' ' SER . 1.2 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.311 0.577 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -58.03 -34.72 70.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.41 9.64 62.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.66 65.29 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -111.14 145.41 38.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -1.165 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -134.5 151.39 51.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 7' ' ' ILE . 72.6 mt -117.21 138.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.452 ' HB3' HD11 ' A' ' 53' ' ' LEU . 69.9 mtm180 -121.54 135.66 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.8 mt -118.03 135.89 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.187 -0.946 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 84.0 mttt -104.36 137.12 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 14.1 mt -106.07 136.26 46.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.376 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.8 mttp -117.68 129.35 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . . . -167.11 143.22 4.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -62.62 -39.46 93.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 18' ' ' LEU . 50.2 t0 -95.07 120.42 35.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.499 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 47.1 t-80 -65.6 -35.43 80.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -56.37 -39.91 73.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.2 mp -63.36 -40.63 97.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.421 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.564 ' CD2' ' CB ' ' A' ' 13' ' ' ALA . 50.3 mt -62.6 -39.8 94.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -61.41 -46.19 91.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.83 -50.74 69.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.7 p -57.51 -43.95 84.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.87 -50.11 72.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -56.67 -40.49 75.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -61.19 -49.34 77.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -67.6 -39.84 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -57.2 -46.69 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.536 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.77 -41.0 94.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 70' ' ' ILE . 35.1 t -72.08 -39.76 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.86 73.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.73 -40.09 86.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -60.56 -26.97 67.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.7 p -81.99 162.58 22.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.463 ' OG ' ' OG ' ' A' ' 60' ' ' SER . 41.9 m -66.87 147.01 53.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.627 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -102.64 147.03 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.32 150.71 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 2.9 t -129.32 142.17 50.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.12 -150.84 17.06 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.21 141.07 68.26 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.675 -1.802 . . . . 0.0 111.727 -0.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.5 131.12 35.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.62 120.31 7.14 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.709 2.273 . . . . 0.0 111.923 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 14.6 mt -93.36 166.99 14.94 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 44.0 Cg_endo -66.76 132.11 27.68 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.749 2.3 . . . . 0.0 111.595 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.471 HG21 ' N ' ' A' ' 46' ' ' GLU . 40.0 m -83.99 151.09 25.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 48' ' ' ARG . 80.5 tt0 -123.99 127.18 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 46' ' ' GLU . 98.4 p 49.39 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLU . 95.9 mtt180 -135.14 21.35 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 45' ' ' THR . 49.9 t -111.36 131.07 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.446 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.565 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 68.7 m80 -105.73 147.02 29.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.6 mtmt -134.97 155.83 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -130.04 151.68 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 36.8 tp -124.33 131.55 53.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 67.7 mt -117.12 123.84 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 37.7 t0 -89.95 137.38 32.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.27 130.39 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.1 mt -111.85 138.4 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.684 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.41 61.32 12.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.41 137.37 33.41 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.649 2.232 . . . . 0.0 111.792 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -129.15 172.73 6.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 44.8 Cg_endo -67.61 -25.28 40.79 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.68 2.253 . . . . 0.0 111.542 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.11 -26.13 67.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -72.34 -39.19 68.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.329 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.61 -42.63 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.5 m-20 -61.43 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.353 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.61 -37.44 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.4 tp -63.47 -39.71 95.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 59.2 mtm -68.31 -32.13 72.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -73.76 -29.07 62.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.506 ' CD1' HG23 ' A' ' 29' ' ' VAL . 73.2 mt -109.39 135.53 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.58 150.94 79.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.89 147.57 62.31 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.662 2.241 . . . . 0.0 111.799 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.35 146.93 32.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.93 69.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 47.1 t -127.82 148.58 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 33.0 t0 -138.04 153.04 49.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.478 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' CG1' HD23 ' A' ' 11' ' ' LEU . 25.6 m -143.07 147.36 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.418 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -114.63 127.09 55.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.4 mm -65.28 -39.57 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -60.41 -34.76 74.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.431 HD23 ' HE3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.07 -34.99 72.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.37 -178.21 31.21 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.94 -72.61 1.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -115.86 154.71 29.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -1.164 . . . . 0.0 109.511 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -109.33 144.43 37.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.502 HD11 ' CB ' ' A' ' 59' ' ' PRO . 69.1 mt -114.7 136.7 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 45.0 mtm180 -122.85 136.8 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.437 ' O ' HD12 ' A' ' 53' ' ' LEU . 83.0 mt -113.26 133.28 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 18.2 tttt -103.13 121.46 42.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 50.3 mt -104.05 126.37 51.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HE2' ' HE2' ' A' ' 10' ' ' LYS . 36.4 mttt -121.72 137.63 54.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 109.415 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.504 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . . . -168.72 146.05 3.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.57 -52.17 49.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.14 130.26 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.569 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.5 p-80 -74.9 -28.88 60.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.878 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.78 -37.89 86.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.36 -36.1 83.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' A' ' 76' ' ' VAL . 70.9 mt -69.94 -36.42 75.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.41 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.67 -41.39 88.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.45 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.03 -43.17 83.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 26' ' ' ILE . 84.2 p -66.26 -35.81 81.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.354 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 27' ' ' VAL . . . -68.61 -38.76 80.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -61.13 -44.54 97.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -61.22 -45.72 93.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.448 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 22' ' ' SER . 29.2 mm -65.73 -41.58 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 23' ' ' ALA . 79.2 t -61.8 -44.42 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.97 -47.26 78.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 66' ' ' ALA . 34.1 t -67.44 -43.38 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.555 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -63.23 -47.06 84.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.444 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -55.74 -39.52 71.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.6 m -56.05 -31.66 63.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 p -78.04 162.21 26.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.49 -29.03 63.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.382 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 26.3 t -69.85 148.3 49.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -107.57 150.29 27.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' CG2' ' CB ' ' A' ' 30' ' ' ALA . 41.7 t -122.08 140.93 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -117.86 141.75 48.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.84 -149.36 16.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.24 145.85 81.6 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.75 -1.771 . . . . 0.0 111.878 0.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 mp -94.26 125.17 53.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.85 118.15 5.54 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.077 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 12.5 mt -97.89 168.25 10.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.897 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.536 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.5 Cg_endo -68.33 147.99 73.0 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.721 2.281 . . . . 0.0 111.67 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 50' ' ' HIS . 18.8 p -102.67 162.44 12.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.537 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 48' ' ' ARG . 96.8 mt-10 -128.7 128.31 43.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m 54.51 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 46' ' ' GLU . 92.6 mtt180 -142.88 33.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' O ' ' HB ' ' A' ' 45' ' ' THR . 48.6 t -123.2 130.16 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.569 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 69.8 m80 -103.39 149.2 25.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 14.5 mtmt -137.02 144.41 43.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.599 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -124.71 152.08 44.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.4 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -125.97 135.0 51.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 67.1 mt -121.07 124.58 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 87.1 m-20 -90.3 145.15 25.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -126.82 125.55 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.471 HG21 HD11 ' A' ' 57' ' ' ILE . 65.6 mt -106.97 139.71 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.654 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' SER . 3.6 t70 53.19 62.23 10.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.636 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.502 ' CB ' HD11 ' A' ' 7' ' ' ILE . 49.8 Cg_endo -70.21 141.33 43.14 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.753 2.302 . . . . 0.0 111.67 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.49 166.59 22.14 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.08 -21.74 42.32 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.663 2.242 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -67.67 -25.49 65.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.113 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 m -70.59 -42.46 70.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.82 -42.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 86.2 m-20 -57.59 -45.56 85.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' HB2' HG12 ' A' ' 29' ' ' VAL . . . -61.33 -37.75 84.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' ILE . 3.8 tp -63.7 -40.45 96.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.98 -29.95 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -74.59 -29.26 61.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.1 mt -110.11 136.62 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.21 134.9 42.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.76 149.32 85.35 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.77 141.04 44.12 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.685 2.257 . . . . 0.0 111.758 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.86 149.77 49.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.7 9.15 56.68 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.519 HG12 ' CD2' ' A' ' 19' ' ' LEU . 58.0 t -133.79 142.05 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -1.113 . . . . 0.0 109.427 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.442 ' N ' HG13 ' A' ' 76' ' ' VAL . 86.6 m-20 -110.89 151.42 27.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.18 142.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.27 145.53 29.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.9 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -60.92 -34.69 75.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 tp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.48 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 16.5 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 76.4 mttt -112.89 143.45 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.429 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.5 mt -117.3 137.51 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HB3' HD11 ' A' ' 53' ' ' LEU . 57.4 mtt85 -118.19 135.96 53.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.654 ' O ' HD22 ' A' ' 53' ' ' LEU . 72.2 mt -120.37 130.32 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.786 ' HG2' HD23 ' A' ' 53' ' ' LEU . 38.7 mttt -99.84 131.6 45.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.7 mp -110.75 134.94 52.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 25.2 mttt -126.81 141.85 51.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -172.13 147.42 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -67.32 -40.99 86.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -94.4 113.97 25.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.585 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 44.4 p-80 -58.97 -37.72 77.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 109.388 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.1 mt-10 -52.98 -54.19 38.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.259 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.2 mp -55.97 -49.38 73.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.5 tt -61.46 -31.51 71.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 65.1 m-20 -66.78 -38.68 87.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.334 -0.854 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.09 -38.82 75.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.8 t -65.43 -45.35 84.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.898 . . . . 0.0 109.44 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -65.24 -48.19 74.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.54 -43.98 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 70' ' ' ILE . 26.5 tttm -59.72 -49.7 76.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 22' ' ' SER . 97.5 mt -61.05 -41.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 23' ' ' ALA . 76.8 t -57.49 -44.89 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.02 -43.96 97.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.8 -41.65 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.934 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.13 -48.26 74.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.443 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.0 m -56.7 -30.98 64.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -75.4 160.45 30.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.13 -35.38 67.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 52.6 p -62.81 157.22 21.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -111.95 148.24 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.934 HG21 ' CB ' ' A' ' 30' ' ' ALA . 24.8 t -122.67 139.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 t -113.51 140.85 47.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 121.97 -149.37 17.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 51.0 Cg_endo -70.8 146.37 84.23 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.782 -1.758 . . . . 0.0 111.674 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 mt -97.36 119.81 62.22 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.03 144.85 48.31 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -123.87 173.56 4.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.444 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.5 Cg_endo -70.01 135.93 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.698 2.265 . . . . 0.0 111.766 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 49' ' ' VAL . 38.0 m . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 45' ' ' THR . 45.7 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 96.3 m-70 -97.92 145.69 26.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.351 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.4 mtmm -141.83 143.81 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' A' ' 19' ' ' LEU . 89.3 mtt-85 -130.88 152.98 49.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.217 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.7 tm? -124.45 125.77 44.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.942 . . . . 0.0 109.663 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.79 ' N ' HD13 ' A' ' 53' ' ' LEU . 64.8 mt -112.12 120.8 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' OD1' ' CD1' ' A' ' 53' ' ' LEU . 86.9 m-20 -86.83 144.09 27.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 68.3 mt -120.94 132.01 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.335 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -111.09 138.98 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.24 63.19 10.57 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.1 Cg_endo -70.11 143.32 48.82 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.641 2.227 . . . . 0.0 111.717 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -120.98 168.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 109.503 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.27 -24.46 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.642 2.228 . . . . 0.0 111.836 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.47 -21.91 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.5 m -73.11 -40.93 64.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.67 -41.25 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 0.0 109.373 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.613 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -60.64 -40.15 90.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 67' ' ' LEU . 23.6 tp -63.27 -38.38 90.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.613 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 68.1 mtm -69.65 -33.89 73.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 29.8 mtp180 -73.19 -27.36 61.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.554 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 71.1 mt -107.24 134.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -108.68 126.56 53.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.93 145.19 54.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 150.82 65.31 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.704 2.269 . . . . 0.0 111.777 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.43 148.33 15.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.19 64.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.89 148.56 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -1.202 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 52.3 t0 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -133.92 145.81 49.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.2 mt -117.11 144.56 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' HB3' HD21 ' A' ' 53' ' ' LEU . 48.2 mtp85 -117.12 135.56 53.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.511 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.779 ' O ' HD22 ' A' ' 53' ' ' LEU . 71.4 mt -120.77 129.57 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.681 ' HG2' HD23 ' A' ' 53' ' ' LEU . 56.5 mttm -103.53 132.9 49.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.659 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -108.11 137.62 45.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 27.2 mttt -125.84 137.23 53.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -168.57 140.51 2.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.601 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -55.63 -48.78 74.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 18' ' ' LEU . 95.5 m-20 -97.63 132.58 43.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.739 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.59 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 46.8 p-80 -69.65 -29.17 66.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -57.17 -45.96 83.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.359 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.2 mp -68.51 -44.77 73.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 11' ' ' LEU . 8.2 tt -62.31 -45.83 91.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.444 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -57.37 -43.74 83.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.84 -41.53 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.34 -45.22 92.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -60.29 -41.31 93.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.853 . . . . 0.0 109.436 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -61.88 -44.3 97.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.5 tttp -60.77 -41.85 96.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.16 -39.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.8 t -61.83 -42.56 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.78 -37.67 88.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.2 t -74.2 -40.35 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.16 76.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -60.36 -37.51 80.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -59.32 -30.92 68.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.0 p -76.95 162.45 27.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.89 -36.23 67.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.4 p -64.71 158.64 24.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -111.96 146.68 37.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.384 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.476 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 4.4 p -119.08 147.14 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -125.18 142.35 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.03 -150.78 18.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 146.67 83.48 Favored 'Cis proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.781 -0.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 53' ' ' LEU . 7.5 mt -94.64 126.52 47.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.3 141.15 42.34 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.611 2.207 . . . . 0.0 111.784 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.58 174.24 4.36 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.465 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -69.41 139.81 42.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 23.4 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' THR . 59.6 t . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.59 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 96.5 m-70 -104.44 145.08 30.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.9 mtmm -137.62 143.03 41.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HG3' HD22 ' A' ' 19' ' ' LEU . 32.4 mtp85 -128.63 153.32 47.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 9' ' ' ILE . 3.4 tm? -123.94 128.04 48.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 53' ' ' LEU . 69.2 mt -111.28 128.32 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.82 142.45 27.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.22 131.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.44 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.86 138.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' SER . 38.8 t70 48.22 60.78 14.97 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.1 Cg_endo -70.26 143.74 49.32 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.698 2.265 . . . . 0.0 111.754 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -126.03 169.71 11.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.3 Cg_endo -68.11 -25.29 37.71 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.719 2.279 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.96 -22.75 66.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.4 m -71.19 -41.75 69.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.99 -41.65 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.385 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.598 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 90.4 m-20 -59.01 -40.08 83.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 0.0 109.395 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.73 91.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 70' ' ' ILE . 5.0 tp -61.04 -40.59 94.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.598 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 70.3 mtm -67.9 -33.19 74.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 93.2 mtt-85 -73.54 -29.48 62.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -107.77 134.13 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.478 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.13 125.64 54.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -58.98 151.12 57.44 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.68 151.43 69.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.786 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.76 150.17 16.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.71 64.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.8 t -126.07 148.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -1.194 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.512 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -121.89 145.75 47.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 59' ' ' PRO . 84.6 mt -116.04 138.47 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.545 ' HD2' HD21 ' A' ' 53' ' ' LEU . 57.0 mtm180 -119.08 137.82 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.85 136.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.441 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' NZ ' ' HD3' ' A' ' 51' ' ' LYS . 44.7 tttt -111.45 124.27 51.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -102.75 126.0 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.377 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 59.0 mttt -116.49 131.06 57.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.801 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -166.28 142.6 4.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.511 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -62.31 -38.35 89.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 60.7 t0 -91.55 118.82 30.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.0 p-80 -65.01 -31.87 73.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.897 . . . . 0.0 109.446 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.8 mt-10 -61.39 -39.23 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 15' ' ' ASP . 75.4 mt -63.63 -38.99 93.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.801 HD21 ' CB ' ' A' ' 13' ' ' ALA . 61.6 mt -64.95 -37.14 86.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.64 -41.86 95.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 97.1 mt-10 -67.24 -37.79 84.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 11' ' ' LEU . 22.3 m -62.5 -40.02 95.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.767 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.56 -44.33 74.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -61.3 -46.35 90.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.4 mttt -63.8 -46.93 82.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 81.8 mt -70.0 -40.44 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.1 t -63.71 -44.74 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -63.31 -42.4 99.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.662 HG11 ' HB1' ' A' ' 66' ' ' ALA . 42.0 t -73.28 -42.22 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.448 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.959 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.57 -48.47 72.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.18 -40.39 77.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.51 -29.81 64.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 29' ' ' VAL . 28.5 p -76.6 161.61 28.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -57.0 -30.78 64.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -66.66 155.01 39.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -108.78 150.15 28.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.959 HG21 ' CB ' ' A' ' 30' ' ' ALA . 47.5 t -125.45 140.87 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -119.1 140.01 50.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 130.79 -151.65 19.65 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 51.3 Cg_endo -70.97 140.24 63.03 Favored 'Cis proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.701 -1.791 . . . . 0.0 111.683 -0.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mt -90.27 122.88 66.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.423 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.74 129.53 17.79 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.738 2.292 . . . . 0.0 112.018 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 2.9 mp -105.59 171.59 4.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.2 Cg_endo -69.54 128.3 16.02 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.669 2.246 . . . . 0.0 111.749 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.741 HG21 ' CE1' ' A' ' 50' ' ' HIS . 35.1 m . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 45' ' ' THR . 59.3 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.254 0.549 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.741 ' CE1' HG21 ' A' ' 45' ' ' THR . 92.8 m-70 -106.9 146.91 30.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HD3' ' NZ ' ' A' ' 10' ' ' LYS . 47.6 mttm -127.59 150.91 49.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 62.6 mtp85 -133.6 144.81 49.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' HD2' ' A' ' 8' ' ' ARG . 28.8 tp -121.53 133.24 55.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 65.9 mt -120.7 120.98 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.69 137.04 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 56' ' ' ILE . 49.4 mt -119.54 127.65 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.99 139.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.05 61.51 13.9 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.23 144.38 51.33 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.723 2.282 . . . . 0.0 111.823 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 165.97 21.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.95 -26.11 37.95 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.797 2.331 . . . . 0.0 111.741 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -67.17 -22.44 65.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.22 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.4 m -71.42 -41.7 69.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.45 -42.28 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.271 -0.893 . . . . 0.0 109.323 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.65 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 91.1 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.342 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -63.07 -40.92 99.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' ILE . 32.1 tp -61.92 -39.59 92.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.44 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.65 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 72.6 mtm -67.02 -31.93 72.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 77.8 mtp180 -70.46 -30.38 67.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.6 mt -110.14 136.04 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -101.32 129.79 47.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 148.61 37.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.12 149.07 64.1 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.65 2.233 . . . . 0.0 111.783 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 148.43 27.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.9 3.43 65.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.3 t -126.31 148.33 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.5 t0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -111.9 149.5 31.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.462 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -110.71 142.35 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.4 mtm180 -118.58 136.76 53.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.17 132.86 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.527 ' HG2' HD13 ' A' ' 53' ' ' LEU . 26.4 mttm -108.58 132.09 54.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.018 ' CB ' HD11 ' A' ' 19' ' ' LEU . 3.4 mp -117.69 129.51 55.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.516 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 83.0 mttt -116.25 137.29 52.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -160.26 145.69 15.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.77 -39.09 90.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.583 ' CB ' HD13 ' A' ' 18' ' ' LEU . 92.3 m-20 -97.33 125.09 41.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.589 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 19.5 p80 -71.17 -30.06 65.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.09 -39.2 89.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.4 mp -72.92 -44.01 61.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.496 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.018 HD11 ' CB ' ' A' ' 11' ' ' LEU . 40.8 tp -58.75 -42.81 89.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.2 -46.33 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -40.3 85.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 m -60.64 -44.29 96.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.43 -42.19 99.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -59.99 -47.14 87.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.8 mtpt -56.32 -47.86 77.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.554 HD12 HD21 ' A' ' 11' ' ' LEU . 75.2 mt -65.64 -41.66 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.862 . . . . 0.0 109.36 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 23' ' ' ALA . 69.1 t -62.67 -46.17 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -59.28 -40.91 87.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' LYS . 38.7 t -70.68 -42.2 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.895 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -66.18 -46.59 76.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' CE ' ' CG1' ' A' ' 27' ' ' VAL . 23.2 mttm -57.43 -37.11 72.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 m -57.41 -34.28 68.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.9 m -74.26 154.71 38.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.43 -29.23 9.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -65.28 158.78 25.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -113.71 152.56 30.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 30' ' ' ALA . 39.4 t -123.42 140.97 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -115.29 149.13 38.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 113.64 -147.32 18.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 50.9 Cg_endo -70.6 148.45 88.64 Favored 'Cis proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.731 -1.779 . . . . 0.0 111.813 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -98.41 123.21 51.21 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.43 140.53 36.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.699 2.266 . . . . 0.0 111.842 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.678 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -120.29 176.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.678 ' HD2' HD23 ' A' ' 43' ' ' LEU . 48.1 Cg_endo -69.8 141.85 46.19 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.536 2.157 . . . . 0.0 111.696 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.545 HG21 ' ND1' ' A' ' 50' ' ' HIS . 18.3 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.602 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 45' ' ' THR . 46.4 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.664 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 76.7 m-70 -105.88 149.79 26.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' HE2' ' A' ' 12' ' ' LYS . 33.4 mtmm -135.18 141.06 45.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HG3' HD23 ' A' ' 19' ' ' LEU . 35.8 mtt-85 -122.87 150.52 42.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.3 tp -121.99 126.91 49.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.532 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.13 128.92 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 85.5 m-20 -97.85 146.45 25.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.462 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.29 133.94 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.44 136.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 47.1 59.53 16.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.4 Cg_endo -70.11 144.24 51.58 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.78 2.32 . . . . 0.0 111.825 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.413 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -121.89 167.96 12.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.426 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.5 Cg_endo -67.42 -26.12 41.22 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.722 2.281 . . . . 0.0 111.631 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.78 -25.29 66.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.173 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -70.23 -39.16 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.5 -42.78 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.0 m-20 -56.78 -44.11 81.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.324 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.55 86.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -65.1 -40.36 94.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.589 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 65.1 mtm -68.38 -29.74 68.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 41.8 mtp85 -75.43 -29.44 59.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 67' ' ' LEU . 74.5 mt -111.26 136.03 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -106.54 155.95 19.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.395 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 1.2 pp -70.35 140.18 87.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.12 154.45 66.32 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.724 2.283 . . . . 0.0 111.74 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 150.63 11.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 88.13 7.28 73.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -131.26 147.9 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -1.154 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 56.0 t0 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -124.97 146.14 49.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.7 mt -113.48 141.72 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 86.5 mtm-85 -121.57 136.7 54.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.593 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 53' ' ' LEU . 68.9 mt -114.72 140.05 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 16.2 tttp -108.15 125.11 51.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 19' ' ' LEU . 47.4 mt -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.374 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' CE ' ' HD3' ' A' ' 10' ' ' LYS . 93.5 mttt -130.63 132.9 45.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.567 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -171.01 151.3 3.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.401 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.5 -32.33 64.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 92.6 m-20 -90.8 108.21 19.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.875 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 46.3 t-80 -58.75 -46.93 86.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.927 . . . . 0.0 109.466 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -59.28 -45.39 91.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 24.6 tp -62.61 -38.46 90.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 11' ' ' LEU . 15.6 tp -57.73 -38.32 75.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . 45.6 t0 -65.08 -40.2 94.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.74 -41.17 85.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.4 p -67.78 -34.05 76.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -71.28 -41.85 69.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -60.45 -43.53 96.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' O ' HG23 ' A' ' 29' ' ' VAL . 64.8 tttt -59.15 -49.17 78.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 109.498 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 22' ' ' SER . 28.2 mm -66.5 -39.51 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 23' ' ' ALA . 82.7 t -60.62 -42.2 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' LYS . 22.0 t -72.25 -40.71 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.53 -45.87 81.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -61.21 -38.09 85.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.8 p -57.34 -28.69 63.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.5 p -82.0 161.18 23.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.64 -35.78 66.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.429 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 19.6 m -64.53 149.5 48.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.25 150.52 25.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.83 147.09 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 39.1 m -119.27 145.06 46.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.1 -155.75 16.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.61 141.27 67.57 Favored 'Cis proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.672 -1.803 . . . . 0.0 111.72 0.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.5 mt -94.36 120.79 64.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.361 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.6 128.16 14.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.728 2.285 . . . . 0.0 111.827 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 3.1 mp -108.29 171.32 4.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.444 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.51 137.0 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.777 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 49' ' ' VAL . 32.6 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 45' ' ' THR . 47.4 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 92.6 m-70 -94.9 148.22 22.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.8 mtmt -138.6 146.63 42.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.555 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 87.6 mtt-85 -128.58 154.29 46.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.898 . . . . 0.0 109.371 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 9' ' ' ILE . 29.5 tp -123.78 129.01 50.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.629 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.565 HD11 HD11 ' A' ' 11' ' ' LEU . 64.2 mt -114.38 122.65 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 86.7 m-20 -93.11 141.53 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ILE . 69.2 mt -118.95 129.37 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.349 -0.844 . . . . 0.0 109.252 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.4 mt -110.13 142.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.642 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 35' ' ' SER . 12.2 t0 50.26 60.84 14.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.33 140.12 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.666 2.244 . . . . 0.0 111.923 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.09 167.81 16.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.18 -26.17 36.49 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.697 2.265 . . . . 0.0 111.64 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -64.55 -21.98 66.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.8 m -73.32 -40.55 64.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.18 -39.69 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 91.2 m-20 -61.99 -42.09 98.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.334 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.7 81.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -62.72 -40.19 96.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -69.23 -29.48 67.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.387 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 50.3 mtt180 -75.96 -29.67 58.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 59.9 mt -113.72 133.21 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -101.93 142.39 33.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 109.475 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.05 155.0 4.74 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HG3' ' HA ' ' A' ' 22' ' ' SER . 50.6 Cg_endo -69.95 144.37 52.82 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.759 2.306 . . . . 0.0 111.792 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.02 147.0 48.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.08 62.32 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 22' ' ' SER . 49.7 t -129.69 147.87 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 86.2 m-20 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 23.8 pttm -130.77 151.2 51.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 59' ' ' PRO . 85.3 mt -118.76 139.76 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.535 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 82.4 mtt180 -118.94 135.09 54.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.04 136.02 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.419 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD13 ' A' ' 53' ' ' LEU . 77.5 mttt -111.74 130.74 55.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 10' ' ' LYS . 13.8 mt -112.72 137.02 51.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.632 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -122.26 142.86 50.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.83 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -170.64 148.05 2.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.691 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -57.3 -48.39 79.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.615 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -89.52 127.9 35.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.599 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.578 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.4 p-80 -75.08 -34.61 61.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.31 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -57.92 -41.42 82.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.865 . . . . 0.0 109.393 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.73 -43.55 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.83 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.4 mt -54.33 -40.7 68.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -64.23 -36.44 84.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -70.36 -38.91 74.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 26' ' ' ILE . 25.6 t -69.86 -42.07 74.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.26 -38.26 81.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 21.3 tttt -61.29 -47.14 87.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -62.33 -43.64 98.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 22' ' ' SER . 79.7 mt -67.49 -39.81 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.7 t -63.08 -43.08 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.7 mt-10 -62.61 -39.27 93.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.5 t -74.92 -37.7 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -68.88 -48.38 63.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 78.6 mttt -58.74 -40.3 83.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -50.27 -28.6 8.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.1 p -78.34 165.7 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -57.72 -32.66 67.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 56.5 p -64.93 157.71 27.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -107.03 152.35 24.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.935 HG21 ' HB3' ' A' ' 30' ' ' ALA . 44.6 t -124.94 143.66 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 5.8 t -123.94 137.84 54.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.541 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.26 -151.2 16.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.527 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.37 56.65 Favored 'Cis proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.677 -1.801 . . . . 0.0 111.794 -0.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.98 124.5 61.73 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.1 140.73 38.3 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.654 2.236 . . . . 0.0 111.664 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -116.68 174.77 2.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.416 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.53 135.39 28.5 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.661 2.241 . . . . 0.0 111.81 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 31.9 m . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.389 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 48.1 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 83.4 m-70 -102.23 153.97 19.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 12.5 mtmt -136.3 141.76 43.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.531 ' CD ' ' HB3' ' A' ' 19' ' ' LEU . 61.0 mtp85 -121.7 149.41 43.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.212 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.533 ' HB2' HD13 ' A' ' 43' ' ' LEU . 32.6 tp -124.57 128.84 49.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.517 HD11 ' CB ' ' A' ' 23' ' ' ALA . 70.1 mt -116.53 121.26 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.335 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 84.6 m-20 -90.9 146.38 23.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.564 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.92 130.73 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.337 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.47 140.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 30.5 t0 47.84 61.69 13.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.9 141.63 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 111.715 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.406 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -124.16 167.88 14.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.14 -22.2 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.725 2.283 . . . . 0.0 111.573 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -67.46 -25.56 65.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.422 ' HA ' HG21 ' A' ' 33' ' ' THR . 32.5 m -70.92 -41.37 71.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.183 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.9 -42.05 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.572 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.5 t0 -57.31 -45.94 83.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.246 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -61.28 -35.24 76.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.4 tp -66.72 -39.09 87.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.572 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 63.8 mtm -70.13 -26.2 63.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.383 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -79.99 -27.85 39.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -112.47 137.12 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.1 139.0 41.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 72' ' ' LEU . 3.3 pp -59.35 144.22 84.16 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 72' ' ' LEU . 51.9 Cg_endo -70.95 151.33 62.21 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.667 2.245 . . . . 0.0 111.818 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.55 26.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.11 5.41 65.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -129.45 147.06 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -1.182 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.7 t0 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -132.75 148.8 52.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.2 mt -114.59 138.99 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 53' ' ' LEU . 88.6 mtt180 -121.26 136.5 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.893 . . . . 0.0 109.549 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.607 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.3 mt -116.02 135.63 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.734 ' HG2' HD13 ' A' ' 53' ' ' LEU . 80.0 mttt -108.64 131.37 54.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 10' ' ' LYS . 15.5 mt -110.47 138.87 46.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 61.2 mttp -122.57 134.2 54.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -168.73 146.62 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.493 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.37 -37.11 86.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -96.64 123.19 40.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.8 p-80 -72.78 -30.01 63.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 16' ' ' HIS . 75.3 mm-40 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.28 -37.19 84.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 13' ' ' ALA . 59.5 mt -70.44 -37.42 74.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -62.18 -42.32 99.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.02 -45.72 73.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.473 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.2 t -63.86 -40.46 96.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -65.7 -41.92 91.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.482 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -57.42 -46.06 83.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.461 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.6 mttm -58.46 -44.42 89.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 22' ' ' SER . 24.6 mm -65.68 -43.13 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.55 -46.23 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -62.83 -44.71 95.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.589 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.7 t -66.77 -45.29 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.901 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.33 -43.64 90.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.602 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -56.02 -39.22 71.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.5 p -60.12 -24.98 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 p -80.42 163.14 24.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -56.74 -30.18 63.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.8 p -72.37 155.35 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -112.11 145.11 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 ' CB ' ' A' ' 30' ' ' ALA . 43.9 t -124.42 141.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -117.6 138.64 51.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.71 -158.41 23.77 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.596 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.35 56.53 Favored 'Cis proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.685 -1.798 . . . . 0.0 111.781 -0.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.98 131.48 37.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.44 141.19 41.86 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.603 2.202 . . . . 0.0 111.82 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -125.37 174.76 3.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 109.482 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 51.6 Cg_endo -70.51 146.66 56.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.747 2.298 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 50' ' ' HIS . 25.3 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 45' ' ' THR . 50.4 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.245 0.545 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 71.1 m80 -101.02 151.1 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 46.9 mtmt -137.76 141.5 40.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -125.9 146.67 49.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.285 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD13 ' HG2' ' A' ' 10' ' ' LYS . 29.0 tp -122.54 133.66 54.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.686 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 68.7 mt -115.26 126.7 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.314 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -91.22 142.14 28.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ILE . 59.6 mt -123.04 130.47 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.969 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.7 mt -112.55 141.58 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.709 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 35' ' ' SER . 65.5 t0 45.9 62.3 11.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.601 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.26 141.63 43.69 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.735 2.29 . . . . 0.0 111.663 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -129.4 170.67 10.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.9 Cg_endo -67.44 -28.67 38.66 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.705 2.27 . . . . 0.0 111.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.54 -24.9 68.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.28 -0.887 . . . . 0.0 109.133 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -71.57 -40.77 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.25 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.616 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.5 m-20 -58.89 -44.12 91.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -62.79 -41.17 99.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.377 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.4 tp -60.96 -39.5 89.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.407 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.29 -31.47 72.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.459 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 19.2 mtp180 -71.06 -30.06 66.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.609 ' CD1' HG21 ' A' ' 29' ' ' VAL . 70.3 mt -112.58 133.82 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.26 141.32 38.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.44 148.59 79.96 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.597 ' HG2' HG21 ' A' ' 76' ' ' VAL . 50.2 Cg_endo -70.3 149.44 63.48 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.742 2.294 . . . . 0.0 111.788 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.21 147.88 28.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.35 70.13 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.0 t -126.75 148.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.147 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 23.0 t70 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 37.1 mtmt -126.84 147.34 50.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.536 HD12 ' HB3' ' A' ' 59' ' ' PRO . 82.2 mt -113.65 137.34 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 53' ' ' LEU . 92.8 mtt180 -123.11 136.47 54.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.5 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HD22 ' A' ' 53' ' ' LEU . 69.4 mt -114.58 134.3 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.796 ' HG2' HD23 ' A' ' 53' ' ' LEU . 40.4 mttt -105.35 128.73 53.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.1 mp -112.67 133.8 54.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 88.3 mttt -128.4 138.4 52.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.808 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -169.57 147.61 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.49 -38.13 86.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -97.24 125.09 41.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.7 p-80 -71.13 -28.6 64.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 49.3 mt -65.75 -39.7 91.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 13' ' ' ALA . 68.2 mt -67.41 -36.62 81.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.59 -43.61 98.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.34 -40.3 85.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.7 t -65.14 -41.54 94.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -68.54 -40.84 80.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -58.99 -48.15 82.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mttm -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 22' ' ' SER . 84.0 mt -62.67 -46.45 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.89 -48.35 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.66 -48.08 83.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.47 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' LYS . 27.6 t -69.0 -42.53 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.847 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -64.46 -47.6 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -54.16 -40.76 67.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -58.39 -33.69 69.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.447 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 62' ' ' LYS . 25.3 m -72.84 153.85 40.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -50.67 -29.51 11.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 45.3 p -69.76 157.72 36.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -117.47 138.87 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.847 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.0 t -117.64 142.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 t -114.86 142.48 46.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.99 -153.15 19.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 49.9 Cg_endo -70.4 140.97 65.7 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.815 -0.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.18 128.06 48.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.414 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.72 138.18 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.74 2.293 . . . . 0.0 111.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -118.3 176.2 1.76 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.317 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.9 Cg_endo -70.21 142.95 47.25 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.562 2.175 . . . . 0.0 111.778 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.6 -179.863 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.589 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 90.7 m-70 -108.85 152.44 24.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.412 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 53.4 mtmt -134.18 145.78 49.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.615 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -131.19 146.66 52.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 109.229 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.943 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.3 tm? -121.81 132.33 54.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.943 ' N ' HD13 ' A' ' 53' ' ' LEU . 66.4 mt -117.77 122.2 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.249 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 37' ' ' VAL . 82.4 m-20 -90.11 145.64 24.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.609 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 37' ' ' VAL . 65.5 mt -127.58 128.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.29 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.95 142.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.83 62.26 12.51 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.61 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.9 Cg_endo -69.95 146.07 57.93 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.691 2.261 . . . . 0.0 111.775 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -129.76 165.75 30.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 60' ' ' SER . 45.3 Cg_endo -67.49 -24.82 41.99 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.611 2.207 . . . . 0.0 111.649 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HB2' HG23 ' A' ' 33' ' ' THR . 40.2 mttm -64.66 -26.35 68.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.055 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 33' ' ' THR . 62.1 m -70.01 -38.71 76.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.242 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.29 -43.65 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -57.73 -41.87 82.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.349 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.58 -39.41 91.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 16.2 tp -63.7 -42.32 98.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 69.0 mtm -64.69 -31.83 73.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 31.4 mtp180 -71.07 -29.79 65.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.7 mt -109.48 136.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -107.76 135.18 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.405 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.33 145.91 93.61 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.29 147.04 58.58 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.676 2.251 . . . . 0.0 111.742 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 152.88 39.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.64 3.61 55.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.79 146.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.8 m-20 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 4.2 pttm -126.06 158.19 36.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.4 mt -116.95 141.22 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 62.1 mtt85 -118.41 135.4 54.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.9 mt -119.49 134.24 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 53' ' ' LEU . 69.6 mttt -107.16 132.64 52.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -111.02 139.65 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -126.78 129.54 48.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.804 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -163.61 151.69 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -71.82 -30.75 65.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.53 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -97.12 115.24 27.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.627 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 45.2 t-80 -61.07 -46.49 90.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -56.38 -41.97 77.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.5 tm? -57.36 -39.61 76.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.292 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD21 ' CB ' ' A' ' 13' ' ' ALA . 66.7 mt -61.86 -39.13 90.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.79 -39.42 84.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.02 -38.3 90.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' HD23 ' A' ' 11' ' ' LEU . 87.0 p -65.55 -33.04 74.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -74.16 -34.34 63.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -63.8 -43.95 94.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.1 mttt -64.54 -46.11 84.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 22' ' ' SER . 26.1 mm -69.68 -44.07 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 23' ' ' ALA . 70.4 t -64.21 -44.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.48 -45.31 93.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 25' ' ' LYS . 37.5 t -71.71 -41.33 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.554 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.803 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.96 -46.31 78.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -59.2 -39.14 81.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.7 m -59.23 -31.11 68.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.3 p -75.37 163.34 27.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -56.03 -33.48 64.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 61.0 p -67.62 161.05 26.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.912 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -122.91 138.0 54.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.803 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.8 t -112.75 140.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.2 m -114.33 146.39 40.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.35 -149.72 16.97 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.98 148.05 86.39 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.767 -1.764 . . . . 0.0 111.8 -0.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.3 mp -90.07 128.61 49.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.543 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.02 123.92 10.11 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.686 2.258 . . . . 0.0 111.595 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.1 mp -106.8 173.25 3.24 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.4 Cg_endo -69.01 151.14 73.36 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.798 2.332 . . . . 0.0 111.909 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 14.8 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' A' ' 45' ' ' THR . 48.3 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.538 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 92.3 m-70 -105.29 150.62 25.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 22.7 mtmm -133.41 146.73 51.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 86.6 mtt-85 -130.62 149.49 52.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 41' ' ' ILE . 27.8 tp -122.38 128.36 50.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG22 ' CG1' ' A' ' 37' ' ' VAL . 66.5 mt -110.23 127.56 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -96.59 138.34 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 62.2 mt -118.16 131.23 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -111.98 138.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 49.22 57.86 18.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.591 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.6 Cg_endo -70.27 138.3 35.88 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.626 2.218 . . . . 0.0 111.826 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -118.22 168.1 10.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.45 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 48.0 Cg_endo -68.3 -21.66 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.707 2.272 . . . . 0.0 111.675 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -68.07 -23.99 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.237 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -70.28 -40.99 73.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.42 -39.54 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.619 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.4 m-20 -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.89 84.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' ILE . 26.7 tp -62.92 -37.53 87.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.619 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 73.9 mtm -69.7 -34.55 74.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.358 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.59 -28.1 61.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -107.07 138.74 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.07 138.96 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 147.52 78.15 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.311 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.64 142.58 48.87 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.678 2.252 . . . . 0.0 111.781 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.96 51.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.68 5.19 60.18 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 ' CG2' HD12 ' A' ' 18' ' ' LEU . 59.6 t -132.16 148.55 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -1.186 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 3.6 pttm -136.82 143.0 42.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 59' ' ' PRO . 69.0 mt -115.37 138.35 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 55' ' ' ASP . 93.4 mtt-85 -118.48 132.81 56.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.1 132.04 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -105.66 136.78 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.1 mp -109.5 138.63 45.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 24.1 mttt -127.33 137.6 52.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -165.15 145.77 7.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -57.44 -51.87 67.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.55 127.66 36.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.708 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 45.8 t-80 -66.49 -37.44 85.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.74 -44.06 81.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.11 -37.79 88.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 19' ' ' LEU . 7.2 tt -65.43 -39.47 92.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -59.99 -42.72 94.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.13 -41.05 91.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.344 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 26' ' ' ILE . 20.3 m -64.57 -44.0 92.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.767 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -68.33 -42.68 78.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 109.401 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -64.25 -42.59 96.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 tttt -58.1 -49.85 75.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 22' ' ' SER . 26.9 mm -64.83 -40.94 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.506 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.7 t -58.43 -45.9 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -61.06 -43.34 99.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 25' ' ' LYS . 21.7 t -71.99 -40.9 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.902 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.08 -47.1 84.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HE2' HG13 ' A' ' 27' ' ' VAL . 28.9 mttm -59.82 -39.63 85.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -53.99 -31.52 51.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 p -76.38 163.0 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.58 -32.5 67.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.3 p -61.73 159.53 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -113.78 145.06 41.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 30' ' ' ALA . 31.5 t -123.75 141.59 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 13.2 t -117.83 140.21 50.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.85 -148.42 17.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 144.21 78.04 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.793 -1.753 . . . . 0.0 111.724 0.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.75 119.78 65.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.77 137.15 31.92 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.584 2.189 . . . . 0.0 111.85 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -118.54 174.77 2.46 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HD2' HD23 ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.03 133.33 24.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.692 2.262 . . . . 0.0 111.776 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.534 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 90.8 m-70 -97.94 153.16 18.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 48.9 mtmt -141.33 141.63 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.664 ' CD ' HD22 ' A' ' 19' ' ' LEU . 21.6 mtp180 -125.94 158.89 34.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.295 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.1 tp -124.04 127.99 48.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.529 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 23' ' ' ALA . 63.7 mt -116.23 120.69 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' CG ' ' NH1' ' A' ' 8' ' ' ARG . 86.5 m-20 -89.2 145.31 25.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 65.8 mt -125.68 126.72 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.0 mt -108.33 141.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 53.12 61.26 11.39 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.54 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.4 Cg_endo -69.95 145.66 56.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.702 2.268 . . . . 0.0 111.737 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.13 166.91 25.71 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.98 -24.03 39.86 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.771 2.314 . . . . 0.0 111.619 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -65.61 -24.6 67.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.217 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.7 m -72.57 -40.75 66.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.312 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.12 -40.84 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.57 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.9 m-20 -62.2 -42.27 99.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.41 89.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.925 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 30.6 tp -64.44 -39.23 93.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.57 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 58.5 mtm -68.66 -29.94 68.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 61.6 mtt-85 -74.78 -28.76 60.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.589 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -111.32 135.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.75 130.91 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.529 HD23 HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -55.99 152.06 22.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.405 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.34 151.15 71.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.647 2.231 . . . . 0.0 111.795 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.89 149.3 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.44 1.87 66.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 72' ' ' LEU . 39.5 t -127.29 147.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 45.2 t0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 12.8 pttm -125.72 161.53 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 71.4 mt -122.11 137.51 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.603 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.613 ' O ' HD13 ' A' ' 9' ' ' ILE . 96.2 mtt180 -113.76 137.2 51.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 8' ' ' ARG . 23.6 mm -118.78 125.1 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.644 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.614 ' C ' HD12 ' A' ' 11' ' ' LEU . 24.4 mttt -106.05 132.28 52.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.253 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -117.92 138.87 51.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 84.9 mttt -128.78 132.58 47.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -157.39 141.37 16.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.557 ' CD1' HG22 ' A' ' 49' ' ' VAL . 98.5 m-85 -65.39 -35.51 81.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.41 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -93.7 116.5 29.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.875 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.718 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 46.8 t-80 -62.95 -35.36 79.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.15 -42.81 91.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.24 -37.11 83.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 11' ' ' LEU . 12.8 tp -70.79 -37.26 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -62.74 -39.96 95.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.2 mm-40 -69.91 -44.27 70.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 26' ' ' ILE . 97.6 p -60.97 -36.51 79.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -73.77 -51.06 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 17.1 mttm -65.22 -46.16 81.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 mtmt -59.85 -47.49 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.663 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 22' ' ' SER . 96.9 mt -68.15 -39.67 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' ALA . 66.5 t -62.01 -43.01 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 97.2 mt-10 -64.78 -38.19 90.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' LYS . 39.7 t -75.17 -38.84 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.634 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.046 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -65.8 -49.25 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.575 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE3' HG13 ' A' ' 27' ' ' VAL . 80.8 mttt -60.14 -37.56 80.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.553 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 m -56.63 -30.19 63.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' VAL . 30.1 p -75.66 164.2 26.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -56.66 -35.95 68.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -60.06 159.17 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -109.45 143.03 39.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.046 HG21 ' HB1' ' A' ' 30' ' ' ALA . 40.7 t -126.38 141.59 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 39.0 m -116.21 149.1 39.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 112.12 -150.49 18.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.8 Cg_endo -70.74 147.92 87.79 Favored 'Cis proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.746 -1.772 . . . . 0.0 111.759 -0.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -101.44 119.97 56.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.94 141.22 39.92 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 111.821 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -118.6 176.17 1.79 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.288 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.6 Cg_endo -69.49 135.55 31.38 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.608 2.206 . . . . 0.0 111.728 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 49' ' ' VAL . 26.0 m . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 45' ' ' THR . 45.1 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.282 0.563 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.718 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 81.9 m-70 -100.75 148.09 25.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 41.6 mtmt -134.88 141.55 46.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' CZ ' ' NE2' ' A' ' 16' ' ' HIS . 86.8 mtt-85 -124.45 151.38 44.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -121.79 125.55 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.693 ' N ' HD23 ' A' ' 53' ' ' LEU . 64.3 mt -115.39 122.28 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 52.4 t0 -91.2 140.34 29.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 7' ' ' ILE . 63.7 mt -117.59 128.06 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 0.0 109.398 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.91 137.83 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 51.29 63.71 9.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.81 143.09 49.47 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.771 2.314 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -131.07 168.17 18.45 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 44.9 Cg_endo -67.21 -24.42 44.17 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.644 2.23 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -65.83 -27.06 67.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 109.175 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.421 ' HA ' HG21 ' A' ' 33' ' ' THR . 40.8 m -68.94 -41.52 77.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.216 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.81 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 109.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 85.6 m-20 -59.16 -42.41 90.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.403 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.33 -38.21 89.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -63.88 -43.24 96.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -65.82 -29.35 69.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.93 . . . . 0.0 109.507 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 12.8 mtt-85 -73.47 -29.77 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -110.85 136.06 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.44 127.9 53.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' A' ' 76' ' ' VAL . 3.3 pp -58.79 143.68 82.29 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.466 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.535 ' O ' HD12 ' A' ' 72' ' ' LEU . 49.6 Cg_endo -70.01 150.31 66.49 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.799 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 151.42 18.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 94.75 5.98 60.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 72' ' ' LEU . 46.2 t -121.32 147.75 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.175 . . . . 0.0 109.439 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 56.6 t0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 8' ' ' ARG . 58.7 pttt -137.26 142.95 41.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.478 ' HB ' HD12 ' A' ' 56' ' ' ILE . 83.9 mt -118.79 143.88 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 6' ' ' LYS . 67.8 mtt85 -116.17 136.44 53.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 73.1 mt -121.53 131.17 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 11' ' ' LEU . 91.0 mttt -97.34 139.04 33.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 19' ' ' LEU . 16.4 mt -115.01 130.77 57.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.355 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 87.3 mttt -120.53 137.16 54.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -167.94 146.32 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -68.22 -39.45 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -101.75 118.19 36.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 20.6 p80 -55.99 -43.87 78.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 81.2 tt0 -51.46 -53.57 35.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.16 -40.5 70.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.226 -0.921 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 11' ' ' LEU . 13.4 tp -68.25 -32.61 72.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 86.8 m-20 -63.76 -38.64 91.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.17 -41.59 81.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.8 t -61.68 -38.91 89.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.28 -37.01 74.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.11 -44.23 97.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.2 mttt -63.43 -41.11 98.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.349 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 22' ' ' SER . 78.2 mt -68.67 -42.2 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.0 t -64.73 -48.86 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.75 -43.83 98.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 25' ' ' LYS . 31.8 t -70.55 -41.9 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.62 76.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -59.99 -37.29 79.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.32 -30.64 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.5 p -76.5 160.58 29.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -55.12 -35.17 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.8 p -66.08 157.74 30.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -113.26 139.38 48.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 7.7 p -113.03 147.33 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 8.9 t -120.81 142.09 49.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.03 -149.72 17.33 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.1 Cg_endo -70.41 144.47 78.13 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 -1.799 . . . . 0.0 111.814 -0.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.1 mp -89.7 114.18 59.64 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.7 139.26 27.71 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.665 2.244 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.0 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.82 176.01 2.08 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.64 132.74 24.16 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.572 2.181 . . . . 0.0 111.753 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.583 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.1 m-70 -91.51 153.37 19.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -130.43 132.35 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.743 ' C ' HD12 ' A' ' 53' ' ' LEU . 30.6 mtt-85 -130.03 140.84 50.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.221 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.0 ' CD1' HD13 ' A' ' 43' ' ' LEU . 4.3 mp -122.43 138.04 54.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.734 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 71.8 mt -117.74 128.46 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.865 . . . . 0.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 91.5 m-20 -91.37 144.55 25.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB ' ' A' ' 7' ' ' ILE . 61.0 mt -120.36 137.11 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.23 136.89 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 45.19 62.17 10.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.3 Cg_endo -70.01 141.16 43.5 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.77 2.313 . . . . 0.0 111.735 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -127.88 173.0 5.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.33 -27.1 40.87 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.724 2.283 . . . . 0.0 111.804 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -64.79 -24.31 67.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.9 m -71.82 -42.39 67.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.247 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.93 -44.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.14 -48.09 76.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -55.46 -40.0 71.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.337 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.1 tp -62.44 -34.57 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.64 -30.51 69.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.469 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 38.5 mtm105 -74.12 -30.4 62.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 29' ' ' VAL . 66.9 mt -114.07 131.41 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -106.61 141.65 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.497 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.81 141.25 80.48 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.54 149.94 62.67 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.692 2.261 . . . . 0.0 111.724 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.95 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.39 -3.18 71.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 40.6 t -120.4 148.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -1.216 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 53.9 t0 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.391 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 25.7 pttm -126.55 158.98 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 76.8 mt -115.63 137.06 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -119.66 137.29 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.67 135.6 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 13.7 tttp -107.34 121.01 43.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.81 ' O ' HD21 ' A' ' 19' ' ' LEU . 37.6 mt -101.65 126.86 48.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 96.4 mttt -121.32 137.37 54.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -167.26 143.69 4.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.516 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.01 -41.34 99.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.76 114.47 26.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.633 ' CE1' ' CG ' ' A' ' 17' ' ' GLU . 21.1 p80 -61.21 -35.44 77.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.422 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CG ' ' CE1' ' A' ' 16' ' ' HIS . 86.8 mt-10 -65.14 -39.87 93.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.04 -39.48 83.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 11' ' ' LEU . 14.0 tp -59.69 -38.22 80.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -65.57 -35.28 80.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.93 -39.54 94.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 76' ' ' VAL . 17.6 m -68.82 -37.5 79.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -72.71 -37.08 67.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 24.0 tttt -61.34 -45.21 95.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 29' ' ' VAL . 80.2 mttt -63.79 -41.34 97.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 79.5 mt -70.52 -43.29 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 23' ' ' ALA . 71.1 t -62.01 -45.36 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.9 mt-10 -61.5 -43.25 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' LYS . 32.2 t -72.94 -37.19 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.003 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -67.18 -49.5 64.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CE ' HG12 ' A' ' 27' ' ' VAL . 5.1 mtmp? -58.42 -37.23 74.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 m -57.12 -34.67 68.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' OG1' ' A' ' 63' ' ' THR . 27.8 m -73.37 154.47 40.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -50.99 -35.17 32.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.0 p -60.76 157.24 15.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -112.73 145.42 40.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.003 HG21 ' HB1' ' A' ' 30' ' ' ALA . 49.9 t -122.42 142.21 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 t -113.91 135.64 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.71 -155.59 21.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.38 138.11 48.94 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.77 0.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.28 115.42 63.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.01 139.41 32.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.619 2.213 . . . . 0.0 111.754 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mp -118.48 175.53 2.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.3 133.23 24.1 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.642 2.228 . . . . 0.0 111.76 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 21.6 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 45' ' ' THR . 50.4 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.249 0.547 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 82.6 m-70 -101.27 150.76 22.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' HE2' ' A' ' 10' ' ' LYS . 9.4 mtmt -133.44 140.75 47.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.688 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 19' ' ' LEU . 88.8 mtt-85 -124.74 149.62 47.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.221 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -122.51 131.68 53.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.745 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.9 mt -119.17 124.39 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.197 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -99.95 140.52 34.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.717 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 66.9 mt -120.89 130.48 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.231 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -111.55 140.2 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t0 51.4 59.91 14.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.7 Cg_endo -70.59 140.66 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 111.712 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.73 165.1 17.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.31 -19.98 49.34 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.631 2.221 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -71.07 -28.03 64.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.518 ' OG1' HG21 ' A' ' 33' ' ' THR . 53.8 m -72.08 -39.23 69.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.244 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.11 -41.58 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.309 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.537 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.878 . . . . 0.0 109.346 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.79 75.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.355 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -66.04 -41.87 90.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.537 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 67.6 mtm -65.53 -28.76 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -77.43 -28.41 52.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.1 mt -110.94 134.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -106.95 131.38 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -46.9 144.54 3.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HG ' ' A' ' 72' ' ' LEU . 49.5 Cg_endo -69.9 148.49 64.31 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.698 2.265 . . . . 0.0 111.827 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.06 152.0 41.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.46 -3.89 56.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG21 ' OG ' ' A' ' 22' ' ' SER . 48.4 t -124.76 148.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -1.181 . . . . 0.0 109.454 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 26.3 pttm -132.79 161.84 33.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 56' ' ' ILE . 10.5 mm -118.75 141.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.727 ' HB3' HD11 ' A' ' 53' ' ' LEU . 77.1 mtm180 -125.71 127.08 45.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 68.5 mt -114.96 135.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' C ' HD12 ' A' ' 11' ' ' LEU . 54.0 mttm -104.87 127.46 52.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -101.24 134.64 43.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.406 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 67.8 mttm -121.48 135.42 55.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -169.33 149.3 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.38 -39.96 67.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.34 119.38 32.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.8 p-80 -64.93 -38.21 90.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.7 mt-10 -59.83 -38.16 81.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.446 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -36.62 61.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 11' ' ' LEU . 14.4 tp -67.22 -35.86 80.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -62.9 -42.4 99.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.36 -40.96 98.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 m -63.26 -37.82 88.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -72.31 -44.62 62.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -59.62 -43.72 93.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.4 tttt -60.89 -45.93 92.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 22' ' ' SER . 89.6 mt -64.55 -40.13 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.5 t -62.47 -44.82 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.1 -41.12 97.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 25' ' ' LYS . 25.8 t -71.81 -43.36 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.017 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -65.83 -48.7 70.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -57.64 -37.89 74.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.86 -29.2 64.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.2 p -73.28 163.84 27.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.5 -33.25 67.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 60.7 p -69.37 158.82 34.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -108.29 151.09 26.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 30' ' ' ALA . 26.6 m -127.98 145.45 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -118.38 147.86 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.32 -156.29 18.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.2 Cg_endo -70.36 142.68 72.42 Favored 'Cis proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.781 -0.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 53' ' ' LEU . 4.4 mt -95.48 121.56 61.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 133.35 24.93 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.714 2.276 . . . . 0.0 111.899 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.9 mp -110.09 172.64 3.44 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -68.92 141.03 47.49 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.701 2.267 . . . . 0.0 111.713 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 11.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.917 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 46.6 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.586 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 72.3 m80 -106.92 145.65 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 16.7 mttt -133.23 145.21 50.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' LEU . 89.0 mtt-85 -129.22 145.71 51.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.174 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 8' ' ' ARG . 26.5 tp -121.62 130.98 53.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.2 mt -116.42 118.21 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 81.5 m-20 -89.47 148.77 23.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.747 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' HB ' ' A' ' 7' ' ' ILE . 32.5 mt -124.51 130.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.354 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.87 136.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t0 48.51 60.86 14.93 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.349 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 49.4 Cg_endo -69.72 142.2 47.47 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.773 2.316 . . . . 0.0 111.846 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -125.27 173.97 4.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.6 Cg_endo -67.88 -22.96 41.75 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.693 2.262 . . . . 0.0 111.663 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.44 -24.73 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.265 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 33' ' ' THR . 52.7 m -73.24 -40.2 64.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.24 -40.25 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.863 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.591 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -63.79 -39.54 94.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.21 -42.32 88.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 20.2 tp -63.78 -38.45 91.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.591 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 60.4 mtm -69.26 -30.41 68.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 52.2 mtt180 -75.77 -29.06 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.518 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 29' ' ' VAL . 72.1 mt -111.4 135.91 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.434 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -112.86 134.68 54.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -51.96 146.76 13.95 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.77 152.37 69.26 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.639 2.226 . . . . 0.0 111.806 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.44 149.12 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.14 -6.03 63.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 67.1 t -125.61 148.53 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -1.192 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.7 m-20 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 22.3 pttm -130.5 153.56 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.6 mt -117.83 142.33 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.362 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 68.3 mtt180 -121.84 134.96 54.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 81.0 mt -117.06 135.7 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.434 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 28.3 tttp -105.75 130.51 53.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 49.8 mt -107.87 127.94 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.571 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HE3' ' HD3' ' A' ' 10' ' ' LYS . 70.6 mttt -122.39 136.5 54.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.091 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -167.08 141.02 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -54.39 -50.78 66.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-20 -83.79 131.78 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.745 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 79.3 t60 -71.08 -35.57 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.339 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.19 -35.49 69.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.424 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 15' ' ' ASP . 82.7 mt -64.31 -35.08 79.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.091 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 6.6 mp -73.56 -39.28 64.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -64.54 -45.33 87.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.15 -41.64 73.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.0 m -65.09 -39.79 93.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.52 87.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.09 -39.68 94.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 mttt -65.04 -43.02 93.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.918 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' SER . 30.2 mm -65.53 -45.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.89 -45.34 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.86 -48.81 77.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 25' ' ' LYS . 64.6 t -69.26 -47.05 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.88 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -61.84 -49.32 76.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -58.32 -37.87 75.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 t -57.75 -30.36 65.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.4 p -75.09 163.3 27.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -56.51 -34.19 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.8 p -64.99 156.84 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -107.9 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.88 HG11 ' CB ' ' A' ' 30' ' ' ALA . 12.6 m -132.42 145.15 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.873 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 9.0 m -122.65 152.74 40.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.81 -143.84 17.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HB3' HG12 ' A' ' 54' ' ' ILE . 50.6 Cg_endo -70.98 146.7 85.46 Favored 'Cis proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.759 -1.767 . . . . 0.0 111.746 -0.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.32 114.47 60.49 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.266 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' O ' HD22 ' A' ' 43' ' ' LEU . 52.8 Cg_endo -72.58 140.0 32.11 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.723 2.282 . . . . 0.0 111.948 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 42' ' ' PRO . 3.9 mm? -118.43 166.87 12.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CD1' ' A' ' 43' ' ' LEU . 49.1 Cg_endo -69.68 128.2 15.75 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.634 2.222 . . . . 0.0 111.756 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 49' ' ' VAL . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' THR . 59.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 70.8 m-70 -97.55 157.9 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 38.6 mtmt -142.07 137.36 30.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.67 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.866 ' C ' HD12 ' A' ' 53' ' ' LEU . 21.5 mtp180 -131.99 150.3 52.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.866 HD12 ' C ' ' A' ' 52' ' ' ARG . 7.7 mp -127.15 145.69 50.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.167 -0.958 . . . . 0.0 109.741 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 40' ' ' PRO . 70.2 mt -123.81 117.94 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 38.7 t0 -78.56 140.67 38.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.14 124.84 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.354 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -107.81 139.48 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.544 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.76 63.62 9.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.5 Cg_endo -70.54 144.78 50.87 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.63 2.22 . . . . 0.0 111.675 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -131.4 172.05 8.03 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.597 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.24 -26.55 35.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 111.829 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -62.63 -20.99 65.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.7 m -74.32 -39.17 63.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.88 -40.17 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.558 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.8 m-20 -62.68 -41.3 99.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -64.5 -40.11 95.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.33 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.0 tp -64.0 -36.69 84.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.327 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.558 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 64.4 mtm -70.65 -27.06 63.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -78.67 -28.03 45.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.4 mt -112.93 135.32 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.82 133.73 51.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 145.7 98.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.58 150.64 63.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.685 2.256 . . . . 0.0 111.823 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.65 150.77 35.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.73 3.41 64.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.66 147.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.174 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HE3' ' NH1' ' A' ' 8' ' ' ARG . 52.0 pttt -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' ILE . 77.0 mt -119.0 140.18 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' NH1' ' HE3' ' A' ' 6' ' ' LYS . 62.6 mtt180 -116.92 137.35 52.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 8' ' ' ARG . 24.1 mm -112.46 133.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 78.4 mttt -109.22 133.89 52.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 23' ' ' ALA . 16.0 mt -112.83 133.23 54.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 77.6 mttt -122.73 131.45 53.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -161.86 144.97 12.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.3 -36.39 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.08 116.74 32.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.542 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 15.4 p80 -60.3 -46.22 90.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 86.9 tt0 -53.91 -46.55 71.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.219 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -61.96 -40.59 96.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.225 -0.922 . . . . 0.0 108.804 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -67.51 -32.8 73.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD1' ' NH1' ' A' ' 52' ' ' ARG . 91.3 m-20 -63.64 -39.54 94.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.438 -0.789 . . . . 0.0 109.325 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.3 mm-40 -64.58 -49.5 70.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.44 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 37.2 m -58.89 -45.71 89.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -62.62 -51.42 67.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -57.78 -45.51 85.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.5 mttm -59.76 -46.24 89.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 22' ' ' SER . 97.2 mt -64.2 -41.14 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.517 HG13 ' HE3' ' A' ' 31' ' ' LYS . 77.7 t -61.13 -46.31 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 -41.26 96.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 70' ' ' ILE . 38.6 t -72.59 -39.97 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.973 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.64 -46.56 78.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HE3' HG13 ' A' ' 27' ' ' VAL . 50.0 mttt -59.56 -37.3 78.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -57.42 -30.79 65.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.2 p -76.35 163.82 26.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.52 -34.16 70.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.6 p -62.85 157.66 20.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -111.84 146.57 37.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.973 HG21 ' CB ' ' A' ' 30' ' ' ALA . 42.7 t -123.66 141.02 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 21.3 t -116.79 138.81 51.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.08 -150.06 17.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.31 143.95 76.4 Favored 'Cis proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.844 -0.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.4 mt -95.7 126.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.374 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.84 136.78 33.64 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.634 2.223 . . . . 0.0 111.827 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.7 HD13 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -120.81 175.62 2.27 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 50.6 Cg_endo -70.84 138.57 34.68 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.695 2.264 . . . . 0.0 111.707 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.584 HG21 ' ND1' ' A' ' 50' ' ' HIS . 21.7 p . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 45' ' ' THR . 55.3 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.584 ' ND1' HG21 ' A' ' 45' ' ' THR . 62.2 m-70 -102.91 148.97 24.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -135.54 141.3 45.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.562 ' CD ' HD22 ' A' ' 19' ' ' LEU . 19.8 mtp180 -123.92 152.05 42.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.1 tp -121.64 130.7 53.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.0 mt -118.49 125.82 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.381 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.491 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 86.9 m-20 -89.79 142.46 27.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.515 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ILE . 61.8 mt -119.5 131.06 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.439 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -109.7 139.39 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.23 63.92 9.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.1 Cg_endo -69.5 144.67 56.2 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.763 2.309 . . . . 0.0 111.748 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.6 m -132.69 166.5 28.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.47 -25.66 41.3 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.7 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -63.57 -25.65 68.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.4 m -67.36 -43.72 80.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.183 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.53 -43.32 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.553 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.1 t0 -54.13 -43.28 70.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.313 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -63.55 -40.13 96.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 70' ' ' ILE . 28.5 tp -59.16 -41.07 87.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 75.3 mtm -64.58 -35.18 80.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -70.57 -27.27 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -107.32 132.92 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -108.17 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.71 141.3 97.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 151.38 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.669 2.246 . . . . 0.0 111.862 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.71 31.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.37 58.45 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 88.4 t -125.62 148.15 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -1.201 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -128.0 145.5 50.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -111.97 137.5 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.378 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 53' ' ' LEU . 57.7 mtm180 -122.96 135.5 54.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.8 mt -116.01 137.74 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.551 ' C ' HD12 ' A' ' 11' ' ' LEU . 11.4 tttp -110.25 128.83 55.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -112.6 120.65 42.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.254 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.488 ' HE3' ' HD3' ' A' ' 51' ' ' LYS . 28.5 mtpt -116.6 138.75 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.815 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -170.41 152.66 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.51 -36.01 73.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' OD2' ' HG ' ' A' ' 18' ' ' LEU . 50.6 t0 -93.13 114.3 26.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 17' ' ' GLU . 30.1 p-80 -67.14 -28.37 68.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HG2' ' CE1' ' A' ' 16' ' ' HIS . 66.3 mm-40 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 57.9 mt -64.1 -38.26 90.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 13' ' ' ALA . 60.1 mt -70.46 -34.52 72.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.514 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -63.92 -42.88 97.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -42.8 73.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.4 m -64.85 -38.62 91.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.417 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.81 -41.33 78.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -60.4 -46.85 88.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.907 ' O ' HG23 ' A' ' 29' ' ' VAL . 17.7 mtmm -60.9 -45.55 94.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 22' ' ' SER . 84.8 mt -65.03 -44.98 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.6 t -59.59 -48.19 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.17 -44.24 97.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 25' ' ' LYS . 18.5 t -68.11 -40.49 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.43 81.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -56.36 -38.16 71.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -57.91 -32.34 67.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 62' ' ' LYS . 23.9 m -74.31 152.25 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -50.32 -31.13 13.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 51.7 p -68.98 156.64 38.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -107.41 148.03 29.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -121.49 147.78 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 66.8 m -124.08 144.74 49.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.537 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.05 -155.09 16.34 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.41 140.61 63.58 Favored 'Cis proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.702 -1.791 . . . . 0.0 111.792 -0.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 10.1 mt -91.03 131.01 38.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.314 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.94 118.81 5.89 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.664 2.243 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -94.55 166.66 14.8 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.371 -0.831 . . . . 0.0 109.529 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.3 Cg_endo -67.66 143.66 62.99 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 111.604 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.6 m . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.958 . . . . 0.0 109.512 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 45' ' ' THR . 50.0 t . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 97.6 m-70 -98.76 145.23 27.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 9.0 mtmm -135.98 151.09 49.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -127.41 147.94 50.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -122.02 131.16 53.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 53' ' ' LEU . 66.8 mt -120.53 117.39 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 83.8 m-20 -89.05 145.36 25.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 7' ' ' ILE . 68.7 mt -124.22 122.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.34 144.16 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' SER . 10.6 t0 47.69 62.66 11.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.419 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.7 Cg_endo -70.41 148.88 61.81 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.73 2.287 . . . . 0.0 111.716 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.421 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -137.18 167.86 19.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.39 -25.86 41.64 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 122.685 2.256 . . . . 0.0 111.673 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB2' HG23 ' A' ' 33' ' ' THR . 67.4 mttm -64.23 -26.11 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.131 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 -42.42 77.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.26 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.56 -44.39 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.573 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 58.5 t0 -55.91 -41.82 75.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.61 84.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' ILE . 21.2 tp -61.38 -40.21 93.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.573 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.6 mtm -67.7 -34.48 76.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -71.23 -29.49 65.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.545 ' CD1' HG21 ' A' ' 29' ' ' VAL . 69.3 mt -108.94 133.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.442 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -116.54 123.45 47.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.82 150.62 26.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.08 148.65 63.43 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.628 2.219 . . . . 0.0 111.742 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.31 153.09 31.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.954 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.11 8.57 55.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.62 147.85 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -1.19 . . . . 0.0 109.472 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 64.7 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.292 0.568 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -132.49 143.22 49.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.461 HG13 ' HG3' ' A' ' 59' ' ' PRO . 79.9 mt -116.96 138.89 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 91.9 mtm-85 -119.71 136.74 54.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.583 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.11 131.97 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.405 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' HD13 ' A' ' 53' ' ' LEU . 68.3 tttt -97.6 125.5 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.6 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.824 ' HB3' HD11 ' A' ' 19' ' ' LEU . 44.3 mt -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 5.4 mtmp? -131.04 134.15 46.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -163.62 144.46 8.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' CD1' HG22 ' A' ' 49' ' ' VAL . 95.9 m-85 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' OD2' HD13 ' A' ' 18' ' ' LEU . 54.1 t0 -95.45 119.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 56.1 p-80 -61.6 -40.27 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.0 mt-10 -51.42 -52.26 47.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.3 mp -59.24 -43.94 92.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 11' ' ' LEU . 12.7 tp -65.58 -29.98 70.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.323 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 90.4 m-20 -67.3 -41.24 85.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 98.8 mt-10 -69.91 -35.45 74.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 26' ' ' ILE . 18.2 m -63.31 -40.22 96.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.2 -36.58 74.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 15.6 tttp -66.71 -39.74 88.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.1 mttm -65.2 -44.04 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 22' ' ' SER . 26.4 mm -69.49 -39.55 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 23' ' ' ALA . 78.7 t -62.2 -43.52 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 98.1 mt-10 -64.75 -38.42 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 25' ' ' LYS . 41.2 t -71.58 -40.82 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 37' ' ' VAL . . . -65.78 -46.81 77.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.53 -38.95 82.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.8 m -59.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.0 p -77.93 163.65 25.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.91 -36.07 67.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 55.7 p -66.47 157.95 30.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -111.91 147.76 35.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -116.72 147.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -124.37 144.24 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.15 -154.15 16.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.1 Cg_endo -70.15 143.18 73.83 Favored 'Cis proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.733 -1.778 . . . . 0.0 111.738 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.2 46.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.82 137.31 32.1 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.685 2.257 . . . . 0.0 111.849 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -127.57 175.83 3.1 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.0 Cg_endo -68.94 141.18 47.86 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.615 2.21 . . . . 0.0 111.751 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 16.0 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 14' ' ' TYR . 44.4 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 99.5 m-70 -88.99 148.79 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.408 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 51.6 mtpt -126.02 128.61 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.801 ' C ' HD22 ' A' ' 53' ' ' LEU . 36.4 mtt-85 -126.46 144.31 50.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.801 HD22 ' C ' ' A' ' 52' ' ' ARG . 4.0 mm? -121.16 139.95 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 11' ' ' LEU . 66.5 mt -122.44 122.28 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 85.0 m-20 -93.0 144.9 24.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.846 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.0 mt -123.75 129.72 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.237 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' OD1' ' A' ' 58' ' ' ASP . 65.4 mt -107.66 141.97 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.895 . . . . 0.0 109.689 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER 46.84 61.43 13.44 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.0 Cg_endo -70.01 142.79 47.73 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.665 2.243 . . . . 0.0 111.699 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.419 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -126.76 168.05 15.67 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.558 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.23 -27.67 40.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.686 2.258 . . . . 0.0 111.619 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -62.62 -25.99 68.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.1 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 m -68.19 -43.51 77.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.241 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.42 -41.76 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.335 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -56.53 -44.1 80.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.119 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.07 -35.57 80.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.293 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.75 -27.38 69.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.296 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.7 mtm -82.1 -29.06 31.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.187 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -76.9 -22.83 52.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.5 mt -119.19 132.34 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -107.19 138.29 43.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.522 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 148.32 61.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.76 145.88 58.53 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.212 . . . . 0.0 111.817 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.45 150.01 32.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.0 58.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.18 148.77 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 90.1 m-20 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -134.5 151.39 51.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.21 138.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 69.9 mtm180 -121.54 135.66 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 53' ' ' LEU . 69.8 mt -118.03 135.89 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.187 -0.946 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.743 ' HG2' HD13 ' A' ' 53' ' ' LEU . 84.0 mttt -104.36 137.12 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 14.1 mt -106.07 136.26 46.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.376 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.8 mttp -117.68 129.35 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.892 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -167.11 143.22 4.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -62.62 -39.46 93.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB3' HD13 ' A' ' 18' ' ' LEU . 50.2 t0 -95.07 120.42 35.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.499 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 47.1 t-80 -65.6 -35.43 80.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -56.37 -39.91 73.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.2 mp -63.36 -40.63 97.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.421 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.892 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.3 mt -62.6 -39.8 94.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -61.41 -46.19 91.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.83 -50.74 69.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.7 p -57.51 -43.95 84.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.87 -50.11 72.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -56.67 -40.49 75.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.8 tttp -61.19 -49.34 77.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -67.6 -39.84 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' ALA . 73.1 t -57.2 -46.69 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.77 -41.0 94.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 70' ' ' ILE . 35.1 t -72.08 -39.76 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.86 73.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.73 -40.09 86.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -60.56 -26.97 67.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' VAL . 23.7 p -81.99 162.58 22.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.481 ' HG ' ' HG ' ' A' ' 60' ' ' SER . 41.9 m -66.87 147.01 53.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.627 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -102.64 147.03 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.32 150.71 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 2.9 t -129.32 142.17 50.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 124.12 -150.84 17.06 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 52.1 Cg_endo -71.21 141.07 68.26 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.675 -1.802 . . . . 0.0 111.727 -0.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.5 131.12 35.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.62 120.31 7.14 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.709 2.273 . . . . 0.0 111.923 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 53' ' ' LEU . 14.6 mt -93.36 166.99 14.94 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 44.0 Cg_endo -66.76 132.11 27.68 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.749 2.3 . . . . 0.0 111.595 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' VAL . 40.0 m . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HG23 ' A' ' 45' ' ' THR . 49.9 t . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.627 ' O ' HD11 ' A' ' 19' ' ' LEU . 68.7 m80 -105.73 147.02 29.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.6 mtmt -134.97 155.83 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 31.8 mtp85 -130.04 151.68 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.302 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.743 HD13 ' HG2' ' A' ' 10' ' ' LYS . 36.8 tp -124.33 131.55 53.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 67.7 mt -117.12 123.84 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 37.7 t0 -89.95 137.38 32.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.27 130.39 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.1 mt -111.85 138.4 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.684 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.41 61.32 12.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.41 137.37 33.41 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.649 2.232 . . . . 0.0 111.792 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.496 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -129.15 172.73 6.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 44.8 Cg_endo -67.61 -25.28 40.79 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.68 2.253 . . . . 0.0 111.542 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.11 -26.13 67.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -72.34 -39.19 68.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.329 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.61 -42.63 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.5 m-20 -61.43 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.353 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.61 -37.44 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.4 tp -63.47 -39.71 95.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 59.2 mtm -68.31 -32.13 72.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -73.76 -29.07 62.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.963 ' CD1' HG21 ' A' ' 29' ' ' VAL . 73.2 mt -109.39 135.53 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.58 150.94 79.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HG2' HG21 ' A' ' 76' ' ' VAL . 49.2 Cg_endo -69.89 147.57 62.31 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.662 2.241 . . . . 0.0 111.799 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.35 146.93 32.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.93 69.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.1 t -127.82 148.58 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.478 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -109.33 144.43 37.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 59' ' ' PRO . 69.1 mt -114.7 136.7 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 45.0 mtm180 -122.85 136.8 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 53' ' ' LEU . 83.0 mt -113.26 133.28 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.462 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 18.2 tttt -103.13 121.46 42.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 50.3 mt -104.05 126.37 51.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE2' ' HE2' ' A' ' 10' ' ' LYS . 36.4 mttt -121.72 137.63 54.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 109.415 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.78 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -168.72 146.05 3.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.57 -52.17 49.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.14 130.26 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.581 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.5 p-80 -74.9 -28.88 60.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.878 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.78 -37.89 86.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.36 -36.1 83.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.78 HD21 ' CB ' ' A' ' 13' ' ' ALA . 70.9 mt -69.94 -36.42 75.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.41 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.67 -41.39 88.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.45 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.03 -43.17 83.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 26' ' ' ILE . 84.2 p -66.26 -35.81 81.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.354 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.61 -38.76 80.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -61.13 -44.54 97.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -61.22 -45.72 93.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 22' ' ' SER . 29.2 mm -65.73 -41.58 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 23' ' ' ALA . 79.2 t -61.8 -44.42 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.97 -47.26 78.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 25' ' ' LYS . 34.1 t -67.44 -43.38 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.86 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.23 -47.06 84.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.444 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -55.74 -39.52 71.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.6 m -56.05 -31.66 63.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 p -78.04 162.21 26.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.49 -29.03 63.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.382 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 26.3 t -69.85 148.3 49.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -107.57 150.29 27.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.86 HG21 ' CB ' ' A' ' 30' ' ' ALA . 41.7 t -122.08 140.93 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -117.86 141.75 48.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.84 -149.36 16.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.24 145.85 81.6 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.75 -1.771 . . . . 0.0 111.878 0.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.6 mp -94.26 125.17 53.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.85 118.15 5.54 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.077 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 44' ' ' PRO . 12.5 mt -97.89 168.25 10.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.897 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 43' ' ' LEU . 46.5 Cg_endo -68.33 147.99 73.0 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.721 2.281 . . . . 0.0 111.67 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CD2' ' A' ' 50' ' ' HIS . 18.8 p . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.537 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 45' ' ' THR . 48.6 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 69.8 m80 -103.39 149.2 25.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.5 mtmt -137.02 144.41 43.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.599 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -124.71 152.08 44.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.4 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -125.97 135.0 51.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 67.1 mt -121.07 124.58 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 87.1 m-20 -90.3 145.15 25.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -126.82 125.55 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -106.97 139.71 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.654 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' SER . 3.6 t70 53.19 62.23 10.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.636 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.8 Cg_endo -70.21 141.33 43.14 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.753 2.302 . . . . 0.0 111.67 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.49 166.59 22.14 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.08 -21.74 42.32 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.663 2.242 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -67.67 -25.49 65.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.113 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 m -70.59 -42.46 70.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.82 -42.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.538 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 86.2 m-20 -57.59 -45.56 85.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.75 84.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' ILE . 3.8 tp -63.7 -40.45 96.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.98 -29.95 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -74.59 -29.26 61.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.1 mt -110.11 136.62 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.21 134.9 42.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -61.76 149.32 85.35 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 72' ' ' LEU . 48.7 Cg_endo -69.77 141.04 44.12 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.685 2.257 . . . . 0.0 111.758 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.86 149.77 49.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.7 9.15 56.68 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.79 142.05 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -1.113 . . . . 0.0 109.427 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.5 mtm -59.94 -35.27 74.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.461 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.61 -127.97 34.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.35 9.93 61.27 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 16.5 mt-30 -108.16 148.7 29.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -1.148 . . . . 0.0 109.474 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 76.4 mttt -112.89 143.45 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.429 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.5 mt -117.3 137.51 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HB3' HD11 ' A' ' 53' ' ' LEU . 57.4 mtt85 -118.19 135.96 53.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.654 ' O ' HD22 ' A' ' 53' ' ' LEU . 72.2 mt -120.37 130.32 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.786 ' HG2' HD23 ' A' ' 53' ' ' LEU . 38.7 mttt -99.84 131.6 45.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.7 mp -110.75 134.94 52.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 25.2 mttt -126.81 141.85 51.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -172.13 147.42 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -67.32 -40.99 86.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -94.4 113.97 25.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.585 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 44.4 p-80 -58.97 -37.72 77.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 109.388 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.1 mt-10 -52.98 -54.19 38.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.259 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.2 mp -55.97 -49.38 73.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.5 tt -61.46 -31.51 71.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 65.1 m-20 -66.78 -38.68 87.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.334 -0.854 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.09 -38.82 75.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.8 t -65.43 -45.35 84.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.898 . . . . 0.0 109.44 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -65.24 -48.19 74.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.54 -43.98 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 70' ' ' ILE . 26.5 tttm -59.72 -49.7 76.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 22' ' ' SER . 97.5 mt -61.05 -41.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 23' ' ' ALA . 76.8 t -57.49 -44.89 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.02 -43.96 97.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.8 -41.65 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.934 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.13 -48.26 74.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.443 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.0 m -56.7 -30.98 64.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -75.4 160.45 30.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.13 -35.38 67.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 52.6 p -62.81 157.22 21.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -111.95 148.24 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.934 HG21 ' CB ' ' A' ' 30' ' ' ALA . 24.8 t -122.67 139.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 t -113.51 140.85 47.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 121.97 -149.37 17.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 51.0 Cg_endo -70.8 146.37 84.23 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.782 -1.758 . . . . 0.0 111.674 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 mt -97.36 119.81 62.22 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.03 144.85 48.31 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -123.87 173.56 4.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.444 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.5 Cg_endo -70.01 135.93 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.698 2.265 . . . . 0.0 111.766 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 49' ' ' VAL . 38.0 m -78.85 138.77 38.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.88 144.35 51.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 31.5 t 47.59 39.55 10.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' SER . 68.6 mtt85 62.2 34.84 15.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 45' ' ' THR . 45.7 t -125.85 133.22 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 96.3 m-70 -97.92 145.69 26.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.351 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.4 mtmm -141.83 143.81 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' A' ' 19' ' ' LEU . 89.3 mtt-85 -130.88 152.98 49.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.217 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.7 tm? -124.45 125.77 44.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.942 . . . . 0.0 109.663 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.79 ' N ' HD13 ' A' ' 53' ' ' LEU . 64.8 mt -112.12 120.8 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' OD1' ' CD1' ' A' ' 53' ' ' LEU . 86.9 m-20 -86.83 144.09 27.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 68.3 mt -120.94 132.01 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.335 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -111.09 138.98 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.24 63.19 10.57 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.1 Cg_endo -70.11 143.32 48.82 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.641 2.227 . . . . 0.0 111.717 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -120.98 168.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 109.503 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.27 -24.46 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.642 2.228 . . . . 0.0 111.836 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.47 -21.91 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.5 m -73.11 -40.93 64.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.67 -41.25 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 0.0 109.373 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.613 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -60.64 -40.15 90.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 67' ' ' LEU . 23.6 tp -63.27 -38.38 90.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.613 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 68.1 mtm -69.65 -33.89 73.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 29.8 mtp180 -73.19 -27.36 61.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.554 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 71.1 mt -107.24 134.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -108.68 126.56 53.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.93 145.19 54.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 150.82 65.31 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.704 2.269 . . . . 0.0 111.777 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.43 148.33 15.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.19 64.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.89 148.56 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -1.202 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 52.3 t0 -136.59 156.77 48.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 27.3 m -134.97 148.47 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.441 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' OE1' ' HD2' ' A' ' 10' ' ' LYS . 85.0 tt0 -112.25 131.69 55.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 9.4 tp -128.7 136.74 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 37.0 tttt 67.22 44.05 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 49.2 mt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.5 mtp -58.32 -34.35 70.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.893 . . . . 0.0 109.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.9 -170.26 45.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 -0.19 55.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -109.28 150.64 27.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.199 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -133.92 145.81 49.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.2 mt -117.11 144.56 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' HB3' HD21 ' A' ' 53' ' ' LEU . 48.2 mtp85 -117.12 135.56 53.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.511 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.779 ' O ' HD22 ' A' ' 53' ' ' LEU . 71.4 mt -120.77 129.57 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.681 ' HG2' HD23 ' A' ' 53' ' ' LEU . 56.5 mttm -103.53 132.9 49.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.659 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -108.11 137.62 45.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 27.2 mttt -125.84 137.23 53.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -168.57 140.51 2.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.601 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -55.63 -48.78 74.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 18' ' ' LEU . 95.5 m-20 -97.63 132.58 43.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.739 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.59 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 46.8 p-80 -69.65 -29.17 66.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -57.17 -45.96 83.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.359 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.2 mp -68.51 -44.77 73.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 11' ' ' LEU . 8.2 tt -62.31 -45.83 91.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.444 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -57.37 -43.74 83.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.84 -41.53 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.34 -45.22 92.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -60.29 -41.31 93.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.853 . . . . 0.0 109.436 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -61.88 -44.3 97.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.5 tttp -60.77 -41.85 96.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.16 -39.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.8 t -61.83 -42.56 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.78 -37.67 88.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.2 t -74.2 -40.35 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.16 76.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -60.36 -37.51 80.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -59.32 -30.92 68.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.0 p -76.95 162.45 27.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.89 -36.23 67.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.4 p -64.71 158.64 24.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -111.96 146.68 37.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.384 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.476 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 4.4 p -119.08 147.14 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -125.18 142.35 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.03 -150.78 18.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 146.67 83.48 Favored 'Cis proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.781 -0.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 53' ' ' LEU . 7.5 mt -94.64 126.52 47.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.3 141.15 42.34 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.611 2.207 . . . . 0.0 111.784 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.58 174.24 4.36 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.465 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -69.41 139.81 42.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 23.4 p -86.87 158.38 19.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 46.5 tp10 -142.28 133.52 26.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 8.9 p 47.41 49.62 15.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' SER . 73.4 mtm180 61.8 28.9 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.459 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 59.6 t -116.01 136.23 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.944 . . . . 0.0 109.429 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.59 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 96.5 m-70 -104.44 145.08 30.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.9 mtmm -137.62 143.03 41.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HG3' HD22 ' A' ' 19' ' ' LEU . 32.4 mtp85 -128.63 153.32 47.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 9' ' ' ILE . 3.4 tm? -123.94 128.04 48.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 53' ' ' LEU . 69.2 mt -111.28 128.32 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.82 142.45 27.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.22 131.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.44 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.86 138.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' SER . 38.8 t70 48.22 60.78 14.97 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.1 Cg_endo -70.26 143.74 49.32 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.698 2.265 . . . . 0.0 111.754 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -126.03 169.71 11.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.3 Cg_endo -68.11 -25.29 37.71 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.719 2.279 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.96 -22.75 66.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.4 m -71.19 -41.75 69.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.99 -41.65 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.385 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.598 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 90.4 m-20 -59.01 -40.08 83.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 0.0 109.395 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.73 91.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 70' ' ' ILE . 5.0 tp -61.04 -40.59 94.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.598 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 70.3 mtm -67.9 -33.19 74.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 93.2 mtt-85 -73.54 -29.48 62.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -107.77 134.13 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.478 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.13 125.64 54.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -58.98 151.12 57.44 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.68 151.43 69.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.786 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.76 150.17 16.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.71 64.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.8 t -126.07 148.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -1.194 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 50.4 t0 -132.92 153.89 50.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.512 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 27.8 m -135.3 147.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' OE2' ' HG ' ' A' ' 82' ' ' LEU . 86.2 tt0 -101.67 143.7 31.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.486 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 18.2 tt -121.44 147.51 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 43.2 tttm 66.85 47.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.608 HD13 ' C ' ' A' ' 82' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.38 136.6 37.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.49 10.66 79.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.93 -32.08 74.13 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -105.85 124.82 50.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 109.471 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -121.89 145.75 47.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 59' ' ' PRO . 84.6 mt -116.04 138.47 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.545 ' HD2' HD21 ' A' ' 53' ' ' LEU . 57.0 mtm180 -119.08 137.82 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.85 136.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.441 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' NZ ' ' HD3' ' A' ' 51' ' ' LYS . 44.7 tttt -111.45 124.27 51.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -102.75 126.0 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.377 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 59.0 mttt -116.49 131.06 57.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.801 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -166.28 142.6 4.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.511 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -62.31 -38.35 89.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 60.7 t0 -91.55 118.82 30.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.0 p-80 -65.01 -31.87 73.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.897 . . . . 0.0 109.446 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.8 mt-10 -61.39 -39.23 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 15' ' ' ASP . 75.4 mt -63.63 -38.99 93.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.801 HD21 ' CB ' ' A' ' 13' ' ' ALA . 61.6 mt -64.95 -37.14 86.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.64 -41.86 95.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 97.1 mt-10 -67.24 -37.79 84.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 11' ' ' LEU . 22.3 m -62.5 -40.02 95.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.767 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.56 -44.33 74.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -61.3 -46.35 90.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.4 mttt -63.8 -46.93 82.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 81.8 mt -70.0 -40.44 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.1 t -63.71 -44.74 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -63.31 -42.4 99.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.662 HG11 ' HB1' ' A' ' 66' ' ' ALA . 42.0 t -73.28 -42.22 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.448 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.959 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.57 -48.47 72.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.18 -40.39 77.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.51 -29.81 64.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 29' ' ' VAL . 28.5 p -76.6 161.61 28.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -57.0 -30.78 64.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -66.66 155.01 39.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -108.78 150.15 28.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.959 HG21 ' CB ' ' A' ' 30' ' ' ALA . 47.5 t -125.45 140.87 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -119.1 140.01 50.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 130.79 -151.65 19.65 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 51.3 Cg_endo -70.97 140.24 63.03 Favored 'Cis proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.701 -1.791 . . . . 0.0 111.683 -0.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mt -90.27 122.88 66.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.423 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.74 129.53 17.79 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.738 2.292 . . . . 0.0 112.018 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 2.9 mp -105.59 171.59 4.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.2 Cg_endo -69.54 128.3 16.02 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.669 2.246 . . . . 0.0 111.749 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.741 HG21 ' CE1' ' A' ' 50' ' ' HIS . 35.1 m -82.91 153.63 24.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 48' ' ' ARG . 80.8 tt0 -126.34 122.48 35.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 t 52.4 -89.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' GLU . 75.4 mtm180 -134.78 22.72 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 45' ' ' THR . 59.3 t -115.33 128.24 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.741 ' CE1' HG21 ' A' ' 45' ' ' THR . 92.8 m-70 -106.9 146.91 30.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HD3' ' NZ ' ' A' ' 10' ' ' LYS . 47.6 mttm -127.59 150.91 49.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 62.6 mtp85 -133.6 144.81 49.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' HD2' ' A' ' 8' ' ' ARG . 28.8 tp -121.53 133.24 55.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 65.9 mt -120.7 120.98 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.69 137.04 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 56' ' ' ILE . 49.4 mt -119.54 127.65 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.99 139.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.05 61.51 13.9 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.23 144.38 51.33 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.723 2.282 . . . . 0.0 111.823 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 165.97 21.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.95 -26.11 37.95 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.797 2.331 . . . . 0.0 111.741 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -67.17 -22.44 65.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.22 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.4 m -71.42 -41.7 69.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.45 -42.28 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.271 -0.893 . . . . 0.0 109.323 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.65 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 91.1 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.342 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -63.07 -40.92 99.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' ILE . 32.1 tp -61.92 -39.59 92.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.44 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.65 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 72.6 mtm -67.02 -31.93 72.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 77.8 mtp180 -70.46 -30.38 67.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.6 mt -110.14 136.04 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -101.32 129.79 47.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 148.61 37.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.12 149.07 64.1 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.65 2.233 . . . . 0.0 111.783 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 148.43 27.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.9 3.43 65.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.3 t -126.31 148.33 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 51.5 t0 -136.14 155.51 50.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 78' ' ' VAL . 14.3 p -139.67 127.23 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -113.33 135.31 53.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.7 mm -66.98 -31.73 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 0.0 109.527 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' O ' HD23 ' A' ' 82' ' ' LEU . 36.5 mttt -59.28 -34.37 72.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 81' ' ' LYS . 51.3 mt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.501 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.0 ttm -58.28 -32.94 68.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -53.2 -34.0 46.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.94 -120.82 23.7 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -104.16 157.68 16.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -1.119 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -111.9 149.5 31.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.462 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -110.71 142.35 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.4 mtm180 -118.58 136.76 53.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.454 HG12 ' OXT' ' A' ' 82' ' ' LEU . 70.6 mt -120.17 132.86 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.527 ' HG2' HD13 ' A' ' 53' ' ' LEU . 26.4 mttm -108.58 132.09 54.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.018 ' CB ' HD11 ' A' ' 19' ' ' LEU . 3.4 mp -117.69 129.51 55.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.516 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 83.0 mttt -116.25 137.29 52.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -160.26 145.69 15.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.77 -39.09 90.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.583 ' CB ' HD13 ' A' ' 18' ' ' LEU . 92.3 m-20 -97.33 125.09 41.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.589 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 19.5 p80 -71.17 -30.06 65.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.09 -39.2 89.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.4 mp -72.92 -44.01 61.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.496 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.018 HD11 ' CB ' ' A' ' 11' ' ' LEU . 40.8 tp -58.75 -42.81 89.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.2 -46.33 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -40.3 85.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 m -60.64 -44.29 96.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.43 -42.19 99.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -59.99 -47.14 87.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.8 mtpt -56.32 -47.86 77.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.554 HD12 HD21 ' A' ' 11' ' ' LEU . 75.2 mt -65.64 -41.66 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.862 . . . . 0.0 109.36 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 23' ' ' ALA . 69.1 t -62.67 -46.17 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -59.28 -40.91 87.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' LYS . 38.7 t -70.68 -42.2 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.895 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -66.18 -46.59 76.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' CE ' ' CG1' ' A' ' 27' ' ' VAL . 23.2 mttm -57.43 -37.11 72.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 m -57.41 -34.28 68.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.9 m -74.26 154.71 38.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.43 -29.23 9.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -65.28 158.78 25.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -113.71 152.56 30.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 30' ' ' ALA . 39.4 t -123.42 140.97 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -115.29 149.13 38.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 113.64 -147.32 18.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 50.9 Cg_endo -70.6 148.45 88.64 Favored 'Cis proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.731 -1.779 . . . . 0.0 111.813 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -98.41 123.21 51.21 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.43 140.53 36.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.699 2.266 . . . . 0.0 111.842 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.678 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -120.29 176.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.678 ' HD2' HD23 ' A' ' 43' ' ' LEU . 48.1 Cg_endo -69.8 141.85 46.19 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.536 2.157 . . . . 0.0 111.696 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.545 HG21 ' ND1' ' A' ' 50' ' ' HIS . 18.3 p -103.81 163.12 12.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.602 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 48' ' ' ARG . 71.5 tt0 -129.27 126.67 39.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.31 -0.869 . . . . 0.0 109.407 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.6 t 56.87 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 46' ' ' GLU . 56.8 mtt180 -143.4 27.71 1.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 45' ' ' THR . 46.4 t -115.41 127.22 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.664 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 76.7 m-70 -105.88 149.79 26.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' HE2' ' A' ' 12' ' ' LYS . 33.4 mtmm -135.18 141.06 45.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HG3' HD23 ' A' ' 19' ' ' LEU . 35.8 mtt-85 -122.87 150.52 42.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.3 tp -121.99 126.91 49.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.532 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.13 128.92 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 85.5 m-20 -97.85 146.45 25.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.462 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.29 133.94 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.44 136.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 47.1 59.53 16.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.4 Cg_endo -70.11 144.24 51.58 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.78 2.32 . . . . 0.0 111.825 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.413 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -121.89 167.96 12.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.426 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.5 Cg_endo -67.42 -26.12 41.22 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.722 2.281 . . . . 0.0 111.631 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.78 -25.29 66.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.173 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -70.23 -39.16 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.5 -42.78 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.0 m-20 -56.78 -44.11 81.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.324 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.55 86.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -65.1 -40.36 94.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.589 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 65.1 mtm -68.38 -29.74 68.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 41.8 mtp85 -75.43 -29.44 59.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 67' ' ' LEU . 74.5 mt -111.26 136.03 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -106.54 155.95 19.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.395 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 1.2 pp -70.35 140.18 87.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.12 154.45 66.32 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.724 2.283 . . . . 0.0 111.74 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 150.63 11.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 88.13 7.28 73.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -131.26 147.9 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -1.154 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 56.0 t0 -130.09 158.3 40.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.385 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 57.0 t -133.86 148.58 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 71.5 mm-40 -93.62 153.85 18.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -61.39 -23.25 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.441 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 82' ' ' LEU . 78.9 mttt -54.43 -35.0 62.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.953 HD23 ' OXT' ' A' ' 82' ' ' LEU . 6.4 tt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.6 mtt -59.06 -35.6 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.503 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 82.0 20.24 63.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.9 57.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -73.17 146.46 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -1.135 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -124.97 146.14 49.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.7 mt -113.48 141.72 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 86.5 mtm-85 -121.57 136.7 54.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.593 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 53' ' ' LEU . 68.9 mt -114.72 140.05 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 16.2 tttp -108.15 125.11 51.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 19' ' ' LEU . 47.4 mt -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.374 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' CE ' ' HD3' ' A' ' 10' ' ' LYS . 93.5 mttt -130.63 132.9 45.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.567 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -171.01 151.3 3.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.401 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.5 -32.33 64.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 92.6 m-20 -90.8 108.21 19.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.875 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 46.3 t-80 -58.75 -46.93 86.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.927 . . . . 0.0 109.466 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -59.28 -45.39 91.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 24.6 tp -62.61 -38.46 90.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 11' ' ' LEU . 15.6 tp -57.73 -38.32 75.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . 45.6 t0 -65.08 -40.2 94.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.74 -41.17 85.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.4 p -67.78 -34.05 76.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -71.28 -41.85 69.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -60.45 -43.53 96.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' O ' HG23 ' A' ' 29' ' ' VAL . 64.8 tttt -59.15 -49.17 78.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 109.498 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 22' ' ' SER . 28.2 mm -66.5 -39.51 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 23' ' ' ALA . 82.7 t -60.62 -42.2 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' LYS . 22.0 t -72.25 -40.71 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.53 -45.87 81.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -61.21 -38.09 85.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.8 p -57.34 -28.69 63.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.5 p -82.0 161.18 23.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.64 -35.78 66.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.429 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 19.6 m -64.53 149.5 48.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.25 150.52 25.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.83 147.09 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 39.1 m -119.27 145.06 46.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.1 -155.75 16.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.61 141.27 67.57 Favored 'Cis proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.672 -1.803 . . . . 0.0 111.72 0.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.5 mt -94.36 120.79 64.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.361 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.6 128.16 14.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.728 2.285 . . . . 0.0 111.827 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 3.1 mp -108.29 171.32 4.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.444 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.51 137.0 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.777 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 49' ' ' VAL . 32.6 m -75.03 143.45 43.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -140.1 144.55 36.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.9 m 49.15 41.28 19.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 59.13 30.24 19.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 47' ' ' SER . 47.4 t -127.14 135.11 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 92.6 m-70 -94.9 148.22 22.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.8 mtmt -138.6 146.63 42.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.555 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 87.6 mtt-85 -128.58 154.29 46.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.898 . . . . 0.0 109.371 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 9' ' ' ILE . 29.5 tp -123.78 129.01 50.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.629 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.565 HD11 HD11 ' A' ' 11' ' ' LEU . 64.2 mt -114.38 122.65 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 86.7 m-20 -93.11 141.53 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ILE . 69.2 mt -118.95 129.37 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.349 -0.844 . . . . 0.0 109.252 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.4 mt -110.13 142.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.642 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 12.2 t0 50.26 60.84 14.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.33 140.12 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.666 2.244 . . . . 0.0 111.923 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.09 167.81 16.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.18 -26.17 36.49 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.697 2.265 . . . . 0.0 111.64 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -64.55 -21.98 66.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.8 m -73.32 -40.55 64.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.18 -39.69 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 91.2 m-20 -61.99 -42.09 98.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.334 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.7 81.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -62.72 -40.19 96.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -69.23 -29.48 67.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.387 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 50.3 mtt180 -75.96 -29.67 58.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 59.9 mt -113.72 133.21 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -101.93 142.39 33.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 109.475 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.05 155.0 4.74 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HG3' ' HA ' ' A' ' 22' ' ' SER . 50.6 Cg_endo -69.95 144.37 52.82 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.759 2.306 . . . . 0.0 111.792 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.02 147.0 48.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.08 62.32 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 22' ' ' SER . 49.7 t -129.69 147.87 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 86.2 m-20 -116.97 149.76 39.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.41 134.21 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -104.76 136.79 43.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 82' ' ' LEU . 69.3 mt -118.56 131.58 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.454 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 19.2 tptp -57.97 -37.42 74.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 109.414 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' H ' HG22 ' A' ' 80' ' ' ILE . 23.8 tp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.464 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.36 -35.1 71.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.466 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.99 -110.54 2.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.98 11.9 58.32 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -111.96 143.86 42.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 23.8 pttm -130.77 151.2 51.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 59' ' ' PRO . 85.3 mt -118.76 139.76 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.535 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 82.4 mtt180 -118.94 135.09 54.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.04 136.02 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.419 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD13 ' A' ' 53' ' ' LEU . 77.5 mttt -111.74 130.74 55.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 10' ' ' LYS . 13.8 mt -112.72 137.02 51.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.632 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -122.26 142.86 50.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.83 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -170.64 148.05 2.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.691 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -57.3 -48.39 79.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.615 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -89.52 127.9 35.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.599 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.578 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.4 p-80 -75.08 -34.61 61.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.31 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -57.92 -41.42 82.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.865 . . . . 0.0 109.393 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.73 -43.55 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.83 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.4 mt -54.33 -40.7 68.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -64.23 -36.44 84.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -70.36 -38.91 74.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 26' ' ' ILE . 25.6 t -69.86 -42.07 74.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.26 -38.26 81.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 21.3 tttt -61.29 -47.14 87.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -62.33 -43.64 98.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 22' ' ' SER . 79.7 mt -67.49 -39.81 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.7 t -63.08 -43.08 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.7 mt-10 -62.61 -39.27 93.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.5 t -74.92 -37.7 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -68.88 -48.38 63.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 78.6 mttt -58.74 -40.3 83.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -50.27 -28.6 8.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.1 p -78.34 165.7 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -57.72 -32.66 67.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 56.5 p -64.93 157.71 27.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -107.03 152.35 24.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.935 HG21 ' HB3' ' A' ' 30' ' ' ALA . 44.6 t -124.94 143.66 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 5.8 t -123.94 137.84 54.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.541 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.26 -151.2 16.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.527 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.37 56.65 Favored 'Cis proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.677 -1.801 . . . . 0.0 111.794 -0.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.98 124.5 61.73 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.1 140.73 38.3 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.654 2.236 . . . . 0.0 111.664 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -116.68 174.77 2.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.416 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.53 135.39 28.5 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.661 2.241 . . . . 0.0 111.81 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 31.9 m -83.22 145.76 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 48' ' ' ARG . 80.7 tt0 -116.83 119.94 36.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.4 m 56.19 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLU . 95.6 mtt-85 -139.1 18.27 2.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 48.1 t -114.96 128.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 83.4 m-70 -102.23 153.97 19.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 12.5 mtmt -136.3 141.76 43.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.531 ' CD ' ' HB3' ' A' ' 19' ' ' LEU . 61.0 mtp85 -121.7 149.41 43.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.212 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.533 ' HB2' HD13 ' A' ' 43' ' ' LEU . 32.6 tp -124.57 128.84 49.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.517 HD11 ' CB ' ' A' ' 23' ' ' ALA . 70.1 mt -116.53 121.26 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.335 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 84.6 m-20 -90.9 146.38 23.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.564 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.92 130.73 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.337 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.47 140.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 30.5 t0 47.84 61.69 13.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.9 141.63 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 111.715 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.406 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -124.16 167.88 14.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.14 -22.2 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.725 2.283 . . . . 0.0 111.573 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -67.46 -25.56 65.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.422 ' HA ' HG21 ' A' ' 33' ' ' THR . 32.5 m -70.92 -41.37 71.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.183 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.9 -42.05 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.572 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.5 t0 -57.31 -45.94 83.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.246 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -61.28 -35.24 76.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.4 tp -66.72 -39.09 87.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.572 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 63.8 mtm -70.13 -26.2 63.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.383 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -79.99 -27.85 39.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -112.47 137.12 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.1 139.0 41.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 72' ' ' LEU . 3.3 pp -59.35 144.22 84.16 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 72' ' ' LEU . 51.9 Cg_endo -70.95 151.33 62.21 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.667 2.245 . . . . 0.0 111.818 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.55 26.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.11 5.41 65.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -129.45 147.06 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -1.182 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 54.7 t0 -130.37 158.08 40.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.6 p -124.62 133.93 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -98.23 139.89 33.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.411 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 82' ' ' LEU . 74.1 mt -116.05 135.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.509 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -54.51 -38.13 66.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' H ' HG22 ' A' ' 80' ' ' ILE . 22.5 tp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.8 mtp -58.91 -35.52 73.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.63 -178.32 49.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.29 -9.66 63.12 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -116.8 154.72 30.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.214 -1.168 . . . . 0.0 109.483 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -132.75 148.8 52.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.2 mt -114.59 138.99 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 53' ' ' LEU . 88.6 mtt180 -121.26 136.5 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.893 . . . . 0.0 109.549 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.607 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.3 mt -116.02 135.63 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.734 ' HG2' HD13 ' A' ' 53' ' ' LEU . 80.0 mttt -108.64 131.37 54.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 10' ' ' LYS . 15.5 mt -110.47 138.87 46.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 61.2 mttp -122.57 134.2 54.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -168.73 146.62 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.493 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.37 -37.11 86.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -96.64 123.19 40.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.8 p-80 -72.78 -30.01 63.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 16' ' ' HIS . 75.3 mm-40 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.28 -37.19 84.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 13' ' ' ALA . 59.5 mt -70.44 -37.42 74.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -62.18 -42.32 99.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.02 -45.72 73.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.473 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.2 t -63.86 -40.46 96.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -65.7 -41.92 91.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.482 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -57.42 -46.06 83.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.461 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.6 mttm -58.46 -44.42 89.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 22' ' ' SER . 24.6 mm -65.68 -43.13 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.55 -46.23 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -62.83 -44.71 95.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.589 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.7 t -66.77 -45.29 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.901 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.33 -43.64 90.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.602 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -56.02 -39.22 71.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.5 p -60.12 -24.98 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 p -80.42 163.14 24.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -56.74 -30.18 63.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.8 p -72.37 155.35 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -112.11 145.11 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 ' CB ' ' A' ' 30' ' ' ALA . 43.9 t -124.42 141.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -117.6 138.64 51.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.71 -158.41 23.77 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.596 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.35 56.53 Favored 'Cis proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.685 -1.798 . . . . 0.0 111.781 -0.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.98 131.48 37.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.44 141.19 41.86 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.603 2.202 . . . . 0.0 111.82 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -125.37 174.76 3.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 109.482 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 51.6 Cg_endo -70.51 146.66 56.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.747 2.298 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 50' ' ' HIS . 25.3 p -103.28 158.09 16.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.484 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' SER . 72.6 mm-40 -151.67 149.77 29.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER 43.68 43.2 4.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 47' ' ' SER . 2.7 mtp85 61.53 39.81 14.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 45' ' ' THR . 50.4 t -128.66 132.22 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 71.1 m80 -101.02 151.1 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 46.9 mtmt -137.76 141.5 40.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -125.9 146.67 49.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.285 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD13 ' HG2' ' A' ' 10' ' ' LYS . 29.0 tp -122.54 133.66 54.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.686 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 68.7 mt -115.26 126.7 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.314 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -91.22 142.14 28.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ILE . 59.6 mt -123.04 130.47 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.969 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.7 mt -112.55 141.58 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.709 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 35' ' ' SER . 65.5 t0 45.9 62.3 11.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.601 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.26 141.63 43.69 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.735 2.29 . . . . 0.0 111.663 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -129.4 170.67 10.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.9 Cg_endo -67.44 -28.67 38.66 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.705 2.27 . . . . 0.0 111.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.54 -24.9 68.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.28 -0.887 . . . . 0.0 109.133 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -71.57 -40.77 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.25 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.5 m-20 -58.89 -44.12 91.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -62.79 -41.17 99.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.377 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.4 tp -60.96 -39.5 89.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.407 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.29 -31.47 72.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.459 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 19.2 mtp180 -71.06 -30.06 66.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.609 ' CD1' HG21 ' A' ' 29' ' ' VAL . 70.3 mt -112.58 133.82 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.26 141.32 38.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.44 148.59 79.96 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.597 ' HG2' HG21 ' A' ' 76' ' ' VAL . 50.2 Cg_endo -70.3 149.44 63.48 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.742 2.294 . . . . 0.0 111.788 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.21 147.88 28.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.35 70.13 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.0 t -126.75 148.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.147 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 23.0 t70 -128.69 153.59 47.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG13 ' CG2' ' A' ' 9' ' ' ILE . 47.0 t -126.0 134.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 10' ' ' LYS . 85.4 tt0 -101.86 139.76 37.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 82' ' ' LEU . 72.9 mt -118.55 133.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 109.618 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 82' ' ' LEU . 15.9 tttt -53.79 -40.11 66.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.478 ' H ' HG22 ' A' ' 80' ' ' ILE . 17.1 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.5 mtt -126.29 163.61 22.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.1 58.68 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.53 -29.22 63.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.43 143.95 42.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 37.1 mtmt -126.84 147.34 50.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.536 HD12 ' HB3' ' A' ' 59' ' ' PRO . 82.2 mt -113.65 137.34 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 53' ' ' LEU . 92.8 mtt180 -123.11 136.47 54.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.5 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HD22 ' A' ' 53' ' ' LEU . 69.4 mt -114.58 134.3 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.796 ' HG2' HD23 ' A' ' 53' ' ' LEU . 40.4 mttt -105.35 128.73 53.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.1 mp -112.67 133.8 54.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 88.3 mttt -128.4 138.4 52.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.808 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -169.57 147.61 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.49 -38.13 86.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -97.24 125.09 41.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.7 p-80 -71.13 -28.6 64.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 49.3 mt -65.75 -39.7 91.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 13' ' ' ALA . 68.2 mt -67.41 -36.62 81.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.59 -43.61 98.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.34 -40.3 85.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.7 t -65.14 -41.54 94.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -68.54 -40.84 80.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -58.99 -48.15 82.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mttm -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 22' ' ' SER . 84.0 mt -62.67 -46.45 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.89 -48.35 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.66 -48.08 83.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.47 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' LYS . 27.6 t -69.0 -42.53 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.847 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -64.46 -47.6 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -54.16 -40.76 67.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -58.39 -33.69 69.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.447 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 62' ' ' LYS . 25.3 m -72.84 153.85 40.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -50.67 -29.51 11.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 45.3 p -69.76 157.72 36.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -117.47 138.87 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.847 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.0 t -117.64 142.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 t -114.86 142.48 46.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.99 -153.15 19.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 49.9 Cg_endo -70.4 140.97 65.7 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.815 -0.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.18 128.06 48.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.414 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.72 138.18 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.74 2.293 . . . . 0.0 111.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -118.3 176.2 1.76 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.317 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.9 Cg_endo -70.21 142.95 47.25 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.562 2.175 . . . . 0.0 111.778 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -110.71 166.85 10.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.6 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 48' ' ' ARG . 79.6 tt0 -143.15 127.73 18.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.338 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 t 53.75 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' GLU . 86.9 mtm-85 -138.45 23.8 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.36 121.12 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.589 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 90.7 m-70 -108.85 152.44 24.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.412 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 53.4 mtmt -134.18 145.78 49.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.615 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -131.19 146.66 52.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 109.229 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.943 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.3 tm? -121.81 132.33 54.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.943 ' N ' HD13 ' A' ' 53' ' ' LEU . 66.4 mt -117.77 122.2 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.249 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 37' ' ' VAL . 82.4 m-20 -90.11 145.64 24.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.609 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 37' ' ' VAL . 65.5 mt -127.58 128.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.29 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.95 142.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.83 62.26 12.51 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.61 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.9 Cg_endo -69.95 146.07 57.93 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.691 2.261 . . . . 0.0 111.775 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -129.76 165.75 30.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 60' ' ' SER . 45.3 Cg_endo -67.49 -24.82 41.99 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.611 2.207 . . . . 0.0 111.649 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HB2' HG23 ' A' ' 33' ' ' THR . 40.2 mttm -64.66 -26.35 68.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.055 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 33' ' ' THR . 62.1 m -70.01 -38.71 76.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.242 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.29 -43.65 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -57.73 -41.87 82.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.349 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.58 -39.41 91.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 16.2 tp -63.7 -42.32 98.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 69.0 mtm -64.69 -31.83 73.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 31.4 mtp180 -71.07 -29.79 65.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.7 mt -109.48 136.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -107.76 135.18 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.405 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD22 HG21 ' A' ' 78' ' ' VAL . 8.1 mp -62.33 145.91 93.61 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.507 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.29 147.04 58.58 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.676 2.251 . . . . 0.0 111.742 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 152.88 39.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.64 3.61 55.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.79 146.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.8 m-20 -113.73 147.37 38.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.527 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 72' ' ' LEU . 40.5 t -124.08 133.25 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -114.63 143.99 44.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 82' ' ' LEU . 70.9 mt -118.67 133.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -57.36 -34.39 68.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.887 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.585 ' H ' HG22 ' A' ' 80' ' ' ILE . 50.7 mt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.4 mtt -121.65 151.28 40.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 87.14 14.28 64.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.47 -22.78 66.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -117.04 146.06 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 4.2 pttm -126.06 158.19 36.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.4 mt -116.95 141.22 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 62.1 mtt85 -118.41 135.4 54.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.9 mt -119.49 134.24 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 53' ' ' LEU . 69.6 mttt -107.16 132.64 52.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -111.02 139.65 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -126.78 129.54 48.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.804 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -163.61 151.69 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -71.82 -30.75 65.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.53 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -97.12 115.24 27.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.627 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 45.2 t-80 -61.07 -46.49 90.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -56.38 -41.97 77.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.5 tm? -57.36 -39.61 76.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.292 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD21 ' CB ' ' A' ' 13' ' ' ALA . 66.7 mt -61.86 -39.13 90.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.79 -39.42 84.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.02 -38.3 90.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' HD23 ' A' ' 11' ' ' LEU . 87.0 p -65.55 -33.04 74.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -74.16 -34.34 63.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -63.8 -43.95 94.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.1 mttt -64.54 -46.11 84.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 22' ' ' SER . 26.1 mm -69.68 -44.07 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 23' ' ' ALA . 70.4 t -64.21 -44.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.48 -45.31 93.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 25' ' ' LYS . 37.5 t -71.71 -41.33 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.554 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.803 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.96 -46.31 78.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -59.2 -39.14 81.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.7 m -59.23 -31.11 68.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.3 p -75.37 163.34 27.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -56.03 -33.48 64.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 61.0 p -67.62 161.05 26.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.912 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -122.91 138.0 54.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.803 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.8 t -112.75 140.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.2 m -114.33 146.39 40.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.35 -149.72 16.97 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.98 148.05 86.39 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.767 -1.764 . . . . 0.0 111.8 -0.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.3 mp -90.07 128.61 49.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.543 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.02 123.92 10.11 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.686 2.258 . . . . 0.0 111.595 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.1 mp -106.8 173.25 3.24 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.4 Cg_endo -69.01 151.14 73.36 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.798 2.332 . . . . 0.0 111.909 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 14.8 t -120.06 163.62 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ARG . 95.1 mt-10 -141.39 139.77 33.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m 48.2 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' GLU . 90.1 mtt180 -138.22 26.17 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' A' ' 45' ' ' THR . 48.3 t -115.05 121.31 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.538 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 92.3 m-70 -105.29 150.62 25.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 22.7 mtmm -133.41 146.73 51.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 86.6 mtt-85 -130.62 149.49 52.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 41' ' ' ILE . 27.8 tp -122.38 128.36 50.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG22 ' CG1' ' A' ' 37' ' ' VAL . 66.5 mt -110.23 127.56 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -96.59 138.34 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 62.2 mt -118.16 131.23 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -111.98 138.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.455 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 4.9 t70 49.22 57.86 18.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.6 Cg_endo -70.27 138.3 35.88 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.626 2.218 . . . . 0.0 111.826 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -118.22 168.1 10.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.45 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 48.0 Cg_endo -68.3 -21.66 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.707 2.272 . . . . 0.0 111.675 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -68.07 -23.99 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.237 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -70.28 -40.99 73.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.42 -39.54 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.619 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.4 m-20 -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.89 84.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' ILE . 26.7 tp -62.92 -37.53 87.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.619 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 73.9 mtm -69.7 -34.55 74.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.358 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.59 -28.1 61.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -107.07 138.74 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.07 138.96 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 147.52 78.15 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.311 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.64 142.58 48.87 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.678 2.252 . . . . 0.0 111.781 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.96 51.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.68 5.19 60.18 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' CG2' HD12 ' A' ' 18' ' ' LEU . 59.6 t -132.16 148.55 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -1.186 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -133.8 147.48 51.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 109.478 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.31 142.25 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -115.4 137.31 52.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.05 -36.83 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' LEU . 26.2 mttt -93.55 147.84 22.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' LYS . 49.9 mt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.405 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.8 mtp -57.4 -34.85 69.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.99 -175.17 50.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.87 6.35 62.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -103.6 150.59 23.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -1.206 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 3.6 pttm -136.82 143.0 42.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 59' ' ' PRO . 69.0 mt -115.37 138.35 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 55' ' ' ASP . 93.4 mtt-85 -118.48 132.81 56.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.1 132.04 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -105.66 136.78 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.1 mp -109.5 138.63 45.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.466 ' HE3' ' OE2' ' A' ' 79' ' ' GLU . 24.1 mttt -127.33 137.6 52.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -165.15 145.77 7.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -57.44 -51.87 67.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.55 127.66 36.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.708 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 45.8 t-80 -66.49 -37.44 85.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.74 -44.06 81.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.11 -37.79 88.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 19' ' ' LEU . 7.2 tt -65.43 -39.47 92.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -59.99 -42.72 94.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.13 -41.05 91.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.344 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 26' ' ' ILE . 20.3 m -64.57 -44.0 92.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.767 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -68.33 -42.68 78.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 109.401 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -64.25 -42.59 96.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 tttt -58.1 -49.85 75.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 22' ' ' SER . 26.9 mm -64.83 -40.94 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.506 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.7 t -58.43 -45.9 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -61.06 -43.34 99.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 25' ' ' LYS . 21.7 t -71.99 -40.9 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.902 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.08 -47.1 84.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HE2' HG13 ' A' ' 27' ' ' VAL . 28.9 mttm -59.82 -39.63 85.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -53.99 -31.52 51.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 p -76.38 163.0 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.58 -32.5 67.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.3 p -61.73 159.53 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -113.78 145.06 41.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 30' ' ' ALA . 31.5 t -123.75 141.59 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 13.2 t -117.83 140.21 50.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.85 -148.42 17.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 144.21 78.04 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.793 -1.753 . . . . 0.0 111.724 0.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.75 119.78 65.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.77 137.15 31.92 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.584 2.189 . . . . 0.0 111.85 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -118.54 174.77 2.46 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HD2' HD23 ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.03 133.33 24.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.692 2.262 . . . . 0.0 111.776 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.5 t -77.77 152.37 33.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ARG . 81.1 tt0 -117.44 125.15 50.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.5 m 54.06 -88.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.518 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' GLU . 56.8 mtt180 -140.55 22.2 2.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.03 131.57 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 90.8 m-70 -97.94 153.16 18.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 48.9 mtmt -141.33 141.63 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.664 ' CD ' HD22 ' A' ' 19' ' ' LEU . 21.6 mtp180 -125.94 158.89 34.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.295 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.1 tp -124.04 127.99 48.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.529 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 23' ' ' ALA . 63.7 mt -116.23 120.69 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' CG ' ' NH1' ' A' ' 8' ' ' ARG . 86.5 m-20 -89.2 145.31 25.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 65.8 mt -125.68 126.72 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.0 mt -108.33 141.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 53.12 61.26 11.39 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.54 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.4 Cg_endo -69.95 145.66 56.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.702 2.268 . . . . 0.0 111.737 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.13 166.91 25.71 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.98 -24.03 39.86 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.771 2.314 . . . . 0.0 111.619 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -65.61 -24.6 67.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.217 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.7 m -72.57 -40.75 66.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.312 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.12 -40.84 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.57 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.9 m-20 -62.2 -42.27 99.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.41 89.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.925 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 30.6 tp -64.44 -39.23 93.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.57 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 58.5 mtm -68.66 -29.94 68.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 61.6 mtt-85 -74.78 -28.76 60.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.589 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -111.32 135.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.75 130.91 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.611 HD13 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -55.99 152.06 22.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.405 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.34 151.15 71.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.647 2.231 . . . . 0.0 111.795 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.89 149.3 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.44 1.87 66.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 72' ' ' LEU . 39.5 t -127.29 147.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 45.2 t0 -124.56 155.1 39.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.611 HG21 HD13 ' A' ' 72' ' ' LEU . 48.4 t -135.41 148.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' OE2' ' HE3' ' A' ' 12' ' ' LYS . 94.1 mt-10 -112.78 156.74 22.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 82' ' ' LEU . 75.6 mt -111.0 140.87 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.45 -37.51 65.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.564 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' MET . 21.7 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' SER . 87.0 mtp 46.15 92.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . -59.53 124.26 35.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.82 -35.97 77.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -118.9 157.65 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -1.162 . . . . 0.0 109.428 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 12.8 pttm -125.72 161.53 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 71.4 mt -122.11 137.51 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.603 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.782 ' HB2' HD11 ' A' ' 82' ' ' LEU . 96.2 mtt180 -113.76 137.2 51.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 8' ' ' ARG . 23.6 mm -118.78 125.1 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.644 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.614 ' C ' HD12 ' A' ' 11' ' ' LEU . 24.4 mttt -106.05 132.28 52.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.253 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -117.92 138.87 51.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 84.9 mttt -128.78 132.58 47.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -157.39 141.37 16.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.557 ' CD1' HG22 ' A' ' 49' ' ' VAL . 98.5 m-85 -65.39 -35.51 81.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.41 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -93.7 116.5 29.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.875 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.718 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 46.8 t-80 -62.95 -35.36 79.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.15 -42.81 91.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.24 -37.11 83.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 11' ' ' LEU . 12.8 tp -70.79 -37.26 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -62.74 -39.96 95.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.2 mm-40 -69.91 -44.27 70.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 26' ' ' ILE . 97.6 p -60.97 -36.51 79.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -73.77 -51.06 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 17.1 mttm -65.22 -46.16 81.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 mtmt -59.85 -47.49 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.663 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 22' ' ' SER . 96.9 mt -68.15 -39.67 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' ALA . 66.5 t -62.01 -43.01 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 97.2 mt-10 -64.78 -38.19 90.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' LYS . 39.7 t -75.17 -38.84 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.634 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.046 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -65.8 -49.25 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.575 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE3' HG13 ' A' ' 27' ' ' VAL . 80.8 mttt -60.14 -37.56 80.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.553 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 m -56.63 -30.19 63.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' VAL . 30.1 p -75.66 164.2 26.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -56.66 -35.95 68.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -60.06 159.17 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -109.45 143.03 39.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.046 HG21 ' HB1' ' A' ' 30' ' ' ALA . 40.7 t -126.38 141.59 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 39.0 m -116.21 149.1 39.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 112.12 -150.49 18.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.8 Cg_endo -70.74 147.92 87.79 Favored 'Cis proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.746 -1.772 . . . . 0.0 111.759 -0.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -101.44 119.97 56.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.94 141.22 39.92 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 111.821 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -118.6 176.17 1.79 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.288 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.6 Cg_endo -69.49 135.55 31.38 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.608 2.206 . . . . 0.0 111.728 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 49' ' ' VAL . 26.0 m -83.43 143.65 30.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ARG . 82.3 tt0 -112.97 128.45 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 m 52.81 -89.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.545 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' GLU . 55.2 ttp85 -141.88 26.35 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 45' ' ' THR . 45.1 t -119.38 131.26 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.718 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 81.9 m-70 -100.75 148.09 25.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 41.6 mtmt -134.88 141.55 46.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' CZ ' ' NE2' ' A' ' 16' ' ' HIS . 86.8 mtt-85 -124.45 151.38 44.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -121.79 125.55 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.693 ' N ' HD23 ' A' ' 53' ' ' LEU . 64.3 mt -115.39 122.28 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 52.4 t0 -91.2 140.34 29.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 7' ' ' ILE . 63.7 mt -117.59 128.06 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 0.0 109.398 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.91 137.83 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.0 t70 51.29 63.71 9.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.81 143.09 49.47 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.771 2.314 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -131.07 168.17 18.45 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 44.9 Cg_endo -67.21 -24.42 44.17 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.644 2.23 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -65.83 -27.06 67.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 109.175 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.421 ' HA ' HG21 ' A' ' 33' ' ' THR . 40.8 m -68.94 -41.52 77.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.216 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.81 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 109.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 85.6 m-20 -59.16 -42.41 90.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.403 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.33 -38.21 89.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -63.88 -43.24 96.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -65.82 -29.35 69.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.93 . . . . 0.0 109.507 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 12.8 mtt-85 -73.47 -29.77 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -110.85 136.06 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.44 127.9 53.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' A' ' 76' ' ' VAL . 3.3 pp -58.79 143.68 82.29 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.466 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.535 ' O ' HD12 ' A' ' 72' ' ' LEU . 49.6 Cg_endo -70.01 150.31 66.49 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.799 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 151.42 18.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 94.75 5.98 60.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 72' ' ' LEU . 46.2 t -121.32 147.75 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.175 . . . . 0.0 109.439 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 56.6 t0 -134.82 156.0 49.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.4 p -135.73 146.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.908 . . . . 0.0 109.353 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -93.67 120.86 34.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.7 mt -68.8 -32.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -86.51 147.7 25.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 8' ' ' ARG . 25.6 tp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.6 mtt -57.63 -35.02 69.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.507 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.59 -167.02 32.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.19 0.62 54.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -105.44 149.06 26.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -1.223 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 8' ' ' ARG . 58.7 pttt -137.26 142.95 41.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.478 ' HB ' HD12 ' A' ' 56' ' ' ILE . 83.9 mt -118.79 143.88 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 6' ' ' LYS . 67.8 mtt85 -116.17 136.44 53.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 73.1 mt -121.53 131.17 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 11' ' ' LEU . 91.0 mttt -97.34 139.04 33.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 19' ' ' LEU . 16.4 mt -115.01 130.77 57.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.355 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 79' ' ' GLU . 87.3 mttt -120.53 137.16 54.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -167.94 146.32 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -68.22 -39.45 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -101.75 118.19 36.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 20.6 p80 -55.99 -43.87 78.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 81.2 tt0 -51.46 -53.57 35.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.16 -40.5 70.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.226 -0.921 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 11' ' ' LEU . 13.4 tp -68.25 -32.61 72.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 86.8 m-20 -63.76 -38.64 91.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.17 -41.59 81.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.8 t -61.68 -38.91 89.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.28 -37.01 74.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.11 -44.23 97.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.2 mttt -63.43 -41.11 98.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.349 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 22' ' ' SER . 78.2 mt -68.67 -42.2 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.0 t -64.73 -48.86 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.75 -43.83 98.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 25' ' ' LYS . 31.8 t -70.55 -41.9 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.62 76.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -59.99 -37.29 79.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.32 -30.64 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.5 p -76.5 160.58 29.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -55.12 -35.17 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.8 p -66.08 157.74 30.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -113.26 139.38 48.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 7.7 p -113.03 147.33 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 8.9 t -120.81 142.09 49.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.03 -149.72 17.33 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.1 Cg_endo -70.41 144.47 78.13 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 -1.799 . . . . 0.0 111.814 -0.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.1 mp -89.7 114.18 59.64 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.7 139.26 27.71 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.665 2.244 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.0 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.82 176.01 2.08 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.64 132.74 24.16 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.572 2.181 . . . . 0.0 111.753 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -72.99 139.33 46.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 48' ' ' ARG . 83.1 tt0 -108.91 132.86 53.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 46' ' ' GLU . 2.7 p 48.66 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.9 mtt180 -140.07 27.16 2.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.949 . . . . 0.0 109.404 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.01 130.44 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.583 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.1 m-70 -91.51 153.37 19.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -130.43 132.35 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.743 ' C ' HD12 ' A' ' 53' ' ' LEU . 30.6 mtt-85 -130.03 140.84 50.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.221 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.0 ' CD1' HD13 ' A' ' 43' ' ' LEU . 4.3 mp -122.43 138.04 54.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.734 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 71.8 mt -117.74 128.46 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.865 . . . . 0.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 91.5 m-20 -91.37 144.55 25.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB ' ' A' ' 7' ' ' ILE . 61.0 mt -120.36 137.11 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.23 136.89 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 45.19 62.17 10.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.3 Cg_endo -70.01 141.16 43.5 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.77 2.313 . . . . 0.0 111.735 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -127.88 173.0 5.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.33 -27.1 40.87 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.724 2.283 . . . . 0.0 111.804 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -64.79 -24.31 67.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.9 m -71.82 -42.39 67.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.247 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.93 -44.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.14 -48.09 76.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -55.46 -40.0 71.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.337 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.1 tp -62.44 -34.57 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.64 -30.51 69.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.469 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 38.5 mtm105 -74.12 -30.4 62.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 29' ' ' VAL . 66.9 mt -114.07 131.41 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -106.61 141.65 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.497 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.81 141.25 80.48 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.54 149.94 62.67 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.692 2.261 . . . . 0.0 111.724 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.95 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.39 -3.18 71.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 40.6 t -120.4 148.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -1.216 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 53.9 t0 -130.39 158.25 40.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.391 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 46.1 t -139.09 140.02 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.573 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 12' ' ' LYS . 93.9 mt-10 -94.26 132.55 38.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.92 -39.43 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 25.6 mttm -104.23 144.6 31.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 41.9 mt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.501 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.7 mtp -58.78 -35.78 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 86.77 10.58 72.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.24 -25.35 62.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -104.61 149.62 25.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.421 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 25.7 pttm -126.55 158.98 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 76.8 mt -115.63 137.06 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -119.66 137.29 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.67 135.6 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 13.7 tttp -107.34 121.01 43.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.81 ' O ' HD21 ' A' ' 19' ' ' LEU . 37.6 mt -101.65 126.86 48.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 96.4 mttt -121.32 137.37 54.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -167.26 143.69 4.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.516 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.01 -41.34 99.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.76 114.47 26.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.633 ' CE1' ' CG ' ' A' ' 17' ' ' GLU . 21.1 p80 -61.21 -35.44 77.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.422 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CG ' ' CE1' ' A' ' 16' ' ' HIS . 86.8 mt-10 -65.14 -39.87 93.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.04 -39.48 83.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 11' ' ' LEU . 14.0 tp -59.69 -38.22 80.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -65.57 -35.28 80.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.93 -39.54 94.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 76' ' ' VAL . 17.6 m -68.82 -37.5 79.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -72.71 -37.08 67.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 24.0 tttt -61.34 -45.21 95.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 29' ' ' VAL . 80.2 mttt -63.79 -41.34 97.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 79.5 mt -70.52 -43.29 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 23' ' ' ALA . 71.1 t -62.01 -45.36 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.9 mt-10 -61.5 -43.25 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' LYS . 32.2 t -72.94 -37.19 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.003 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -67.18 -49.5 64.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CE ' HG12 ' A' ' 27' ' ' VAL . 5.1 mtmp? -58.42 -37.23 74.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 m -57.12 -34.67 68.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' OG1' ' A' ' 63' ' ' THR . 27.8 m -73.37 154.47 40.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -50.99 -35.17 32.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.0 p -60.76 157.24 15.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -112.73 145.42 40.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.003 HG21 ' HB1' ' A' ' 30' ' ' ALA . 49.9 t -122.42 142.21 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 t -113.91 135.64 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.71 -155.59 21.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.38 138.11 48.94 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.77 0.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.28 115.42 63.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.01 139.41 32.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.619 2.213 . . . . 0.0 111.754 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mp -118.48 175.53 2.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.3 133.23 24.1 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.642 2.228 . . . . 0.0 111.76 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 21.6 m -78.63 142.62 37.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 48' ' ' ARG . 82.3 tt0 -112.45 126.31 55.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.0 t 53.25 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 46' ' ' GLU . 91.3 mtt180 -140.3 22.5 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 45' ' ' THR . 50.4 t -119.65 131.24 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.591 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 82.6 m-70 -101.27 150.76 22.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' HE2' ' A' ' 10' ' ' LYS . 9.4 mtmt -133.44 140.75 47.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.688 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 19' ' ' LEU . 88.8 mtt-85 -124.74 149.62 47.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.221 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -122.51 131.68 53.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.745 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.9 mt -119.17 124.39 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.197 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -99.95 140.52 34.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.717 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 66.9 mt -120.89 130.48 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.231 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -111.55 140.2 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 8.2 t0 51.4 59.91 14.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.7 Cg_endo -70.59 140.66 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 111.712 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.73 165.1 17.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.31 -19.98 49.34 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.631 2.221 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -71.07 -28.03 64.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.518 ' OG1' HG21 ' A' ' 33' ' ' THR . 53.8 m -72.08 -39.23 69.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.244 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.11 -41.58 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.309 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.537 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.878 . . . . 0.0 109.346 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.79 75.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.355 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -66.04 -41.87 90.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.537 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 67.6 mtm -65.53 -28.76 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -77.43 -28.41 52.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.1 mt -110.94 134.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -106.95 131.38 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -46.9 144.54 3.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HG ' ' A' ' 72' ' ' LEU . 49.5 Cg_endo -69.9 148.49 64.31 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.698 2.265 . . . . 0.0 111.827 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.06 152.0 41.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.46 -3.89 56.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG21 ' OG ' ' A' ' 22' ' ' SER . 48.4 t -124.76 148.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -1.181 . . . . 0.0 109.454 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.5 m-20 -118.26 157.14 27.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.3 148.99 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -108.86 137.43 46.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.72 158.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.432 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -85.74 134.07 33.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.475 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.479 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.462 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mmm -59.71 -35.56 74.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.84 66.97 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.62 -28.67 52.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -101.39 145.18 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 0.0 109.49 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 26.3 pttm -132.79 161.84 33.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 56' ' ' ILE . 10.5 mm -118.75 141.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.727 ' HB3' HD11 ' A' ' 53' ' ' LEU . 77.1 mtm180 -125.71 127.08 45.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 68.5 mt -114.96 135.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' C ' HD12 ' A' ' 11' ' ' LEU . 54.0 mttm -104.87 127.46 52.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -101.24 134.64 43.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.406 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 67.8 mttm -121.48 135.42 55.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -169.33 149.3 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.38 -39.96 67.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.34 119.38 32.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.8 p-80 -64.93 -38.21 90.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.7 mt-10 -59.83 -38.16 81.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.446 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -36.62 61.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 11' ' ' LEU . 14.4 tp -67.22 -35.86 80.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -62.9 -42.4 99.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.36 -40.96 98.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 m -63.26 -37.82 88.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -72.31 -44.62 62.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -59.62 -43.72 93.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.4 tttt -60.89 -45.93 92.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 22' ' ' SER . 89.6 mt -64.55 -40.13 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.5 t -62.47 -44.82 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.1 -41.12 97.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 25' ' ' LYS . 25.8 t -71.81 -43.36 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.017 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -65.83 -48.7 70.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -57.64 -37.89 74.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.86 -29.2 64.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.2 p -73.28 163.84 27.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.5 -33.25 67.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 60.7 p -69.37 158.82 34.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -108.29 151.09 26.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 30' ' ' ALA . 26.6 m -127.98 145.45 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -118.38 147.86 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.32 -156.29 18.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.2 Cg_endo -70.36 142.68 72.42 Favored 'Cis proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.781 -0.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 53' ' ' LEU . 4.4 mt -95.48 121.56 61.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 133.35 24.93 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.714 2.276 . . . . 0.0 111.899 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.9 mp -110.09 172.64 3.44 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -68.92 141.03 47.49 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.701 2.267 . . . . 0.0 111.713 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 11.7 t -80.09 141.24 35.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.917 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 79.4 tt0 -129.29 129.98 45.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.357 -0.84 . . . . 0.0 109.36 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 50.9 p 47.43 49.79 15.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.38 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' SER . 13.2 mtt-85 61.75 27.17 16.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 46.6 t -114.51 140.8 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.586 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 72.3 m80 -106.92 145.65 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 16.7 mttt -133.23 145.21 50.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' LEU . 89.0 mtt-85 -129.22 145.71 51.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.174 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 8' ' ' ARG . 26.5 tp -121.62 130.98 53.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.2 mt -116.42 118.21 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 81.5 m-20 -89.47 148.77 23.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.747 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' HB ' ' A' ' 7' ' ' ILE . 32.5 mt -124.51 130.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.354 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.87 136.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 1' ' ' SER . 39.0 t0 48.51 60.86 14.93 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.349 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 49.4 Cg_endo -69.72 142.2 47.47 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.773 2.316 . . . . 0.0 111.846 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -125.27 173.97 4.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.6 Cg_endo -67.88 -22.96 41.75 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.693 2.262 . . . . 0.0 111.663 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.44 -24.73 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.265 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 33' ' ' THR . 52.7 m -73.24 -40.2 64.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.24 -40.25 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.863 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.591 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -63.79 -39.54 94.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.21 -42.32 88.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 20.2 tp -63.78 -38.45 91.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.591 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 60.4 mtm -69.26 -30.41 68.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 52.2 mtt180 -75.77 -29.06 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.518 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 29' ' ' VAL . 72.1 mt -111.4 135.91 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.434 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -112.86 134.68 54.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -51.96 146.76 13.95 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.77 152.37 69.26 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.639 2.226 . . . . 0.0 111.806 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.44 149.12 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.14 -6.03 63.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 67.1 t -125.61 148.53 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -1.192 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.7 m-20 -124.05 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.421 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.421 HG23 HD13 ' A' ' 72' ' ' LEU . 39.2 t -132.59 135.14 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -94.56 125.07 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.48 -36.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -123.18 148.14 46.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.55 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.473 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.1 mmm -58.29 -33.96 70.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.409 ' HA3' ' CG ' ' A' ' 58' ' ' ASP . . . 94.38 5.93 61.59 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.2 -31.15 65.2 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -71.0 149.61 46.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.406 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 22.3 pttm -130.5 153.56 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.6 mt -117.83 142.33 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.362 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 68.3 mtt180 -121.84 134.96 54.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.688 ' CG2' HG13 ' A' ' 78' ' ' VAL . 81.0 mt -117.06 135.7 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.434 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 28.3 tttp -105.75 130.51 53.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 49.8 mt -107.87 127.94 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.571 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HE3' ' HD3' ' A' ' 10' ' ' LYS . 70.6 mttt -122.39 136.5 54.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.091 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -167.08 141.02 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -54.39 -50.78 66.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-20 -83.79 131.78 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.745 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 79.3 t60 -71.08 -35.57 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.339 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.19 -35.49 69.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.424 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 15' ' ' ASP . 82.7 mt -64.31 -35.08 79.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.091 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 6.6 mp -73.56 -39.28 64.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -64.54 -45.33 87.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.15 -41.64 73.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.0 m -65.09 -39.79 93.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.52 87.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.09 -39.68 94.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 mttt -65.04 -43.02 93.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.918 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' SER . 30.2 mm -65.53 -45.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.89 -45.34 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.86 -48.81 77.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 25' ' ' LYS . 64.6 t -69.26 -47.05 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.88 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -61.84 -49.32 76.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -58.32 -37.87 75.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 t -57.75 -30.36 65.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.4 p -75.09 163.3 27.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -56.51 -34.19 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.8 p -64.99 156.84 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -107.9 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.88 HG11 ' CB ' ' A' ' 30' ' ' ALA . 12.6 m -132.42 145.15 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.873 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 9.0 m -122.65 152.74 40.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.81 -143.84 17.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HB3' HG12 ' A' ' 54' ' ' ILE . 50.6 Cg_endo -70.98 146.7 85.46 Favored 'Cis proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.759 -1.767 . . . . 0.0 111.746 -0.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.32 114.47 60.49 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.266 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' O ' HD22 ' A' ' 43' ' ' LEU . 52.8 Cg_endo -72.58 140.0 32.11 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.723 2.282 . . . . 0.0 111.948 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 42' ' ' PRO . 3.9 mm? -118.43 166.87 12.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CD1' ' A' ' 43' ' ' LEU . 49.1 Cg_endo -69.68 128.2 15.75 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.634 2.222 . . . . 0.0 111.756 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 49' ' ' VAL . 19.0 m -68.88 154.37 42.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 48' ' ' ARG . 74.3 tt0 -122.83 119.58 30.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 m 59.9 -85.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' GLU . 92.6 mtt180 -143.85 22.99 1.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.422 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' THR . 59.6 t -122.52 128.55 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 70.8 m-70 -97.55 157.9 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 38.6 mtmt -142.07 137.36 30.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.67 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.866 ' C ' HD12 ' A' ' 53' ' ' LEU . 21.5 mtp180 -131.99 150.3 52.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.866 HD12 ' C ' ' A' ' 52' ' ' ARG . 7.7 mp -127.15 145.69 50.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.167 -0.958 . . . . 0.0 109.741 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 40' ' ' PRO . 70.2 mt -123.81 117.94 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 38.7 t0 -78.56 140.67 38.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.14 124.84 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.354 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -107.81 139.48 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.544 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' CG ' ' HA3' ' A' ' 3' ' ' GLY . 1.0 OUTLIER 50.76 63.62 9.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.5 Cg_endo -70.54 144.78 50.87 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.63 2.22 . . . . 0.0 111.675 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -131.4 172.05 8.03 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.597 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.24 -26.55 35.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 111.829 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -62.63 -20.99 65.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.7 m -74.32 -39.17 63.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.88 -40.17 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.558 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.8 m-20 -62.68 -41.3 99.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -64.5 -40.11 95.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.33 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.0 tp -64.0 -36.69 84.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.327 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.558 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 64.4 mtm -70.65 -27.06 63.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -78.67 -28.03 45.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.4 mt -112.93 135.32 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.82 133.73 51.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD22 ' CG2' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -64.29 145.7 98.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.58 150.64 63.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.685 2.256 . . . . 0.0 111.823 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.65 150.77 35.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.73 3.41 64.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.66 147.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.174 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 36.7 t0 -129.61 158.38 39.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.688 HG13 ' CG2' ' A' ' 9' ' ' ILE . 41.2 t -127.9 128.35 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 82.3 tt0 -121.1 139.47 53.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.49 131.25 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.82 146.17 26.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.928 ' OG ' HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -56.8 -38.03 71.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 109.499 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.28 92.36 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.98 75.53 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -117.13 127.2 53.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.458 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HE3' ' NH1' ' A' ' 8' ' ' ARG . 52.0 pttt -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' ILE . 77.0 mt -119.0 140.18 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' NH1' ' HE3' ' A' ' 6' ' ' LYS . 62.6 mtt180 -116.92 137.35 52.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 8' ' ' ARG . 24.1 mm -112.46 133.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 78.4 mttt -109.22 133.89 52.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 23' ' ' ALA . 16.0 mt -112.83 133.23 54.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 77.6 mttt -122.73 131.45 53.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -161.86 144.97 12.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.3 -36.39 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.08 116.74 32.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.542 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 15.4 p80 -60.3 -46.22 90.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 86.9 tt0 -53.91 -46.55 71.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.219 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -61.96 -40.59 96.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.225 -0.922 . . . . 0.0 108.804 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -67.51 -32.8 73.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD1' ' NH1' ' A' ' 52' ' ' ARG . 91.3 m-20 -63.64 -39.54 94.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.438 -0.789 . . . . 0.0 109.325 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.3 mm-40 -64.58 -49.5 70.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.44 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 37.2 m -58.89 -45.71 89.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -62.62 -51.42 67.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -57.78 -45.51 85.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.5 mttm -59.76 -46.24 89.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 22' ' ' SER . 97.2 mt -64.2 -41.14 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.517 HG13 ' HE3' ' A' ' 31' ' ' LYS . 77.7 t -61.13 -46.31 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 -41.26 96.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 70' ' ' ILE . 38.6 t -72.59 -39.97 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.973 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.64 -46.56 78.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HE3' HG13 ' A' ' 27' ' ' VAL . 50.0 mttt -59.56 -37.3 78.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -57.42 -30.79 65.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.2 p -76.35 163.82 26.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.52 -34.16 70.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.6 p -62.85 157.66 20.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -111.84 146.57 37.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.973 HG21 ' CB ' ' A' ' 30' ' ' ALA . 42.7 t -123.66 141.02 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 21.3 t -116.79 138.81 51.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.08 -150.06 17.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.31 143.95 76.4 Favored 'Cis proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.844 -0.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.4 mt -95.7 126.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.374 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.84 136.78 33.64 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.634 2.223 . . . . 0.0 111.827 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.7 HD13 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -120.81 175.62 2.27 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 50.6 Cg_endo -70.84 138.57 34.68 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.695 2.264 . . . . 0.0 111.707 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.584 HG21 ' ND1' ' A' ' 50' ' ' HIS . 21.7 p -91.14 162.75 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 48' ' ' ARG . 71.9 tt0 -126.66 126.34 43.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.537 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m 54.46 -88.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 46' ' ' GLU . 14.4 mtp180 -140.2 34.94 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 45' ' ' THR . 55.3 t -128.74 134.59 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.88 . . . . 0.0 109.568 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.584 ' ND1' HG21 ' A' ' 45' ' ' THR . 62.2 m-70 -102.91 148.97 24.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -135.54 141.3 45.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.562 ' CD ' HD22 ' A' ' 19' ' ' LEU . 19.8 mtp180 -123.92 152.05 42.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.1 tp -121.64 130.7 53.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.0 mt -118.49 125.82 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.381 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 86.9 m-20 -89.79 142.46 27.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.515 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ILE . 61.8 mt -119.5 131.06 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.439 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.928 HG23 ' OG ' ' A' ' 1' ' ' SER . 70.4 mt -109.7 139.39 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.23 63.92 9.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.1 Cg_endo -69.5 144.67 56.2 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.763 2.309 . . . . 0.0 111.748 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.6 m -132.69 166.5 28.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.47 -25.66 41.3 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.7 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -63.57 -25.65 68.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.4 m -67.36 -43.72 80.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.183 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.53 -43.32 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.1 t0 -54.13 -43.28 70.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.313 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -63.55 -40.13 96.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 70' ' ' ILE . 28.5 tp -59.16 -41.07 87.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 75.3 mtm -64.58 -35.18 80.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -70.57 -27.27 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -107.32 132.92 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -108.17 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.71 141.3 97.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 151.38 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.669 2.246 . . . . 0.0 111.862 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.71 31.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.37 58.45 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 88.4 t -125.62 148.15 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -1.201 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 51.1 t0 -134.58 155.3 50.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 24.0 m -132.68 148.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.95 146.52 29.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.457 HG12 ' HG3' ' A' ' 81' ' ' LYS . 13.4 tt -122.52 133.89 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HG3' HG12 ' A' ' 80' ' ' ILE . 61.1 mttm 61.17 44.03 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.9 tp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.472 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.5 mtp -58.53 -35.55 72.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 109.415 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 96.44 -7.17 65.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.7 -30.21 59.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -75.14 141.12 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -128.0 145.5 50.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -111.97 137.5 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.378 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 53' ' ' LEU . 57.7 mtm180 -122.96 135.5 54.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.8 mt -116.01 137.74 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' C ' HD12 ' A' ' 11' ' ' LEU . 11.4 tttp -110.25 128.83 55.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -112.6 120.65 42.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.254 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.488 ' HE3' ' HD3' ' A' ' 51' ' ' LYS . 28.5 mtpt -116.6 138.75 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.815 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -170.41 152.66 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.51 -36.01 73.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' OD2' ' HG ' ' A' ' 18' ' ' LEU . 50.6 t0 -93.13 114.3 26.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 17' ' ' GLU . 30.1 p-80 -67.14 -28.37 68.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HG2' ' CE1' ' A' ' 16' ' ' HIS . 66.3 mm-40 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 57.9 mt -64.1 -38.26 90.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 13' ' ' ALA . 60.1 mt -70.46 -34.52 72.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.514 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -63.92 -42.88 97.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -42.8 73.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.4 m -64.85 -38.62 91.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.417 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.81 -41.33 78.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -60.4 -46.85 88.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.907 ' O ' HG23 ' A' ' 29' ' ' VAL . 17.7 mtmm -60.9 -45.55 94.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 22' ' ' SER . 84.8 mt -65.03 -44.98 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.6 t -59.59 -48.19 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.17 -44.24 97.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 25' ' ' LYS . 18.5 t -68.11 -40.49 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.43 81.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -56.36 -38.16 71.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -57.91 -32.34 67.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 62' ' ' LYS . 23.9 m -74.31 152.25 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -50.32 -31.13 13.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 51.7 p -68.98 156.64 38.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -107.41 148.03 29.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -121.49 147.78 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 66.8 m -124.08 144.74 49.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.537 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.05 -155.09 16.34 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.41 140.61 63.58 Favored 'Cis proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.702 -1.791 . . . . 0.0 111.792 -0.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 10.1 mt -91.03 131.01 38.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.314 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.94 118.81 5.89 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.664 2.243 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -94.55 166.66 14.8 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.371 -0.831 . . . . 0.0 109.529 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.3 Cg_endo -67.66 143.66 62.99 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 111.604 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.6 m -85.76 142.93 28.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.958 . . . . 0.0 109.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.99 138.0 36.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.443 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 49' ' ' VAL . 13.5 p 45.87 49.39 11.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.04 36.83 27.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 47' ' ' SER . 50.0 t -123.15 132.35 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 109.521 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 97.6 m-70 -98.76 145.23 27.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 9.0 mtmm -135.98 151.09 49.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -127.41 147.94 50.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -122.02 131.16 53.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 53' ' ' LEU . 66.8 mt -120.53 117.39 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 83.8 m-20 -89.05 145.36 25.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 7' ' ' ILE . 68.7 mt -124.22 122.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.34 144.16 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 10.6 t0 47.69 62.66 11.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.419 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.7 Cg_endo -70.41 148.88 61.81 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.73 2.287 . . . . 0.0 111.716 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.421 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -137.18 167.86 19.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.39 -25.86 41.64 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 122.685 2.256 . . . . 0.0 111.673 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB2' HG23 ' A' ' 33' ' ' THR . 67.4 mttm -64.23 -26.11 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.131 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 -42.42 77.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.26 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.56 -44.39 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.573 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 58.5 t0 -55.91 -41.82 75.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.61 84.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' ILE . 21.2 tp -61.38 -40.21 93.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.573 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.6 mtm -67.7 -34.48 76.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -71.23 -29.49 65.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.545 ' CD1' HG21 ' A' ' 29' ' ' VAL . 69.3 mt -108.94 133.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.442 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -116.54 123.45 47.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.82 150.62 26.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.08 148.65 63.43 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.628 2.219 . . . . 0.0 111.742 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.31 153.09 31.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.954 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.11 8.57 55.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.62 147.85 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -1.19 . . . . 0.0 109.472 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.9 m-20 -112.82 150.59 31.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.97 143.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.441 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 80' ' ' ILE . 84.2 tt0 -99.08 136.95 38.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 79' ' ' GLU . 24.7 mm -117.23 127.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.502 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -58.55 -37.84 76.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 0.0 109.489 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 82' ' ' LEU . 7.3 tt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.6 mtp -125.55 158.49 34.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.09 -123.42 23.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.09 65.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 64.7 tt0 -100.2 126.58 46.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -1.221 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -132.49 143.22 49.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.461 HG13 ' HG3' ' A' ' 59' ' ' PRO . 79.9 mt -116.96 138.89 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 91.9 mtm-85 -119.71 136.74 54.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.583 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.11 131.97 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.405 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' HD13 ' A' ' 53' ' ' LEU . 68.3 tttt -97.6 125.5 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.6 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.824 ' HB3' HD11 ' A' ' 19' ' ' LEU . 44.3 mt -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 5.4 mtmp? -131.04 134.15 46.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -163.62 144.46 8.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' CD1' HG22 ' A' ' 49' ' ' VAL . 95.9 m-85 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' OD2' HD13 ' A' ' 18' ' ' LEU . 54.1 t0 -95.45 119.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 56.1 p-80 -61.6 -40.27 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.0 mt-10 -51.42 -52.26 47.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.3 mp -59.24 -43.94 92.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 11' ' ' LEU . 12.7 tp -65.58 -29.98 70.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.323 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 90.4 m-20 -67.3 -41.24 85.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 98.8 mt-10 -69.91 -35.45 74.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 26' ' ' ILE . 18.2 m -63.31 -40.22 96.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.2 -36.58 74.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 15.6 tttp -66.71 -39.74 88.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.1 mttm -65.2 -44.04 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 22' ' ' SER . 26.4 mm -69.49 -39.55 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 23' ' ' ALA . 78.7 t -62.2 -43.52 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 98.1 mt-10 -64.75 -38.42 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 25' ' ' LYS . 41.2 t -71.58 -40.82 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 37' ' ' VAL . . . -65.78 -46.81 77.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.53 -38.95 82.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.8 m -59.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.0 p -77.93 163.65 25.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.91 -36.07 67.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 55.7 p -66.47 157.95 30.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -111.91 147.76 35.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -116.72 147.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -124.37 144.24 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.15 -154.15 16.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.1 Cg_endo -70.15 143.18 73.83 Favored 'Cis proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.733 -1.778 . . . . 0.0 111.738 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.2 46.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.82 137.31 32.1 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.685 2.257 . . . . 0.0 111.849 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -127.57 175.83 3.1 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.0 Cg_endo -68.94 141.18 47.86 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.615 2.21 . . . . 0.0 111.751 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 16.0 p -95.45 162.22 13.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 48' ' ' ARG . 96.9 mt-10 -123.15 128.94 50.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.396 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.2 t 51.56 -90.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' GLU . 27.2 mmm180 -138.08 32.22 2.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 14' ' ' TYR . 44.4 t -122.7 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 99.5 m-70 -88.99 148.79 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.408 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 51.6 mtpt -126.02 128.61 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.801 ' C ' HD22 ' A' ' 53' ' ' LEU . 36.4 mtt-85 -126.46 144.31 50.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.801 HD22 ' C ' ' A' ' 52' ' ' ARG . 4.0 mm? -121.16 139.95 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 11' ' ' LEU . 66.5 mt -122.44 122.28 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 85.0 m-20 -93.0 144.9 24.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.846 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.0 mt -123.75 129.72 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.237 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' OD1' ' A' ' 58' ' ' ASP . 65.4 mt -107.66 141.97 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.895 . . . . 0.0 109.689 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER 46.84 61.43 13.44 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.0 Cg_endo -70.01 142.79 47.73 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.665 2.243 . . . . 0.0 111.699 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.419 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -126.76 168.05 15.67 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.558 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.23 -27.67 40.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.686 2.258 . . . . 0.0 111.619 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -62.62 -25.99 68.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.1 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 m -68.19 -43.51 77.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.241 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.42 -41.76 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.335 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -56.53 -44.1 80.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.119 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.07 -35.57 80.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.293 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.75 -27.38 69.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.296 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.7 mtm -82.1 -29.06 31.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.187 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -76.9 -22.83 52.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.5 mt -119.19 132.34 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -107.19 138.29 43.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.522 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 148.32 61.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.76 145.88 58.53 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.212 . . . . 0.0 111.817 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.45 150.01 32.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.0 58.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.18 148.77 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 90.1 m-20 -122.22 147.26 46.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.69 130.46 56.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 82' ' ' LEU . 71.7 mt -124.77 131.89 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.72 -34.94 70.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 80' ' ' ILE . 51.1 mt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 1' ' ' SER . 1.2 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.311 0.577 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -58.03 -34.72 70.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.41 9.64 62.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.66 65.29 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -111.14 145.41 38.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -1.165 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -134.5 151.39 51.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.21 138.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 69.9 mtm180 -121.54 135.66 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 53' ' ' LEU . 69.8 mt -118.03 135.89 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.187 -0.946 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.773 ' HE3' HD23 ' A' ' 82' ' ' LEU . 84.0 mttt -104.36 137.12 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 78' ' ' VAL . 14.1 mt -106.07 136.26 46.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.376 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.8 mttp -117.68 129.35 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.892 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -167.11 143.22 4.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -62.62 -39.46 93.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB3' HD13 ' A' ' 18' ' ' LEU . 50.2 t0 -95.07 120.42 35.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.499 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 47.1 t-80 -65.6 -35.43 80.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -56.37 -39.91 73.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.2 mp -63.36 -40.63 97.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.421 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.892 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.3 mt -62.6 -39.8 94.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -61.41 -46.19 91.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.83 -50.74 69.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.7 p -57.51 -43.95 84.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.87 -50.11 72.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -56.67 -40.49 75.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.8 tttp -61.19 -49.34 77.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -67.6 -39.84 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' ALA . 73.1 t -57.2 -46.69 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.77 -41.0 94.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 70' ' ' ILE . 35.1 t -72.08 -39.76 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.86 73.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.73 -40.09 86.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -60.56 -26.97 67.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' VAL . 23.7 p -81.99 162.58 22.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.481 ' HG ' ' HG ' ' A' ' 60' ' ' SER . 41.9 m -66.87 147.01 53.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.627 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -102.64 147.03 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.32 150.71 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 2.9 t -129.32 142.17 50.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 124.12 -150.84 17.06 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 52.1 Cg_endo -71.21 141.07 68.26 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.675 -1.802 . . . . 0.0 111.727 -0.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.5 131.12 35.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.62 120.31 7.14 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.709 2.273 . . . . 0.0 111.923 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 53' ' ' LEU . 14.6 mt -93.36 166.99 14.94 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 44.0 Cg_endo -66.76 132.11 27.68 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.749 2.3 . . . . 0.0 111.595 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' VAL . 40.0 m -83.99 151.09 25.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' C ' ' HG ' ' A' ' 47' ' ' SER . 80.5 tt0 -123.99 127.18 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.566 ' HG ' ' C ' ' A' ' 46' ' ' GLU . 98.4 p 49.39 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLU . 95.9 mtt180 -135.14 21.35 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HG23 ' A' ' 45' ' ' THR . 49.9 t -111.36 131.07 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.446 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.627 ' O ' HD11 ' A' ' 19' ' ' LEU . 68.7 m80 -105.73 147.02 29.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.6 mtmt -134.97 155.83 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 31.8 mtp85 -130.04 151.68 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.302 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.743 HD13 ' HG2' ' A' ' 10' ' ' LYS . 36.8 tp -124.33 131.55 53.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 67.7 mt -117.12 123.84 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 37.7 t0 -89.95 137.38 32.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.27 130.39 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.1 mt -111.85 138.4 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.684 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.41 61.32 12.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.41 137.37 33.41 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.649 2.232 . . . . 0.0 111.792 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.496 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -129.15 172.73 6.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 44.8 Cg_endo -67.61 -25.28 40.79 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.68 2.253 . . . . 0.0 111.542 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.11 -26.13 67.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -72.34 -39.19 68.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.329 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.61 -42.63 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.5 m-20 -61.43 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.353 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.61 -37.44 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.4 tp -63.47 -39.71 95.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 59.2 mtm -68.31 -32.13 72.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -73.76 -29.07 62.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.963 ' CD1' HG21 ' A' ' 29' ' ' VAL . 73.2 mt -109.39 135.53 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.58 150.94 79.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HG2' HG21 ' A' ' 76' ' ' VAL . 49.2 Cg_endo -69.89 147.57 62.31 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.662 2.241 . . . . 0.0 111.799 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.35 146.93 32.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.93 69.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.1 t -127.82 148.58 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 33.0 t0 -138.04 153.04 49.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.478 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG12 ' CD2' ' A' ' 11' ' ' LEU . 25.6 m -143.07 147.36 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.418 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -114.63 127.09 55.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.4 mm -65.28 -39.57 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.499 ' O ' HD12 ' A' ' 82' ' ' LEU . 26.0 mttm -60.41 -34.76 74.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.773 HD23 ' HE3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.07 -34.99 72.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.37 -178.21 31.21 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.94 -72.61 1.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -115.86 154.71 29.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -1.164 . . . . 0.0 109.511 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -109.33 144.43 37.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 59' ' ' PRO . 69.1 mt -114.7 136.7 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 45.0 mtm180 -122.85 136.8 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 53' ' ' LEU . 83.0 mt -113.26 133.28 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 18.2 tttt -103.13 121.46 42.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 50.3 mt -104.05 126.37 51.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE2' ' HE2' ' A' ' 10' ' ' LYS . 36.4 mttt -121.72 137.63 54.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 109.415 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.78 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -168.72 146.05 3.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.57 -52.17 49.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.14 130.26 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.581 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.5 p-80 -74.9 -28.88 60.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.878 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.78 -37.89 86.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.36 -36.1 83.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.78 HD21 ' CB ' ' A' ' 13' ' ' ALA . 70.9 mt -69.94 -36.42 75.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.41 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.67 -41.39 88.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.45 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.03 -43.17 83.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 26' ' ' ILE . 84.2 p -66.26 -35.81 81.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.354 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.61 -38.76 80.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -61.13 -44.54 97.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -61.22 -45.72 93.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 22' ' ' SER . 29.2 mm -65.73 -41.58 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 23' ' ' ALA . 79.2 t -61.8 -44.42 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.97 -47.26 78.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 25' ' ' LYS . 34.1 t -67.44 -43.38 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.86 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.23 -47.06 84.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.444 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -55.74 -39.52 71.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.6 m -56.05 -31.66 63.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 p -78.04 162.21 26.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.49 -29.03 63.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.382 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 26.3 t -69.85 148.3 49.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -107.57 150.29 27.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.86 HG21 ' CB ' ' A' ' 30' ' ' ALA . 41.7 t -122.08 140.93 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -117.86 141.75 48.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.84 -149.36 16.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.24 145.85 81.6 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.75 -1.771 . . . . 0.0 111.878 0.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.6 mp -94.26 125.17 53.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.85 118.15 5.54 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.077 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 44' ' ' PRO . 12.5 mt -97.89 168.25 10.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.897 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 43' ' ' LEU . 46.5 Cg_endo -68.33 147.99 73.0 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.721 2.281 . . . . 0.0 111.67 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CD2' ' A' ' 50' ' ' HIS . 18.8 p -102.67 162.44 12.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.537 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 48' ' ' ARG . 96.8 mt-10 -128.7 128.31 43.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m 54.51 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 46' ' ' GLU . 92.6 mtt180 -142.88 33.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 45' ' ' THR . 48.6 t -123.2 130.16 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 69.8 m80 -103.39 149.2 25.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.5 mtmt -137.02 144.41 43.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.599 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -124.71 152.08 44.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.4 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -125.97 135.0 51.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 67.1 mt -121.07 124.58 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 87.1 m-20 -90.3 145.15 25.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -126.82 125.55 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -106.97 139.71 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.654 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' SER . 3.6 t70 53.19 62.23 10.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.636 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.8 Cg_endo -70.21 141.33 43.14 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.753 2.302 . . . . 0.0 111.67 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.49 166.59 22.14 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.08 -21.74 42.32 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.663 2.242 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -67.67 -25.49 65.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.113 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 m -70.59 -42.46 70.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.82 -42.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.538 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 86.2 m-20 -57.59 -45.56 85.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.75 84.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' ILE . 3.8 tp -63.7 -40.45 96.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.98 -29.95 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -74.59 -29.26 61.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.1 mt -110.11 136.62 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.21 134.9 42.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -61.76 149.32 85.35 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 72' ' ' LEU . 48.7 Cg_endo -69.77 141.04 44.12 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.685 2.257 . . . . 0.0 111.758 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.86 149.77 49.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.7 9.15 56.68 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.79 142.05 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -1.113 . . . . 0.0 109.427 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -110.89 151.42 27.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.18 142.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.27 145.53 29.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 82' ' ' LEU . 66.9 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -60.92 -34.69 75.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.484 ' H ' HG22 ' A' ' 80' ' ' ILE . 27.2 tp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.48 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 16.5 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 76.4 mttt -112.89 143.45 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.429 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.5 mt -117.3 137.51 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HB3' HD11 ' A' ' 53' ' ' LEU . 57.4 mtt85 -118.19 135.96 53.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.654 ' O ' HD22 ' A' ' 53' ' ' LEU . 72.2 mt -120.37 130.32 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.786 ' HG2' HD23 ' A' ' 53' ' ' LEU . 38.7 mttt -99.84 131.6 45.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.7 mp -110.75 134.94 52.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 25.2 mttt -126.81 141.85 51.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -172.13 147.42 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -67.32 -40.99 86.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -94.4 113.97 25.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.585 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 44.4 p-80 -58.97 -37.72 77.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 109.388 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.1 mt-10 -52.98 -54.19 38.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.259 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.2 mp -55.97 -49.38 73.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.5 tt -61.46 -31.51 71.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 65.1 m-20 -66.78 -38.68 87.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.334 -0.854 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.09 -38.82 75.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.8 t -65.43 -45.35 84.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.898 . . . . 0.0 109.44 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -65.24 -48.19 74.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.54 -43.98 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 70' ' ' ILE . 26.5 tttm -59.72 -49.7 76.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 22' ' ' SER . 97.5 mt -61.05 -41.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 23' ' ' ALA . 76.8 t -57.49 -44.89 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.02 -43.96 97.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.8 -41.65 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.934 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.13 -48.26 74.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.443 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.0 m -56.7 -30.98 64.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -75.4 160.45 30.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.13 -35.38 67.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 52.6 p -62.81 157.22 21.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -111.95 148.24 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.934 HG21 ' CB ' ' A' ' 30' ' ' ALA . 24.8 t -122.67 139.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 t -113.51 140.85 47.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 121.97 -149.37 17.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 51.0 Cg_endo -70.8 146.37 84.23 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.782 -1.758 . . . . 0.0 111.674 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 mt -97.36 119.81 62.22 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.03 144.85 48.31 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -123.87 173.56 4.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.444 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.5 Cg_endo -70.01 135.93 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.698 2.265 . . . . 0.0 111.766 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 49' ' ' VAL . 38.0 m . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 45' ' ' THR . 45.7 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 96.3 m-70 -97.92 145.69 26.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.351 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.4 mtmm -141.83 143.81 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' A' ' 19' ' ' LEU . 89.3 mtt-85 -130.88 152.98 49.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.217 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.7 tm? -124.45 125.77 44.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.942 . . . . 0.0 109.663 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.79 ' N ' HD13 ' A' ' 53' ' ' LEU . 64.8 mt -112.12 120.8 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' OD1' ' CD1' ' A' ' 53' ' ' LEU . 86.9 m-20 -86.83 144.09 27.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 68.3 mt -120.94 132.01 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.335 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -111.09 138.98 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.24 63.19 10.57 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.1 Cg_endo -70.11 143.32 48.82 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.641 2.227 . . . . 0.0 111.717 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -120.98 168.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 109.503 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.27 -24.46 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.642 2.228 . . . . 0.0 111.836 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.47 -21.91 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.5 m -73.11 -40.93 64.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.67 -41.25 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 0.0 109.373 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.613 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -60.64 -40.15 90.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 67' ' ' LEU . 23.6 tp -63.27 -38.38 90.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.613 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 68.1 mtm -69.65 -33.89 73.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 29.8 mtp180 -73.19 -27.36 61.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.554 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 71.1 mt -107.24 134.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -108.68 126.56 53.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.93 145.19 54.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 150.82 65.31 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.704 2.269 . . . . 0.0 111.777 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.43 148.33 15.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.19 64.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.89 148.56 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -1.202 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 52.3 t0 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -133.92 145.81 49.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.2 mt -117.11 144.56 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' HB3' HD21 ' A' ' 53' ' ' LEU . 48.2 mtp85 -117.12 135.56 53.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.511 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.779 ' O ' HD22 ' A' ' 53' ' ' LEU . 71.4 mt -120.77 129.57 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.681 ' HG2' HD23 ' A' ' 53' ' ' LEU . 56.5 mttm -103.53 132.9 49.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.659 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -108.11 137.62 45.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 27.2 mttt -125.84 137.23 53.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -168.57 140.51 2.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.601 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -55.63 -48.78 74.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 18' ' ' LEU . 95.5 m-20 -97.63 132.58 43.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.739 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.59 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 46.8 p-80 -69.65 -29.17 66.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -57.17 -45.96 83.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.359 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.2 mp -68.51 -44.77 73.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 11' ' ' LEU . 8.2 tt -62.31 -45.83 91.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.444 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -57.37 -43.74 83.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.84 -41.53 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.34 -45.22 92.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -60.29 -41.31 93.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.853 . . . . 0.0 109.436 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -61.88 -44.3 97.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.5 tttp -60.77 -41.85 96.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.16 -39.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.8 t -61.83 -42.56 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.78 -37.67 88.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.2 t -74.2 -40.35 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.16 76.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -60.36 -37.51 80.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -59.32 -30.92 68.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.0 p -76.95 162.45 27.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.89 -36.23 67.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.4 p -64.71 158.64 24.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -111.96 146.68 37.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.384 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.476 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 4.4 p -119.08 147.14 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -125.18 142.35 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.03 -150.78 18.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 146.67 83.48 Favored 'Cis proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.781 -0.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 53' ' ' LEU . 7.5 mt -94.64 126.52 47.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.3 141.15 42.34 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.611 2.207 . . . . 0.0 111.784 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.58 174.24 4.36 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.465 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -69.41 139.81 42.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 23.4 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.458 ' O ' ' HB ' ' A' ' 45' ' ' THR . 59.6 t . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.59 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 96.5 m-70 -104.44 145.08 30.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.9 mtmm -137.62 143.03 41.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HG3' HD22 ' A' ' 19' ' ' LEU . 32.4 mtp85 -128.63 153.32 47.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 9' ' ' ILE . 3.4 tm? -123.94 128.04 48.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 53' ' ' LEU . 69.2 mt -111.28 128.32 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.82 142.45 27.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.22 131.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.44 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.86 138.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' SER . 38.8 t70 48.22 60.78 14.97 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.1 Cg_endo -70.26 143.74 49.32 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.698 2.265 . . . . 0.0 111.754 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -126.03 169.71 11.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.3 Cg_endo -68.11 -25.29 37.71 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.719 2.279 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.96 -22.75 66.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.4 m -71.19 -41.75 69.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.99 -41.65 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.385 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.598 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 90.4 m-20 -59.01 -40.08 83.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 0.0 109.395 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.73 91.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 70' ' ' ILE . 5.0 tp -61.04 -40.59 94.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.598 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 70.3 mtm -67.9 -33.19 74.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 93.2 mtt-85 -73.54 -29.48 62.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -107.77 134.13 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.478 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.13 125.64 54.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -58.98 151.12 57.44 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.68 151.43 69.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.786 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.76 150.17 16.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.71 64.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.8 t -126.07 148.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -1.194 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.512 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -121.89 145.75 47.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 59' ' ' PRO . 84.6 mt -116.04 138.47 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.545 ' HD2' HD21 ' A' ' 53' ' ' LEU . 57.0 mtm180 -119.08 137.82 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.85 136.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.441 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' NZ ' ' HD3' ' A' ' 51' ' ' LYS . 44.7 tttt -111.45 124.27 51.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -102.75 126.0 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.377 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 59.0 mttt -116.49 131.06 57.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.801 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -166.28 142.6 4.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.511 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -62.31 -38.35 89.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 60.7 t0 -91.55 118.82 30.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.0 p-80 -65.01 -31.87 73.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.897 . . . . 0.0 109.446 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.8 mt-10 -61.39 -39.23 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 15' ' ' ASP . 75.4 mt -63.63 -38.99 93.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.801 HD21 ' CB ' ' A' ' 13' ' ' ALA . 61.6 mt -64.95 -37.14 86.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.64 -41.86 95.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 97.1 mt-10 -67.24 -37.79 84.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 11' ' ' LEU . 22.3 m -62.5 -40.02 95.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.767 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.56 -44.33 74.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -61.3 -46.35 90.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.4 mttt -63.8 -46.93 82.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 81.8 mt -70.0 -40.44 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.1 t -63.71 -44.74 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -63.31 -42.4 99.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.662 HG11 ' HB1' ' A' ' 66' ' ' ALA . 42.0 t -73.28 -42.22 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.448 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.959 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.57 -48.47 72.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.18 -40.39 77.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.51 -29.81 64.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 29' ' ' VAL . 28.5 p -76.6 161.61 28.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -57.0 -30.78 64.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -66.66 155.01 39.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -108.78 150.15 28.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.959 HG21 ' CB ' ' A' ' 30' ' ' ALA . 47.5 t -125.45 140.87 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -119.1 140.01 50.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 130.79 -151.65 19.65 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 51.3 Cg_endo -70.97 140.24 63.03 Favored 'Cis proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.701 -1.791 . . . . 0.0 111.683 -0.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mt -90.27 122.88 66.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.423 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.74 129.53 17.79 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.738 2.292 . . . . 0.0 112.018 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 2.9 mp -105.59 171.59 4.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.2 Cg_endo -69.54 128.3 16.02 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.669 2.246 . . . . 0.0 111.749 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.741 HG21 ' CE1' ' A' ' 50' ' ' HIS . 35.1 m . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 45' ' ' THR . 59.3 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.254 0.549 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.741 ' CE1' HG21 ' A' ' 45' ' ' THR . 92.8 m-70 -106.9 146.91 30.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HD3' ' NZ ' ' A' ' 10' ' ' LYS . 47.6 mttm -127.59 150.91 49.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 62.6 mtp85 -133.6 144.81 49.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' HD2' ' A' ' 8' ' ' ARG . 28.8 tp -121.53 133.24 55.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 65.9 mt -120.7 120.98 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.69 137.04 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 56' ' ' ILE . 49.4 mt -119.54 127.65 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.99 139.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.05 61.51 13.9 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.23 144.38 51.33 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.723 2.282 . . . . 0.0 111.823 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 165.97 21.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.95 -26.11 37.95 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.797 2.331 . . . . 0.0 111.741 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -67.17 -22.44 65.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.22 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.4 m -71.42 -41.7 69.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.45 -42.28 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.271 -0.893 . . . . 0.0 109.323 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.65 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 91.1 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.342 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -63.07 -40.92 99.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' ILE . 32.1 tp -61.92 -39.59 92.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.44 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.65 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 72.6 mtm -67.02 -31.93 72.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 77.8 mtp180 -70.46 -30.38 67.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.6 mt -110.14 136.04 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -101.32 129.79 47.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 148.61 37.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.12 149.07 64.1 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.65 2.233 . . . . 0.0 111.783 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 148.43 27.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.9 3.43 65.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.3 t -126.31 148.33 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.5 t0 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -111.9 149.5 31.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.462 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -110.71 142.35 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.4 mtm180 -118.58 136.76 53.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.6 mt -120.17 132.86 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.527 ' HG2' HD13 ' A' ' 53' ' ' LEU . 26.4 mttm -108.58 132.09 54.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.018 ' CB ' HD11 ' A' ' 19' ' ' LEU . 3.4 mp -117.69 129.51 55.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.516 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 83.0 mttt -116.25 137.29 52.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -160.26 145.69 15.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.77 -39.09 90.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.583 ' CB ' HD13 ' A' ' 18' ' ' LEU . 92.3 m-20 -97.33 125.09 41.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.589 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 19.5 p80 -71.17 -30.06 65.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.09 -39.2 89.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.4 mp -72.92 -44.01 61.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.496 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.018 HD11 ' CB ' ' A' ' 11' ' ' LEU . 40.8 tp -58.75 -42.81 89.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.2 -46.33 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -40.3 85.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 m -60.64 -44.29 96.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.43 -42.19 99.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -59.99 -47.14 87.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.8 mtpt -56.32 -47.86 77.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.554 HD12 HD21 ' A' ' 11' ' ' LEU . 75.2 mt -65.64 -41.66 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.862 . . . . 0.0 109.36 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 23' ' ' ALA . 69.1 t -62.67 -46.17 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -59.28 -40.91 87.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' LYS . 38.7 t -70.68 -42.2 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.895 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -66.18 -46.59 76.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' CE ' ' CG1' ' A' ' 27' ' ' VAL . 23.2 mttm -57.43 -37.11 72.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 m -57.41 -34.28 68.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.9 m -74.26 154.71 38.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.43 -29.23 9.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -65.28 158.78 25.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -113.71 152.56 30.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 30' ' ' ALA . 39.4 t -123.42 140.97 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -115.29 149.13 38.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 113.64 -147.32 18.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 50.9 Cg_endo -70.6 148.45 88.64 Favored 'Cis proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.731 -1.779 . . . . 0.0 111.813 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -98.41 123.21 51.21 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.43 140.53 36.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.699 2.266 . . . . 0.0 111.842 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.678 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -120.29 176.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.678 ' HD2' HD23 ' A' ' 43' ' ' LEU . 48.1 Cg_endo -69.8 141.85 46.19 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.536 2.157 . . . . 0.0 111.696 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.806 HG21 ' HD2' ' A' ' 50' ' ' HIS . 18.3 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.602 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 45' ' ' THR . 46.4 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.806 ' HD2' HG21 ' A' ' 45' ' ' THR . 61.8 m80 -105.88 149.79 26.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' HE2' ' A' ' 12' ' ' LYS . 33.4 mtmm -135.18 141.06 45.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HG3' HD23 ' A' ' 19' ' ' LEU . 35.8 mtt-85 -122.87 150.52 42.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.537 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.3 tp -121.99 126.91 49.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.532 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.13 128.92 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 85.5 m-20 -97.85 146.45 25.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.462 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.29 133.94 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.44 136.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 47.1 59.53 16.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.4 Cg_endo -70.11 144.24 51.58 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.78 2.32 . . . . 0.0 111.825 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.413 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -121.89 167.96 12.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.426 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.5 Cg_endo -67.42 -26.12 41.22 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.722 2.281 . . . . 0.0 111.631 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.78 -25.29 66.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.173 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -70.23 -39.16 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.5 -42.78 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.0 m-20 -56.78 -44.11 81.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.324 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.55 86.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -65.1 -40.36 94.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.589 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 65.1 mtm -68.38 -29.74 68.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 41.8 mtp85 -75.43 -29.44 59.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 67' ' ' LEU . 74.5 mt -111.26 136.03 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -106.54 155.95 19.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.395 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 1.2 pp -70.35 140.18 87.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.12 154.45 66.32 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.724 2.283 . . . . 0.0 111.74 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 150.63 11.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 88.13 7.28 73.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -131.26 147.9 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -1.154 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 56.0 t0 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -124.97 146.14 49.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.7 mt -113.48 141.72 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 86.5 mtm-85 -121.57 136.7 54.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.593 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 53' ' ' LEU . 68.9 mt -114.72 140.05 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 16.2 tttp -108.15 125.11 51.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 19' ' ' LEU . 47.4 mt -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.374 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' CE ' ' HD3' ' A' ' 10' ' ' LYS . 93.5 mttt -130.63 132.9 45.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.567 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -171.01 151.3 3.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.401 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.5 -32.33 64.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 92.6 m-20 -90.8 108.21 19.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.875 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 46.3 t-80 -58.75 -46.93 86.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.927 . . . . 0.0 109.466 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -59.28 -45.39 91.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 24.6 tp -62.61 -38.46 90.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 11' ' ' LEU . 15.6 tp -57.73 -38.32 75.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . 45.6 t0 -65.08 -40.2 94.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.74 -41.17 85.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.4 p -67.78 -34.05 76.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -71.28 -41.85 69.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -60.45 -43.53 96.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' O ' HG23 ' A' ' 29' ' ' VAL . 64.8 tttt -59.15 -49.17 78.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 109.498 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 22' ' ' SER . 28.2 mm -66.5 -39.51 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 23' ' ' ALA . 82.7 t -60.62 -42.2 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' LYS . 22.0 t -72.25 -40.71 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.53 -45.87 81.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -61.21 -38.09 85.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.8 p -57.34 -28.69 63.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.5 p -82.0 161.18 23.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.64 -35.78 66.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.429 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 19.6 m -64.53 149.5 48.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.25 150.52 25.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.83 147.09 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 39.1 m -119.27 145.06 46.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.1 -155.75 16.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.61 141.27 67.57 Favored 'Cis proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.672 -1.803 . . . . 0.0 111.72 0.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.5 mt -94.36 120.79 64.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.361 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.6 128.16 14.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.728 2.285 . . . . 0.0 111.827 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 3.1 mp -108.29 171.32 4.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.444 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.51 137.0 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.777 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 49' ' ' VAL . 32.6 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 45' ' ' THR . 47.4 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 75.4 m80 -94.9 148.22 22.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.8 mtmt -138.6 146.63 42.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.555 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 87.6 mtt-85 -128.58 154.29 46.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.898 . . . . 0.0 109.371 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 9' ' ' ILE . 29.5 tp -123.78 129.01 50.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.629 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.565 HD11 HD11 ' A' ' 11' ' ' LEU . 64.2 mt -114.38 122.65 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 86.7 m-20 -93.11 141.53 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ILE . 69.2 mt -118.95 129.37 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.349 -0.844 . . . . 0.0 109.252 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.4 mt -110.13 142.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.642 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 35' ' ' SER . 12.2 t0 50.26 60.84 14.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.33 140.12 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.666 2.244 . . . . 0.0 111.923 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.09 167.81 16.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.18 -26.17 36.49 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.697 2.265 . . . . 0.0 111.64 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -64.55 -21.98 66.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.8 m -73.32 -40.55 64.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.18 -39.69 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 91.2 m-20 -61.99 -42.09 98.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.334 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.7 81.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -62.72 -40.19 96.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -69.23 -29.48 67.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.387 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 50.3 mtt180 -75.96 -29.67 58.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 59.9 mt -113.72 133.21 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -101.93 142.39 33.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 109.475 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.05 155.0 4.74 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HG3' ' HA ' ' A' ' 22' ' ' SER . 50.6 Cg_endo -69.95 144.37 52.82 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.759 2.306 . . . . 0.0 111.792 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.02 147.0 48.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.08 62.32 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 22' ' ' SER . 49.7 t -129.69 147.87 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 86.2 m-20 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 23.8 pttm -130.77 151.2 51.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 59' ' ' PRO . 85.3 mt -118.76 139.76 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.535 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 82.4 mtt180 -118.94 135.09 54.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.04 136.02 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.419 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD13 ' A' ' 53' ' ' LEU . 77.5 mttt -111.74 130.74 55.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 10' ' ' LYS . 13.8 mt -112.72 137.02 51.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.632 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -122.26 142.86 50.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.83 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -170.64 148.05 2.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.691 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -57.3 -48.39 79.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.615 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -89.52 127.9 35.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.599 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.578 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.4 p-80 -75.08 -34.61 61.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.31 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -57.92 -41.42 82.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.865 . . . . 0.0 109.393 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.73 -43.55 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.83 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.4 mt -54.33 -40.7 68.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -64.23 -36.44 84.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -70.36 -38.91 74.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 26' ' ' ILE . 25.6 t -69.86 -42.07 74.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.26 -38.26 81.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 21.3 tttt -61.29 -47.14 87.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -62.33 -43.64 98.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 22' ' ' SER . 79.7 mt -67.49 -39.81 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.7 t -63.08 -43.08 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.7 mt-10 -62.61 -39.27 93.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.5 t -74.92 -37.7 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -68.88 -48.38 63.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 78.6 mttt -58.74 -40.3 83.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -50.27 -28.6 8.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.1 p -78.34 165.7 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -57.72 -32.66 67.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 56.5 p -64.93 157.71 27.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -107.03 152.35 24.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.935 HG21 ' HB3' ' A' ' 30' ' ' ALA . 44.6 t -124.94 143.66 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 5.8 t -123.94 137.84 54.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.541 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.26 -151.2 16.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.527 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.37 56.65 Favored 'Cis proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.677 -1.801 . . . . 0.0 111.794 -0.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.98 124.5 61.73 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.1 140.73 38.3 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.654 2.236 . . . . 0.0 111.664 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -116.68 174.77 2.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.416 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.53 135.39 28.5 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.661 2.241 . . . . 0.0 111.81 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 31.9 m . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.389 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 48.1 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 83.4 m-70 -102.23 153.97 19.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 12.5 mtmt -136.3 141.76 43.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.531 ' CD ' ' HB3' ' A' ' 19' ' ' LEU . 61.0 mtp85 -121.7 149.41 43.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.212 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.533 ' HB2' HD13 ' A' ' 43' ' ' LEU . 32.6 tp -124.57 128.84 49.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.517 HD11 ' CB ' ' A' ' 23' ' ' ALA . 70.1 mt -116.53 121.26 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.335 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 84.6 m-20 -90.9 146.38 23.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.564 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.92 130.73 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.337 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.47 140.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 30.5 t0 47.84 61.69 13.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.9 141.63 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 111.715 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.406 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -124.16 167.88 14.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.14 -22.2 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.725 2.283 . . . . 0.0 111.573 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -67.46 -25.56 65.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.422 ' HA ' HG21 ' A' ' 33' ' ' THR . 32.5 m -70.92 -41.37 71.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.183 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.9 -42.05 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.572 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.5 t0 -57.31 -45.94 83.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.246 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -61.28 -35.24 76.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.4 tp -66.72 -39.09 87.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.572 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 63.8 mtm -70.13 -26.2 63.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.383 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -79.99 -27.85 39.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -112.47 137.12 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.1 139.0 41.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 72' ' ' LEU . 3.3 pp -59.35 144.22 84.16 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 72' ' ' LEU . 51.9 Cg_endo -70.95 151.33 62.21 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.667 2.245 . . . . 0.0 111.818 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.55 26.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.11 5.41 65.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -129.45 147.06 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -1.182 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.7 t0 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -132.75 148.8 52.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.2 mt -114.59 138.99 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 53' ' ' LEU . 88.6 mtt180 -121.26 136.5 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.893 . . . . 0.0 109.549 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.607 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.3 mt -116.02 135.63 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.734 ' HG2' HD13 ' A' ' 53' ' ' LEU . 80.0 mttt -108.64 131.37 54.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 10' ' ' LYS . 15.5 mt -110.47 138.87 46.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 61.2 mttp -122.57 134.2 54.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -168.73 146.62 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.493 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.37 -37.11 86.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -96.64 123.19 40.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.8 p-80 -72.78 -30.01 63.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 16' ' ' HIS . 75.3 mm-40 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.28 -37.19 84.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 13' ' ' ALA . 59.5 mt -70.44 -37.42 74.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -62.18 -42.32 99.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.02 -45.72 73.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.473 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.2 t -63.86 -40.46 96.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -65.7 -41.92 91.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.482 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -57.42 -46.06 83.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.461 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.6 mttm -58.46 -44.42 89.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 22' ' ' SER . 24.6 mm -65.68 -43.13 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.55 -46.23 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -62.83 -44.71 95.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.589 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.7 t -66.77 -45.29 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.901 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.33 -43.64 90.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.602 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -56.02 -39.22 71.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.5 p -60.12 -24.98 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 p -80.42 163.14 24.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -56.74 -30.18 63.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.8 p -72.37 155.35 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -112.11 145.11 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 ' CB ' ' A' ' 30' ' ' ALA . 43.9 t -124.42 141.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -117.6 138.64 51.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.71 -158.41 23.77 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.596 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.35 56.53 Favored 'Cis proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.685 -1.798 . . . . 0.0 111.781 -0.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.98 131.48 37.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.44 141.19 41.86 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.603 2.202 . . . . 0.0 111.82 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -125.37 174.76 3.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 109.482 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 51.6 Cg_endo -70.51 146.66 56.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.747 2.298 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 50' ' ' HIS . 25.3 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 45' ' ' THR . 50.4 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.245 0.545 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 71.1 m80 -101.02 151.1 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 46.9 mtmt -137.76 141.5 40.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -125.9 146.67 49.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.285 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.734 HD13 ' HG2' ' A' ' 10' ' ' LYS . 29.0 tp -122.54 133.66 54.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.686 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 68.7 mt -115.26 126.7 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.314 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -91.22 142.14 28.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ILE . 59.6 mt -123.04 130.47 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.969 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.7 mt -112.55 141.58 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.709 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 35' ' ' SER . 65.5 t0 45.9 62.3 11.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.601 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.26 141.63 43.69 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.735 2.29 . . . . 0.0 111.663 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -129.4 170.67 10.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.9 Cg_endo -67.44 -28.67 38.66 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.705 2.27 . . . . 0.0 111.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.54 -24.9 68.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.28 -0.887 . . . . 0.0 109.133 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -71.57 -40.77 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.25 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.616 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.5 m-20 -58.89 -44.12 91.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -62.79 -41.17 99.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.377 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.4 tp -60.96 -39.5 89.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.407 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.29 -31.47 72.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.459 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 19.2 mtp180 -71.06 -30.06 66.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.609 ' CD1' HG21 ' A' ' 29' ' ' VAL . 70.3 mt -112.58 133.82 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.26 141.32 38.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.44 148.59 79.96 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.597 ' HG2' HG21 ' A' ' 76' ' ' VAL . 50.2 Cg_endo -70.3 149.44 63.48 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.742 2.294 . . . . 0.0 111.788 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.21 147.88 28.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.35 70.13 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.0 t -126.75 148.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.147 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 23.0 t70 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 37.1 mtmt -126.84 147.34 50.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.536 HD12 ' HB3' ' A' ' 59' ' ' PRO . 82.2 mt -113.65 137.34 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 53' ' ' LEU . 92.8 mtt180 -123.11 136.47 54.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.5 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HD22 ' A' ' 53' ' ' LEU . 69.4 mt -114.58 134.3 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.796 ' HG2' HD23 ' A' ' 53' ' ' LEU . 40.4 mttt -105.35 128.73 53.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.1 mp -112.67 133.8 54.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 88.3 mttt -128.4 138.4 52.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.808 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -169.57 147.61 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.49 -38.13 86.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -97.24 125.09 41.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.7 p-80 -71.13 -28.6 64.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 49.3 mt -65.75 -39.7 91.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 13' ' ' ALA . 68.2 mt -67.41 -36.62 81.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.59 -43.61 98.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.34 -40.3 85.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.7 t -65.14 -41.54 94.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -68.54 -40.84 80.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -58.99 -48.15 82.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mttm -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 22' ' ' SER . 84.0 mt -62.67 -46.45 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.89 -48.35 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.66 -48.08 83.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.47 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' LYS . 27.6 t -69.0 -42.53 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.847 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -64.46 -47.6 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -54.16 -40.76 67.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -58.39 -33.69 69.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.447 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 62' ' ' LYS . 25.3 m -72.84 153.85 40.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -50.67 -29.51 11.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 45.3 p -69.76 157.72 36.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -117.47 138.87 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.847 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.0 t -117.64 142.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 t -114.86 142.48 46.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.99 -153.15 19.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 49.9 Cg_endo -70.4 140.97 65.7 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.815 -0.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.18 128.06 48.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.414 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.72 138.18 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.74 2.293 . . . . 0.0 111.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -118.3 176.2 1.76 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.317 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.9 Cg_endo -70.21 142.95 47.25 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.562 2.175 . . . . 0.0 111.778 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.6 -179.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.589 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 90.7 m-70 -108.85 152.44 24.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.412 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 53.4 mtmt -134.18 145.78 49.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.615 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -131.19 146.66 52.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 109.229 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.943 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.3 tm? -121.81 132.33 54.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.943 ' N ' HD13 ' A' ' 53' ' ' LEU . 66.4 mt -117.77 122.2 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.249 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 37' ' ' VAL . 82.4 m-20 -90.11 145.64 24.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.609 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 37' ' ' VAL . 65.5 mt -127.58 128.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.29 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.95 142.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.83 62.26 12.51 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.61 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.9 Cg_endo -69.95 146.07 57.93 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.691 2.261 . . . . 0.0 111.775 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -129.76 165.75 30.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 60' ' ' SER . 45.3 Cg_endo -67.49 -24.82 41.99 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.611 2.207 . . . . 0.0 111.649 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HB2' HG23 ' A' ' 33' ' ' THR . 40.2 mttm -64.66 -26.35 68.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.055 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 33' ' ' THR . 62.1 m -70.01 -38.71 76.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.242 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.29 -43.65 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -57.73 -41.87 82.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.349 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.58 -39.41 91.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 16.2 tp -63.7 -42.32 98.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 69.0 mtm -64.69 -31.83 73.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 31.4 mtp180 -71.07 -29.79 65.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.7 mt -109.48 136.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -107.76 135.18 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.405 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 mp -62.33 145.91 93.61 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.29 147.04 58.58 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.676 2.251 . . . . 0.0 111.742 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 152.88 39.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.64 3.61 55.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.79 146.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.8 m-20 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 4.2 pttm -126.06 158.19 36.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.4 mt -116.95 141.22 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 62.1 mtt85 -118.41 135.4 54.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.9 mt -119.49 134.24 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 53' ' ' LEU . 69.6 mttt -107.16 132.64 52.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -111.02 139.65 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -126.78 129.54 48.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.804 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -163.61 151.69 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -71.82 -30.75 65.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.53 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -97.12 115.24 27.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.627 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 45.2 t-80 -61.07 -46.49 90.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -56.38 -41.97 77.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.5 tm? -57.36 -39.61 76.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.292 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.804 HD21 ' CB ' ' A' ' 13' ' ' ALA . 66.7 mt -61.86 -39.13 90.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.79 -39.42 84.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.02 -38.3 90.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' HD23 ' A' ' 11' ' ' LEU . 87.0 p -65.55 -33.04 74.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -74.16 -34.34 63.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -63.8 -43.95 94.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.1 mttt -64.54 -46.11 84.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 22' ' ' SER . 26.1 mm -69.68 -44.07 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 23' ' ' ALA . 70.4 t -64.21 -44.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.48 -45.31 93.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 25' ' ' LYS . 37.5 t -71.71 -41.33 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.554 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.803 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.96 -46.31 78.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -59.2 -39.14 81.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.7 m -59.23 -31.11 68.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.3 p -75.37 163.34 27.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -56.03 -33.48 64.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 61.0 p -67.62 161.05 26.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.912 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -122.91 138.0 54.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.803 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.8 t -112.75 140.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.2 m -114.33 146.39 40.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.35 -149.72 16.97 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.98 148.05 86.39 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.767 -1.764 . . . . 0.0 111.8 -0.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.3 mp -90.07 128.61 49.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.543 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.02 123.92 10.11 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.686 2.258 . . . . 0.0 111.595 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.1 mp -106.8 173.25 3.24 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.4 Cg_endo -69.01 151.14 73.36 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.798 2.332 . . . . 0.0 111.909 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 14.8 t . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' A' ' 45' ' ' THR . 48.3 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.538 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 92.3 m-70 -105.29 150.62 25.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 22.7 mtmm -133.41 146.73 51.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 86.6 mtt-85 -130.62 149.49 52.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 41' ' ' ILE . 27.8 tp -122.38 128.36 50.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.427 HG22 ' CG1' ' A' ' 37' ' ' VAL . 66.5 mt -110.23 127.56 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -96.59 138.34 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 62.2 mt -118.16 131.23 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -111.98 138.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 49.22 57.86 18.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.591 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.6 Cg_endo -70.27 138.3 35.88 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.626 2.218 . . . . 0.0 111.826 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -118.22 168.1 10.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.45 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 48.0 Cg_endo -68.3 -21.66 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.707 2.272 . . . . 0.0 111.675 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -68.07 -23.99 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.237 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -70.28 -40.99 73.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.42 -39.54 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.619 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.4 m-20 -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.89 84.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' ILE . 26.7 tp -62.92 -37.53 87.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.619 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 73.9 mtm -69.7 -34.55 74.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.358 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.59 -28.1 61.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -107.07 138.74 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.07 138.96 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 147.52 78.15 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.311 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.64 142.58 48.87 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.678 2.252 . . . . 0.0 111.781 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.96 51.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.68 5.19 60.18 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 ' CG2' HD12 ' A' ' 18' ' ' LEU . 59.6 t -132.16 148.55 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -1.186 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 109.478 -179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 3.6 pttm -136.82 143.0 42.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 59' ' ' PRO . 69.0 mt -115.37 138.35 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 55' ' ' ASP . 93.4 mtt-85 -118.48 132.81 56.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.1 132.04 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -105.66 136.78 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.1 mp -109.5 138.63 45.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 24.1 mttt -127.33 137.6 52.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -165.15 145.77 7.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -57.44 -51.87 67.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.55 127.66 36.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.708 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 45.8 t-80 -66.49 -37.44 85.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.74 -44.06 81.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.11 -37.79 88.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 19' ' ' LEU . 7.2 tt -65.43 -39.47 92.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -59.99 -42.72 94.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.13 -41.05 91.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.344 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 26' ' ' ILE . 20.3 m -64.57 -44.0 92.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.767 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -68.33 -42.68 78.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 109.401 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -64.25 -42.59 96.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 tttt -58.1 -49.85 75.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 22' ' ' SER . 26.9 mm -64.83 -40.94 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.506 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.7 t -58.43 -45.9 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -61.06 -43.34 99.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 25' ' ' LYS . 21.7 t -71.99 -40.9 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.902 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.08 -47.1 84.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HE2' HG13 ' A' ' 27' ' ' VAL . 28.9 mttm -59.82 -39.63 85.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -53.99 -31.52 51.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 p -76.38 163.0 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.58 -32.5 67.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.3 p -61.73 159.53 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -113.78 145.06 41.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 30' ' ' ALA . 31.5 t -123.75 141.59 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 13.2 t -117.83 140.21 50.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.85 -148.42 17.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 144.21 78.04 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.793 -1.753 . . . . 0.0 111.724 0.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.75 119.78 65.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.77 137.15 31.92 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.584 2.189 . . . . 0.0 111.85 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -118.54 174.77 2.46 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HD2' HD23 ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.03 133.33 24.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.692 2.262 . . . . 0.0 111.776 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.534 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 90.8 m-70 -97.94 153.16 18.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 48.9 mtmt -141.33 141.63 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.664 ' CD ' HD22 ' A' ' 19' ' ' LEU . 21.6 mtp180 -125.94 158.89 34.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.295 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.1 tp -124.04 127.99 48.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.529 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 23' ' ' ALA . 63.7 mt -116.23 120.69 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' CG ' ' NH1' ' A' ' 8' ' ' ARG . 86.5 m-20 -89.2 145.31 25.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 65.8 mt -125.68 126.72 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.0 mt -108.33 141.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 53.12 61.26 11.39 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.54 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.4 Cg_endo -69.95 145.66 56.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.702 2.268 . . . . 0.0 111.737 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.13 166.91 25.71 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.98 -24.03 39.86 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.771 2.314 . . . . 0.0 111.619 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -65.61 -24.6 67.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.217 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.7 m -72.57 -40.75 66.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.312 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.12 -40.84 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.57 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.9 m-20 -62.2 -42.27 99.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.41 89.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.925 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 30.6 tp -64.44 -39.23 93.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.57 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 58.5 mtm -68.66 -29.94 68.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 61.6 mtt-85 -74.78 -28.76 60.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.589 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -111.32 135.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.75 130.91 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.529 HD23 HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -55.99 152.06 22.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.405 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.34 151.15 71.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.647 2.231 . . . . 0.0 111.795 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.89 149.3 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.44 1.87 66.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 72' ' ' LEU . 39.5 t -127.29 147.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 45.2 t0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 12.8 pttm -125.72 161.53 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 71.4 mt -122.11 137.51 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.603 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.613 ' O ' HD13 ' A' ' 9' ' ' ILE . 96.2 mtt180 -113.76 137.2 51.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 8' ' ' ARG . 23.6 mm -118.78 125.1 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.644 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.614 ' C ' HD12 ' A' ' 11' ' ' LEU . 24.4 mttt -106.05 132.28 52.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.253 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -117.92 138.87 51.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 84.9 mttt -128.78 132.58 47.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -157.39 141.37 16.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.557 ' CD1' HG22 ' A' ' 49' ' ' VAL . 98.5 m-85 -65.39 -35.51 81.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.41 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -93.7 116.5 29.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.875 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.574 ' NE2' ' CZ ' ' A' ' 52' ' ' ARG . 46.8 t-80 -62.95 -35.36 79.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.15 -42.81 91.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.24 -37.11 83.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 11' ' ' LEU . 12.8 tp -70.79 -37.26 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -62.74 -39.96 95.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.2 mm-40 -69.91 -44.27 70.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 26' ' ' ILE . 97.6 p -60.97 -36.51 79.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -73.77 -51.06 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 17.1 mttm -65.22 -46.16 81.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 mtmt -59.85 -47.49 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.663 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 22' ' ' SER . 96.9 mt -68.15 -39.67 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' ALA . 66.5 t -62.01 -43.01 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 97.2 mt-10 -64.78 -38.19 90.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' LYS . 39.7 t -75.17 -38.84 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.634 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.046 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -65.8 -49.25 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.575 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE3' HG13 ' A' ' 27' ' ' VAL . 80.8 mttt -60.14 -37.56 80.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.553 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 m -56.63 -30.19 63.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' VAL . 30.1 p -75.66 164.2 26.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -56.66 -35.95 68.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -60.06 159.17 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -109.45 143.03 39.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.046 HG21 ' HB1' ' A' ' 30' ' ' ALA . 40.7 t -126.38 141.59 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 39.0 m -116.21 149.1 39.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 112.12 -150.49 18.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.8 Cg_endo -70.74 147.92 87.79 Favored 'Cis proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.746 -1.772 . . . . 0.0 111.759 -0.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -101.44 119.97 56.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.94 141.22 39.92 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 111.821 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -118.6 176.17 1.79 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.288 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.6 Cg_endo -69.49 135.55 31.38 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.608 2.206 . . . . 0.0 111.728 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 49' ' ' VAL . 26.0 m . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 45' ' ' THR . 45.1 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.282 0.563 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' HB2' ' A' ' 16' ' ' HIS . 70.3 m80 -100.75 148.09 25.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 41.6 mtmt -134.88 141.55 46.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' CZ ' ' NE2' ' A' ' 16' ' ' HIS . 86.8 mtt-85 -124.45 151.38 44.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -121.79 125.55 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.693 ' N ' HD23 ' A' ' 53' ' ' LEU . 64.3 mt -115.39 122.28 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 52.4 t0 -91.2 140.34 29.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 7' ' ' ILE . 63.7 mt -117.59 128.06 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 0.0 109.398 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.91 137.83 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 51.29 63.71 9.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.81 143.09 49.47 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.771 2.314 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -131.07 168.17 18.45 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 44.9 Cg_endo -67.21 -24.42 44.17 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.644 2.23 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -65.83 -27.06 67.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 109.175 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.421 ' HA ' HG21 ' A' ' 33' ' ' THR . 40.8 m -68.94 -41.52 77.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.216 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.81 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 109.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 85.6 m-20 -59.16 -42.41 90.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.403 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.33 -38.21 89.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -63.88 -43.24 96.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -65.82 -29.35 69.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.93 . . . . 0.0 109.507 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 12.8 mtt-85 -73.47 -29.77 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -110.85 136.06 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.44 127.9 53.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' A' ' 76' ' ' VAL . 3.3 pp -58.79 143.68 82.29 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.466 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.535 ' O ' HD12 ' A' ' 72' ' ' LEU . 49.6 Cg_endo -70.01 150.31 66.49 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.799 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 151.42 18.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 94.75 5.98 60.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 72' ' ' LEU . 46.2 t -121.32 147.75 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.175 . . . . 0.0 109.439 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 56.6 t0 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 8' ' ' ARG . 58.7 pttt -137.26 142.95 41.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.478 ' HB ' HD12 ' A' ' 56' ' ' ILE . 83.9 mt -118.79 143.88 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 6' ' ' LYS . 67.8 mtt85 -116.17 136.44 53.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 73.1 mt -121.53 131.17 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 11' ' ' LEU . 91.0 mttt -97.34 139.04 33.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 19' ' ' LEU . 16.4 mt -115.01 130.77 57.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.355 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 87.3 mttt -120.53 137.16 54.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -167.94 146.32 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -68.22 -39.45 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -101.75 118.19 36.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 20.6 p80 -55.99 -43.87 78.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 81.2 tt0 -51.46 -53.57 35.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.16 -40.5 70.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.226 -0.921 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 11' ' ' LEU . 13.4 tp -68.25 -32.61 72.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 86.8 m-20 -63.76 -38.64 91.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.17 -41.59 81.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.8 t -61.68 -38.91 89.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.28 -37.01 74.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.11 -44.23 97.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.2 mttt -63.43 -41.11 98.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.349 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 22' ' ' SER . 78.2 mt -68.67 -42.2 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.0 t -64.73 -48.86 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.75 -43.83 98.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 25' ' ' LYS . 31.8 t -70.55 -41.9 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.62 76.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -59.99 -37.29 79.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.32 -30.64 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.5 p -76.5 160.58 29.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -55.12 -35.17 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.8 p -66.08 157.74 30.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -113.26 139.38 48.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 7.7 p -113.03 147.33 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 8.9 t -120.81 142.09 49.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.03 -149.72 17.33 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.1 Cg_endo -70.41 144.47 78.13 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 -1.799 . . . . 0.0 111.814 -0.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.1 mp -89.7 114.18 59.64 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.7 139.26 27.71 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.665 2.244 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.0 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.82 176.01 2.08 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.64 132.74 24.16 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.572 2.181 . . . . 0.0 111.753 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.583 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.1 m-70 -91.51 153.37 19.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -130.43 132.35 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.743 ' C ' HD12 ' A' ' 53' ' ' LEU . 30.6 mtt-85 -130.03 140.84 50.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.221 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.0 ' CD1' HD13 ' A' ' 43' ' ' LEU . 4.3 mp -122.43 138.04 54.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.734 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 71.8 mt -117.74 128.46 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.865 . . . . 0.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 91.5 m-20 -91.37 144.55 25.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB ' ' A' ' 7' ' ' ILE . 61.0 mt -120.36 137.11 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.23 136.89 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 45.19 62.17 10.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.3 Cg_endo -70.01 141.16 43.5 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.77 2.313 . . . . 0.0 111.735 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -127.88 173.0 5.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.33 -27.1 40.87 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.724 2.283 . . . . 0.0 111.804 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -64.79 -24.31 67.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.9 m -71.82 -42.39 67.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.247 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.93 -44.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.14 -48.09 76.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -55.46 -40.0 71.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.337 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.1 tp -62.44 -34.57 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.64 -30.51 69.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.469 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 38.5 mtm105 -74.12 -30.4 62.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 29' ' ' VAL . 66.9 mt -114.07 131.41 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -106.61 141.65 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.497 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.81 141.25 80.48 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.54 149.94 62.67 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.692 2.261 . . . . 0.0 111.724 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.95 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.39 -3.18 71.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 40.6 t -120.4 148.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -1.216 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 53.9 t0 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.391 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 25.7 pttm -126.55 158.98 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 76.8 mt -115.63 137.06 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -119.66 137.29 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.67 135.6 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 13.7 tttp -107.34 121.01 43.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.81 ' O ' HD21 ' A' ' 19' ' ' LEU . 37.6 mt -101.65 126.86 48.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 96.4 mttt -121.32 137.37 54.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -167.26 143.69 4.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.516 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.01 -41.34 99.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.76 114.47 26.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.633 ' CE1' ' CG ' ' A' ' 17' ' ' GLU . 21.1 p80 -61.21 -35.44 77.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.422 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CG ' ' CE1' ' A' ' 16' ' ' HIS . 86.8 mt-10 -65.14 -39.87 93.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.04 -39.48 83.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 11' ' ' LEU . 14.0 tp -59.69 -38.22 80.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -65.57 -35.28 80.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.93 -39.54 94.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 76' ' ' VAL . 17.6 m -68.82 -37.5 79.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -72.71 -37.08 67.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 24.0 tttt -61.34 -45.21 95.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 29' ' ' VAL . 80.2 mttt -63.79 -41.34 97.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 79.5 mt -70.52 -43.29 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 23' ' ' ALA . 71.1 t -62.01 -45.36 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.9 mt-10 -61.5 -43.25 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' LYS . 32.2 t -72.94 -37.19 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.003 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -67.18 -49.5 64.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CE ' HG12 ' A' ' 27' ' ' VAL . 5.1 mtmp? -58.42 -37.23 74.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 m -57.12 -34.67 68.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' OG1' ' A' ' 63' ' ' THR . 27.8 m -73.37 154.47 40.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -50.99 -35.17 32.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.0 p -60.76 157.24 15.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -112.73 145.42 40.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.003 HG21 ' HB1' ' A' ' 30' ' ' ALA . 49.9 t -122.42 142.21 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 t -113.91 135.64 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.71 -155.59 21.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.38 138.11 48.94 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.77 0.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.28 115.42 63.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.01 139.41 32.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.619 2.213 . . . . 0.0 111.754 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mp -118.48 175.53 2.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.3 133.23 24.1 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.642 2.228 . . . . 0.0 111.76 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 21.6 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 45' ' ' THR . 50.4 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.249 0.547 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 82.6 m-70 -101.27 150.76 22.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' HE2' ' A' ' 10' ' ' LYS . 9.4 mtmt -133.44 140.75 47.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.688 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 19' ' ' LEU . 88.8 mtt-85 -124.74 149.62 47.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.221 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -122.51 131.68 53.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.745 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.9 mt -119.17 124.39 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.197 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -99.95 140.52 34.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.717 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 66.9 mt -120.89 130.48 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.231 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -111.55 140.2 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t0 51.4 59.91 14.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.7 Cg_endo -70.59 140.66 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 111.712 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.73 165.1 17.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.31 -19.98 49.34 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.631 2.221 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -71.07 -28.03 64.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.518 ' OG1' HG21 ' A' ' 33' ' ' THR . 53.8 m -72.08 -39.23 69.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.244 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.11 -41.58 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.309 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.537 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.878 . . . . 0.0 109.346 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.79 75.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.355 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -66.04 -41.87 90.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.537 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 67.6 mtm -65.53 -28.76 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -77.43 -28.41 52.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.1 mt -110.94 134.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -106.95 131.38 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -46.9 144.54 3.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HG ' ' A' ' 72' ' ' LEU . 49.5 Cg_endo -69.9 148.49 64.31 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.698 2.265 . . . . 0.0 111.827 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.06 152.0 41.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.46 -3.89 56.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG21 ' OG ' ' A' ' 22' ' ' SER . 48.4 t -124.76 148.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -1.181 . . . . 0.0 109.454 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.5 m-20 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 26.3 pttm -132.79 161.84 33.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 56' ' ' ILE . 10.5 mm -118.75 141.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.727 ' HB3' HD11 ' A' ' 53' ' ' LEU . 77.1 mtm180 -125.71 127.08 45.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 68.5 mt -114.96 135.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' C ' HD12 ' A' ' 11' ' ' LEU . 54.0 mttm -104.87 127.46 52.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -101.24 134.64 43.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.406 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 67.8 mttm -121.48 135.42 55.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -169.33 149.3 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.38 -39.96 67.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.34 119.38 32.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.8 p-80 -64.93 -38.21 90.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.7 mt-10 -59.83 -38.16 81.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.446 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -36.62 61.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 11' ' ' LEU . 14.4 tp -67.22 -35.86 80.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -62.9 -42.4 99.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.36 -40.96 98.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 m -63.26 -37.82 88.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -72.31 -44.62 62.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -59.62 -43.72 93.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.4 tttt -60.89 -45.93 92.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 22' ' ' SER . 89.6 mt -64.55 -40.13 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.5 t -62.47 -44.82 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.1 -41.12 97.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 25' ' ' LYS . 25.8 t -71.81 -43.36 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.017 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -65.83 -48.7 70.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -57.64 -37.89 74.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.86 -29.2 64.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.2 p -73.28 163.84 27.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.5 -33.25 67.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 60.7 p -69.37 158.82 34.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -108.29 151.09 26.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 30' ' ' ALA . 26.6 m -127.98 145.45 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -118.38 147.86 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.32 -156.29 18.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.2 Cg_endo -70.36 142.68 72.42 Favored 'Cis proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.781 -0.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 53' ' ' LEU . 4.4 mt -95.48 121.56 61.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 133.35 24.93 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.714 2.276 . . . . 0.0 111.899 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.9 mp -110.09 172.64 3.44 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -68.92 141.03 47.49 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.701 2.267 . . . . 0.0 111.713 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 11.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.917 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 46.6 t . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.586 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 72.3 m80 -106.92 145.65 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 16.7 mttt -133.23 145.21 50.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' LEU . 89.0 mtt-85 -129.22 145.71 51.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.174 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 8' ' ' ARG . 26.5 tp -121.62 130.98 53.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.2 mt -116.42 118.21 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 81.5 m-20 -89.47 148.77 23.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.747 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' HB ' ' A' ' 7' ' ' ILE . 32.5 mt -124.51 130.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.354 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.87 136.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.0 t0 48.51 60.86 14.93 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.349 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 49.4 Cg_endo -69.72 142.2 47.47 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.773 2.316 . . . . 0.0 111.846 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -125.27 173.97 4.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.6 Cg_endo -67.88 -22.96 41.75 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.693 2.262 . . . . 0.0 111.663 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.44 -24.73 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.265 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 33' ' ' THR . 52.7 m -73.24 -40.2 64.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.24 -40.25 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.863 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.591 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -63.79 -39.54 94.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.21 -42.32 88.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 20.2 tp -63.78 -38.45 91.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.591 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 60.4 mtm -69.26 -30.41 68.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 52.2 mtt180 -75.77 -29.06 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.518 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 29' ' ' VAL . 72.1 mt -111.4 135.91 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.434 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -112.86 134.68 54.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -51.96 146.76 13.95 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.77 152.37 69.26 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.639 2.226 . . . . 0.0 111.806 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.44 149.12 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.14 -6.03 63.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 67.1 t -125.61 148.53 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -1.192 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.7 m-20 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 22.3 pttm -130.5 153.56 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.6 mt -117.83 142.33 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.362 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 68.3 mtt180 -121.84 134.96 54.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 81.0 mt -117.06 135.7 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.434 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 28.3 tttp -105.75 130.51 53.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 49.8 mt -107.87 127.94 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.571 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HE3' ' HD3' ' A' ' 10' ' ' LYS . 70.6 mttt -122.39 136.5 54.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.091 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -167.08 141.02 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -54.39 -50.78 66.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-20 -83.79 131.78 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.745 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 79.3 t60 -71.08 -35.57 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.339 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.19 -35.49 69.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.424 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 15' ' ' ASP . 82.7 mt -64.31 -35.08 79.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.091 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 6.6 mp -73.56 -39.28 64.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -64.54 -45.33 87.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.15 -41.64 73.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.0 m -65.09 -39.79 93.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.52 87.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.09 -39.68 94.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 mttt -65.04 -43.02 93.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.918 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' SER . 30.2 mm -65.53 -45.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.89 -45.34 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.86 -48.81 77.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 25' ' ' LYS . 64.6 t -69.26 -47.05 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.88 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -61.84 -49.32 76.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -58.32 -37.87 75.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 t -57.75 -30.36 65.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.4 p -75.09 163.3 27.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -56.51 -34.19 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.8 p -64.99 156.84 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -107.9 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.88 HG11 ' CB ' ' A' ' 30' ' ' ALA . 12.6 m -132.42 145.15 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.873 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 9.0 m -122.65 152.74 40.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.81 -143.84 17.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HB3' HG12 ' A' ' 54' ' ' ILE . 50.6 Cg_endo -70.98 146.7 85.46 Favored 'Cis proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.759 -1.767 . . . . 0.0 111.746 -0.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.32 114.47 60.49 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.266 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' O ' HD22 ' A' ' 43' ' ' LEU . 52.8 Cg_endo -72.58 140.0 32.11 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.723 2.282 . . . . 0.0 111.948 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 42' ' ' PRO . 3.9 mm? -118.43 166.87 12.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CD1' ' A' ' 43' ' ' LEU . 49.1 Cg_endo -69.68 128.2 15.75 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.634 2.222 . . . . 0.0 111.756 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 49' ' ' VAL . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' THR . 59.6 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 70.8 m-70 -97.55 157.9 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 38.6 mtmt -142.07 137.36 30.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.67 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.866 ' C ' HD12 ' A' ' 53' ' ' LEU . 21.5 mtp180 -131.99 150.3 52.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.866 HD12 ' C ' ' A' ' 52' ' ' ARG . 7.7 mp -127.15 145.69 50.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.167 -0.958 . . . . 0.0 109.741 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 40' ' ' PRO . 70.2 mt -123.81 117.94 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 38.7 t0 -78.56 140.67 38.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.14 124.84 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.354 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -107.81 139.48 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.544 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.76 63.62 9.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.5 Cg_endo -70.54 144.78 50.87 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.63 2.22 . . . . 0.0 111.675 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -131.4 172.05 8.03 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.597 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.24 -26.55 35.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 111.829 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -62.63 -20.99 65.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.7 m -74.32 -39.17 63.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.88 -40.17 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.558 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.8 m-20 -62.68 -41.3 99.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -64.5 -40.11 95.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.33 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.0 tp -64.0 -36.69 84.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.327 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.558 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 64.4 mtm -70.65 -27.06 63.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -78.67 -28.03 45.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.4 mt -112.93 135.32 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.82 133.73 51.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 145.7 98.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.58 150.64 63.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.685 2.256 . . . . 0.0 111.823 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.65 150.77 35.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.73 3.41 64.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.66 147.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.174 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HE3' ' NH1' ' A' ' 8' ' ' ARG . 52.0 pttt -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' ILE . 77.0 mt -119.0 140.18 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' NH1' ' HE3' ' A' ' 6' ' ' LYS . 62.6 mtt180 -116.92 137.35 52.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 8' ' ' ARG . 24.1 mm -112.46 133.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 78.4 mttt -109.22 133.89 52.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 23' ' ' ALA . 16.0 mt -112.83 133.23 54.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 77.6 mttt -122.73 131.45 53.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -161.86 144.97 12.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.3 -36.39 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.08 116.74 32.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.542 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 15.4 p80 -60.3 -46.22 90.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 86.9 tt0 -53.91 -46.55 71.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.219 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -61.96 -40.59 96.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.225 -0.922 . . . . 0.0 108.804 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -67.51 -32.8 73.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD1' ' NH1' ' A' ' 52' ' ' ARG . 91.3 m-20 -63.64 -39.54 94.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.438 -0.789 . . . . 0.0 109.325 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.3 mm-40 -64.58 -49.5 70.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.44 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 37.2 m -58.89 -45.71 89.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -62.62 -51.42 67.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -57.78 -45.51 85.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.5 mttm -59.76 -46.24 89.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 22' ' ' SER . 97.2 mt -64.2 -41.14 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.517 HG13 ' HE3' ' A' ' 31' ' ' LYS . 77.7 t -61.13 -46.31 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 -41.26 96.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 70' ' ' ILE . 38.6 t -72.59 -39.97 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.973 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.64 -46.56 78.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HE3' HG13 ' A' ' 27' ' ' VAL . 50.0 mttt -59.56 -37.3 78.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -57.42 -30.79 65.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.2 p -76.35 163.82 26.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.52 -34.16 70.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.6 p -62.85 157.66 20.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -111.84 146.57 37.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.973 HG21 ' CB ' ' A' ' 30' ' ' ALA . 42.7 t -123.66 141.02 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 21.3 t -116.79 138.81 51.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.08 -150.06 17.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.31 143.95 76.4 Favored 'Cis proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.844 -0.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.4 mt -95.7 126.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.374 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.84 136.78 33.64 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.634 2.223 . . . . 0.0 111.827 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.7 HD13 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -120.81 175.62 2.27 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 50.6 Cg_endo -70.84 138.57 34.68 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.695 2.264 . . . . 0.0 111.707 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.584 HG21 ' ND1' ' A' ' 50' ' ' HIS . 21.7 p . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 45' ' ' THR . 55.3 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.584 ' ND1' HG21 ' A' ' 45' ' ' THR . 62.2 m-70 -102.91 148.97 24.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -135.54 141.3 45.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.562 ' CD ' HD22 ' A' ' 19' ' ' LEU . 19.8 mtp180 -123.92 152.05 42.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.1 tp -121.64 130.7 53.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.0 mt -118.49 125.82 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.381 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.491 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 86.9 m-20 -89.79 142.46 27.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.515 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ILE . 61.8 mt -119.5 131.06 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.439 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 70.4 mt -109.7 139.39 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.23 63.92 9.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.1 Cg_endo -69.5 144.67 56.2 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.763 2.309 . . . . 0.0 111.748 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.6 m -132.69 166.5 28.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.47 -25.66 41.3 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.7 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -63.57 -25.65 68.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.4 m -67.36 -43.72 80.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.183 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.53 -43.32 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.553 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.1 t0 -54.13 -43.28 70.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.313 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -63.55 -40.13 96.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 70' ' ' ILE . 28.5 tp -59.16 -41.07 87.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 75.3 mtm -64.58 -35.18 80.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -70.57 -27.27 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -107.32 132.92 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -108.17 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.71 141.3 97.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 151.38 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.669 2.246 . . . . 0.0 111.862 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.71 31.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.37 58.45 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 88.4 t -125.62 148.15 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -1.201 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 51.1 t0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -128.0 145.5 50.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -111.97 137.5 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.378 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 53' ' ' LEU . 57.7 mtm180 -122.96 135.5 54.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.8 mt -116.01 137.74 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.551 ' C ' HD12 ' A' ' 11' ' ' LEU . 11.4 tttp -110.25 128.83 55.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -112.6 120.65 42.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.254 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.488 ' HE3' ' HD3' ' A' ' 51' ' ' LYS . 28.5 mtpt -116.6 138.75 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.815 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -170.41 152.66 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.51 -36.01 73.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' OD2' ' HG ' ' A' ' 18' ' ' LEU . 50.6 t0 -93.13 114.3 26.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.58 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 6.5 p80 -67.14 -28.37 68.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.445 ' OE2' ' CE1' ' A' ' 16' ' ' HIS . 66.3 mm-40 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 57.9 mt -64.1 -38.26 90.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 13' ' ' ALA . 60.1 mt -70.46 -34.52 72.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.514 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -63.92 -42.88 97.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -42.8 73.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.4 m -64.85 -38.62 91.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.417 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.81 -41.33 78.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -60.4 -46.85 88.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.907 ' O ' HG23 ' A' ' 29' ' ' VAL . 17.7 mtmm -60.9 -45.55 94.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 22' ' ' SER . 84.8 mt -65.03 -44.98 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.6 t -59.59 -48.19 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.17 -44.24 97.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 25' ' ' LYS . 18.5 t -68.11 -40.49 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.43 81.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -56.36 -38.16 71.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -57.91 -32.34 67.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 62' ' ' LYS . 23.9 m -74.31 152.25 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -50.32 -31.13 13.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 51.7 p -68.98 156.64 38.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -107.41 148.03 29.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -121.49 147.78 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 66.8 m -124.08 144.74 49.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.537 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.05 -155.09 16.34 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.41 140.61 63.58 Favored 'Cis proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.702 -1.791 . . . . 0.0 111.792 -0.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 10.1 mt -91.03 131.01 38.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.314 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.94 118.81 5.89 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.664 2.243 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -94.55 166.66 14.8 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.371 -0.831 . . . . 0.0 109.529 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.3 Cg_endo -67.66 143.66 62.99 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 111.604 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.6 m . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.958 . . . . 0.0 109.512 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 45' ' ' THR . 50.0 t . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 97.6 m-70 -98.76 145.23 27.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 9.0 mtmm -135.98 151.09 49.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -127.41 147.94 50.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -122.02 131.16 53.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 53' ' ' LEU . 66.8 mt -120.53 117.39 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 83.8 m-20 -89.05 145.36 25.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 7' ' ' ILE . 68.7 mt -124.22 122.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.34 144.16 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' SER . 10.6 t0 47.69 62.66 11.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.419 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.7 Cg_endo -70.41 148.88 61.81 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.73 2.287 . . . . 0.0 111.716 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.421 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -137.18 167.86 19.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.39 -25.86 41.64 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 122.685 2.256 . . . . 0.0 111.673 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB2' HG23 ' A' ' 33' ' ' THR . 67.4 mttm -64.23 -26.11 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.131 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 -42.42 77.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.26 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.56 -44.39 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.573 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 58.5 t0 -55.91 -41.82 75.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.61 84.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' ILE . 21.2 tp -61.38 -40.21 93.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.573 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.6 mtm -67.7 -34.48 76.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -71.23 -29.49 65.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.545 ' CD1' HG21 ' A' ' 29' ' ' VAL . 69.3 mt -108.94 133.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.442 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -116.54 123.45 47.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.82 150.62 26.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.08 148.65 63.43 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.628 2.219 . . . . 0.0 111.742 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.31 153.09 31.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.954 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.11 8.57 55.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.62 147.85 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -1.19 . . . . 0.0 109.472 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 64.7 tt0 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.292 0.568 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -132.49 143.22 49.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.461 HG13 ' HG3' ' A' ' 59' ' ' PRO . 79.9 mt -116.96 138.89 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 91.9 mtm-85 -119.71 136.74 54.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.583 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.11 131.97 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.405 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' HD13 ' A' ' 53' ' ' LEU . 68.3 tttt -97.6 125.5 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.6 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.824 ' HB3' HD11 ' A' ' 19' ' ' LEU . 44.3 mt -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 5.4 mtmp? -131.04 134.15 46.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -163.62 144.46 8.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' CD1' HG22 ' A' ' 49' ' ' VAL . 95.9 m-85 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' OD2' HD13 ' A' ' 18' ' ' LEU . 54.1 t0 -95.45 119.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 56.1 p-80 -61.6 -40.27 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.0 mt-10 -51.42 -52.26 47.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.3 mp -59.24 -43.94 92.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 11' ' ' LEU . 12.7 tp -65.58 -29.98 70.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.323 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 90.4 m-20 -67.3 -41.24 85.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 98.8 mt-10 -69.91 -35.45 74.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 26' ' ' ILE . 18.2 m -63.31 -40.22 96.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.2 -36.58 74.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 15.6 tttp -66.71 -39.74 88.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.1 mttm -65.2 -44.04 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 22' ' ' SER . 26.4 mm -69.49 -39.55 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 23' ' ' ALA . 78.7 t -62.2 -43.52 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 98.1 mt-10 -64.75 -38.42 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 25' ' ' LYS . 41.2 t -71.58 -40.82 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 37' ' ' VAL . . . -65.78 -46.81 77.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.53 -38.95 82.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.8 m -59.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.0 p -77.93 163.65 25.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.91 -36.07 67.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 55.7 p -66.47 157.95 30.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -111.91 147.76 35.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -116.72 147.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -124.37 144.24 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.15 -154.15 16.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.1 Cg_endo -70.15 143.18 73.83 Favored 'Cis proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.733 -1.778 . . . . 0.0 111.738 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.2 46.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.82 137.31 32.1 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.685 2.257 . . . . 0.0 111.849 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -127.57 175.83 3.1 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.0 Cg_endo -68.94 141.18 47.86 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.615 2.21 . . . . 0.0 111.751 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 16.0 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 14' ' ' TYR . 44.4 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 99.5 m-70 -88.99 148.79 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.408 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 51.6 mtpt -126.02 128.61 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.801 ' C ' HD22 ' A' ' 53' ' ' LEU . 36.4 mtt-85 -126.46 144.31 50.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.801 HD22 ' C ' ' A' ' 52' ' ' ARG . 4.0 mm? -121.16 139.95 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 11' ' ' LEU . 66.5 mt -122.44 122.28 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 85.0 m-20 -93.0 144.9 24.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.846 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.0 mt -123.75 129.72 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.237 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' OD1' ' A' ' 58' ' ' ASP . 65.4 mt -107.66 141.97 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.895 . . . . 0.0 109.689 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER 46.84 61.43 13.44 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.0 Cg_endo -70.01 142.79 47.73 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.665 2.243 . . . . 0.0 111.699 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.419 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -126.76 168.05 15.67 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.558 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.23 -27.67 40.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.686 2.258 . . . . 0.0 111.619 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -62.62 -25.99 68.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.1 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 m -68.19 -43.51 77.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.241 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.42 -41.76 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.335 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -56.53 -44.1 80.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.119 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.07 -35.57 80.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.293 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.75 -27.38 69.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.296 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.7 mtm -82.1 -29.06 31.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.187 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -76.9 -22.83 52.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.5 mt -119.19 132.34 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -107.19 138.29 43.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.522 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 148.32 61.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.76 145.88 58.53 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.212 . . . . 0.0 111.817 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.45 150.01 32.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.0 58.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.18 148.77 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 90.1 m-20 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -134.5 151.39 51.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.21 138.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 69.9 mtm180 -121.54 135.66 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 53' ' ' LEU . 69.8 mt -118.03 135.89 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.187 -0.946 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.743 ' HG2' HD13 ' A' ' 53' ' ' LEU . 84.0 mttt -104.36 137.12 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 14.1 mt -106.07 136.26 46.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.376 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.8 mttp -117.68 129.35 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.892 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -167.11 143.22 4.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -62.62 -39.46 93.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB3' HD13 ' A' ' 18' ' ' LEU . 50.2 t0 -95.07 120.42 35.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.499 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 47.1 t-80 -65.6 -35.43 80.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -56.37 -39.91 73.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.2 mp -63.36 -40.63 97.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.421 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.892 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.3 mt -62.6 -39.8 94.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -61.41 -46.19 91.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.83 -50.74 69.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.7 p -57.51 -43.95 84.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.87 -50.11 72.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -56.67 -40.49 75.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.8 tttp -61.19 -49.34 77.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -67.6 -39.84 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' ALA . 73.1 t -57.2 -46.69 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.77 -41.0 94.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 70' ' ' ILE . 35.1 t -72.08 -39.76 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.86 73.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.73 -40.09 86.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -60.56 -26.97 67.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' VAL . 23.7 p -81.99 162.58 22.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.481 ' HG ' ' HG ' ' A' ' 60' ' ' SER . 41.9 m -66.87 147.01 53.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.627 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -102.64 147.03 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.32 150.71 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 2.9 t -129.32 142.17 50.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 124.12 -150.84 17.06 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 52.1 Cg_endo -71.21 141.07 68.26 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.675 -1.802 . . . . 0.0 111.727 -0.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.5 131.12 35.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.62 120.31 7.14 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.709 2.273 . . . . 0.0 111.923 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 53' ' ' LEU . 14.6 mt -93.36 166.99 14.94 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 44.0 Cg_endo -66.76 132.11 27.68 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.749 2.3 . . . . 0.0 111.595 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' VAL . 40.0 m . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HG23 ' A' ' 45' ' ' THR . 49.9 t . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.627 ' O ' HD11 ' A' ' 19' ' ' LEU . 68.7 m80 -105.73 147.02 29.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.6 mtmt -134.97 155.83 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 31.8 mtp85 -130.04 151.68 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.302 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.743 HD13 ' HG2' ' A' ' 10' ' ' LYS . 36.8 tp -124.33 131.55 53.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 67.7 mt -117.12 123.84 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 37.7 t0 -89.95 137.38 32.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.27 130.39 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.1 mt -111.85 138.4 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.684 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.41 61.32 12.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.41 137.37 33.41 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.649 2.232 . . . . 0.0 111.792 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.496 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -129.15 172.73 6.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 44.8 Cg_endo -67.61 -25.28 40.79 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.68 2.253 . . . . 0.0 111.542 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.11 -26.13 67.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -72.34 -39.19 68.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.329 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.61 -42.63 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.5 m-20 -61.43 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.353 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.61 -37.44 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.4 tp -63.47 -39.71 95.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 59.2 mtm -68.31 -32.13 72.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -73.76 -29.07 62.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.963 ' CD1' HG21 ' A' ' 29' ' ' VAL . 73.2 mt -109.39 135.53 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.58 150.94 79.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HG2' HG21 ' A' ' 76' ' ' VAL . 49.2 Cg_endo -69.89 147.57 62.31 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.662 2.241 . . . . 0.0 111.799 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.35 146.93 32.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.93 69.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.1 t -127.82 148.58 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.0 t0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.478 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -109.33 144.43 37.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 59' ' ' PRO . 69.1 mt -114.7 136.7 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 45.0 mtm180 -122.85 136.8 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 53' ' ' LEU . 83.0 mt -113.26 133.28 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.462 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 18.2 tttt -103.13 121.46 42.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 50.3 mt -104.05 126.37 51.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE2' ' HE2' ' A' ' 10' ' ' LYS . 36.4 mttt -121.72 137.63 54.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 109.415 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.78 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -168.72 146.05 3.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.57 -52.17 49.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.14 130.26 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.581 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.5 p-80 -74.9 -28.88 60.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.878 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.78 -37.89 86.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.36 -36.1 83.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.78 HD21 ' CB ' ' A' ' 13' ' ' ALA . 70.9 mt -69.94 -36.42 75.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.41 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.67 -41.39 88.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.45 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.03 -43.17 83.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 26' ' ' ILE . 84.2 p -66.26 -35.81 81.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.354 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.61 -38.76 80.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -61.13 -44.54 97.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -61.22 -45.72 93.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 22' ' ' SER . 29.2 mm -65.73 -41.58 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 23' ' ' ALA . 79.2 t -61.8 -44.42 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.97 -47.26 78.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 25' ' ' LYS . 34.1 t -67.44 -43.38 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.86 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.23 -47.06 84.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.444 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -55.74 -39.52 71.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.6 m -56.05 -31.66 63.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 p -78.04 162.21 26.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.49 -29.03 63.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.382 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 26.3 t -69.85 148.3 49.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -107.57 150.29 27.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.86 HG21 ' CB ' ' A' ' 30' ' ' ALA . 41.7 t -122.08 140.93 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -117.86 141.75 48.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.84 -149.36 16.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.24 145.85 81.6 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.75 -1.771 . . . . 0.0 111.878 0.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.6 mp -94.26 125.17 53.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.85 118.15 5.54 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.077 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 44' ' ' PRO . 12.5 mt -97.89 168.25 10.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.897 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 43' ' ' LEU . 46.5 Cg_endo -68.33 147.99 73.0 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.721 2.281 . . . . 0.0 111.67 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CD2' ' A' ' 50' ' ' HIS . 18.8 p . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.537 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 45' ' ' THR . 48.6 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 69.8 m80 -103.39 149.2 25.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.5 mtmt -137.02 144.41 43.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.599 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -124.71 152.08 44.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.4 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -125.97 135.0 51.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 67.1 mt -121.07 124.58 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 87.1 m-20 -90.3 145.15 25.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -126.82 125.55 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -106.97 139.71 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.654 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' SER . 3.6 t70 53.19 62.23 10.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.636 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.8 Cg_endo -70.21 141.33 43.14 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.753 2.302 . . . . 0.0 111.67 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.49 166.59 22.14 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.08 -21.74 42.32 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.663 2.242 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -67.67 -25.49 65.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.113 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 m -70.59 -42.46 70.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.82 -42.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.538 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 86.2 m-20 -57.59 -45.56 85.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.75 84.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' ILE . 3.8 tp -63.7 -40.45 96.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.98 -29.95 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -74.59 -29.26 61.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.1 mt -110.11 136.62 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.21 134.9 42.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -61.76 149.32 85.35 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 72' ' ' LEU . 48.7 Cg_endo -69.77 141.04 44.12 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.685 2.257 . . . . 0.0 111.758 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.86 149.77 49.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.7 9.15 56.68 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.79 142.05 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -1.113 . . . . 0.0 109.427 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.5 mtm -59.94 -35.27 74.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.461 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.61 -127.97 34.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.35 9.93 61.27 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 16.5 mt-30 -108.16 148.7 29.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -1.148 . . . . 0.0 109.474 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 76.4 mttt -112.89 143.45 44.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.466 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.429 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.5 mt -117.3 137.51 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HB3' HD11 ' A' ' 53' ' ' LEU . 57.4 mtt85 -118.19 135.96 53.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.654 ' O ' HD22 ' A' ' 53' ' ' LEU . 72.2 mt -120.37 130.32 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.786 ' HG2' HD23 ' A' ' 53' ' ' LEU . 38.7 mttt -99.84 131.6 45.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.7 mp -110.75 134.94 52.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 25.2 mttt -126.81 141.85 51.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -172.13 147.42 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.444 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -67.32 -40.99 86.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -94.4 113.97 25.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.248 -0.907 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.585 ' CE1' ' HG3' ' A' ' 17' ' ' GLU . 44.4 p-80 -58.97 -37.72 77.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 109.388 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.585 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.1 mt-10 -52.98 -54.19 38.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 0.0 109.259 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.2 mp -55.97 -49.38 73.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.306 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 19' ' ' LEU . 8.5 tt -61.46 -31.51 71.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 65.1 m-20 -66.78 -38.68 87.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.334 -0.854 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -70.09 -38.82 75.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.8 t -65.43 -45.35 84.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.262 -0.898 . . . . 0.0 109.44 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.737 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -65.24 -48.19 74.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -64.54 -43.98 92.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 70' ' ' ILE . 26.5 tttm -59.72 -49.7 76.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 22' ' ' SER . 97.5 mt -61.05 -41.01 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -0.884 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 23' ' ' ALA . 76.8 t -57.49 -44.89 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -62.02 -43.96 97.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.8 -41.65 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.934 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.13 -48.26 74.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.16 -39.12 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.443 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.0 m -56.7 -30.98 64.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -75.4 160.45 30.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.13 -35.38 67.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -0.923 . . . . 0.0 109.423 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 52.6 p -62.81 157.22 21.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.468 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -111.95 148.24 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.934 HG21 ' CB ' ' A' ' 30' ' ' ALA . 24.8 t -122.67 139.76 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 t -113.51 140.85 47.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 121.97 -149.37 17.12 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 51.0 Cg_endo -70.8 146.37 84.23 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.782 -1.758 . . . . 0.0 111.674 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 mt -97.36 119.81 62.22 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.03 144.85 48.31 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.693 2.262 . . . . 0.0 111.783 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.3 mp -123.87 173.56 4.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.444 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.5 Cg_endo -70.01 135.93 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.698 2.265 . . . . 0.0 111.766 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 49' ' ' VAL . 38.0 m -78.85 138.77 38.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.59 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.88 144.35 51.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 31.5 t 47.59 39.55 10.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' SER . 68.6 mtt85 62.2 34.84 15.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.864 . . . . 0.0 109.479 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.816 ' O ' HG23 ' A' ' 45' ' ' THR . 45.7 t -125.85 133.22 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.578 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 96.3 m-70 -97.92 145.69 26.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.351 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.4 mtmm -141.83 143.81 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HB2' HD21 ' A' ' 19' ' ' LEU . 89.3 mtt-85 -130.88 152.98 49.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.217 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.7 tm? -124.45 125.77 44.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.942 . . . . 0.0 109.663 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.79 ' N ' HD13 ' A' ' 53' ' ' LEU . 64.8 mt -112.12 120.8 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.237 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' OD1' ' CD1' ' A' ' 53' ' ' LEU . 86.9 m-20 -86.83 144.09 27.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 68.3 mt -120.94 132.01 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.335 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -111.09 138.98 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.24 63.19 10.57 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.1 Cg_endo -70.11 143.32 48.82 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.641 2.227 . . . . 0.0 111.717 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 1.0 OUTLIER -120.98 168.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.975 . . . . 0.0 109.503 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.27 -24.46 37.64 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.642 2.228 . . . . 0.0 111.836 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.47 -21.91 64.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.5 m -73.11 -40.93 64.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.1 mt -66.67 -41.25 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.28 -0.887 . . . . 0.0 109.373 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.613 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -60.64 -40.15 90.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.91 92.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 67' ' ' LEU . 23.6 tp -63.27 -38.38 90.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.882 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.613 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 68.1 mtm -69.65 -33.89 73.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 29.8 mtp180 -73.19 -27.36 61.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.554 HG21 ' NZ ' ' A' ' 25' ' ' LYS . 71.1 mt -107.24 134.15 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -108.68 126.56 53.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -0.861 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.93 145.19 54.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.33 150.82 65.31 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.704 2.269 . . . . 0.0 111.777 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.43 148.33 15.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.19 64.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.89 148.56 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -1.202 . . . . 0.0 109.451 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 52.3 t0 -136.59 156.77 48.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 27.3 m -134.97 148.47 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.441 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' OE1' ' HD2' ' A' ' 10' ' ' LYS . 85.0 tt0 -112.25 131.69 55.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 9.4 tp -128.7 136.74 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.347 -0.846 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 37.0 tttt 67.22 44.05 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 49.2 mt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.5 mtp -58.32 -34.35 70.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.27 -0.893 . . . . 0.0 109.488 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.9 -170.26 45.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 -0.19 55.7 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -109.28 150.64 27.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.199 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -133.92 145.81 49.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.542 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 59' ' ' PRO . 76.2 mt -117.11 144.56 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' HB3' HD21 ' A' ' 53' ' ' LEU . 48.2 mtp85 -117.12 135.56 53.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.944 . . . . 0.0 109.511 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.779 ' O ' HD22 ' A' ' 53' ' ' LEU . 71.4 mt -120.77 129.57 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.681 ' HG2' HD23 ' A' ' 53' ' ' LEU . 56.5 mttm -103.53 132.9 49.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.659 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -108.11 137.62 45.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.337 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 27.2 mttt -125.84 137.23 53.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 109.566 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -168.57 140.51 2.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.959 . . . . 0.0 109.601 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -55.63 -48.78 74.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.537 ' HB2' HD13 ' A' ' 18' ' ' LEU . 95.5 m-20 -97.63 132.58 43.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.739 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.59 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 46.8 p-80 -69.65 -29.17 66.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -57.17 -45.96 83.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.359 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.695 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.2 mp -68.51 -44.77 73.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.387 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 11' ' ' LEU . 8.2 tt -62.31 -45.83 91.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.444 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -57.37 -43.74 83.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -64.84 -41.53 95.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.351 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.5 m -63.34 -45.22 92.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.399 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -60.29 -41.31 93.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.853 . . . . 0.0 109.436 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -61.88 -44.3 97.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.376 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.608 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.5 tttp -60.77 -41.85 96.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.8 mt -67.16 -39.48 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.8 t -61.83 -42.56 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.463 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.78 -37.67 88.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.2 t -74.2 -40.35 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.16 76.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.491 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 tttt -60.36 -37.51 80.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.526 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -59.32 -30.92 68.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.0 p -76.95 162.45 27.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -55.89 -36.23 67.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.4 p -64.71 158.64 24.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -111.96 146.68 37.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.384 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.476 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 4.4 p -119.08 147.14 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -125.18 142.35 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.03 -150.78 18.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 146.67 83.48 Favored 'Cis proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.781 -0.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 53' ' ' LEU . 7.5 mt -94.64 126.52 47.26 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 0.0 109.413 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.3 141.15 42.34 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.611 2.207 . . . . 0.0 111.784 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -126.58 174.24 4.36 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.465 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -69.41 139.81 42.38 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 23.4 p -86.87 158.38 19.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 46.5 tp10 -142.28 133.52 26.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 8.9 p 47.41 49.62 15.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' SER . 73.4 mtm180 61.8 28.9 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.459 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 46' ' ' GLU . 59.6 t -116.01 136.23 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.189 -0.944 . . . . 0.0 109.429 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.59 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 96.5 m-70 -104.44 145.08 30.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.9 mtmm -137.62 143.03 41.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HG3' HD22 ' A' ' 19' ' ' LEU . 32.4 mtp85 -128.63 153.32 47.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.779 HD22 ' O ' ' A' ' 9' ' ' ILE . 3.4 tm? -123.94 128.04 48.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.764 ' N ' HD13 ' A' ' 53' ' ' LEU . 69.2 mt -111.28 128.32 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -92.82 142.45 27.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.219 -0.926 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.22 131.91 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.44 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.86 138.71 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.885 . . . . 0.0 109.472 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 35' ' ' SER . 38.8 t70 48.22 60.78 14.97 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.46 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.1 Cg_endo -70.26 143.74 49.32 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.698 2.265 . . . . 0.0 111.754 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -126.03 169.71 11.05 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 46.3 Cg_endo -68.11 -25.29 37.71 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.719 2.279 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.96 -22.75 66.49 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.288 -0.883 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.4 m -71.19 -41.75 69.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.99 -41.65 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.385 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.598 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 90.4 m-20 -59.01 -40.08 83.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.907 . . . . 0.0 109.395 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.73 91.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.474 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 70' ' ' ILE . 5.0 tp -61.04 -40.59 94.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.472 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.598 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 70.3 mtm -67.9 -33.19 74.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.45 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 93.2 mtt-85 -73.54 -29.48 62.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -107.77 134.13 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.478 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -112.13 125.64 54.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -58.98 151.12 57.44 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.68 151.43 69.5 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.702 2.268 . . . . 0.0 111.786 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.76 150.17 16.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.472 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.71 64.8 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.8 t -126.07 148.1 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -1.194 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 50.4 t0 -132.92 153.89 50.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.512 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 27.8 m -135.3 147.37 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' OE2' ' HG ' ' A' ' 82' ' ' LEU . 86.2 tt0 -101.67 143.7 31.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.486 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 18.2 tt -121.44 147.51 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.521 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 80' ' ' ILE . 43.2 tttm 66.85 47.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.608 HD13 ' C ' ' A' ' 82' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.421 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.38 136.6 37.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.49 10.66 79.31 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.93 -32.08 74.13 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -105.85 124.82 50.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -1.143 . . . . 0.0 109.471 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -121.89 145.75 47.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.499 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.514 HD12 ' CB ' ' A' ' 59' ' ' PRO . 84.6 mt -116.04 138.47 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.545 ' HD2' HD21 ' A' ' 53' ' ' LEU . 57.0 mtm180 -119.08 137.82 53.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.532 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.6 mt -113.85 136.27 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.441 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' NZ ' ' HD3' ' A' ' 51' ' ' LYS . 44.7 tttt -111.45 124.27 51.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -102.75 126.0 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.377 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 59.0 mttt -116.49 131.06 57.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.801 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -166.28 142.6 4.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.511 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -62.31 -38.35 89.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 60.7 t0 -91.55 118.82 30.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.0 p-80 -65.01 -31.87 73.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.897 . . . . 0.0 109.446 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.8 mt-10 -61.39 -39.23 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 15' ' ' ASP . 75.4 mt -63.63 -38.99 93.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.801 HD21 ' CB ' ' A' ' 13' ' ' ALA . 61.6 mt -64.95 -37.14 86.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.48 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -60.64 -41.86 95.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 97.1 mt-10 -67.24 -37.79 84.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 11' ' ' LEU . 22.3 m -62.5 -40.02 95.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.767 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.56 -44.33 74.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -61.3 -46.35 90.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.521 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' VAL . 44.4 mttt -63.8 -46.93 82.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 81.8 mt -70.0 -40.44 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.1 t -63.71 -44.74 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -63.31 -42.4 99.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.662 HG11 ' HB1' ' A' ' 66' ' ' ALA . 42.0 t -73.28 -42.22 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.448 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.959 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.57 -48.47 72.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.18 -40.39 77.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.53 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.51 -29.81 64.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 29' ' ' VAL . 28.5 p -76.6 161.61 28.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -57.0 -30.78 64.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 109.439 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -66.66 155.01 39.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 0.0 109.466 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -108.78 150.15 28.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.48 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.959 HG21 ' CB ' ' A' ' 30' ' ' ALA . 47.5 t -125.45 140.87 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -119.1 140.01 50.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 130.79 -151.65 19.65 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 51.3 Cg_endo -70.97 140.24 63.03 Favored 'Cis proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.701 -1.791 . . . . 0.0 111.683 -0.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 mt -90.27 122.88 66.97 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.423 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.74 129.53 17.79 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.738 2.292 . . . . 0.0 112.018 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 2.9 mp -105.59 171.59 4.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.2 Cg_endo -69.54 128.3 16.02 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.669 2.246 . . . . 0.0 111.749 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.741 HG21 ' CE1' ' A' ' 50' ' ' HIS . 35.1 m -82.91 153.63 24.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 48' ' ' ARG . 80.8 tt0 -126.34 122.48 35.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 t 52.4 -89.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' GLU . 75.4 mtm180 -134.78 22.72 3.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.716 ' O ' HG23 ' A' ' 45' ' ' THR . 59.3 t -115.33 128.24 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.587 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.741 ' CE1' HG21 ' A' ' 45' ' ' THR . 92.8 m-70 -106.9 146.91 30.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.497 ' HD3' ' NZ ' ' A' ' 10' ' ' LYS . 47.6 mttm -127.59 150.91 49.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD3' ' HB3' ' A' ' 19' ' ' LEU . 62.6 mtp85 -133.6 144.81 49.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.324 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' HD2' ' A' ' 8' ' ' ARG . 28.8 tp -121.53 133.24 55.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 65.9 mt -120.7 120.98 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.69 137.04 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 56' ' ' ILE . 49.4 mt -119.54 127.65 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.5 mt -106.99 139.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 49.05 61.51 13.9 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.523 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.23 144.38 51.33 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.723 2.282 . . . . 0.0 111.823 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 165.97 21.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.95 -26.11 37.95 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.797 2.331 . . . . 0.0 111.741 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -67.17 -22.44 65.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.926 . . . . 0.0 109.22 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.4 m -71.42 -41.7 69.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.339 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.45 -42.28 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.271 -0.893 . . . . 0.0 109.323 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.65 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 91.1 m-20 -57.81 -40.9 81.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.342 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -63.07 -40.92 99.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' ILE . 32.1 tp -61.92 -39.59 92.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.44 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.65 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 72.6 mtm -67.02 -31.93 72.8 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 77.8 mtp180 -70.46 -30.38 67.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.6 mt -110.14 136.04 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.491 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -101.32 129.79 47.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.9 148.61 37.36 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.12 149.07 64.1 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.65 2.233 . . . . 0.0 111.783 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.4 148.43 27.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.9 3.43 65.91 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 44.3 t -126.31 148.33 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 109.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 51.5 t0 -136.14 155.51 50.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 78' ' ' VAL . 14.3 p -139.67 127.23 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.469 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -113.33 135.31 53.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.7 mm -66.98 -31.73 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.345 -0.847 . . . . 0.0 109.527 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' O ' HD23 ' A' ' 82' ' ' LEU . 36.5 mttt -59.28 -34.37 72.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.513 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 81' ' ' LYS . 51.3 mt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.501 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.9 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.0 ttm -58.28 -32.94 68.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.415 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -53.2 -34.0 46.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.94 -120.82 23.7 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -104.16 157.68 16.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -1.119 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -111.9 149.5 31.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.935 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.462 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -110.71 142.35 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 109.464 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.4 mtm180 -118.58 136.76 53.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.454 HG12 ' OXT' ' A' ' 82' ' ' LEU . 70.6 mt -120.17 132.86 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.527 ' HG2' HD13 ' A' ' 53' ' ' LEU . 26.4 mttm -108.58 132.09 54.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.018 ' CB ' HD11 ' A' ' 19' ' ' LEU . 3.4 mp -117.69 129.51 55.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.516 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 83.0 mttt -116.25 137.29 52.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.306 -0.871 . . . . 0.0 109.448 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -160.26 145.69 15.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -65.77 -39.09 90.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.583 ' CB ' HD13 ' A' ' 18' ' ' LEU . 92.3 m-20 -97.33 125.09 41.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.589 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 19.5 p80 -71.17 -30.06 65.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.437 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -61.09 -39.2 89.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 18' ' ' LEU . 9.4 mp -72.92 -44.01 61.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 109.496 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.018 HD11 ' CB ' ' A' ' 11' ' ' LEU . 40.8 tp -58.75 -42.81 89.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.2 -46.33 88.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.41 -40.3 85.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.304 -0.873 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.8 m -60.64 -44.29 96.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.354 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.592 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.43 -42.19 99.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -59.99 -47.14 87.04 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' VAL . 56.8 mtpt -56.32 -47.86 77.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.554 HD12 HD21 ' A' ' 11' ' ' LEU . 75.2 mt -65.64 -41.66 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.862 . . . . 0.0 109.36 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 23' ' ' ALA . 69.1 t -62.67 -46.17 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -59.28 -40.91 87.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' LYS . 38.7 t -70.68 -42.2 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.895 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -66.18 -46.59 76.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' CE ' ' CG1' ' A' ' 27' ' ' VAL . 23.2 mttm -57.43 -37.11 72.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.497 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.4 m -57.41 -34.28 68.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.9 m -74.26 154.71 38.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -50.43 -29.23 9.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.449 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 59.8 p -65.28 158.78 25.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -113.71 152.56 30.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.408 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 30' ' ' ALA . 39.4 t -123.42 140.97 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.895 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -115.29 149.13 38.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 113.64 -147.32 18.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 50.9 Cg_endo -70.6 148.45 88.64 Favored 'Cis proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.731 -1.779 . . . . 0.0 111.813 -0.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -98.41 123.21 51.21 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 109.395 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.43 140.53 36.79 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.699 2.266 . . . . 0.0 111.842 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.678 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -120.29 176.27 1.9 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.39 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.678 ' HD2' HD23 ' A' ' 43' ' ' LEU . 48.1 Cg_endo -69.8 141.85 46.19 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.536 2.157 . . . . 0.0 111.696 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.806 HG21 ' HD2' ' A' ' 50' ' ' HIS . 18.3 p -103.81 163.12 12.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.602 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 48' ' ' ARG . 71.5 tt0 -129.27 126.67 39.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.31 -0.869 . . . . 0.0 109.407 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.6 t 56.87 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 46' ' ' GLU . 56.8 mtt180 -143.4 27.71 1.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 45' ' ' THR . 46.4 t -115.41 127.22 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.806 ' HD2' HG21 ' A' ' 45' ' ' THR . 61.8 m80 -105.88 149.79 26.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HD2' ' HE2' ' A' ' 12' ' ' LYS . 33.4 mtmm -135.18 141.06 45.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HG3' HD23 ' A' ' 19' ' ' LEU . 35.8 mtt-85 -122.87 150.52 42.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.537 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.3 tp -121.99 126.91 49.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.532 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.4 mt -113.13 128.92 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 85.5 m-20 -97.85 146.45 25.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.462 HD12 ' HB ' ' A' ' 7' ' ' ILE . 66.4 mt -120.29 133.94 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -111.44 136.94 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t0 47.1 59.53 16.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.4 Cg_endo -70.11 144.24 51.58 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.78 2.32 . . . . 0.0 111.825 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.413 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -121.89 167.96 12.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.426 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.5 Cg_endo -67.42 -26.12 41.22 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.722 2.281 . . . . 0.0 111.631 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -66.78 -25.29 66.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.173 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.4 m -70.23 -39.16 75.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.163 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.5 -42.78 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.0 m-20 -56.78 -44.11 81.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.324 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.55 86.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -65.1 -40.36 94.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.425 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.589 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 65.1 mtm -68.38 -29.74 68.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 41.8 mtp85 -75.43 -29.44 59.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 67' ' ' LEU . 74.5 mt -111.26 136.03 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 44.2 p-10 -106.54 155.95 19.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.395 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 1.2 pp -70.35 140.18 87.46 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.12 154.45 66.32 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.724 2.283 . . . . 0.0 111.74 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 150.63 11.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 88.13 7.28 73.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -131.26 147.9 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.239 -1.154 . . . . 0.0 109.478 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 56.0 t0 -130.09 158.3 40.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 109.385 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 57.0 t -133.86 148.58 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.53 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 71.5 mm-40 -93.62 153.85 18.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.9 tt -61.39 -23.25 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.441 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 82' ' ' LEU . 78.9 mttt -54.43 -35.0 62.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.447 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.953 HD23 ' OXT' ' A' ' 82' ' ' LEU . 6.4 tt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.6 mtt -59.06 -35.6 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.503 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 82.0 20.24 63.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.9 57.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -73.17 146.46 45.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -1.135 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -124.97 146.14 49.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.466 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.7 mt -113.48 141.72 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 86.5 mtm-85 -121.57 136.7 54.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.593 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 53' ' ' LEU . 68.9 mt -114.72 140.05 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HD3' ' CE ' ' A' ' 12' ' ' LYS . 16.2 tttp -108.15 125.11 51.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 19' ' ' LEU . 47.4 mt -99.3 135.6 40.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.374 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' CE ' ' HD3' ' A' ' 10' ' ' LYS . 93.5 mttt -130.63 132.9 45.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.567 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -171.01 151.3 3.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.401 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -73.5 -32.33 64.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 92.6 m-20 -90.8 108.21 19.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.875 . . . . 0.0 109.509 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 46.3 t-80 -58.75 -46.93 86.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.927 . . . . 0.0 109.466 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -59.28 -45.39 91.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.467 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 24.6 tp -62.61 -38.46 90.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.477 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 11' ' ' LEU . 15.6 tp -57.73 -38.32 75.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . 45.6 t0 -65.08 -40.2 94.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.56 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.74 -41.17 85.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.22 -0.925 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 83.4 p -67.78 -34.05 76.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.531 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.74 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -71.28 -41.85 69.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -60.45 -43.53 96.77 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' O ' HG23 ' A' ' 29' ' ' VAL . 64.8 tttt -59.15 -49.17 78.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -0.941 . . . . 0.0 109.498 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 22' ' ' SER . 28.2 mm -66.5 -39.51 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 23' ' ' ALA . 82.7 t -60.62 -42.2 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.479 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.67 -40.06 95.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 25' ' ' LYS . 22.0 t -72.25 -40.71 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.514 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.53 -45.87 81.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -61.21 -38.09 85.35 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.557 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.8 p -57.34 -28.69 63.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.5 p -82.0 161.18 23.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.64 -35.78 66.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 109.429 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 19.6 m -64.53 149.5 48.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -105.25 150.52 25.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.83 147.09 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 39.1 m -119.27 145.06 46.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.1 -155.75 16.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.61 141.27 67.57 Favored 'Cis proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.672 -1.803 . . . . 0.0 111.72 0.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.5 mt -94.36 120.79 64.8 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.361 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.6 128.16 14.89 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.728 2.285 . . . . 0.0 111.827 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 3.1 mp -108.29 171.32 4.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.923 . . . . 0.0 109.444 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.51 137.0 35.11 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.679 2.253 . . . . 0.0 111.777 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 49' ' ' VAL . 32.6 m -75.03 143.45 43.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -140.1 144.55 36.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.412 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.9 m 49.15 41.28 19.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.1 mtt85 59.13 30.24 19.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 109.47 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 47' ' ' SER . 47.4 t -127.14 135.11 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.438 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 75.4 m80 -94.9 148.22 22.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.404 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.8 mtmt -138.6 146.63 42.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.195 -0.941 . . . . 0.0 109.555 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 87.6 mtt-85 -128.58 154.29 46.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.898 . . . . 0.0 109.371 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 9' ' ' ILE . 29.5 tp -123.78 129.01 50.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.082 -1.011 . . . . 0.0 109.629 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.565 HD11 HD11 ' A' ' 11' ' ' LEU . 64.2 mt -114.38 122.65 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 86.7 m-20 -93.11 141.53 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.681 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 7' ' ' ILE . 69.2 mt -118.95 129.37 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.349 -0.844 . . . . 0.0 109.252 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.4 mt -110.13 142.56 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.642 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 12.2 t0 50.26 60.84 14.52 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.33 140.12 39.81 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.666 2.244 . . . . 0.0 111.923 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.485 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.09 167.81 16.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.286 -0.884 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.18 -26.17 36.49 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.697 2.265 . . . . 0.0 111.64 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -64.55 -21.98 66.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.8 m -73.32 -40.55 64.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.316 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 82.9 mt -66.18 -39.69 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 91.2 m-20 -61.99 -42.09 98.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.334 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.05 -37.7 81.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.404 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.834 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.4 tm? -62.72 -40.19 96.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -69.23 -29.48 67.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.387 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 50.3 mtt180 -75.96 -29.67 58.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.449 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 67' ' ' LEU . 59.9 mt -113.72 133.21 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -101.93 142.39 33.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 109.475 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.05 155.0 4.74 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.305 -0.872 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' HG3' ' HA ' ' A' ' 22' ' ' SER . 50.6 Cg_endo -69.95 144.37 52.82 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.759 2.306 . . . . 0.0 111.792 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.02 147.0 48.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.459 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.85 6.08 62.32 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 22' ' ' SER . 49.7 t -129.69 147.87 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -1.173 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 86.2 m-20 -116.97 149.76 39.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.41 134.21 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -104.76 136.79 43.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.219 -0.926 . . . . 0.0 109.469 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 82' ' ' LEU . 69.3 mt -118.56 131.58 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.454 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 19.2 tptp -57.97 -37.42 74.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 109.414 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' H ' HG22 ' A' ' 80' ' ' ILE . 23.8 tp . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.464 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.36 -35.1 71.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 109.466 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -119.99 -110.54 2.3 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.98 11.9 58.32 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -111.96 143.86 42.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 23.8 pttm -130.77 151.2 51.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 59' ' ' PRO . 85.3 mt -118.76 139.76 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.44 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.535 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 82.4 mtt180 -118.94 135.09 54.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.534 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.04 136.02 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.419 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD13 ' A' ' 53' ' ' LEU . 77.5 mttt -111.74 130.74 55.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.461 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 10' ' ' LYS . 13.8 mt -112.72 137.02 51.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.632 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -122.26 142.86 50.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.83 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -170.64 148.05 2.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.235 -0.916 . . . . 0.0 109.691 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -57.3 -48.39 79.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.328 -0.857 . . . . 0.0 109.615 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -89.52 127.9 35.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.599 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.578 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.4 p-80 -75.08 -34.61 61.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.91 . . . . 0.0 109.31 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -57.92 -41.42 82.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.865 . . . . 0.0 109.393 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.73 -43.55 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.34 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.83 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.4 mt -54.33 -40.7 68.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -64.23 -36.44 84.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.261 -0.9 . . . . 0.0 109.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -70.36 -38.91 74.87 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' HG13 ' A' ' 26' ' ' ILE . 25.6 t -69.86 -42.07 74.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.731 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.26 -38.26 81.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 21.3 tttt -61.29 -47.14 87.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -62.33 -43.64 98.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 22' ' ' SER . 79.7 mt -67.49 -39.81 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.7 t -63.08 -43.08 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.93 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.7 mt-10 -62.61 -39.27 93.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.5 t -74.92 -37.7 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.935 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -68.88 -48.38 63.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HE3' ' CG1' ' A' ' 27' ' ' VAL . 78.6 mttt -58.74 -40.3 83.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.477 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -50.27 -28.6 8.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.1 p -78.34 165.7 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -57.72 -32.66 67.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 56.5 p -64.93 157.71 27.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -107.03 152.35 24.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.935 HG21 ' HB3' ' A' ' 30' ' ' ALA . 44.6 t -124.94 143.66 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 5.8 t -123.94 137.84 54.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.541 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.26 -151.2 16.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.527 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.37 56.65 Favored 'Cis proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.677 -1.801 . . . . 0.0 111.794 -0.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -90.98 124.5 61.73 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.1 140.73 38.3 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.654 2.236 . . . . 0.0 111.664 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -116.68 174.77 2.27 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.416 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.53 135.39 28.5 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.661 2.241 . . . . 0.0 111.81 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 31.9 m -83.22 145.76 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 48' ' ' ARG . 80.7 tt0 -116.83 119.94 36.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 109.526 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.4 m 56.19 -87.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLU . 95.6 mtt-85 -139.1 18.27 2.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 48.1 t -114.96 128.95 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.529 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 83.4 m-70 -102.23 153.97 19.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.362 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 12.5 mtmt -136.3 141.76 43.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 0.0 109.729 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.531 ' CD ' ' HB3' ' A' ' 19' ' ' LEU . 61.0 mtp85 -121.7 149.41 43.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -0.852 . . . . 0.0 109.212 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.533 ' HB2' HD13 ' A' ' 43' ' ' LEU . 32.6 tp -124.57 128.84 49.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.517 HD11 ' CB ' ' A' ' 23' ' ' ALA . 70.1 mt -116.53 121.26 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.335 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 84.6 m-20 -90.9 146.38 23.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.564 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.9 mt -126.92 130.73 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.337 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.47 140.21 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' SER . 30.5 t0 47.84 61.69 13.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.3 Cg_endo -70.9 141.63 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 111.715 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.406 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -124.16 167.88 14.32 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.516 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.7 Cg_endo -68.14 -22.2 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.725 2.283 . . . . 0.0 111.573 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -67.46 -25.56 65.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.057 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.422 ' HA ' HG21 ' A' ' 33' ' ' THR . 32.5 m -70.92 -41.37 71.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.183 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.9 -42.05 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.572 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.5 t0 -57.31 -45.94 83.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 109.246 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -61.28 -35.24 76.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.473 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.4 tp -66.72 -39.09 87.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.572 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 63.8 mtm -70.13 -26.2 63.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.383 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -79.99 -27.85 39.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.361 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.8 mt -112.47 137.12 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.325 -0.859 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.1 139.0 41.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 72' ' ' LEU . 3.3 pp -59.35 144.22 84.16 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.508 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 72' ' ' LEU . 51.9 Cg_endo -70.95 151.33 62.21 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.667 2.245 . . . . 0.0 111.818 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.52 150.55 26.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.11 5.41 65.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -129.45 147.06 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -1.182 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 54.7 t0 -130.37 158.08 40.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.6 p -124.62 133.93 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -98.23 139.89 33.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.411 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 82' ' ' LEU . 74.1 mt -116.05 135.16 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.509 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -54.51 -38.13 66.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' H ' HG22 ' A' ' 80' ' ' ILE . 22.5 tp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.8 mtp -58.91 -35.52 73.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.63 -178.32 49.36 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.29 -9.66 63.12 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -116.8 154.72 30.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.214 -1.168 . . . . 0.0 109.483 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -132.75 148.8 52.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.329 -0.857 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ILE . 73.2 mt -114.59 138.99 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.534 ' HB3' HD11 ' A' ' 53' ' ' LEU . 88.6 mtt180 -121.26 136.5 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.893 . . . . 0.0 109.549 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.607 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.3 mt -116.02 135.63 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.385 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.734 ' HG2' HD13 ' A' ' 53' ' ' LEU . 80.0 mttt -108.64 131.37 54.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 10' ' ' LYS . 15.5 mt -110.47 138.87 46.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 61.2 mttp -122.57 134.2 54.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -168.73 146.62 3.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.894 . . . . 0.0 109.493 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.37 -37.11 86.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -96.64 123.19 40.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.8 p-80 -72.78 -30.01 63.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 16' ' ' HIS . 75.3 mm-40 -63.86 -36.53 84.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -66.28 -37.19 84.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 13' ' ' ALA . 59.5 mt -70.44 -37.42 74.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -62.18 -42.32 99.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.02 -45.72 73.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.473 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.2 t -63.86 -40.46 96.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -65.7 -41.92 91.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.482 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -57.42 -46.06 83.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 109.461 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.6 mttm -58.46 -44.42 89.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 22' ' ' SER . 24.6 mm -65.68 -43.13 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.7 t -63.55 -46.23 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.514 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -62.83 -44.71 95.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.855 . . . . 0.0 109.589 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 25' ' ' LYS . 40.7 t -66.77 -45.29 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.901 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.33 -43.64 90.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.602 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -56.02 -39.22 71.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.5 p -60.12 -24.98 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.3 p -80.42 163.14 24.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -56.74 -30.18 63.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.959 . . . . 0.0 109.422 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 53.8 p -72.37 155.35 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -112.11 145.11 40.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.901 HG21 ' CB ' ' A' ' 30' ' ' ALA . 43.9 t -124.42 141.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.478 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -117.6 138.64 51.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.48 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.71 -158.41 23.77 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.596 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.3 Cg_endo -70.59 139.35 56.53 Favored 'Cis proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.685 -1.798 . . . . 0.0 111.781 -0.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mt -90.98 131.48 37.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.44 141.19 41.86 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.603 2.202 . . . . 0.0 111.82 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -125.37 174.76 3.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 109.482 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 51.6 Cg_endo -70.51 146.66 56.19 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.747 2.298 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 50' ' ' HIS . 25.3 p -103.28 158.09 16.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.484 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' SER . 72.6 mm-40 -151.67 149.77 29.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 0.3 OUTLIER 43.68 43.2 4.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 47' ' ' SER . 2.7 mtp85 61.53 39.81 14.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 45' ' ' THR . 50.4 t -128.66 132.22 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 71.1 m80 -101.02 151.1 22.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 46.9 mtmt -137.76 141.5 40.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.667 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -125.9 146.67 49.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.285 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.734 HD13 ' HG2' ' A' ' 10' ' ' LYS . 29.0 tp -122.54 133.66 54.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.686 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 68.7 mt -115.26 126.7 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 0.0 109.314 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -91.22 142.14 28.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 7' ' ' ILE . 59.6 mt -123.04 130.47 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.149 -0.969 . . . . 0.0 109.336 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.7 mt -112.55 141.58 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.159 -0.963 . . . . 0.0 109.709 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 35' ' ' SER . 65.5 t0 45.9 62.3 11.28 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.601 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.26 141.63 43.69 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.735 2.29 . . . . 0.0 111.663 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.467 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -129.4 170.67 10.32 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.9 Cg_endo -67.44 -28.67 38.66 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.705 2.27 . . . . 0.0 111.545 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -63.54 -24.9 68.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.28 -0.887 . . . . 0.0 109.133 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 m -71.57 -40.77 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.25 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.5 m-20 -58.89 -44.12 91.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.359 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.618 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -62.79 -41.17 99.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.377 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' ILE . 30.4 tp -60.96 -39.5 89.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.407 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.616 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.29 -31.47 72.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.459 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 19.2 mtp180 -71.06 -30.06 66.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.609 ' CD1' HG21 ' A' ' 29' ' ' VAL . 70.3 mt -112.58 133.82 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.26 141.32 38.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.503 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.44 148.59 79.96 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.597 ' HG2' HG21 ' A' ' 76' ' ' VAL . 50.2 Cg_endo -70.3 149.44 63.48 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.742 2.294 . . . . 0.0 111.788 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.21 147.88 28.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.564 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.35 70.13 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.0 t -126.75 148.65 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -1.147 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 23.0 t70 -128.69 153.59 47.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG13 ' CG2' ' A' ' 9' ' ' ILE . 47.0 t -126.0 134.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.44 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 10' ' ' LYS . 85.4 tt0 -101.86 139.76 37.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 82' ' ' LEU . 72.9 mt -118.55 133.75 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 109.618 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.456 ' O ' ' OXT' ' A' ' 82' ' ' LEU . 15.9 tttt -53.79 -40.11 66.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.478 ' H ' HG22 ' A' ' 80' ' ' ILE . 17.1 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.468 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.5 mtt -126.29 163.61 22.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.1 58.68 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.53 -29.22 63.45 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.43 143.95 42.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 37.1 mtmt -126.84 147.34 50.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.536 HD12 ' HB3' ' A' ' 59' ' ' PRO . 82.2 mt -113.65 137.34 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.541 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 53' ' ' LEU . 92.8 mtt180 -123.11 136.47 54.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.5 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HD22 ' A' ' 53' ' ' LEU . 69.4 mt -114.58 134.3 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.5 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.796 ' HG2' HD23 ' A' ' 53' ' ' LEU . 40.4 mttt -105.35 128.73 53.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.512 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.827 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.1 mp -112.67 133.8 54.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 88.3 mttt -128.4 138.4 52.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.808 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -169.57 147.61 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -61.49 -38.13 86.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.92 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -97.24 125.09 41.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.589 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.7 p-80 -71.13 -28.6 64.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.229 -0.92 . . . . 0.0 109.419 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -63.15 -37.43 87.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 18' ' ' LEU . 49.3 mt -65.75 -39.7 91.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.412 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 13' ' ' ALA . 68.2 mt -67.41 -36.62 81.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.48 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.59 -43.61 98.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.34 -40.3 85.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.433 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.448 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.7 t -65.14 -41.54 94.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.459 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.576 ' HB1' ' HB3' ' A' ' 40' ' ' PRO . . . -68.54 -40.84 80.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -58.99 -48.15 82.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.4 mttm -59.01 -44.87 91.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.481 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 22' ' ' SER . 84.0 mt -62.67 -46.45 96.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.483 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.89 -48.35 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -59.66 -48.08 83.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.47 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' LYS . 27.6 t -69.0 -42.53 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.442 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.847 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -64.46 -47.6 78.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -54.16 -40.76 67.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 m -58.39 -33.69 69.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.219 -0.926 . . . . 0.0 109.447 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 62' ' ' LYS . 25.3 m -72.84 153.85 40.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -50.67 -29.51 11.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 45.3 p -69.76 157.72 36.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -117.47 138.87 51.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.847 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.0 t -117.64 142.05 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 t -114.86 142.48 46.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.99 -153.15 19.66 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 49.9 Cg_endo -70.4 140.97 65.7 Favored 'Cis proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.815 -0.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.18 128.06 48.91 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.414 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.72 138.18 34.21 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.74 2.293 . . . . 0.0 111.913 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -118.3 176.2 1.76 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.317 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.9 Cg_endo -70.21 142.95 47.25 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.562 2.175 . . . . 0.0 111.778 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -110.71 166.85 10.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.6 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 48' ' ' ARG . 79.6 tt0 -143.15 127.73 18.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.847 . . . . 0.0 109.338 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.8 t 53.75 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.313 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' GLU . 86.9 mtm-85 -138.45 23.8 2.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.36 121.12 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.589 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 90.7 m-70 -108.85 152.44 24.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.412 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 53.4 mtmt -134.18 145.78 49.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.615 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -131.19 146.66 52.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 109.229 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.943 HD13 ' N ' ' A' ' 54' ' ' ILE . 2.3 tm? -121.81 132.33 54.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.943 ' N ' HD13 ' A' ' 53' ' ' LEU . 66.4 mt -117.77 122.2 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.249 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 37' ' ' VAL . 82.4 m-20 -90.11 145.64 24.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.188 -0.945 . . . . 0.0 109.609 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.492 HG12 HG22 ' A' ' 37' ' ' VAL . 65.5 mt -127.58 128.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.258 -0.901 . . . . 0.0 109.29 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.2 mt -109.95 142.21 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.83 62.26 12.51 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.351 -0.843 . . . . 0.0 109.61 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.536 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.9 Cg_endo -69.95 146.07 57.93 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.691 2.261 . . . . 0.0 111.775 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.464 ' OG ' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -129.76 165.75 30.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.86 . . . . 0.0 109.447 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD2' ' OG ' ' A' ' 60' ' ' SER . 45.3 Cg_endo -67.49 -24.82 41.99 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.611 2.207 . . . . 0.0 111.649 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HB2' HG23 ' A' ' 33' ' ' THR . 40.2 mttm -64.66 -26.35 68.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.055 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 33' ' ' THR . 62.1 m -70.01 -38.71 76.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.242 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.29 -43.65 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 109.314 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 21.4 t70 -57.73 -41.87 82.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.349 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.58 -39.41 91.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 16.2 tp -63.7 -42.32 98.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 69.0 mtm -64.69 -31.83 73.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 31.4 mtp180 -71.07 -29.79 65.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.7 mt -109.48 136.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -0.863 . . . . 0.0 109.529 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -107.76 135.18 49.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.405 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD22 HG21 ' A' ' 78' ' ' VAL . 8.1 mp -62.33 145.91 93.61 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.507 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.29 147.04 58.58 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.676 2.251 . . . . 0.0 111.742 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 152.88 39.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.933 . . . . 0.0 109.511 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.64 3.61 55.07 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.79 146.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.8 m-20 -113.73 147.37 38.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.527 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 72' ' ' LEU . 40.5 t -124.08 133.25 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -114.63 143.99 44.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 82' ' ' LEU . 70.9 mt -118.67 133.61 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -57.36 -34.39 68.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.887 . . . . 0.0 109.464 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.585 ' H ' HG22 ' A' ' 80' ' ' ILE . 50.7 mt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.492 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.4 mtt -121.65 151.28 40.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 87.14 14.28 64.64 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.47 -22.78 66.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -117.04 146.06 43.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.548 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 4.2 pttm -126.06 158.19 36.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.404 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.4 mt -116.95 141.22 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 62.1 mtt85 -118.41 135.4 54.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 53' ' ' LEU . 67.9 mt -119.49 134.24 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.419 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HG2' HD13 ' A' ' 53' ' ' LEU . 69.6 mttt -107.16 132.64 52.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.917 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.0 mp -111.02 139.65 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.439 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -126.78 129.54 48.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.0 109.528 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.804 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -163.61 151.69 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 109.42 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -71.82 -30.75 65.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.53 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -97.12 115.24 27.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.627 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 45.2 t-80 -61.07 -46.49 90.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.416 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -56.38 -41.97 77.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.5 tm? -57.36 -39.61 76.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.292 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.804 HD21 ' CB ' ' A' ' 13' ' ' ALA . 66.7 mt -61.86 -39.13 90.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.295 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.79 -39.42 84.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.204 -0.935 . . . . 0.0 109.531 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.02 -38.3 90.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' HD23 ' A' ' 11' ' ' LEU . 87.0 p -65.55 -33.04 74.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.491 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -74.16 -34.34 63.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.562 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -63.8 -43.95 94.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.1 mttt -64.54 -46.11 84.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 22' ' ' SER . 26.1 mm -69.68 -44.07 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 23' ' ' ALA . 70.4 t -64.21 -44.58 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.54 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -62.48 -45.31 93.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.549 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 25' ' ' LYS . 37.5 t -71.71 -41.33 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.554 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.803 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.96 -46.31 78.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -59.2 -39.14 81.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.7 m -59.23 -31.11 68.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 29' ' ' VAL . 25.3 p -75.37 163.34 27.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -56.03 -33.48 64.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 61.0 p -67.62 161.05 26.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.912 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -122.91 138.0 54.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.803 HG21 ' CB ' ' A' ' 30' ' ' ALA . 44.8 t -112.75 140.92 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.2 m -114.33 146.39 40.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.527 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.35 -149.72 16.97 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.98 148.05 86.39 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.767 -1.764 . . . . 0.0 111.8 -0.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.3 mp -90.07 128.61 49.04 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.858 . . . . 0.0 109.543 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.02 123.92 10.11 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.686 2.258 . . . . 0.0 111.595 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.1 mp -106.8 173.25 3.24 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.578 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.4 Cg_endo -69.01 151.14 73.36 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.798 2.332 . . . . 0.0 111.909 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 49' ' ' VAL . 14.8 t -120.06 163.62 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ARG . 95.1 mt-10 -141.39 139.77 33.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m 48.2 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' GLU . 90.1 mtt180 -138.22 26.17 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' O ' ' OG1' ' A' ' 45' ' ' THR . 48.3 t -115.05 121.31 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.555 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.538 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 92.3 m-70 -105.29 150.62 25.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.283 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 22.7 mtmm -133.41 146.73 51.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' NH2' ' CE1' ' A' ' 16' ' ' HIS . 86.6 mtt-85 -130.62 149.49 52.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 109.181 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.68 ' O ' HD12 ' A' ' 41' ' ' ILE . 27.8 tp -122.38 128.36 50.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -0.953 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.427 HG22 ' CG1' ' A' ' 37' ' ' VAL . 66.5 mt -110.23 127.56 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.326 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -96.59 138.34 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.64 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 62.2 mt -118.16 131.23 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.299 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -111.98 138.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.603 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.455 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 4.9 t70 49.22 57.86 18.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.591 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 50.6 Cg_endo -70.27 138.3 35.88 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.626 2.218 . . . . 0.0 111.826 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -118.22 168.1 10.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.45 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 48.0 Cg_endo -68.3 -21.66 41.06 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.707 2.272 . . . . 0.0 111.675 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -68.07 -23.99 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.237 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.1 m -70.28 -40.99 73.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.42 -39.54 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.619 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.4 m-20 -59.43 -41.18 88.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.89 84.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.5 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' ILE . 26.7 tp -62.92 -37.53 87.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.619 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 73.9 mtm -69.7 -34.55 74.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.358 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.59 -28.1 61.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.465 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -107.07 138.74 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -94.07 138.96 31.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.186 -0.946 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 147.52 78.15 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.311 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.64 142.58 48.87 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.678 2.252 . . . . 0.0 111.781 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.96 51.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.68 5.19 60.18 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' CG2' HD12 ' A' ' 18' ' ' LEU . 59.6 t -132.16 148.55 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -1.186 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -133.8 147.48 51.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.163 -0.961 . . . . 0.0 109.478 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.31 142.25 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.925 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -115.4 137.31 52.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.05 -36.83 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 82' ' ' LEU . 26.2 mttt -93.55 147.84 22.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 81' ' ' LYS . 49.9 mt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.405 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.8 mtp -57.4 -34.85 69.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.99 -175.17 50.29 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.87 6.35 62.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -103.6 150.59 23.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -1.206 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 3.6 pttm -136.82 143.0 42.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.429 HD12 ' HB3' ' A' ' 59' ' ' PRO . 69.0 mt -115.37 138.35 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.239 -0.913 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' A' ' 55' ' ' ASP . 93.4 mtt-85 -118.48 132.81 56.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.435 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.3 mt -125.1 132.04 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.426 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -105.66 136.78 44.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.913 . . . . 0.0 109.457 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.842 HD12 ' N ' ' A' ' 11' ' ' LEU . 3.1 mp -109.5 138.63 45.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.437 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.466 ' HE3' ' OE2' ' A' ' 79' ' ' GLU . 24.1 mttt -127.33 137.6 52.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.383 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -165.15 145.77 7.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.547 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -57.44 -51.87 67.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.398 -0.814 . . . . 0.0 109.603 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -90.55 127.66 36.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.323 -0.861 . . . . 0.0 109.708 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.562 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 45.8 t-80 -66.49 -37.44 85.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -56.74 -44.06 81.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.248 -0.907 . . . . 0.0 109.469 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.9 mt -65.11 -37.79 88.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.421 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 19' ' ' LEU . 7.2 tt -65.43 -39.47 92.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -59.99 -42.72 94.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.496 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.13 -41.05 91.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.344 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 26' ' ' ILE . 20.3 m -64.57 -44.0 92.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.767 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -68.33 -42.68 78.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 0.0 109.401 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -64.25 -42.59 96.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 tttt -58.1 -49.85 75.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.476 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 22' ' ' SER . 26.9 mm -64.83 -40.94 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.506 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 23' ' ' ALA . 74.7 t -58.43 -45.9 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.431 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -61.06 -43.34 99.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 109.525 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 25' ' ' LYS . 21.7 t -71.99 -40.9 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.905 . . . . 0.0 109.491 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.902 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.08 -47.1 84.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HE2' HG13 ' A' ' 27' ' ' VAL . 28.9 mttm -59.82 -39.63 85.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.9 m -53.99 -31.52 51.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.451 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 p -76.38 163.0 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.58 -32.5 67.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.3 p -61.73 159.53 13.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -113.78 145.06 41.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.902 HG21 ' CB ' ' A' ' 30' ' ' ALA . 31.5 t -123.75 141.59 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 13.2 t -117.83 140.21 50.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.85 -148.42 17.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.74 144.21 78.04 Favored 'Cis proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.793 -1.753 . . . . 0.0 111.724 0.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.75 119.78 65.63 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.367 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.77 137.15 31.92 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.584 2.189 . . . . 0.0 111.85 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.614 HD23 ' HD2' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -118.54 174.77 2.46 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.475 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HD2' HD23 ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.03 133.33 24.81 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.692 2.262 . . . . 0.0 111.776 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.5 t -77.77 152.37 33.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 109.534 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ARG . 81.1 tt0 -117.44 125.15 50.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.447 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.5 m 54.06 -88.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.518 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' N ' ' O ' ' A' ' 46' ' ' GLU . 56.8 mtt180 -140.55 22.2 2.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.03 131.57 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.562 ' CG ' ' HB2' ' A' ' 16' ' ' HIS . 90.8 m-70 -97.94 153.16 18.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 48.9 mtmt -141.33 141.63 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.664 ' CD ' HD22 ' A' ' 19' ' ' LEU . 21.6 mtp180 -125.94 158.89 34.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.295 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.1 tp -124.04 127.99 48.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.529 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.417 HD11 ' HB1' ' A' ' 23' ' ' ALA . 63.7 mt -116.23 120.69 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.371 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' CG ' ' NH1' ' A' ' 8' ' ' ARG . 86.5 m-20 -89.2 145.31 25.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 65.8 mt -125.68 126.72 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.0 mt -108.33 141.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t70 53.12 61.26 11.39 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 109.54 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' HB3' HD12 ' A' ' 7' ' ' ILE . 49.4 Cg_endo -69.95 145.66 56.7 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.702 2.268 . . . . 0.0 111.737 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.13 166.91 25.71 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.98 -24.03 39.86 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.771 2.314 . . . . 0.0 111.619 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -65.61 -24.6 67.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 109.217 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.7 m -72.57 -40.75 66.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.312 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.12 -40.84 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.373 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.57 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 89.9 m-20 -62.2 -42.27 99.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.41 89.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.925 . . . . 0.0 109.323 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 30.6 tp -64.44 -39.23 93.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.57 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 58.5 mtm -68.66 -29.94 68.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 61.6 mtt-85 -74.78 -28.76 60.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.589 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.0 mt -111.32 135.97 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.467 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -111.75 130.91 55.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.611 HD13 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -55.99 152.06 22.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.405 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.34 151.15 71.43 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.647 2.231 . . . . 0.0 111.795 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.89 149.3 27.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.44 1.87 66.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 72' ' ' LEU . 39.5 t -127.29 147.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 45.2 t0 -124.56 155.1 39.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.611 HG21 HD13 ' A' ' 72' ' ' LEU . 48.4 t -135.41 148.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' OE2' ' HE3' ' A' ' 12' ' ' LYS . 94.1 mt-10 -112.78 156.74 22.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 82' ' ' LEU . 75.6 mt -111.0 140.87 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -54.45 -37.51 65.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.295 -0.878 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.564 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' MET . 21.7 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' SER . 87.0 mtp 46.15 92.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 0.0 109.496 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . -59.53 124.26 35.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.82 -35.97 77.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -118.9 157.65 27.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -1.162 . . . . 0.0 109.428 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 12.8 pttm -125.72 161.53 27.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.365 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 71.4 mt -122.11 137.51 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.603 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.782 ' HB2' HD11 ' A' ' 82' ' ' LEU . 96.2 mtt180 -113.76 137.2 51.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.613 HD13 ' O ' ' A' ' 8' ' ' ARG . 23.6 mm -118.78 125.1 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.281 -0.887 . . . . 0.0 109.644 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.614 ' C ' HD12 ' A' ' 11' ' ' LEU . 24.4 mttt -106.05 132.28 52.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.253 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.2 mp -117.92 138.87 51.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 84.9 mttt -128.78 132.58 47.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 75' ' ' GLY . . . -157.39 141.37 16.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.557 ' CD1' HG22 ' A' ' 49' ' ' VAL . 98.5 m-85 -65.39 -35.51 81.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.41 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -93.7 116.5 29.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.299 -0.875 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.574 ' NE2' ' CZ ' ' A' ' 52' ' ' ARG . 46.8 t-80 -62.95 -35.36 79.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.15 -42.81 91.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.24 -37.11 83.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 11' ' ' LEU . 12.8 tp -70.79 -37.26 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -62.74 -39.96 95.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.525 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.2 mm-40 -69.91 -44.27 70.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 26' ' ' ILE . 97.6 p -60.97 -36.51 79.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -73.77 -51.06 17.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 17.1 mttm -65.22 -46.16 81.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' O ' HG23 ' A' ' 29' ' ' VAL . 28.8 mtmt -59.85 -47.49 85.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.663 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 22' ' ' SER . 96.9 mt -68.15 -39.67 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 109.694 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' ALA . 66.5 t -62.01 -43.01 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 109.65 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 97.2 mt-10 -64.78 -38.19 90.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 25' ' ' LYS . 39.7 t -75.17 -38.84 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.634 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.046 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -65.8 -49.25 68.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.575 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HE3' HG13 ' A' ' 27' ' ' VAL . 80.8 mttt -60.14 -37.56 80.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.553 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 m -56.63 -30.19 63.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.608 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' VAL . 30.1 p -75.66 164.2 26.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -56.66 -35.95 68.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 p -60.06 159.17 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -109.45 143.03 39.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.046 HG21 ' HB1' ' A' ' 30' ' ' ALA . 40.7 t -126.38 141.59 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 39.0 m -116.21 149.1 39.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 112.12 -150.49 18.17 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.8 Cg_endo -70.74 147.92 87.79 Favored 'Cis proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.746 -1.772 . . . . 0.0 111.759 -0.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -101.44 119.97 56.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.94 141.22 39.92 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.753 2.302 . . . . 0.0 111.821 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -118.6 176.17 1.79 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.288 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 48.6 Cg_endo -69.49 135.55 31.38 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.608 2.206 . . . . 0.0 111.728 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 49' ' ' VAL . 26.0 m -83.43 143.65 30.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 109.636 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 48' ' ' ARG . 82.3 tt0 -112.97 128.45 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.361 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 m 52.81 -89.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.545 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 46' ' ' GLU . 55.2 ttp85 -141.88 26.35 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.693 ' O ' HG23 ' A' ' 45' ' ' THR . 45.1 t -119.38 131.26 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.518 ' ND1' ' HB2' ' A' ' 16' ' ' HIS . 70.3 m80 -100.75 148.09 25.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 41.6 mtmt -134.88 141.55 46.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' CZ ' ' NE2' ' A' ' 16' ' ' HIS . 86.8 mtt-85 -124.45 151.38 44.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -121.79 125.55 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.693 ' N ' HD23 ' A' ' 53' ' ' LEU . 64.3 mt -115.39 122.28 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.365 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 52.4 t0 -91.2 140.34 29.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' HB ' ' HB ' ' A' ' 7' ' ' ILE . 63.7 mt -117.59 128.06 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.902 . . . . 0.0 109.398 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.91 137.83 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.514 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 10.0 t70 51.29 63.71 9.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.81 143.09 49.47 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.771 2.314 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -131.07 168.17 18.45 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 44.9 Cg_endo -67.21 -24.42 44.17 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.644 2.23 . . . . 0.0 111.657 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -65.83 -27.06 67.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.254 -0.904 . . . . 0.0 109.175 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.421 ' HA ' HG21 ' A' ' 33' ' ' THR . 40.8 m -68.94 -41.52 77.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 109.216 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.0 mt -63.81 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.851 . . . . 0.0 109.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 69' ' ' ARG . 85.6 m-20 -59.16 -42.41 90.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.403 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -65.33 -38.21 89.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 70' ' ' ILE . 25.2 tp -63.88 -43.24 96.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.485 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.6 mtm -65.82 -29.35 69.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.93 . . . . 0.0 109.507 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 12.8 mtt-85 -73.47 -29.77 62.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.441 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -110.85 136.06 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -106.44 127.9 53.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.654 HD13 ' HB ' ' A' ' 76' ' ' VAL . 3.3 pp -58.79 143.68 82.29 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.466 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.535 ' O ' HD12 ' A' ' 72' ' ' LEU . 49.6 Cg_endo -70.01 150.31 66.49 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.799 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.01 151.42 18.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 94.75 5.98 60.99 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 72' ' ' LEU . 46.2 t -121.32 147.75 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.175 . . . . 0.0 109.439 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 56.6 t0 -134.82 156.0 49.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.491 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.4 p -135.73 146.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.908 . . . . 0.0 109.353 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -93.67 120.86 34.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.7 mt -68.8 -32.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.427 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -86.51 147.7 25.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 8' ' ' ARG . 25.6 tp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.529 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.6 mtt -57.63 -35.02 69.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.507 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.59 -167.02 32.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.19 0.62 54.33 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -105.44 149.06 26.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -1.223 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 8' ' ' ARG . 58.7 pttt -137.26 142.95 41.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.478 ' HB ' HD12 ' A' ' 56' ' ' ILE . 83.9 mt -118.79 143.88 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 6' ' ' LYS . 67.8 mtt85 -116.17 136.44 53.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.48 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 73.1 mt -121.53 131.17 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.541 ' O ' HD23 ' A' ' 11' ' ' LEU . 91.0 mttt -97.34 139.04 33.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.604 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 19' ' ' LEU . 16.4 mt -115.01 130.77 57.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.355 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 79' ' ' GLU . 87.3 mttt -120.53 137.16 54.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.55 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.617 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -167.94 146.32 4.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -68.22 -39.45 82.36 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -101.75 118.19 36.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 20.6 p80 -55.99 -43.87 78.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 81.2 tt0 -51.46 -53.57 35.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tt -55.16 -40.5 70.7 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.226 -0.921 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 11' ' ' LEU . 13.4 tp -68.25 -32.61 72.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 86.8 m-20 -63.76 -38.64 91.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -68.17 -41.59 81.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' ILE . 22.8 t -61.68 -38.91 89.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.28 -37.01 74.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.11 -44.23 97.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 29' ' ' VAL . 95.2 mttt -63.43 -41.11 98.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.349 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 22' ' ' SER . 78.2 mt -68.67 -42.2 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.0 t -64.73 -48.86 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.75 -43.83 98.09 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 25' ' ' LYS . 31.8 t -70.55 -41.9 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.62 76.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -59.99 -37.29 79.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.465 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.1 t -60.32 -30.64 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.5 p -76.5 160.58 29.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -55.12 -35.17 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.8 p -66.08 157.74 30.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.443 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -113.26 139.38 48.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 0.0 109.442 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' CG2' ' CG2' ' A' ' 54' ' ' ILE . 7.7 p -113.03 147.33 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 109.463 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 8.9 t -120.81 142.09 49.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.347 -0.845 . . . . 0.0 109.453 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.03 -149.72 17.33 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HD3' HG21 ' A' ' 27' ' ' VAL . 50.1 Cg_endo -70.41 144.47 78.13 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.683 -1.799 . . . . 0.0 111.814 -0.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 53' ' ' LEU . 4.1 mp -89.7 114.18 59.64 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.415 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.7 139.26 27.71 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.665 2.244 . . . . 0.0 111.809 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.0 HD13 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -120.82 176.01 2.08 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.6 Cg_endo -69.64 132.74 24.16 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.572 2.181 . . . . 0.0 111.753 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -72.99 139.33 46.6 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 48' ' ' ARG . 83.1 tt0 -108.91 132.86 53.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 46' ' ' GLU . 2.7 p 48.66 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 46' ' ' GLU . 63.9 mtt180 -140.07 27.16 2.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.182 -0.949 . . . . 0.0 109.404 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.01 130.44 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.583 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 83.1 m-70 -91.51 153.37 19.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -130.43 132.35 45.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.743 ' C ' HD12 ' A' ' 53' ' ' LEU . 30.6 mtt-85 -130.03 140.84 50.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.221 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.0 ' CD1' HD13 ' A' ' 43' ' ' LEU . 4.3 mp -122.43 138.04 54.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.734 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 71.8 mt -117.74 128.46 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.865 . . . . 0.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 91.5 m-20 -91.37 144.55 25.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB ' ' A' ' 7' ' ' ILE . 61.0 mt -120.36 137.11 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.1 mt -114.23 136.89 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 t0 45.19 62.17 10.96 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.3 Cg_endo -70.01 141.16 43.5 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.77 2.313 . . . . 0.0 111.735 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -127.88 173.0 5.94 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.528 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.33 -27.1 40.87 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.724 2.283 . . . . 0.0 111.804 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -64.79 -24.31 67.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.9 m -71.82 -42.39 67.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.247 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.93 -44.35 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -56.14 -48.09 76.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -55.46 -40.0 71.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.337 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.1 tp -62.44 -34.57 77.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.333 -0.854 . . . . 0.0 109.449 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.64 -30.51 69.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.469 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 38.5 mtm105 -74.12 -30.4 62.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 29' ' ' VAL . 66.9 mt -114.07 131.41 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -106.61 141.65 37.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.497 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.81 141.25 80.48 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.54 149.94 62.67 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.692 2.261 . . . . 0.0 111.724 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.18 148.95 16.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.39 -3.18 71.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 40.6 t -120.4 148.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -1.216 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 53.9 t0 -130.39 158.25 40.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.391 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 46.1 t -139.09 140.02 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.573 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 12' ' ' LYS . 93.9 mt-10 -94.26 132.55 38.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.0 mt -60.92 -39.43 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.422 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' LEU . 25.6 mttm -104.23 144.6 31.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 41.9 mt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.501 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.9 p . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.7 mtp -58.78 -35.78 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 86.77 10.58 72.41 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.24 -25.35 62.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -104.61 149.62 25.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.421 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 25.7 pttm -126.55 158.98 34.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 76.8 mt -115.63 137.06 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.443 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -119.66 137.29 53.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.521 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.67 135.6 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.426 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 13.7 tttp -107.34 121.01 43.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.525 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.81 ' O ' HD21 ' A' ' 19' ' ' LEU . 37.6 mt -101.65 126.86 48.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 96.4 mttt -121.32 137.37 54.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.908 . . . . 0.0 109.455 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -167.26 143.69 4.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.516 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -63.01 -41.34 99.55 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.76 114.47 26.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.633 ' CE1' ' CG ' ' A' ' 17' ' ' GLU . 21.1 p80 -61.21 -35.44 77.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.422 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CG ' ' CE1' ' A' ' 16' ' ' HIS . 86.8 mt-10 -65.14 -39.87 93.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.04 -39.48 83.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.419 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 11' ' ' LEU . 14.0 tp -59.69 -38.22 80.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -65.57 -35.28 80.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.93 -39.54 94.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.482 ' OG ' HG21 ' A' ' 76' ' ' VAL . 17.6 m -68.82 -37.5 79.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.48 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -72.71 -37.08 67.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 0.0 109.411 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 24.0 tttt -61.34 -45.21 95.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 29' ' ' VAL . 80.2 mttt -63.79 -41.34 97.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.518 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' SER . 79.5 mt -70.52 -43.29 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 23' ' ' ALA . 71.1 t -62.01 -45.36 98.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 96.9 mt-10 -61.5 -43.25 99.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.613 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 25' ' ' LYS . 32.2 t -72.94 -37.19 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.937 . . . . 0.0 109.533 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.003 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -67.18 -49.5 64.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' CE ' HG12 ' A' ' 27' ' ' VAL . 5.1 mtmp? -58.42 -37.23 74.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.476 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.8 m -57.12 -34.67 68.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.518 HG21 ' OG1' ' A' ' 63' ' ' THR . 27.8 m -73.37 154.47 40.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -50.99 -35.17 32.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.0 p -60.76 157.24 15.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.452 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -112.73 145.42 40.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.88 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.003 HG21 ' HB1' ' A' ' 30' ' ' ALA . 49.9 t -122.42 142.21 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.4 t -113.91 135.64 53.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.71 -155.59 21.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.38 138.11 48.94 Favored 'Cis proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.77 0.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -89.28 115.42 63.65 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.01 139.41 32.86 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.619 2.213 . . . . 0.0 111.754 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.2 mp -118.48 175.53 2.07 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.449 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.8 Cg_endo -70.3 133.23 24.1 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.642 2.228 . . . . 0.0 111.76 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.64 HG21 ' CE1' ' A' ' 50' ' ' HIS . 21.6 m -78.63 142.62 37.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 48' ' ' ARG . 82.3 tt0 -112.45 126.31 55.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 109.39 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.0 t 53.25 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 46' ' ' GLU . 91.3 mtt180 -140.3 22.5 2.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 45' ' ' THR . 50.4 t -119.65 131.24 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 109.591 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.64 ' CE1' HG21 ' A' ' 45' ' ' THR . 82.6 m-70 -101.27 150.76 22.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 109.408 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HD2' ' HE2' ' A' ' 10' ' ' LYS . 9.4 mtmt -133.44 140.75 47.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.688 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HG3' HD23 ' A' ' 19' ' ' LEU . 88.8 mtt-85 -124.74 149.62 47.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.221 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.4 tp -122.51 131.68 53.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.745 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.9 mt -119.17 124.39 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.197 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -99.95 140.52 34.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 109.717 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 66.9 mt -120.89 130.48 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.231 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -111.55 140.2 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 8.2 t0 51.4 59.91 14.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.581 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.7 Cg_endo -70.59 140.66 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.686 2.257 . . . . 0.0 111.712 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.73 165.1 17.65 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.31 -19.98 49.34 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.631 2.221 . . . . 0.0 111.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -71.07 -28.03 64.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.266 -0.896 . . . . 0.0 109.233 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.518 ' OG1' HG21 ' A' ' 33' ' ' THR . 53.8 m -72.08 -39.23 69.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.244 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -65.11 -41.58 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.309 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.537 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -58.74 -47.75 83.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.878 . . . . 0.0 109.346 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.81 -35.79 75.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.929 . . . . 0.0 109.355 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -66.04 -41.87 90.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.856 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.537 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 67.6 mtm -65.53 -28.76 69.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -77.43 -28.41 52.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' LEU . 67.1 mt -110.94 134.77 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -106.95 131.38 54.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -0.851 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HG ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -46.9 144.54 3.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.458 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HD2' ' HG ' ' A' ' 72' ' ' LEU . 49.5 Cg_endo -69.9 148.49 64.31 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.698 2.265 . . . . 0.0 111.827 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.06 152.0 41.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.406 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.46 -3.89 56.59 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG21 ' OG ' ' A' ' 22' ' ' SER . 48.4 t -124.76 148.64 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -1.181 . . . . 0.0 109.454 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.5 m-20 -118.26 157.14 27.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.3 148.99 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -108.86 137.43 46.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.72 158.11 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.432 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -85.74 134.07 33.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.89 . . . . 0.0 109.475 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.014 -0.994 . . . . 0.0 109.479 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.462 ' N ' ' OD2' ' A' ' 58' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mmm -59.71 -35.56 74.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.8 17.84 66.97 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.62 -28.67 52.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -101.39 145.18 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -1.184 . . . . 0.0 109.49 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 26.3 pttm -132.79 161.84 33.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.813 ' HB ' HD12 ' A' ' 56' ' ' ILE . 10.5 mm -118.75 141.57 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.159 -0.963 . . . . 0.0 109.443 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.727 ' HB3' HD11 ' A' ' 53' ' ' LEU . 77.1 mtm180 -125.71 127.08 45.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 53' ' ' LEU . 68.5 mt -114.96 135.91 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' C ' HD12 ' A' ' 11' ' ' LEU . 54.0 mttm -104.87 127.46 52.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 109.604 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -101.24 134.64 43.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.895 . . . . 0.0 109.406 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 67.8 mttm -121.48 135.42 55.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.721 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -169.33 149.3 4.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.38 -39.96 67.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.34 119.38 32.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 55.8 p-80 -64.93 -38.21 90.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 94.7 mt-10 -59.83 -38.16 81.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.446 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.08 -36.62 61.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.36 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 11' ' ' LEU . 14.4 tp -67.22 -35.86 80.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -62.9 -42.4 99.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.36 -40.96 98.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 m -63.26 -37.82 88.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.763 ' HB2' HD22 ' A' ' 11' ' ' LEU . . . -72.31 -44.62 62.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 0.0 109.444 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -59.62 -43.72 93.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 29' ' ' VAL . 55.4 tttt -60.89 -45.93 92.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 22' ' ' SER . 89.6 mt -64.55 -40.13 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 23' ' ' ALA . 75.5 t -62.47 -44.82 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.1 -41.12 97.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.536 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 25' ' ' LYS . 25.8 t -71.81 -43.36 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.017 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -65.83 -48.7 70.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -57.64 -37.89 74.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -57.86 -29.2 64.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 63' ' ' THR . 27.2 p -73.28 163.84 27.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.5 -33.25 67.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.521 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 60.7 p -69.37 158.82 34.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -108.29 151.09 26.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.017 HG11 ' CB ' ' A' ' 30' ' ' ALA . 26.6 m -127.98 145.45 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.0 m -118.38 147.86 43.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -0.953 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.32 -156.29 18.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.2 Cg_endo -70.36 142.68 72.42 Favored 'Cis proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.781 -0.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 53' ' ' LEU . 4.4 mt -95.48 121.56 61.41 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.45 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 133.35 24.93 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.714 2.276 . . . . 0.0 111.899 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CB ' ' HD2' ' A' ' 44' ' ' PRO . 1.9 mp -110.09 172.64 3.44 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 47.7 Cg_endo -68.92 141.03 47.49 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.701 2.267 . . . . 0.0 111.713 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 49' ' ' VAL . 11.7 t -80.09 141.24 35.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -0.917 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 79.4 tt0 -129.29 129.98 45.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.357 -0.84 . . . . 0.0 109.36 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' ARG . 50.9 p 47.43 49.79 15.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.38 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 47' ' ' SER . 13.2 mtt-85 61.75 27.17 16.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 46.6 t -114.51 140.8 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.586 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 72.3 m80 -106.92 145.65 31.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 16.7 mttt -133.23 145.21 50.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HB2' ' HB2' ' A' ' 11' ' ' LEU . 89.0 mtt-85 -129.22 145.71 51.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.174 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 8' ' ' ARG . 26.5 tp -121.62 130.98 53.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.731 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 66.2 mt -116.42 118.21 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.251 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' HG2' ' A' ' 8' ' ' ARG . 81.5 m-20 -89.47 148.77 23.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.747 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' HB ' ' A' ' 7' ' ' ILE . 32.5 mt -124.51 130.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.354 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.87 136.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 1' ' ' SER . 39.0 t0 48.51 60.86 14.93 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.349 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 35' ' ' SER . 49.4 Cg_endo -69.72 142.2 47.47 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.773 2.316 . . . . 0.0 111.846 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -125.27 173.97 4.37 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 45.6 Cg_endo -67.88 -22.96 41.75 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.693 2.262 . . . . 0.0 111.663 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -67.44 -24.73 65.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.229 -0.919 . . . . 0.0 109.265 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' HG21 ' A' ' 33' ' ' THR . 52.7 m -73.24 -40.2 64.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.24 -40.25 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.863 . . . . 0.0 109.43 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.591 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.3 m-20 -63.79 -39.54 94.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.428 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.21 -42.32 88.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 67' ' ' LEU . 20.2 tp -63.78 -38.45 91.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.591 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 60.4 mtm -69.26 -30.41 68.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.478 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 52.2 mtt180 -75.77 -29.06 58.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.518 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.467 ' CD1' HG21 ' A' ' 29' ' ' VAL . 72.1 mt -111.4 135.91 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.434 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -112.86 134.68 54.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -51.96 146.76 13.95 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.77 152.37 69.26 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.639 2.226 . . . . 0.0 111.806 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.44 149.12 25.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.14 -6.03 63.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 67.1 t -125.61 148.53 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -1.192 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 88.7 m-20 -124.05 146.71 48.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.421 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.421 HG23 HD13 ' A' ' 72' ' ' LEU . 39.2 t -132.59 135.14 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -94.56 125.07 38.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.47 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -65.48 -36.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -123.18 148.14 46.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.55 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.473 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.1 mmm -58.29 -33.96 70.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.418 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.409 ' HA3' ' CG ' ' A' ' 58' ' ' ASP . . . 94.38 5.93 61.59 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.2 -31.15 65.2 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -71.0 149.61 46.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -1.159 . . . . 0.0 109.406 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.543 ' HE2' ' CZ ' ' A' ' 8' ' ' ARG . 22.3 pttm -130.5 153.56 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 HG13 ' HG3' ' A' ' 59' ' ' PRO . 72.6 mt -117.83 142.33 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 109.362 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' CZ ' ' HE2' ' A' ' 6' ' ' LYS . 68.3 mtt180 -121.84 134.96 54.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.688 ' CG2' HG13 ' A' ' 78' ' ' VAL . 81.0 mt -117.06 135.7 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.434 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 28.3 tttp -105.75 130.51 53.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 109.604 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 49.8 mt -107.87 127.94 54.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.571 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HE3' ' HD3' ' A' ' 10' ' ' LYS . 70.6 mttt -122.39 136.5 54.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.091 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -167.08 141.02 3.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.602 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -54.39 -50.78 66.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.681 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-20 -83.79 131.78 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.745 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 50' ' ' HIS . 79.3 t60 -71.08 -35.57 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.883 . . . . 0.0 109.339 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.19 -35.49 69.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.424 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 15' ' ' ASP . 82.7 mt -64.31 -35.08 79.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.091 ' CD1' ' HB3' ' A' ' 13' ' ' ALA . 6.6 mp -73.56 -39.28 64.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -64.54 -45.33 87.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.15 -41.64 73.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.433 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . 23.0 m -65.09 -39.79 93.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.52 87.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.43 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -64.09 -39.68 94.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.7 mttt -65.04 -43.02 93.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.918 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 22' ' ' SER . 30.2 mm -65.53 -45.73 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.563 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.89 -45.34 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.86 -48.81 77.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 25' ' ' LYS . 64.6 t -69.26 -47.05 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.88 ' CB ' HG11 ' A' ' 37' ' ' VAL . . . -61.84 -49.32 76.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.477 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -58.32 -37.87 75.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.4 t -57.75 -30.36 65.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 29' ' ' VAL . 29.4 p -75.09 163.3 27.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -56.51 -34.19 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.8 p -64.99 156.84 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -107.9 158.54 17.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.88 HG11 ' CB ' ' A' ' 30' ' ' ALA . 12.6 m -132.42 145.15 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.304 -0.873 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 55' ' ' ASP . 9.0 m -122.65 152.74 40.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.81 -143.84 17.14 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HB3' HG12 ' A' ' 54' ' ' ILE . 50.6 Cg_endo -70.98 146.7 85.46 Favored 'Cis proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.759 -1.767 . . . . 0.0 111.746 -0.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.32 114.47 60.49 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.266 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' O ' HD22 ' A' ' 43' ' ' LEU . 52.8 Cg_endo -72.58 140.0 32.11 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.723 2.282 . . . . 0.0 111.948 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 42' ' ' PRO . 3.9 mm? -118.43 166.87 12.72 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' CD1' ' A' ' 43' ' ' LEU . 49.1 Cg_endo -69.68 128.2 15.75 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 122.634 2.222 . . . . 0.0 111.756 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 49' ' ' VAL . 19.0 m -68.88 154.37 42.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 48' ' ' ARG . 74.3 tt0 -122.83 119.58 30.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 m 59.9 -85.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.38 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' GLU . 92.6 mtt180 -143.85 22.99 1.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.422 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 45' ' ' THR . 59.6 t -122.52 128.55 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 16' ' ' HIS . 70.8 m-70 -97.55 157.9 15.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.477 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 38.6 mtmt -142.07 137.36 30.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.67 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.866 ' C ' HD12 ' A' ' 53' ' ' LEU . 21.5 mtp180 -131.99 150.3 52.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.866 HD12 ' C ' ' A' ' 52' ' ' ARG . 7.7 mp -127.15 145.69 50.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.167 -0.958 . . . . 0.0 109.741 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.449 HG12 ' HB3' ' A' ' 40' ' ' PRO . 70.2 mt -123.81 117.94 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.305 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 38.7 t0 -78.56 140.67 38.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.486 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.1 mt -121.14 124.84 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.354 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -107.81 139.48 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.544 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' CG ' ' HA3' ' A' ' 3' ' ' GLY . 1.0 OUTLIER 50.76 63.62 9.58 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.6 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.5 Cg_endo -70.54 144.78 50.87 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.63 2.22 . . . . 0.0 111.675 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.501 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -131.4 172.05 8.03 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.597 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 46.1 Cg_endo -68.24 -26.55 35.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 111.829 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -62.63 -20.99 65.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.7 m -74.32 -39.17 63.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.88 -40.17 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.558 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 88.8 m-20 -62.68 -41.3 99.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -64.5 -40.11 95.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.33 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 70' ' ' ILE . 24.0 tp -64.0 -36.69 84.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.327 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.558 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 64.4 mtm -70.65 -27.06 63.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.18 -0.95 . . . . 0.0 109.415 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -78.67 -28.03 45.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 67' ' ' LEU . 72.4 mt -112.93 135.32 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.338 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -107.82 133.73 51.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.492 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD22 ' CG2' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -64.29 145.7 98.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.58 150.64 63.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.685 2.256 . . . . 0.0 111.823 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.65 150.77 35.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.73 3.41 64.34 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.66 147.16 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -1.174 . . . . 0.0 109.449 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 36.7 t0 -129.61 158.38 39.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.688 HG13 ' CG2' ' A' ' 9' ' ' ILE . 41.2 t -127.9 128.35 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 10' ' ' LYS . 82.3 tt0 -121.1 139.47 53.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.49 131.25 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.82 146.17 26.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.899 . . . . 0.0 109.475 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 82' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.928 ' OG ' HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -56.8 -38.03 71.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 109.499 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.28 -39.28 92.36 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.98 75.53 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -117.13 127.2 53.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -1.148 . . . . 0.0 109.458 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HE3' ' NH1' ' A' ' 8' ' ' ARG . 52.0 pttt -126.8 141.67 51.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' ILE . 77.0 mt -119.0 140.18 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 109.489 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' NH1' ' HE3' ' A' ' 6' ' ' LYS . 62.6 mtt180 -116.92 137.35 52.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.465 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 8' ' ' ARG . 24.1 mm -112.46 133.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HG2' ' CD1' ' A' ' 53' ' ' LEU . 78.4 mttt -109.22 133.89 52.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.553 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 23' ' ' ALA . 16.0 mt -112.83 133.23 54.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 77.6 mttt -122.73 131.45 53.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 0.0 109.463 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -161.86 144.97 12.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.3 -36.39 83.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.873 . . . . 0.0 109.472 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -99.08 116.74 32.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.542 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 15.4 p80 -60.3 -46.22 90.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 16' ' ' HIS . 86.9 tt0 -53.91 -46.55 71.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.219 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 18' ' ' LEU . 3.4 tm? -61.96 -40.59 96.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.225 -0.922 . . . . 0.0 108.804 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 19' ' ' LEU . 6.5 tt -67.51 -32.8 73.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 108.931 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' OD1' ' NH1' ' A' ' 52' ' ' ARG . 91.3 m-20 -63.64 -39.54 94.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.438 -0.789 . . . . 0.0 109.325 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 76.3 mm-40 -64.58 -49.5 70.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.44 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 37.2 m -58.89 -45.71 89.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 11' ' ' LEU . . . -62.62 -51.42 67.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -57.78 -45.51 85.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 29' ' ' VAL . 49.5 mttm -59.76 -46.24 89.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.348 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 22' ' ' SER . 97.2 mt -64.2 -41.14 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.442 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.517 HG13 ' HE3' ' A' ' 31' ' ' LYS . 77.7 t -61.13 -46.31 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.43 -41.26 96.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 70' ' ' ILE . 38.6 t -72.59 -39.97 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.499 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.973 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -65.64 -46.56 78.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HE3' HG13 ' A' ' 27' ' ' VAL . 50.0 mttt -59.56 -37.3 78.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -57.42 -30.79 65.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.2 p -76.35 163.82 26.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.52 -34.16 70.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.6 p -62.85 157.66 20.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -111.84 146.57 37.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.431 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.973 HG21 ' CB ' ' A' ' 30' ' ' ALA . 42.7 t -123.66 141.02 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 55' ' ' ASP . 21.3 t -116.79 138.81 51.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.08 -150.06 17.13 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.31 143.95 76.4 Favored 'Cis proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.67 -1.804 . . . . 0.0 111.844 -0.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.4 mt -95.7 126.62 44.54 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.374 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.84 136.78 33.64 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.634 2.223 . . . . 0.0 111.827 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.7 HD13 ' HB2' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -120.81 175.62 2.27 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 109.522 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 50.6 Cg_endo -70.84 138.57 34.68 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.695 2.264 . . . . 0.0 111.707 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.584 HG21 ' ND1' ' A' ' 50' ' ' HIS . 21.7 p -91.14 162.75 14.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 48' ' ' ARG . 71.9 tt0 -126.66 126.34 43.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.537 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m 54.46 -88.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 46' ' ' GLU . 14.4 mtp180 -140.2 34.94 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 45' ' ' THR . 55.3 t -128.74 134.59 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.88 . . . . 0.0 109.568 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.584 ' ND1' HG21 ' A' ' 45' ' ' THR . 62.2 m-70 -102.91 148.97 24.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -135.54 141.3 45.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.611 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.562 ' CD ' HD22 ' A' ' 19' ' ' LEU . 19.8 mtp180 -123.92 152.05 42.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.893 . . . . 0.0 109.292 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HB2' HD13 ' A' ' 43' ' ' LEU . 27.1 tp -121.64 130.7 53.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 109.611 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 66.0 mt -118.49 125.82 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.922 . . . . 0.0 109.381 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 86.9 m-20 -89.79 142.46 27.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.515 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ILE . 61.8 mt -119.5 131.06 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 0.0 109.439 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.928 HG23 ' OG ' ' A' ' 1' ' ' SER . 70.4 mt -109.7 139.39 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.23 63.92 9.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.1 Cg_endo -69.5 144.67 56.2 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.763 2.309 . . . . 0.0 111.748 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 1.6 m -132.69 166.5 28.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.47 -25.66 41.3 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.707 2.271 . . . . 0.0 111.7 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -63.57 -25.65 68.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.155 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.4 m -67.36 -43.72 80.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.183 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.53 -43.32 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.247 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 57.1 t0 -54.13 -43.28 70.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.313 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -63.55 -40.13 96.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 70' ' ' ILE . 28.5 tp -59.16 -41.07 87.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 75.3 mtm -64.58 -35.18 80.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.206 -0.934 . . . . 0.0 109.408 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -70.57 -27.27 63.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.387 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.692 ' CD1' HG21 ' A' ' 29' ' ' VAL . 71.2 mt -107.32 132.92 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.466 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -108.17 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.524 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.71 141.3 97.11 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.08 151.38 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.669 2.246 . . . . 0.0 111.862 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.7 147.71 31.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.37 58.45 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' LYS . 88.4 t -125.62 148.15 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -1.201 . . . . 0.0 109.472 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 51.1 t0 -134.58 155.3 50.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 24.0 m -132.68 148.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -105.95 146.52 29.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.504 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.457 HG12 ' HG3' ' A' ' 81' ' ' LYS . 13.4 tt -122.52 133.89 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.463 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HG3' HG12 ' A' ' 80' ' ' ILE . 61.1 mttm 61.17 44.03 10.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.9 tp . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.472 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.5 mtp -58.53 -35.55 72.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 109.415 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 96.44 -7.17 65.99 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.7 -30.21 59.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -75.14 141.12 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -128.0 145.5 50.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' HD12 ' A' ' 56' ' ' ILE . 73.0 mt -111.97 137.5 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.378 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HB3' HD21 ' A' ' 53' ' ' LEU . 57.7 mtm180 -122.96 135.5 54.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.518 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.8 mt -116.01 137.74 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' C ' HD12 ' A' ' 11' ' ' LEU . 11.4 tttp -110.25 128.83 55.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.811 HD12 ' N ' ' A' ' 11' ' ' LEU . 4.5 mp -112.6 120.65 42.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.254 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.488 ' HE3' ' HD3' ' A' ' 51' ' ' LYS . 28.5 mtpt -116.6 138.75 51.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.815 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -170.41 152.66 4.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.418 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.51 -36.01 73.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.931 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' OD2' ' HG ' ' A' ' 18' ' ' LEU . 50.6 t0 -93.13 114.3 26.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.58 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 6.5 p80 -67.14 -28.37 68.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' OE2' ' CE1' ' A' ' 16' ' ' HIS . 66.3 mm-40 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.895 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 57.9 mt -64.1 -38.26 90.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 13' ' ' ALA . 60.1 mt -70.46 -34.52 72.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.514 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -63.92 -42.88 97.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -42.8 73.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.4 m -64.85 -38.62 91.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.417 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.81 -41.33 78.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.478 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -60.4 -46.85 88.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.518 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.907 ' O ' HG23 ' A' ' 29' ' ' VAL . 17.7 mtmm -60.9 -45.55 94.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.519 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 22' ' ' SER . 84.8 mt -65.03 -44.98 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.267 -0.896 . . . . 0.0 109.519 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 23' ' ' ALA . 72.6 t -59.59 -48.19 88.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.524 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.17 -44.24 97.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 25' ' ' LYS . 18.5 t -68.11 -40.49 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.545 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.43 81.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.487 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -56.36 -38.16 71.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.589 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m -57.91 -32.34 67.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 62' ' ' LYS . 23.9 m -74.31 152.25 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -50.32 -31.13 13.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 51.7 p -68.98 156.64 38.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -107.41 148.03 29.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.41 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -121.49 147.78 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 66.8 m -124.08 144.74 49.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.537 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.05 -155.09 16.34 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.41 140.61 63.58 Favored 'Cis proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.702 -1.791 . . . . 0.0 111.792 -0.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 10.1 mt -91.03 131.01 38.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.314 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.94 118.81 5.89 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.664 2.243 . . . . 0.0 111.927 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 44' ' ' PRO . 13.9 mt -94.55 166.66 14.8 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.371 -0.831 . . . . 0.0 109.529 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 46.3 Cg_endo -67.66 143.66 62.99 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 111.604 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 49' ' ' VAL . 36.6 m -85.76 142.93 28.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.958 . . . . 0.0 109.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -138.99 138.0 36.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 109.443 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 49' ' ' VAL . 13.5 p 45.87 49.39 11.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 109.392 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.04 36.83 27.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 47' ' ' SER . 50.0 t -123.15 132.35 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 109.521 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 16' ' ' HIS . 97.6 m-70 -98.76 145.23 27.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.445 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 9.0 mtmm -135.98 151.09 49.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -127.41 147.94 50.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -122.02 131.16 53.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.68 ' N ' HD23 ' A' ' 53' ' ' LEU . 66.8 mt -120.53 117.39 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 83.8 m-20 -89.05 145.36 25.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' HB ' ' A' ' 7' ' ' ILE . 68.7 mt -124.22 122.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -104.34 144.16 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.453 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 10.6 t0 47.69 62.66 11.57 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.553 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.419 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.7 Cg_endo -70.41 148.88 61.81 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.73 2.287 . . . . 0.0 111.716 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.421 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -137.18 167.86 19.11 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 109.526 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 60' ' ' SER . 45.7 Cg_endo -67.39 -25.86 41.64 Favored 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 122.685 2.256 . . . . 0.0 111.673 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB2' HG23 ' A' ' 33' ' ' THR . 67.4 mttm -64.23 -26.11 68.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.131 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.0 m -68.83 -42.42 77.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.26 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.56 -44.39 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.573 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 58.5 t0 -55.91 -41.82 75.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.61 84.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' ILE . 21.2 tp -61.38 -40.21 93.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.514 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.573 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.6 mtm -67.7 -34.48 76.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -71.23 -29.49 65.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.545 ' CD1' HG21 ' A' ' 29' ' ' VAL . 69.3 mt -108.94 133.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.442 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -116.54 123.45 47.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.82 150.62 26.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.08 148.65 63.43 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.628 2.219 . . . . 0.0 111.742 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.31 153.09 31.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.954 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.11 8.57 55.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.1 t -128.62 147.85 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -1.19 . . . . 0.0 109.472 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 89.9 m-20 -112.82 150.59 31.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -132.97 143.31 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.441 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' O ' HD13 ' A' ' 80' ' ' ILE . 84.2 tt0 -99.08 136.95 38.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.559 HD13 ' O ' ' A' ' 79' ' ' GLU . 24.7 mm -117.23 127.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.927 . . . . 0.0 109.502 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -58.55 -37.84 76.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 0.0 109.489 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 82' ' ' LEU . 7.3 tt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.6 mtp -125.55 158.49 34.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.09 -123.42 23.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.62 -3.09 65.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD ' ' A' ' 59' ' ' PRO . 64.7 tt0 -100.2 126.58 46.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -1.221 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -132.49 143.22 49.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.461 HG13 ' HG3' ' A' ' 59' ' ' PRO . 79.9 mt -116.96 138.89 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 91.9 mtm-85 -119.71 136.74 54.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.583 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 74.0 mt -114.11 131.97 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.405 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' HD13 ' A' ' 53' ' ' LEU . 68.3 tttt -97.6 125.5 42.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.6 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.824 ' HB3' HD11 ' A' ' 19' ' ' LEU . 44.3 mt -107.34 130.82 54.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 109.276 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 5.4 mtmp? -131.04 134.15 46.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 19' ' ' LEU . . . -163.62 144.46 8.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.408 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' CD1' HG22 ' A' ' 49' ' ' VAL . 95.9 m-85 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' OD2' HD13 ' A' ' 18' ' ' LEU . 54.1 t0 -95.45 119.48 34.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 50' ' ' HIS . 56.1 p-80 -61.6 -40.27 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 95.0 mt-10 -51.42 -52.26 47.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 18' ' ' LEU . 8.3 mp -59.24 -43.94 92.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.205 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 11' ' ' LEU . 12.7 tp -65.58 -29.98 70.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.323 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' OD1' ' NE ' ' A' ' 52' ' ' ARG . 90.4 m-20 -67.3 -41.24 85.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 98.8 mt-10 -69.91 -35.45 74.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.128 -0.982 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 26' ' ' ILE . 18.2 m -63.31 -40.22 96.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.919 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -70.2 -36.58 74.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.582 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 15.6 tttp -66.71 -39.74 88.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 29' ' ' VAL . 67.1 mttm -65.2 -44.04 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 22' ' ' SER . 26.4 mm -69.49 -39.55 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 23' ' ' ALA . 78.7 t -62.2 -43.52 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 98.1 mt-10 -64.75 -38.42 90.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.583 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 25' ' ' LYS . 41.2 t -71.58 -40.82 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.95 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 37' ' ' VAL . . . -65.78 -46.81 77.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.53 -38.95 82.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.8 m -59.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 29' ' ' VAL . 26.0 p -77.93 163.65 25.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.938 . . . . 0.0 109.553 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -55.91 -36.07 67.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 55.7 p -66.47 157.95 30.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -111.91 147.76 35.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 30' ' ' ALA . 6.1 p -116.72 147.36 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.532 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -124.37 144.24 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 119.15 -154.15 16.58 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 50.1 Cg_endo -70.15 143.18 73.83 Favored 'Cis proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.733 -1.778 . . . . 0.0 111.738 -0.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mp -93.7 127.2 46.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.42 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.82 137.31 32.1 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.685 2.257 . . . . 0.0 111.849 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 53' ' ' LEU . 0.5 OUTLIER -127.57 175.83 3.1 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.344 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 43' ' ' LEU . 49.0 Cg_endo -68.94 141.18 47.86 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.615 2.21 . . . . 0.0 111.751 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 49' ' ' VAL . 16.0 p -95.45 162.22 13.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 48' ' ' ARG . 96.9 mt-10 -123.15 128.94 50.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.396 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.2 t 51.56 -90.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' GLU . 27.2 mmm180 -138.08 32.22 2.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 14' ' ' TYR . 44.4 t -122.7 130.65 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 16' ' ' HIS . 99.5 m-70 -88.99 148.79 23.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.408 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' HE3' ' CE ' ' A' ' 10' ' ' LYS . 51.6 mtpt -126.02 128.61 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.801 ' C ' HD22 ' A' ' 53' ' ' LEU . 36.4 mtt-85 -126.46 144.31 50.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.801 HD22 ' C ' ' A' ' 52' ' ' ARG . 4.0 mm? -121.16 139.95 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.909 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.657 HD11 HD11 ' A' ' 11' ' ' LEU . 66.5 mt -122.44 122.28 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 85.0 m-20 -93.0 144.9 24.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.846 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.0 mt -123.75 129.72 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 109.237 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' OD1' ' A' ' 58' ' ' ASP . 65.4 mt -107.66 141.97 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.895 . . . . 0.0 109.689 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER 46.84 61.43 13.44 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.461 ' HG3' HG13 ' A' ' 7' ' ' ILE . 50.0 Cg_endo -70.01 142.79 47.73 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.665 2.243 . . . . 0.0 111.699 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.419 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -126.76 168.05 15.67 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.558 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 45.4 Cg_endo -67.23 -27.67 40.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.686 2.258 . . . . 0.0 111.619 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -62.62 -25.99 68.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.1 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 m -68.19 -43.51 77.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.241 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.42 -41.76 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -0.921 . . . . 0.0 109.335 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -56.53 -44.1 80.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.119 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.07 -35.57 80.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.293 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 tp -63.75 -27.38 69.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.296 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.7 mtm -82.1 -29.06 31.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -0.874 . . . . 0.0 109.187 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -76.9 -22.83 52.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.5 mt -119.19 132.34 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.376 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -107.19 138.29 43.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.522 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 148.32 61.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.76 145.88 58.53 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.619 2.212 . . . . 0.0 111.817 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.45 150.01 32.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.68 10.0 58.23 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.18 148.77 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 90.1 m-20 -122.22 147.26 46.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.419 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -113.69 130.46 56.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 82' ' ' LEU . 71.7 mt -124.77 131.89 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.44 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -57.72 -34.94 70.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.558 ' H ' HG22 ' A' ' 80' ' ' ILE . 51.1 mt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 1' ' ' SER . 1.2 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.311 0.577 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -58.03 -34.72 70.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.41 9.64 62.96 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.83 8.66 65.29 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -111.14 145.41 38.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -1.165 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -134.5 151.39 51.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.6 mt -117.21 138.59 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.34 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 69.9 mtm180 -121.54 135.66 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' HD12 ' A' ' 53' ' ' LEU . 69.8 mt -118.03 135.89 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.187 -0.946 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.773 ' HE3' HD23 ' A' ' 82' ' ' LEU . 84.0 mttt -104.36 137.12 42.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 78' ' ' VAL . 14.1 mt -106.07 136.26 46.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.376 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 42.8 mttp -117.68 129.35 55.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.552 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.892 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -167.11 143.22 4.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -62.62 -39.46 93.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB3' HD13 ' A' ' 18' ' ' LEU . 50.2 t0 -95.07 120.42 35.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 0.0 109.499 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.57 ' HB2' ' CG ' ' A' ' 50' ' ' HIS . 47.1 t-80 -65.6 -35.43 80.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.433 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -56.37 -39.91 73.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.2 mp -63.36 -40.63 97.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.421 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.892 HD21 ' CB ' ' A' ' 13' ' ' ALA . 50.3 mt -62.6 -39.8 94.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -61.41 -46.19 91.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -62.83 -50.74 69.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.405 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.7 p -57.51 -43.95 84.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.573 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -62.87 -50.11 72.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.462 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -56.67 -40.49 75.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 29' ' ' VAL . 32.8 tttp -61.19 -49.34 77.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.897 . . . . 0.0 109.507 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.8 mm -67.6 -39.84 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 23' ' ' ALA . 73.1 t -57.2 -46.69 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.77 -41.0 94.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.963 HG21 ' CD1' ' A' ' 70' ' ' ILE . 35.1 t -72.08 -39.76 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.92 -46.86 73.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -59.73 -40.09 86.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 86.0 p -60.56 -26.97 67.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' VAL . 23.7 p -81.99 162.58 22.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.453 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.481 ' HG ' ' HG ' ' A' ' 60' ' ' SER . 41.9 m -66.87 147.01 53.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.285 -0.885 . . . . 0.0 109.627 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.8 mttt -102.64 147.03 27.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.32 150.71 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 2.9 t -129.32 142.17 50.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 40' ' ' PRO . . . 124.12 -150.84 17.06 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HB3' ' HB1' ' A' ' 23' ' ' ALA . 52.1 Cg_endo -71.21 141.07 68.26 Favored 'Cis proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.675 -1.802 . . . . 0.0 111.727 -0.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -92.5 131.12 35.03 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.395 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.62 120.31 7.14 Favored 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 122.709 2.273 . . . . 0.0 111.923 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 53' ' ' LEU . 14.6 mt -93.36 166.99 14.94 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.357 -0.839 . . . . 0.0 109.542 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.503 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 44.0 Cg_endo -66.76 132.11 27.68 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.749 2.3 . . . . 0.0 111.595 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' VAL . 40.0 m -83.99 151.09 25.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' C ' ' HG ' ' A' ' 47' ' ' SER . 80.5 tt0 -123.99 127.18 47.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.566 ' HG ' ' C ' ' A' ' 46' ' ' GLU . 98.4 p 49.39 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -0.945 . . . . 0.0 109.521 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLU . 95.9 mtt180 -135.14 21.35 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HG23 ' A' ' 45' ' ' THR . 49.9 t -111.36 131.07 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.446 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.627 ' O ' HD11 ' A' ' 19' ' ' LEU . 68.7 m80 -105.73 147.02 29.03 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 9.6 mtmt -134.97 155.83 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.616 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' LYS . 31.8 mtp85 -130.04 151.68 50.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.302 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.743 HD13 ' HG2' ' A' ' 10' ' ' LYS . 36.8 tp -124.33 131.55 53.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.595 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 67.7 mt -117.12 123.84 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.445 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 37.7 t0 -89.95 137.38 32.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -0.885 . . . . 0.0 109.633 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.7 mt -117.27 130.39 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.1 mt -111.85 138.4 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.684 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 52.41 61.32 12.03 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.41 137.37 33.41 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.649 2.232 . . . . 0.0 111.792 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.496 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -129.15 172.73 6.63 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 109.448 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 60' ' ' SER . 44.8 Cg_endo -67.61 -25.28 40.79 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.68 2.253 . . . . 0.0 111.542 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.11 -26.13 67.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -72.34 -39.19 68.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.329 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.61 -42.63 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.326 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.548 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 87.5 m-20 -61.43 -43.31 99.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.353 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB1' ' CG1' ' A' ' 29' ' ' VAL . . . -66.61 -37.44 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.361 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 70' ' ' ILE . 27.4 tp -63.47 -39.71 95.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.405 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 59.2 mtm -68.31 -32.13 72.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -73.76 -29.07 62.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -0.872 . . . . 0.0 109.508 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.963 ' CD1' HG21 ' A' ' 29' ' ' VAL . 73.2 mt -109.39 135.53 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 0.0 109.47 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.556 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 pp -61.58 150.94 79.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.411 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HG2' HG21 ' A' ' 76' ' ' VAL . 49.2 Cg_endo -69.89 147.57 62.31 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.662 2.241 . . . . 0.0 111.799 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.35 146.93 32.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.434 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.93 69.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG21 ' HG2' ' A' ' 73' ' ' PRO . 47.1 t -127.82 148.58 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.526 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 78' ' ' VAL . 33.0 t0 -138.04 153.04 49.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.478 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG12 ' CD2' ' A' ' 11' ' ' LEU . 25.6 m -143.07 147.36 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.418 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -114.63 127.09 55.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.4 mm -65.28 -39.57 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 109.518 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.499 ' O ' HD12 ' A' ' 82' ' ' LEU . 26.0 mttm -60.41 -34.76 74.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.773 HD23 ' HE3' ' A' ' 10' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 88.4 mtp -59.07 -34.99 72.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.37 -178.21 31.21 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.94 -72.61 1.2 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -115.86 154.71 29.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -1.164 . . . . 0.0 109.511 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -109.33 144.43 37.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 59' ' ' PRO . 69.1 mt -114.7 136.7 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 55' ' ' ASP . 45.0 mtm180 -122.85 136.8 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.45 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 53' ' ' LEU . 83.0 mt -113.26 133.28 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' CE ' ' HE3' ' A' ' 51' ' ' LYS . 18.2 tttt -103.13 121.46 42.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' LYS . 50.3 mt -104.05 126.37 51.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.469 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE2' ' HE2' ' A' ' 10' ' ' LYS . 36.4 mttt -121.72 137.63 54.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.333 -0.854 . . . . 0.0 109.415 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.78 ' CB ' HD21 ' A' ' 19' ' ' LEU . . . -168.72 146.05 3.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -51.57 -52.17 49.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.14 130.26 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.249 -0.907 . . . . 0.0 109.536 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.581 ' HB3' ' CG ' ' A' ' 50' ' ' HIS . 56.5 p-80 -74.9 -28.88 60.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.878 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -61.78 -37.89 86.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.36 -36.1 83.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.78 HD21 ' CB ' ' A' ' 13' ' ' ALA . 70.9 mt -69.94 -36.42 75.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.925 . . . . 0.0 109.41 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.67 -41.39 88.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.45 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.03 -43.17 83.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 26' ' ' ILE . 84.2 p -66.26 -35.81 81.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.354 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -68.61 -38.76 80.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.324 -0.86 . . . . 0.0 109.429 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -61.13 -44.54 97.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.619 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.2 mttm -61.22 -45.72 93.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.448 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 22' ' ' SER . 29.2 mm -65.73 -41.58 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 23' ' ' ALA . 79.2 t -61.8 -44.42 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.97 -47.26 78.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 25' ' ' LYS . 34.1 t -67.44 -43.38 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.86 ' CB ' HG21 ' A' ' 37' ' ' VAL . . . -63.23 -47.06 84.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.444 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -55.74 -39.52 71.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.6 m -56.05 -31.66 63.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.419 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.4 p -78.04 162.21 26.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -57.49 -29.03 63.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.382 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 26.3 t -69.85 148.3 49.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -107.57 150.29 27.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.147 -0.971 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.86 HG21 ' CB ' ' A' ' 30' ' ' ALA . 41.7 t -122.08 140.93 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 t -117.86 141.75 48.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.84 -149.36 16.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.24 145.85 81.6 Favored 'Cis proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.75 -1.771 . . . . 0.0 111.878 0.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 53' ' ' LEU . 2.6 mp -94.26 125.17 53.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.338 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.85 118.15 5.54 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.077 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 44' ' ' PRO . 12.5 mt -97.89 168.25 10.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.266 -0.897 . . . . 0.0 109.568 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 43' ' ' LEU . 46.5 Cg_endo -68.33 147.99 73.0 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.721 2.281 . . . . 0.0 111.67 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.683 HG21 ' CD2' ' A' ' 50' ' ' HIS . 18.8 p -102.67 162.44 12.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.537 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 48' ' ' ARG . 96.8 mt-10 -128.7 128.31 43.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 m 54.51 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 109.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 46' ' ' GLU . 92.6 mtt180 -142.88 33.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 109.518 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' O ' ' HB ' ' A' ' 45' ' ' THR . 48.6 t -123.2 130.16 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 69.8 m80 -103.39 149.2 25.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.932 . . . . 0.0 109.467 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.5 mtmt -137.02 144.41 43.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.599 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -124.71 152.08 44.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.4 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -125.97 135.0 51.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.488 ' CG2' ' CG1' ' A' ' 37' ' ' VAL . 67.1 mt -121.07 124.58 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 87.1 m-20 -90.3 145.15 25.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.1 mt -126.82 125.55 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -106.97 139.71 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.654 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' SER . 3.6 t70 53.19 62.23 10.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 109.636 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HG3' HG13 ' A' ' 7' ' ' ILE . 49.8 Cg_endo -70.21 141.33 43.14 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.753 2.302 . . . . 0.0 111.67 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.49 166.59 22.14 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.08 -21.74 42.32 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.663 2.242 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -67.67 -25.49 65.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.113 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 m -70.59 -42.46 70.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.82 -42.02 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.329 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.538 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 86.2 m-20 -57.59 -45.56 85.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.75 84.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' ILE . 3.8 tp -63.7 -40.45 96.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.437 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 65' ' ' ASP . 71.2 mtm -66.98 -29.95 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.89 . . . . 0.0 109.402 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -74.59 -29.26 61.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 109.414 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 67' ' ' LEU . 68.1 mt -110.11 136.62 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.21 134.9 42.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -61.76 149.32 85.35 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD2' HD23 ' A' ' 72' ' ' LEU . 48.7 Cg_endo -69.77 141.04 44.12 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.685 2.257 . . . . 0.0 111.758 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.86 149.77 49.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.7 9.15 56.68 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.79 142.05 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -1.113 . . . . 0.0 109.427 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -110.89 151.42 27.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.18 142.54 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.27 145.53 29.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 82' ' ' LEU . 66.9 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -60.92 -34.69 75.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.484 ' H ' HG22 ' A' ' 80' ' ' ILE . 27.2 tp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.48 -179.962 . . . . . . . . 1 1 . 1 stop_ save_